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Abbreviations 
bs broad singlet 
13 
C  n.m.r. carbon-13 nuclear magnetic resonance 
d doublet 
dd doublet of doublets 
B extinction coefficient 
h hours 
1 
H n. m. r. proton nuclear magnetic resonance 
i. r. infra-red 
J coupling constant 
max 
wavelength of maximum absorption 
lit, literature 
m multiplet 
m/e mass to charge ratio 
M. P. melting point 
M+ molecular weight 
P. p_ M. parts per million 
5 chemical shift 
s strong (i. r.), 	singlet (1H n. m. r.) 
t triplet 
U. V. ultra-violet 
max 	
frequency of maximum absorption 
The configuration of the hydrogen atoms at the ring junctions 
of the steroids will be 5a, 813,  9a, and 14a, unless otherwise specified. 
In the diagrams the configurations are shown as follows: 
A solid line indicates a P -configuration. 
A broken line indicates an a- configuration. 























The naming of steroids with heterocyclic rings fused to the 
nucleus of the steroid, the syntheses of some of which are described 
in this present work, is somewhat complicated. The steroid fragments 
of these compounds have been named in accordance with ITJPAC rules 
whilst the heterocyclic systems have been named after the analogous 
heterocyclic systems prepared by the condensation of simple aliphatic 
3-dicarbonyl compounds and various aminoazoles, and by the condensation 
of a-halo carbonyl compounds with 2-mercaptoimidazoles and 3-mercapto-
1, 2,4-triazoles. This procedure can be justified by the similarity in 
the properties of steroid heterocycles and the simple model compounds. 
Thus, since structure (69) is known as s-triazolo[1, 5-a]pyrimidine, 
the steroid (210) has been assigned the name 17-hydroxy-17 a-methyl- 
5 a-androstano[3, 2-f]- s-triazolo[l, 5-a]pyrimidine. 	[3, 2-f] describes 
the fusion of the steroid fragment to the pyrimidine ring of the s-triazolo-
[1, 5-a]pyrimidinium fragment. Similarly the steroid (211) has been 
named as 173-hydroxy-17a-methyl-5a-androst-2-eno[2, 3-g]-s-triazolo-
[1, 5-a]pyrirnidine. 
Structure (74) is known as thiazolo[3, 2-b]-s-triazole and the 
analogous steroid (353) has been given the name, 17-hydroxy-17a- 
methyl-5a-androst-2-eno[2, 3-f]thiazolo[3, 2-b]-s-triazole. 	[2, 3-f] 
describes the fusion of the steroid fragment to the thiazole ring of the 
thiazolo[3, 2-b]-s-triazole fragment. 
A RSTR ACT 
The work contained in this thesis describes some of the many 
possible condensation reactions which take place between steroidal p-
ketoaldehydes and aminoazoles; in all ten examples of p-dicarbonyl 
steroids were variously condensed with ten representative aminoazoles. 
Also reported are the reactions which are observed between steroidal 
a.-bromo ketones and mercaptoazoles; nine examples of niercaptoazoles 
were used in conjunction with four steroids to illustrate these particular 
reactions. Throughout the above reactions, satisfactory mechanisms 
have been proposed to account for the observed products. 
It is shown that when 2-amino- 1, 3, 4-thiadiazole is condensed with 
1,2-hydroxymethylene-3-oxo steroid, the product resulting from the 
cyclisation reaction, namely 2 -thiocyanato-5ct-androst-2-eno[3, 2-d]pyrimi-
dine, contains a thiocyanato group formed by cleavage of the thiadiazole 
ring. A more typical reaction is observed during the condensation of 3-
aminopyrazole with a 2-hydroxymethylene-3-oxo steroid. The reaction 
products are the linearly fused heterocycle, 5a-androstano[3,2-f]pyrazolo-
[1, 5_a]pyrimidine and the angularly fused isomer, 5a-androst-2-eno[2, 3- g]- 
pyrazolo[1, 5-a]pyrimidine. 
The observance of two products from this type of condensation reaction 
appears to be quite general, however, the actual ratio of linearly fused to 
angularly fused isomer is found to be dependent upon the aminoazole as well 
as the steroid employed in the reaction. Condensation involving 2-hydroxy- 
methylene-Lx4-3-oxo steroids and 16-hydroxymethylene-17-oxo steroids 
always result in a single reaction product. 
During the reaction between 3-amino-5-methylthio- 1, 2, 4-triazole 
and 1 6-hydroxymethylene -17 -oxo steroids, the intermediate -ketoanils 
were isolated. These intermediates could be cyclised to the angularly 
fused triazolopyrimidine s. p-Ketoanils, independently prepared from 2-
hydr oxymethylene -3- oxa steroids and 2- aminopyridine, have been shown 
to react with various aminoazoles to afford linearly fused heterocyclic 
products and these observations lend support to the reaction mechanism 
proposed for the general condensation reaction. The linearly fused con-
densation products were distinguished from the angularly fused isomers 
with the help of i. r. , u. v. , 1 H n. m. r. and 
13
C n. m. r. spectroscopy. 
The reaction of various aminoazoles with 4, 4-dimethoxybutan- 2- one, 
2 -hydr oxymethylenec yclohexanone, 2 -hydr oxymethylenec yclopentanone and 
their corresponding 13-ketoanils obtained by the reaction of these -keto-
aldehydes with 2-aminopyridine, has also been investigated. 
The reaction of 2-mercaptoimidazoles and 3-mercapto-1, 2, 4-tria-
zoles with 2a-bromo-3-oxo steroids gave the expected cyclised products 
5a-androst-2-eno[2, 3-b]imidazo[2, 1-bjthiazoles and 5a_androst-2-eno[2, 3-f]-
thiazolo[3, 2-b]-s-triazoles respectively. However, the reaction of 2-
mercaptoimidazole with 2a.-bromo-5a-c hole stan-3-one in ethanol gave 5a.-
chole stano[2, 3 -b]-3 p-ethoxy- 2', 3' _dihydroimidazo[2, 1 -b]thiazole in addition 
to the expected cyclised product. The reaction of 3-mercapto-1,2,4-
triazoles with 16a._bromo_3_methoxyoestra-1,3,5(10)-triefl-17-one gave 




The study of structural modification of steroidal compounds, 
the scope of which is unequalled in any other branch of medicinal 
chemistry, has the aim of finding more active and more specific steroidal 
pharmaceutical preparations, free from harmful side action. Among 
the many known analogues of the steroids, a special place is occupied 
by heterocyclic derivatives, the synthesis of which is linked with the 
hope of obtaining compounds which exhibit instead of the ordinary 
hormonal action, completely different types of physiological activity- 
anabolic, anti-inflammatory, hypotensive, anti-tumor, etc. 
The heterocyclic derivatives of steroids can be divided into two 
groups, the first of which includes compounds containing the hetero- 
atom in the constitution of the cyclopentanoperhydrophenanthrene 
skeleton, and the second are the steroids with the normal carbon 
skeleton and heterocyclic substituents fused with it in some manner 
or other. The present work considers steroids with N and/or S atoms 
condensed with the steroid skeleton and having not less than two C 
atoms in common with it. 
Kockakian, in 1935, first observed that the androgens, the male 
sex hormones, possessed the ability to stimulate the synthesis of 
cellular protein, associated with the secondary male characteristic of 
muscle development. It was quickly appreciated that compounds with 
this property would provide valuable medications in the treatment of 
conditions involving abnormally low tissue protein content. However, 
the natural steroids which possess this anabolic effect were unacceptable 











virilising androgen effect. 
An assay of the relative anabolic and adrogenic ratio was 
developed by Eisenberg and Gordan3 and later modified by Herschberger 
et al. 4 Examination of the natural androgens showed that almost all 
had an anabolic/androgenic ratio of ca 1, 0, so that if strongly adrogenic 
they were also strongly anabolic but if only weak androgens, the 
anabolic effect was weak. The opinion of Kruskemper5 that "the 
androgenic effect differs from the anabolic effect only in its location and 
not in its essence, thus anabolic steroids which possess no androgenic 
character cannot exist" is not universally shared and anabolic steroids 
with no adrogenic action are still sought. 6 
The need for an anabolic agent with few or no androgenic or 
progestational side effects led to attempts to vary endocrine activity 
patterns by means of alteration within, or substitutions on the steroid 
nucleus. It was assumed by most workers in this field that the target 
receptors (enzyme systems, for example) at the sites of anabolic and 
androgenic activities differed sufficiently to make at least theoretically 
feasible the synthesis of a compound which would "fit" only one of these 
cellular receptor systems. In 1961, Clinton et al. in an attempt to 
alter the type or stability of receptor site bonding, by substituting an 
"aromatic" nitrogen for oxygen at 3-C position, prepared a series of 
5a-androstano[3. 2-c]pyrazoles (1) and their 	analogues (2) by the 
reaction of hydrazine or a substituted hydrazine with 173-hydroxy-2-
hydroxymethylene-5 cz-androstan-3--one (3) and 17-hydroxy-2-hydroxy-
methyleneandrost-4-en-3-one (4) respectively. The fusion of a 
coplanar pyrazole ring to the steroid nucleus leads to substitution of 
the 3-oxygen atom by nitrogen which changes the nucleophilic 
environment in this region. In this, there is a change in the 
distance between the active centres of the steroid molecule at 3-C 
and 17-C, since the length of the C=N bond is 	1.4X, the length of 
the C=O bond in the original ketone is 1. 2. This evidently shows some 
influence of the strength of the bond of the steroid molecule with the 
chelate receptors and can lead to selectivity in the reaction between 
the steroid and the receptor. 	Indeed the introduction of a [3, 2-c]- 
pyrazole ring on to a steroid was found to produce quite pronounced 
changes in endocrinological activity especially in the altered anabolic/ 
androgenic ratios and in the development of new types of activity. For 
example 1 7 -hydroxy- 17 a-methyl- 5 a- andro stan- 3-one has little clinical 
application as it is both anabolic and androgenic. The corresponding 
[3, 2-c]pyrazole (1, R=CH3) is 120 times more anabolic than its 
precursor. 	The high value of androstano[3, 2-c]pyrazoles as anabolic 
agents was also confirmed by the results of clinical tests. 
8 
 The 
compounds (1, RCH3) and (2, RCH3) are now manufactured on an 
industrial scale for use as oral anabolitics. 
Both anabolic and androgenic activities fall off abruptly in the 
17a-aLkyl-173_hydroxy-5a-androstano[3, 2-c]pyrazoles when the 17-
alkyl group is larger than ethyl indicating rather severe restrictions 
on "fit" to the cellular receptor site in the presence of the [3, 2-c]-
pyrazole ring. N-Methylation also decreased both androgenic and 
anabolic activities in comparison with the parent steroidal[3, 2-c]-
pyrazole, whilst acylation of the pyrazole ring imparted a low degree 
of estrogenicity to the androstano[3, 2-cjpyrazoles without affecting 






























The series of 173-hydroxyandrost-4-eno- and 17-hydroxy-
andro st-4, 6- dieno[3, 2-c]pyrazoles had anabolic /androgenic ratios 
comparable to their saturated analogues in 5a-androstano[3, 2-c]pyrazole 
7 
series. 
33-Hydroxy-5a-androstano-, 3-hydroxyandrost-5-eno- and 
3-methoxy-oestra-1, 3 5(10)-trieno[17,  16-c]pyrazoles (5) and (6) have 
been synthesised 
9 
 by the action of hydrazine hydrate on the corresponding 
l6-hydroxym ethylene- 17-ketones (7), (8) and (9) respectively but have 
been found not to exhibit any androgenic or anabolic activity. However 
a number of 5a-androstano- and androst-5-eno[17, 16_c]_5?_ methyl_ 
pyrazoles (10) synthesised from pregnan- and pregn-ene- 16, 20-diones 
(11) and hydrazine hydrate have been found to be useful as diuretic and 
anabolic steroids. 0 
Recently, cycloaddition of 31 -ac etoxypr egna- 5,16 -dien- 20-one 
with diazoacetic acid ester at 20 
0 
and 14000 atm has been reported to 
give 75% of a 3:2 mixture of pregnenopyrazolines (12) and (13). The 
pyrazoline (12) isomerisesto (13) in the presence of acids. 11 
It was shown by analogy with androstanopyrazoles that fusion 
of an isoxazole ring to the 2, 3-position of androstane also increases 
the anabolic activity and reduces the androgenic activity. 
12 
 The most 
interesting preparation of this class was 1-hydroxy-17a-methyl-5a-
androst-2-eno[2, 3-d]isoxazole (14, R=CH3) which in comparison with 
1 73-hydroxy- 17 a-methyl-5 a-androstan- 3-one exhibits 9. 7 times more 
anabolic, twice the miotropic, and 0. 24 times the androgenic activity. 13 
The androst-2-eno[2, 3-d]- and androstano[3, 2-c]isoxazoles (14) 








methylene-3-oxo steroids with hydroxylamine hydrochloride. The 
ratio of (15) to (14) depends upon the pH, the solvent and the temperature. 
Thus when the reaction was carried out in aqueous ethanol, 8% (15) and 
82% (14) were obtained, but in pyridine solution the composition of 
the mixture is the reverse - 91% (15) and 6% (14). 13, 14 Androstano-
[3, 2-c]isoxazoles (15) have also been synthesised by the reaction of 2-
cyano-3-oxo steroids with hydroxylamine hydrochloride in pyridine. 15 
4 	46 
The reaction of A -, ' -, and 4, 4-dimethyisteroids lead exclusively 
to [2, 3-d]isoxazoles, however these products exhibited lower activity 
of both types. 
13 
 Results have been obtained, 
16
on the presence of 
antitumour activity in the androst-4-.eno[2, 3-d]isoxazoles (16). 
Irradiation of 3-acetoxy-6-nitrocho1est- 5- ene has been recently 
reported 
17
to give cholestenoisoxazole (17, R=OAc) and A-norcholest- 
anoisaxazolinone (18, ROAc). Similarly 6 -nitrocholest- 5- ene upon 
irradiation gave (17, R=H) and (18, R=H). 
Androst-16-eno[16, 17-d1isoxazoles (19) were obtained by the 
condensation of 16 -hydroxymethylene- 17 -oxo steroids. 
18 
 The preparation 
of the isomeric androst- 16-eno[17, 16_d]_3t_methylisoxazole (20) has 
also been described. 19 
Steroidal[3, 2-d]thiazoles (21) have been prepared by boiling 
alcoholic solutions of 2a-bromo-3-oxo steroids of the androstane, 
pregnane and cholestane series with thiourea and its N-alkyl derivatives 20, 21 
and also with thioamides. 
21(b), 22-24
Reaction of 33-bromo-2-oxo 
steroids with thioamides gave the isomeric [2, 3-d]thiazole derivatives 
(22). 
25 
 High anabolic and low androgenic activity has been noted for 
both types of derivatives in the androstane series. 24, 25 
R 
H  
(29) RH,CH3I NH2  
H 













The reaction of 12-oxo-ll-thiocyanatosteroids (23) of the 
cholane and spirostane series with secondary amines in dioxaneledto 
2'-piperidinosteroido[12, 11-d]thiazoles (24) or the corresponding 2'-
morpholino-, 2' - piperazino- and 2 - diethylamino derivatives. The 
compounds obtained exhibit antihormonal activity. 26 
2'-Substituted [17, 16-d]thiazole derivatives (25) were obtained by 
heating 16 a-bromo-17-oxo steroids with thioacetamide or thiourea in 
ethanol. 27 
Various steroidal[3, 2-d]pyrimidines have been prepared by the 
well studied reaction of 2-hydroxymethylene- 5 a- androstan- 3-ones with 
guanidine, urea, and thiourea. 
15 
 2'  -Amino-, 2'-hydroxy- and 2'-
mercapto-derivatives (26) were obtained in this way. On treating the 
mercapto-derivative (26, RzSH) with Raney nickel, it was smoothly 
15 
converted into the unsubstituted derivative (26, RH). 	17f3-Hydroxy- 
17 a-methyl-5 a-androstano[3, 2-d]-- 2'-aminopyrimidine (27) has been 
found to decrease nitrogen excretion in male and female humans but 
to increase 17-oxo steroid excretion in the female and decrease it in 
the male. 
28 
 1 7-Hydroxy- 5 a-androst- 2- eno[3,  2-d]- 2', 6 '-diamino- 
pyrimidine and their 	analogue (28) have been prepared 29, 30 by the 
reactions of cyanoguanidine and 3-oxo steroids at 230 500.  These steroids 
have been reported to be androgenic and exhibit significant antibacterial 
activity against Gram-positive micro-organisms. 31 
The reaction of 16-hydroxymethylene-17-oxo steroids with tris-
formylaminome than e, acetamidine or cyanoguanidine gave the corres- 
ponding [17, 16-d]pyrimidines (29). 	[3, 2-d: 17, 16-d]Dipyrimidines (30) 
were obtained from 2, 16-bishydroxym ethylene -3, 17-bis oxo steroids by 

























the same methods. 3 1-34 
Greater variation in the substituents at the 2 and 6 positions in 
the pyrimidine ring has been obtained by the modification of 2-cyano-3-
oxo steroids prior to either reaction with ammonia or hydroxylamine, 
or cyclisation at high temperature. De Ruggieri et al. 3 	prepared 
a series of androst-2-eno{3, Z-d]-6'-amino-2'-hydroxypyrimidines (31) 
from 2-cyano-3-oxo steroids by conversion of the latter to the 2-cyano-
3-aminourethanoandrost-2-ene (32) in two stages followed by cyclisation 
at 1300  in an autoclave. This mode of synthesis was further developed 
35(b) 
by the same workers 	who having prepared an androstano[3,2-c]-5'- 
aminoisoxazole (33) by condensing hydroxylamine and 2-cyano-5a-androstan-
3-one, opened the isoxazole ring by hydrogenation to give the enamine (34), 
which was then treated with ethyl orthoformate to give the androst-2-
eno[3, 2_d]_6' -hydroxypyrimidine (35). The 1 71- 0-carbomethoxy 
derivative of this steroid has been prepared more recentl 6 by treatment 
of 2a, 1713-O-dicarbomethoxy-3 -ethoxyformimido-5a.-androst-2-ene (36), 
derived from Za, 17f3-O-dicarbomethoxy-5a-androstan-3-one, with a 
saturated ethanolic ammonia solution. Formation of the 5'-N-ethyl-
urethane derivative (37) of the steroidal[3,2_c]-51 _aminoisoxazole (33) 
followed by reduction to give the enamine (38) and then treatment with 
base yielded the androst- 2-eno[3, 2-c]-21 , 6' -dihydroxypyrimidine (39). 
N-Heterocyclic analogues of anabolic steroids with two ring 
systems are also known. The formation of quinoxaline derivatives of 
steroids on reaction with o-phenylenediamine served as a proof of the 
existence of a-dicarbonyl groupings in the molecule. Saturated a.-
diketones exist predominantly in the ketoenol form (41) and not in the 
Vk 
 
(/.3) X C[orBr 14Z I 
 
1, 








diketo form (40) and reacted with o-phenylenediamine only on fusion 
37 
up to 120? 	The same product [3, 4-b]quinoxaline (42) was also formed 
on boiling the 4-bromo- and 4-chioro-derivatives (43) with o-phenylene-
diamine in acetic acid. 38 
The preparation of quinoxaline derivatives (44) and (45) from 
2, 3-diketo, 
39 
 6, 7-diketo- 
40
steroids respectively has also been 
described. 
More recently androst- 1 6-eno[16, 17-b]quinoxalines (46) have 
been prepared in good yield by refluxing 33-hydroxy-16a-bromo-5a-
androstan-17-one and 3-acetoxy-16a.-bromoandrost-5- en- l7-one with 
o-ph.enylenediamine and 4, 5-dimethyl--o-phenylenediamine in xylene. 
The reaction of Za-bromo-5a-c hole stan-3- one, 2a-acetoxychole stan-3 - 
one, and 3 n-ac etoxy-Za, 3a- oxido- 5a-chole stane, with o-diphenylene - 
diamine or 3,4-dimethyl-1,2-phenylenediamine have been reported to 
give the chole stano[2, 3 -b]quinoxaline s (47). 41,42  
Bardoset al. 
43 
 prepared 1 7-acetoxy-5a-androst-3-eno[4, 3-g]-
2', 4'-diaminopteridine (48) which was found to be folic acid antagonist 
with lipid solubility, by heating 4-chior 0- 1 73-hydroxyandr ost-4- en- 3-
one in a mixture of absolute alcohol and acetic acid with the bisulphite 
of 2,4,5,6-tetraaminopyrimidine. The analogous [2,3_g]_2T,41_ 
diaminopteridine (49), synthesised from 2a.-bromo- 1 7-hydroxy-5a-
androstan-3-one, has oral anti-androgenic activity in rat and chick 
assays. Yonedaet al. 
44 
 developed an alternative synthesis of 17f3-
hydroxy-5a-androst-2-eno[2, 3- g]_2', 4'-diaminopteridine by fusing 
5-( 1, 2- diethoxyc arbonylhydra z.i n o)_ 2, 4, 6-triarninopyriniidine with 
17f3-hydroxy-3-morpholino-5a-androst-2-ene. The [2,3-g]-21-amino- 
(5k) 
ru 	3 
(53) RH. CH 
  
(51) X0) SJNH 
C5H5  
C0 H1  W= CH3,C2H5 , C5H5 
3,  
4'-hydroxypteridine derivative was similarly prepared. In a later 
paper, 45 the same authors describe improved methods of synthesis 
of pteridino steroids with a variety of substituents on the pteridine ring 
system. 




androstan-3-one (3) and 13-hydroxy-2-hydroxymethyleneandrost-4-en-3 - 
one (4) on condensation with 4-aminouracils in aqueous acetic acid gave 
173-hydroxy-5a-androst-2-eno[2, 3-g]- 1', 2', 3', 4'-tetrahydropyrido[2, 3-d]-
pyrimidine (50)46  and the iS' analogue 47  respectively. The analogous 
33-hydroxy-5ct-androst-16-eno[17, 16-fl-l',  2', 3', 4'-tetrahydropyrido-
[2, 3 -d]pyrimidine (51)48  was synthesised from the 16- aminomethylene-
17-oxo derivative of 33-hydroxy-16-hydroxymethy1ene-5a-androstan-17-
one (7). 
Steroidal pyrazolopyridines (52) and (53) have been prepared in 
38-75% yield by condensing aminopyrazoles with 17-hydroxy-2-hydroxy-
methyleneandro st-4-en-3 -one (4) and 3 -hydroxy- 16-hydroxymethylene-
5a-androstan-17-one (7) respectively. 49 
Steroids containing a bridgehead nitrogen atom 
There have been only two reports so far on the synthesis of 
steroids containing a bridgehead nitrogen. In 1951, Antaki and Petrow20  
reported the synthesis of 5a-chole stano[3, 2 -b]benzimidazo[1, 2-a]-
pyrimidine (54) by the reaction of 2-hydroxymethylene-5a-cholestan-3-
one with 2-aminobenzimidazole. However no evidence was given in 






(55) (5-H ore) RH,CH3  
( 57) (5a-H org) 
-I 
I  
Catsoulacas and Souli50 prepared steroidal imidazo[1, 2_a]-
pyridines (55) from 3-acetoxy-16a-bromo-5a-androstan-17-one, its 
A 	analogue and 2-aminomethylpyridine s. 
Recently, Burgess 
51 
 has described the synthesis of androstane 
derivatives with a pyrido[1, 2-a]pyrimidine ring system fused to the 
steroid nucleus. 1 73-Hydr oxy- 2- hydroxymethylene - 5- andr ostan- 3- 
one (3) and its 	analogue (4) condensed with 2-aminopyridine to give 
17p-hydroxy-2(2'-pyridyl-aminomethylene)-5a-androstan-3-one and its 
A 4 analogue (56). The 17-acetates of these enaminones (56) were 
cyclised in an acid catalysed reaction to give 17f3-acetoxy-5a.-androst-
2_ eno[2,3_e]pyr ido[1,2_a]pyrimidin 5Iium  iodide and its A  analogue 
(57, ROAc). 	17f3-Hydroxy-5a-androst-2-eno[2, 3-e]pyrido[1, 2-a]- 
pyrimidin-5'-ium iodide and its A  analogue (57, R=OH) were obtained 
in one step reaction when the corresponding 2-hydroxymethylene-3-oxo 
steroids were condensed with 2-aminopyridinium iodide. 
3-Hydroxy- 16-hydroxymethyleneandrost-5-en- 17-one reacted 
with 2- aminopyridine to give 3 P -hydr oxy- 16(2 T-pyridyl- aminomethylene)-
androst-5-en-17-one (58). It was not possible to obtain 3-hydroxy-
androst-5, 16-dieno[2,3-e]pyrido[l,2-a]pyrimidin-5'-ium iodide (59)by 
cycli.sation of the enaminone (58) or by the condensation of -ketoaldehyde 
(8) with 2-aminopyridinium iodide. 17-Acetoxy-5a-androst-2-eno-
[2, 3_e]_2t_methylpyrido[1,  2-a]pyrimidin-5 '-ium iodide (60) was isolated 
in very low yield from the condensation of 17-acetoxy-2a-acetyl-5a.-
andr o stan- 3-one (61) and 2 -aminopyr idinium iodide. However the 
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The synthesis of 17-hydroxy-l7cL-methyl-5cL-androst-2-eno-
[3, 2-d]-4'H-pyrido[l, 2-a]pyrirnidin-4'-one (62) and 17f3-hydroxy- 1 7a.-
methyl-5a-androst-2-eno[2, 3-e]-2'H-pyrido[l, 2-a]pyrimidin-2-one 
(63) has also been described. 
Schmidt reaction (HN3-BF3 ) of cholest-4-en-3, 6-dione has been 
recently reported 
52 
 to give a mixture of three isomers (64a)-(64c). 
Similarly the Schmidt reaction of 7-oxaspirost-5-en-3-y1 acetate and 
hec ogenin acetate gave azahomo Spiro stenotetrazole (65) and azahomo-
spirostanotetraz ole (66) respectively. 
The present work describes the 'synthesis of androstane 
derivatives in which the steroid nucleus is fused with one of the following 
ring systems which contain a bridgehead nitrogen: s-triazolo[4,3-b]-
pyridazine (67), pyrazolo[1,5-a]pyrimidine (68), s-triazolo[1,5-a]-
pyrimidine (69), tetrazolo[1, 5-a]pyrimidine (70), pyrimido[l,2-a]-
benzimidazole (71), imidazo[2, 1 -b]thiazole (72), thiazolo[3, 2 -a]benz-
imidazole (73) and thiazolo[3, 2-b]-s-triazole (74). The preparation 
of some steroidal heterocycles containing 2'-thiocyanatopyrirnidine ring 
fused to the steroid nucleus is also described. 
The condensation of 1,3-dicarbonyl compounds with substituted 
2-amino-1, 3, 4-thiadiazoles gave the expected fused bicyclic products 
(75) and (76). While examining reactions of this type Lauer and 
Zenchoff53 discovered that in the case of the parent compound (77), two 
distinctively different products could be obtained depending upon the 
type of 1,3-dicarbonyl compound employed. 
When 2, 4-pentanedione and 2-amino- 1, 3, 4-thiadiazole (77) were 
condensed in toluene at reflux in the presence of a catalytic amount of 
(75) 
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toluene -4- sulphonic acid, a single product was obtained in good yield. 
On the basis of spectroscopic and analytical data, the structure of this 
compound was ascertained to be that of 2-thiocyanato-4, 6-dimethyl-
pyrimidine (78). With ethyl acetoacetate as the 1, 3-dicarbonyl component, 
the same reaction conditions produced the bicyclic product (80) plus some 
of its monocyclic precursor (79), which was converted into 80) by prolonged 
refiux in toluene. In the case of diethylmalonate as the 1, 3-dicarbonyl 
component, it was necessary to use 1, 2, 4-trichlorobenzene at reflux as the 
reaction medium and the product was found to be the monocyclic compound 
(81) which could be converted into the anticipated bicyclic product (82) by 
subsequent exposure to toluene -4- sulphonic acid in refluxing toluene. On 
the basis of this limited data, it appears that the pathway leading to the 
thiocyan atop yriniidine (78) is unique to the f3-diketone type of 1, 3-dicarbonyl 
component, and the synthesis of steroidal pyrimidines is based upon this 
reaction. 
p-Ketoesters and 3-diketones react with 4-amino-1, 2,4-triazole (83) 
leading to s-triozolo[4, 3-b]pyridazine derivatives. 54-59 in general, the 
structure (84) was not unambiguously ascertained and 8-hydroxy-s-triazoio-
[4, 3-b]pyridazines (84) were assumed to result from the condensation of 4-
amino-1, 2, 4-triazole (83) with -ketoesters. This was proved to be correct 
for the condensation of aminotriazole (83) with ethyl acetoacetate, a reaction 
that afforded 6-methyl-8-hydroxy- s-triazolo[4, 3-b]pyridazine55 (84, R =CH 3, 
R =H) contrary to an earlier report. 60 
The reaction. of asymmetric 13-diketones with 4- amino- i, 2,4-triazole 
(83) which posed the problem of position isomerism has not been fully 
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and obtained a single product which he formulated as 8-phenyl-6-
methyl-s-triazolo[4, 3-b]pyridazine (85; R1  =CH3, R2=C 6H) without 
any proof of structure. Allen etal2d as well as Libermann and 
Jacquier 54 obtained 6-methyl-s -triazolo[4, 3-b]pyridazine (85; R1  CH 3, 
R2 =H) as the sole product from the reaction of 4-amino-1, 2, 4-triazole 
(83) and 4, 4-dimethoxybutaxi- 2-one (86). However it will be seen in 
section 9 that the reaction of the aminotriazole (83) with 4, 4-dimethoxy-
butan- 2-one (86) leads to a mixture of 6-methyl- and 8-methyl-s-triazolo-
[4, 3-b]pyridazine (85; R =CH 3, R
2 
 =H)and (85; RH, R2 =CH 3) 
respectively. 
The synthesis of s-triazoio[4, 3-b]pyridazine derivatives of steroids 
is based upon the reaction of 4-amino-1, 2, 4-triazole (83) with asymmetric 
13-diketones. The problem of position isomerism has been solved with 
the help of 
1 
 H n. m. r. and 
13
C n. m. r. spectroscopy. 
63 
Checchi et al treated 3-aminopyrazoles with acetoacetic and 
benzoyiacetic esters and isolated products of type (87). Condensation 
of aminopyrazoles with acetylacetone yielded products (88). Later it 
was shown that the substituents on the pyrazole nucleus markedly influence 
the course of the condensation of 3-aminopyrazoles and f3-dicarbonyl corn-
pounds. Thus the activation of position 4 of 3- amino- 5-hydroxypyrazole 
(89) towards electrophilic attack induced the formation of the pyrazolo-
[4, 3-b]pyridines (91) along with the expected pyrozolo[i, 5-a]pyrimidines 
(90). This observation caused a controversy over the actual structures 
of the products. 64 The influence of the substituents was also illustrated 
in this series by the condensation of 3-amino-4-cyano-5-cyanomethyl-















Precursors or derivatives of f3-dicarbonyl compounds have also 
been condensed with 3-aminopyrazoles. Takamizawa and co-workers 
have studied the condensations of f3-ketonitriles or their ketals and 
various 3-aminopyrazoles leading to 5 -aminopyrazolo[ 1, 5- a]pyrimidines 
of pharmaceutical importance. 66, 67 Low yields of 5-hydroxy- and 7-
hydroxypyrazolo[2, 3-a]pyrimidines have been reported from the 
reaction of 3-aminopyrazole and acetylenic esters. 
68a 
 Diketene and 
cyanoacetyihydrazide yielded the same pyrazolo[4, 3- a]pyrimidine 
derivative as aminopyrazole (89) and ethyl acetoacetate. 69 The 
reaction of asymmetric 3-diketcnes, -ketoaldehydes or 13-ketoacetals 
with aminopyrazoles has been almost untouched. 64 
Numerous investigations of the preparation of s-triazolo[l, 5-a]-
pyrimidines from 3-amino-1, 2, 4-triazoles, often motivated by the 
practical importance of these compounds, have been carried out. 
Bulow and Hass 70 ss7 prepared the first examples of this ring system by 
condensing 3-amino-1, 2,4-triazole (95) with various 1, 3-dicarbonyl 
compounds (96). With symmetrically constituted -diketones such as 
acetylacetone (96; R1 R 2 CH3) products of either type (98; or 99; 
R1 zR 2 CH3) might be expected. Bulow and Hass assigned structure 
(98) to their products but without any evidence. 
Mechanistic studies have been hampered by the many possible 
orientations of the condensation and the potential tautomerism of both, 
the 3-dicarbonyl compound (96) and the aminotriazole (95). In 
discussing the condensation of 3-amino-1, 2,4-triazole (95) with ethyl 
acetoacetate, Allen and co-workers, proposed a two step mechanism involvin 
first the interaction of the exocyclic amino group (assumed to be the 
0 








NA H3  
OH 
(101 a) 	 (lOib) 	 (10 1c) 
most highly nucleophilic centre of the 3-amino- 1, 2, 4-triazole nucleus) 
with the enol of the ketonic carbonyl. Cyclisation of the intermediate 
(97) then occurs with a nuclear nitrogen atom at position a or a' attacking 
6 2b 
the ester group. 	This proposition has been substantiated by the 
isolation of intermediates of type (97) in reactions involving 3-amino- 
66, 71,72 	 73 
pyrazoles 	 and 4- amino- imidazoles and 3-amino-1, 2,4- 
triazoles. 74,75 
1 	 76-78 
H N. m. r. spectroscopy 	provided a means of determining 
the structures of the positional isomers and nuclear isomers and 
prompted new investigations into the direction of cyclisation of the 
reaction. Ring closure of the intermediate (97) always involves N-2 of 
the 3-amino- 1, 2,4-triazole nucleus. 	s-Triazolo[4, 3-a]pyrimidines (99) 
have never been obtained in this reaction, 79 however these have been 
prepared in good yields by the condensation of 2-hydrazinopyrimidines 
80a 
with one carbon-cyclising agents. 
Tetrazolo[l, 5-a]pyrimidines have been prepared by the interaction 
of 5-aminotetrazole and -dicarbonyl derivatives  2d, 81 or acetylenic 
68b 	 62, 82, 83 
esters, 	although this route has been much less utilized 	than 
the synthesis from 2-hydrazinopyrimidines and nitrous acid. The 
tetrazolo-azido isomerism observed in this series caused a controversy 
over the actual structure of the products. For example, Allen and co-
workers 	assigned structure (101a) to the product obtained by the 
condensation of 5-aminotetrazole (100) and ethyl acetoacetate in analogy 
with the structure of 7-hydroxy-5-methyl-s-triazolo[1, 5-a]pyrimidine 
(98; R1  =CH 3, R2 =OH). However Temple etal 4 have shown with the help 
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as 7-methyltetrazolo [1, 5-a]pyrimidin —5-one (lOic) in the solid state, 
and mainly as a mixture of (101a) and (lOic) in most solvents. 
The reaction of 2-aminobenzimidazole (102) with ethyl acetoacetate 
and 4, 4-dimethoxybutan- 2-one has been reported to give 2-methylpyrimido-
[1, 2-a]benzimidazol-4-ol (103) and 2-methylpyrimido[1, 2-a]benzimidazole 
(104) respectively. The structure of the products was elucidated by 
1 	 85 
H n. m. r. spectroscopy. 
The synthesis of pyrazolo[1, 5-a]pyrimidine, triazolo[1, 5-a]-
pyrimidine, tetrazolo[1, 5 -a]pyrimidine and benz imidazo[ 1, 2- a]pyr imidine 
derivatives of steroids is based upon the reaction of the above mentioned 
aminoazoles with asymmetric -diketones and -ketoacetals. 
Imidazo[2, 1-b]thiazoles (107; YCH)and thiazolo[3, 2-b]-s-
triazoles (107; YN) have been prepared by the reaction of compounds 
of type (105) with an a-halo carbonyl or a-halo carboxyl compound to 
give S-alkylated products, which have been shown to exist in the acyclic 
(106a) and cyclic alcohol (106b) forms, 
86-88 
 which can then be 
dehydrated to give fused thiazoles (107). 
Kochergin and Shchukina 
89
have reported that acid or strong 
dehydrating agents are necessary to cyclise aldehydes and ketones of 
type (106; Y=N, R1 =H, alkyl, aryl) to fused triazoles (107; YN, R 
and R1=H, alkyl, aryl). Phosphoryl chloride is the cyclising agent 
usually employed, 
86 
 although sulphuric acid, 
90 




 and polyphosphoric 	acid have also been used. Acetic 
anhydride has also been used as a cyclodehydrating agent for ring 
closures of this type, 
92 
 but it usually enters into the reaction. 	There 
are, however, some examples of the direct cyclisation of 3-mercapto- 
17 
1, 2, 4-triazoles (105, YN)86' 
	
94 and 2-mercaptoimidazoles (105; 
YCH)95' 96 upon treatment with a-halo ketones. The effect of sub-
stituents in the imidazole (or benzimidazole) rings on the direction of 
ring closure has also been studied. 92, 97  
The synthesis of imidazo[2, 1-b]thiazole and thiazolo[3, 2-b]triazole 
derivatives of steroids is based upon the direct cyclisation of thiols (105) 
upon treatment with a-halo ketones. 
10 
General Experimental Procedures 
Melpg points were determined on a Gallenkamp apparatus and are 
uncorrected. 
Infra-red spectra were recorded in bromoform (unless otherwise stated) 
on a Perkin Elmer 157G spectrometer. 
Ultra-violet spectra were recorded in methanol on a tJnicam SP800 
spectrometer. 
1 
- H-Nuclear Magnetic Resonance Spectra were recorded in deuterated 
chloroform solution (unless otherwise stated) using tetramethylsilane 
as an internal standard on a Nuclear Magnetic Resonance Ltd EM-360 
(60MHz) spectrometer or a Varian HA 100 (100MHz) spectrometer 
(operated by Mr. J. Millar). 
13 C-Nuclear Magnetic Resonance Spectra were obtained in deuterated 
chloroform (unless otherwise stated) on a Varian CFT-20 spectrometer 
operating at 20-80 MHz in the Fourier Transform mode at a probe 
temperature of 300. 
Mass spectrometry was carried out on an AEI MS 902 instrument 
(operated by Mr. D. Thomas). 
Column chromatography was carried out using alumina, activity II. 
Thin layer chromatography was performed on Merck silica gel GF 254. 
The eluting system was benzene-ethanol (9:1). The plates were developed 
with sulphuric acid in ethanol (1:19) spray and then heated. Where 
appropriate inspection of the plate was made with an ultraviolet lamp 
prior to developing. 
HO 





(108) 	R1 OH, RCH3  
(log) R1=R2=H 
2 
(110) 	R1= 08H17, RH 
HOH 
(4) R=OH 
(112) RC8H17  
U 
i7 
2 	Preparation of starting compounds 
All the steroidal f3-ketoaldehydes were prepared by the following 
procedure of Ringold et al. 98 
Sodium hydride (3 g) was added to a solution of 3- or 17-keto 
steroid (10 g) in dry benzene (300 ml) and ethyl formate (10 ml). The 
mixture was stirred overnight, then methanol (20 ml) was added to 
destroy excess sodium hydride. Water (400 ml) was added and the 
layers were separated. The aqueous solution was extracted with diethyl 
ether to remove any neutral material and then acidified with 30% 
hydrochloric acid (100 ml). The precipitate formed was filtered, 
washed with water, dried and recrystallised from a suitable solvent. 
2. 1 	17-Hydroxy-2-hydroxymethylene-17a-methy1-5a-androstan-3-one(108) 
was prepared from 17-hydroxy-17a-methy1-5a-androstan-3-one and 
recrystallised from ethyl acetate, m. p.  177-179°  (70%) (lit. 
98 
 M. P. 
178-180). 
2.2 	1713-Hydroxy-2-hydroxymethylene- 5c-androstan-3-one (3) 
was obtained from 1 7-hydroxy-5a.-androstan-3 -one and recrystallised 
from ethanol, m.p. 140-142°  (90%) (lit. 
98 
 m. p. 140-146°). 
2.3 	2-Hydroxymethylene-5ct-androstan-3-one (109) was obtained 
from 5a-androstan-3-one and recrystallised from acetone, m. p.  155-
158°  (68%) (lit. 99 m. p. 156-158 ). 
2.4 	2-Hydroxymethylene-5a.-cholestan-3-one (110) was prepared from 
5a-cholestan-3-one and recrystallised from chloroform-ethanol, m. p. 
178-180°  (68%) (lit. 
100 
 m. p. 180-1810). 
2. 5 	2-H ydroxymethylene-5 a-spirostan- 3, 11 -dione (ill) was 
obtained from 5 a-spirostan-3, 1 1-dione and recrystallised from ethanol, 
m. p.  165-166 (66%); i. r. , 	max 1700 (C=O), 1640 (Co. CH=CH•OH, 
C=O' 1580 cm '  (C0.CH=CH•OH, y 	'H n. m. r. (60 MHz), 
60. 72, 0. 95, 1.00 (methyl groups) and 8.60 (s, 1H, 2CH0) 
(Found: C, 73.20; H, 8.91. 	C 28H4005 requires C, 73. 68; H, 8 . 77%). 
2.6 	17P - Hydroxy-  2-hydroxymethyleneandrost-4- en- 3-one (4) was 
prepared from 1 7 -hydroxyandros t-4 - en- 3-one and recrystallised from 
ether, m. p.  163-165° (80%) (lit. 
101 
 m. p.  165-165.5). 
2.7 	2-Hydroxymethylenecholest-4- en- 3-one (112) was obtained from 
cholest-4-en-3-one and recrystallised from pentane, m. p. 108_1100 
(72%) (lit. 101 M. P. 109. 5-111. 5°) 
2. 8 	3t3-Hydroxy-  16 -hydroxymethylene- 5  a-andros tan- 17 -one  (7) was 
obtained from 33 -h:ydroxy- 5 a- androstan- l7-one and recrystallised from 
acetone, m. p.  227-229°  (77%) (lit. 
102 
 m. p.  228-231°)- .
2.9 	3-Hydroxy- 16-hydroxymethyleneandrost- 5- en- 17 -one  (8) was 
obtained from 3 -hydroxyandros t- 5-en- i7-one and recrystallised  from 
° 	
102 	 o 
ethanol, m. p.  237-239 (84%) (lit. m. p.  238-239  ). 
2.10 	16-Hydroxymethylene- 3-methoxyoestra- 1, 3, 5(10)-trien- i7-one 
.L2L was obtained from 3-methoxyoestra-1, 3, 5(10)-trien-17-one and 
recrystallised from acetone, m. p.  226-229°  (64%) (lit. m. p.  228-230°). 
1 71 - Hydroxy- 2-methoxycarbonyl(hydroxy)methylene- 17 a-
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(61) 
(119) 
methylene-5a-cholestan-3-one (114) were prepared from 173-hydroxy-
17a-methyl-5a.-androstan-3-one and 5a.-cholestan-3-one respectively by 
the procedure previously described except that ethyl formate was 
replaced by dimethyl oxalate. 
2. 11 	1 71-  Hydr oxy-2-methoxyc arbonyl(hydr oxy)methylene -170.- 
methyl-5a-androstan-3-one (113) could not be recrystallised. Yield of 
the crude product was 72%. I. r. , 	max 1740 (ester C=O), 1620 and 
1575 (conj. C=0, chelate structure); 
1 
 Hn.m.r. (60 MHz), 6 0.80 (s, 
3H, 18-CH3), 0. 85 (s, 3H, 19-CH3), 1. 22 (s, 3H, 17-CH3), 3. 85 (s, 
3H, 2-C(OH)COOCH3)and 15.0(s, 1H, 2-C(OH)COOCH3 ). 
2. 12 2- Methoxyc arbonyl(hydr oxy)methylene- 5a.-c hole stan-3 -one 
(114) was recrystallised from methanol, mp. 103-105 (80%) (lit. 103  
m. p. 106-107). 
2.13 	176-Acetoxv-5a-androstan-3-one (115 
A solution of 17-hydroxy-5a-androstan-3-one (3. 4 g, 1. 2 x 102 
mole) and acetic anhydride (1 ml) in pyridine (15 ml) was refluxed 1 h. 
On cooling, the mixture was poured into diethyl ether, washed successively 
with water, 5% hydrochloric acid, 5% sodium hydroxide and finally with 
water again. The ether solution was dried over anhydrous magnesium 
sulphate and evaporated to dryness to give 17-acetoxy-5ct-androstan-3-
one (115) (3.8 g, 92%), m. p.  154-156 (lit. 
104 
 m. p.  158-160). 
2. 14 	173-Acetoxy-2a-acetyl-5a-androstan-3-one (61) was prepared 
by a two step synthesis. 
(a) 	Borofluoride complex (116). A solution of glacial acetic acid 
(5-3 ml) in ethylene chloride (10 ml) was cooled on an ice bath. 
Boron trifluoride gas, washed through concentrated sulphuric acid, 
was poured into the stirred solution until saturation was reached. To 
the resulting white paste kept under nitrogen with continued cooling and 
stirring, a solution of 17-acetoxy-5a-androstan-3-one (115) (3.8 g, 
1. 1 x 10 2  mole) and acetic anh.ydride (4 ml) in ethylene chloride (8 ml) 
was added. The addition required 15 min during which time the 
mixture became homogeneous. Alter a further 30 min in the ice bath, 
the solution was allowed to stand at room temperature for 3 h. The 
solution was then washed with water, saturated sodium bicarbonate solu-
tion and water again. The organic phase was dried over anhydrous 
magnesium sulphate and evaporated to dryness to give the borofluoride 
complex (116) (4. 1 g, 91%), m. p.  254-264° (lit. 
105
m. p.  265-277°). 
(b) 	173-Acetoxy- 2a-acetyl-5 a-androstan- 3-one (61). A mixture 
of borofluoride complex (4. 1 g, 1. 0 x 10 2 mole) in methanol (170 ml) 
containing sodium acetate (1.58 g), glacial acetic acid (1. 09 ml) was 
refluxed for 2. 5 h. On cooling and refrigeration crystals formed. 
These were filtered to give 1 73-acetoxy- 2a-acetyl-5 a-androstan- 3-one 
(61) (3. 3 g, 88%), m. p.  181-1820 (lit. 
105 
 m. p.  180-181°). 
2.15 	2a-Bromo-173-hydroxy-17a-methyl-5a-androstan-3-one (117). 
To a solution of 17-hydroxy-17a-methyl-5a-androstan-3-one (3 g, 
0. 98 x IC  mole) in glacial acetic acid (25 ml) containing 5 drops of 
48% hydrogen bromide in glacial acetic acid was added dropwise over a 
period of 30 min a solution of bromine (1.6 g, 0.98 x 16 2  mole) 
anhydrous sodium acetate (1.41 g) in glacial acetic acid (17 ml). The 
reaction mixture was diluted with water to precipitate the bromosteroid. 
The product was filtered, washed with water and dried. Recrystallisation 
from ethanol gave white crystals (2 g, 53%), m. p.  194-1960 (lit. 106  
m.p. 203-206); i. r., 1 max 3600 (OH), 1720 cm (C =0); 'H n. m. r. 
(60 MHz), 	6 0.92 (s, 3H, 18-CH3), 1. 15 (s, 3H, 19-CH3), 1. 22 (s, 
3H, 17-CH3) and 4. 76 (dd, lH, 2-H). 
2.16 	2a-Bromo-5a-cholestan-3-one (118). A solution of bromine 
(4. 2 g, 2. 6 x 10 
2 
 mole) and 48% hydrobromic acid (0. 3 ml) in glacial 
acetic acid (20 ml) was added over 10 min to a vigorously stirred 
solution of 5a-cholestan- 3-one (10 g, 2.6 x 102  mole) in acetic acid 
(300 ml). Alter stirring for 2 min the resulting suspension was cooled 
to 100,  the bromoketone was filtered off and washed free of bromine 
with acetic acid. Recrystallisation from ethanol-acetone gave 2a-
bromo-5a-cholestan- 3-one (118) (72 g, 60%), m. p. 167-169°  (lit. 107 
m.p. 168-169°). 
2. 17 	2a-Bromo-l713-hydroxyandrost-4- en- 3-one (119) was prepared 
by treating 1 73 -hydroxy- 2-hydroxymethyleneandrost-4 - en- 3-one (4) 
(4 g,  1. 27 x 102  mole), methanol (55 ml) and anhydrous potassium 
acetate (1.6 g) with bromine (2 g, 1. 27 x i0 2 mole) dissolved in 
carbontetrachlo ride (8 ml). The reaction mixture was stirred for 50 
min below 15°, refluxed 10 min with 2N methanol-sodium methoxide 
(8 ml), evaporated to dryness and the residue was recrystallised from 
methanol to give 2a-bromo-173-hydroxyandrost-4- en- 3-one (119) as 
light yellow crystals (2 g,  43%), m.p. 125-127°  (lit. 
108 
 m.p. 127-128°). 
2. 18 	3-Methoxyoestra-1, 3, 5(l0)-trien-17-one (120) was prepared by 
adding slowly, with vigorous stirring dim ethyl suiphate (30 ml) to a 
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maintained at 25-30°  and the solution was kept alkaline (to litmus) 
by frequent addition of 17% potassium hydroxide (ca. 100 ml altogether). 
After addition was complete (2. 5 h), ammonium hydroxide (20 ml) was 
added and stirring continued for 30 mm. The finely divided precipitate 
which separated was filtered, washed with water and dried. Recrystal-
lisation from ethanol gave 3-methoxyoestra-1, 3, 5(10)-trien-17-one (120) 
109 (4.95 g, 94%), m. p. 167-169
0 
 (lit. 	m. p. 168-169°). 
2. 19 	16-Acetoxy-3-methoxyoestra-1, 3, 5(10), 16-tetraene (121) was 
prepared as follows. A solution of 3-methoxyoestra-1, 3, 5(10)-trien-
17-one (120) (5.96 g, 2. 1 x 102  mole) in isopropenyl acetate (90 ml, 
8. 1 x 10 2  mole) containing toluene -4-sulphonic acid (1 g) was distilled 
slowly (high reflux ratio) through a vigreux column to half of its volume 
over a period of 14 h. The solution was cooled, diluted with ether, 
washed with saturated sodium bicarbonate solution, water and dried 
over anhydrous magnesium sulphate. The residue obtained on evapora-
tion of the solvent was adsorbed on a column of Florisil (90 g). Elution 
with petroleum ether (65-68°) gave crude enol acetate (5. 80 g) which 
on recrystallisation from petroleum ether (65-68°) afforded colorless 
plates (5.51 g, 84%), m. p. 112-114°  (lit. 
110 
 M.P. 114. 5-115. 5°). 
2.20 	16a-Bromo-3-methoxyoestra-1, 3, 5(10)-trien-17-one (122). A 
suspension of anhydrous potassium carbonate (0. 5 g) in a solution of the 
afore mentioned enol acetate (0. 77 g, 2.45 x 10 mole) in carbon tetra-
chloride (35 ml) was stirred at 00, while a solution of bromine (0.4 g, 
2.45 x 10 mole) in carbon tetrachloride (10 ml) was added over 5 mm. 
The colourless mixture was poured into water containing a little sodium 
bisuiphite, the aqueous layer was extracted with chloroform. The 
combined organic layers were dried over anhydrous magnesium 
sulphate. The residue obtained on evaporation of the solvent under 
reduced pressure was recrystallised from methanol to give white crystals 
of 16a-bromo-3-methoxyoestra-1, 3, 5(10)-trien-17-one (122) (0. 790 g, 
88. 8%), m. p.  174-176°  (lit. 
110
m. p.  176-177). 
2. 21 	2-Hydroxymethylenecyclohexanone (123). A mixture of sodium 
hydride (12 g, 0.5 mole), dry ether (1000 ml), and ethyl alcohol (5 ml) 
was placed in a 3 1 three necked flask equipped with a stirrer, dropping 
funnel and a vent tube. This reaction vessel was cooled by means of a 
cold water bath, and a solution of redistilled cyclohexanone (49 g, 0. 5 
mole) and ethyl formate (55 g, 0. 75 mole) was added dropwise during half 
an hour. Stirring was continued for 6 h and the solution was allowed to 
stand overnight. After the addition of ethyl alcohol (15 ml), the mixture 
was stirred for 1 h. Water (100 ml) was added to the flask with stirring. 
The mixture was taken in a 3 1 separating funnel, the upper ether layer 
separated and the aqueous layer collected. The ether layer was washed 
with water (25 ml) and the combined aqueous extracts were washed with 
ether (50 ml). The aqueous layer was acidified with 6N hydrochloric 
acid (80 ml) and the mixture extracted twice with ether (150 ml). The 
ether solution was washed with saturated sodium chloride solution (25 ml) 
and then dried over anhydrous magnesium sulphate. The drying agent was 
removed by filtration and the ether evaporated. The residue was 
distilled under reduced pressure. After a small fore-run 2-hydroxy-
methylenecyclohexanone (123) (40 g, 63%) was obtained, b. p. 85-900! 
26 
15 mm (illa 
 
it. 	b. p. 70-72°/5 mm); i. r., 1718 (y 	=' ketone and 
aldehyde), 1639 ( 	 and 1607-1587 cm' 	 H 	
'H 
n. m. r. (60MHz), 6 8. 61 (s, 2-CHO) and 14. 24 (s, enolic hydrogen). 
2. 22 	2-Hydroxymethylenecyclopentanone (124) was obtained from 
cyclopentanone (42 g, 0. 5 mole) by the procedure described for 2-
hydroxymethylenecyclohexanone (123). The oil obtained was distilled 
under reduced pressure (12-16 mm). The product sublimed and was 
obtained as light yellow solid (124), m. p.  73-760 (18 g, 32%) (lit 112 
m. p.  76-77°) which was used as such without further purification. This 
substance gradually decomposes on standing at room temperature. I. r. 
1748 	 ketone), 1724 ( 'f C=o, aldehyde), 1675 1CCCO and 
1 
1607 cm' (Vc0  H 	
H n.m. r. (60MHz), 6 7. 34 (s, 2-CHO) and 
11. 30 (s, enolic hydrogen). 
2. 23 	2-Carbethoxycyclohexanone (125'. A solution of sodium 
ethoxide was prepared from absolute ethanol (400 ml) and sodium (23 g, 
1 mole). This solution was cooled to 00,  when a solution of cyclo-
hexanone (98 g, 1 mole) in diethyl oxalate (146 g, 1 mole) at 00  was 
added over 30 mm. When all the cyclohexanone and diethyl oxalate 
solution had been added, the mixture was stirred at 00  for a further 1 h, 
and then stirred at room temperature overnight. Concentrated sulphuric 
acid (28 ml) and ice (220 g) were added during which time the temperature 
of the mixture was not allowed to exceed 100.  The reaction mixture 
was then diluted to 2 1 with ice and water, and the product separated. 
The aqueous layer was extracted with ether (4 x 250 ml) and the ether 
solutions were combined and dried. Alter evaporation of the ether under 
27 
reduced pressure, the crude product was distilled to afford ethyl- 2-
oxocyclohexyiglyoxalate (130. 6 g, 66%), b. p. 105-1650 /12 mm. 
Distillation of the above compound in the presence of finely 
ground glass (0. 5 g) and a trace of iron powder, at 40 mm at a bath 
temperature of 165-185°  gave 2-carbethoxycyclohexanone (125) (95 g, 
56 %), b. p. 125-1400 /40 mm (lit 3b. p. 70-72°/0.4 mm). 
	
2. 24 	2-Amino- 1, 3,4-thiadiazole (77) was prepared by the method 
of Lauer and Zenchoff. 53 A solution of thiosemicarbazide (25 g. 0. 27 
mole) in 98% formic acid (180 ml) was refluxed for 15 h, evaporated to 
dryness in vacuo, then refluxed for 2 h in 10% hydrochloric acid 
(250 ml). The resulting solution was then evaporated in vacuo to 
dryness again, the residue was dissolved in hot water (175 ml), made 
basic with 50% sodium hydroxide (40 ml), concentrated (to 50 ml) and 
filtered. The solid was washed with water, dissolved in hot methanol 
(400 ml), treated with activated charcoal, filtered and concentrated 
(to 75 ml). The product (16 g) was collected and dried, concentration 
of the mother liquors gave a second crop (1.5 g), for a total of 65% 
yield, m. p. 195-19 70 (lit 3 m. p.  196-1970). 
2.25 	4-Amino-1, 2,4-triazole (83). In a round bottom flask, equipped 
with an efficient water condenser, was placed ethyl formate (37 g, 0. 5 
mole) and ethanol (35 ml). Hydrazine hydrate (30 g, 0. 5 mole) was 
added cautiously to this solution with shaking over a period of 10 mm. 
After the reaction subsided, the solution was refluxed on a steam bath 
for 18 h. The bulk of the water and alcohol was then removed by 
evaporation under reduced pressure (until the volume in the flask was 
R!NH2 	
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about 40 ml). The resulting syrup, crude form hydrazide was 
heated under atmospheric pressure for 3 h, during which time the 
0 
temperature of the bath was raised to 150-200 . After cooling to 
about 100°, the oil was taken up in 95% ethanol (15 ml) and activated 
charcoal (1. 5 g) was added. The filtered solution was then diluted 
with ether (20 ml). Alter cooling the solution in ice, white crystals 
of 4-amino-1, 2,4-triazole (83) (55 g, 65%), m. p. 76-780 (lit 
114a 
 M. P. 
77-78°) were obtained. 
2. 26 	3-Amino-4-cyanopyrazole (126) was prepared by carefully 
adding ethoxymethylenemalanonitrile (15 g, 0. 12 mole) in small 
portions to hydrazine hydrate (8. 5 g, 0. 17 mole). Alter approximately 
one-half of the e thoxym ethyl en emalano nitril e had been added, the reaction 
mixture was cooled slightly in cold water and the remaining ethoxy- 
m ethyl enemalanonitrile added at such a rate that the contents of the 
flask boiled gently upon the addition of each 3 to 5 g portion. Alter 
all the ethoxymethyienemalanonitrile had been added, the reaction flask 
was heated for 1 h on the steam bath. To the solidified mass was 
added water (10 ml) and the solution was set aside in the refrigerator. 
The mushy solution was then filtered and the solid washed with 50 ml 
of cold water and sucked as dry as possible. The crude product was 
dried in a vacuo desiccator over calcium chloride. The crude yield 
of tan coloured material was 96% (9. 7 g), m. p.  169-70
0
. Recrystal- 
o 	115 	 o 
lisation from water raised the m. p. to 172-174 (lit. mp. 174-175 ). 
2. 27 	3-Amino-4-cyano-5-cyanomethylpyrazole (92). To a solution 
of malanonitrile (16. 5 g, 0. 25 mole) in ethanol (45 ml) was added 
hydrazine hydrate (2 g) and the mixture was carefully heated to 
boiling. The remaining hydrazine hydrate (5 g, total 0. 12 mole) was 
then added at such a rate that the reaction mixture continued to boil 
without external heating. Ammonia was continually evolved during this 
time. After all the hydrazine had been added, the reaction mixture was 
boiled for an additional 5 min and then quickly cooled to 00. The light 
reddish tan crystals which had separated were collected by filtration 
and immediately recrystallised from glacial acetic acid with the 
addition of charcoal 	A further recrystallisation from water yielded 
colourless long needles (7 g, 46%), m. p.  196-198°  (lit 6m. p. 197-198°). 
2.28 	3-Amino- 1, 2,4-triazole (95) was prepared by the method 
described by Allen and Bell. 114b Toa solution of aminoguanidine 
bicarbonate (17 g, 0.12 mole) in a round bottom flask was added carefully 
cold dilute sulphuric acid (0. 06 mole), made from concentrated sulphuric 
acid (sp. gr . 1. 84, 6 g) and water (12 ml). After gas evolution subsided, 
the solution was heated for 1 h on a steam bath and then evaporated to 
dryness under reduced pressure. 
To the white residue was added 98% formic acid (25 g) and 2, 3-
drops of concentrated nitric acid. The mixture was heated for 24 h on 
a steam bath, the resulting syrup was dissolved in water (25 ml) and 
with temperature at 500,  was carefully treated with anhydrous sodium 
carbonate (6 g). The solution was then placed in an evaporating dish 
and evaporated to dryness on a steam bath. The residue was extracted 
by boiling with ethanol (2 x 50 ml) and the alcohol solution was filtered. 
The alcohol was removed by evaporation and the residue triturated with 
a mixture (25 ml) of equal parts of dry ethanol and dry ethyl ether, and 
collected on a filter. 	The yield of crude 3- amino -i, 2,4-triazole (95) 
was 79% (8 g), and the m. p. was variable. The crude product was 
purified by dissolving it in boiling absolute alcohol (35 ml), treating it 
with activated charcoal (1 g) and filtering. 	To the filtrate was added 
ether (12 ml) and the solution was placed in a refrigerator for 48 h. The 
aminotriazole (95) was obtained as white crystals (5 g, 48%), m. p.  148- 
1500 (lit. 14b 	° m. p. 153). 
2.29 	3-Amino-5-methyl-1, 2,4-triazole (127) was prepared by the 
above procedure except that formic acid was replaced by acetic acid 
and the crude 3-amino-5-methyl-1, 2,4-triazole (127) was purified by 
extraction with ethyl acetate in a Soxhlet apparatus. 3-Amino-5-methyl-
1, 2,4-triazole (127), m. p.145-147°  (lit 7m. p.146-148°) was obtained 
in a quantitative yield. 
2. 30 	5 -Amino tetrazole (100). A suspension of dicyandiamide (20. 5 g 
0. 25 mole) and sodium azide (29 g, 0.45 mole) in water (50 ml) was 
warmed to 650  on a water bath under a reflux condenser and concentrated 
hydrochloric acid (37.5 ml, 0.45 mole) was added in small portions with 
frequent manual agitation. Alter complete addition of the acid, the 
mixture was kept at 65-70°  on the water bath for 6 h during which time 
the product began to crystallize. The semi solid mass was allowed to 
stand overnight and was filtered off, and was washed with ice water. 
The crude 5-aminotetrazole (100) was recrystallized from boiling water 
as a monohydrate, m. P. 204-206° (33 g, 73%) (lit8m. p.  206. 5-207. 5). 
2.31 	2-Mercaptoimidazole (128). An aqueous solution of amino acetaldehyde 
dimethyl acetal (10. 5 g, 0. 1 mole) and potassium thiocyanate (9-7, 
0. 1 mole) in water (50 ml) was boiled down to a syrup which was then 
heated in an oil bath at 140°. After hydrogen sulphide was given off, the 
solid formed was dissolved in ethanol, treated with charcoal and the 
solution was concentrated. 2-Mercaptoimidazole (128) was obtained 
as white crystals (5. 3 g, 53%), m. p.  221-2230 (lit 9m. p.  222°). 
	
2. 32 	4, 5- Diphenyl- 2-mercaptoimidazole (129) was prepared by 
heating a solution of benzoin (5 g. 2.8 x 10 mole) and thiourea (1.8 g, 
2.8 x 1C 3mole) in alcohol (15 ml) in a sealed tube, in an oil bath at a 
temperature of 1200.  After 3 h, the solution was cooled down to room 
temperature and fine white crystals (4. 5 g, 7 5%), m. p.  >300 (lit 20 
m. p.  >310°) were obtained. 
2.33 	2-Mercapto-5-methylbenzimidazole (130) was prepared by 
heating a mixture of 3, 4-diaminotoluene (20 g, 0. 16 mole) and thiourea 
(12 g, 0. 16 mole) together in a round bottom flask on an oil bath at a 
temperature of 170-180°. The solids formed a melt which solidified 
to a hard cake after some time at this temperature. This solid cake 
was dissolved in warm sodium hydroxide and the solution was filtered. 
The filtrate was acidified with concentrated hydrochloric acid. The 
solid formed was filtered, dried and recrystallised from ethanol after 
charcoal treatment to give fine plates (13.7 g, 55%), m. p. 284-286°  
.121 	o 
(lit. m. p.  285  ). 
2. 34 	2-Mercapto-4-methylimidazoline (131) was prepared by adding 
dropwise 1, 2-diaminopropane (37 g, 0. 53 mole) to carbon disulphide (50 
g, 0. 65 mole) placed in a round bottom flask fitted with a reflux condenser 
32 
The reaction was found to be vigorous. Alter final addition of the 
amine, the mixture was carefully refluxed for 30 min and then cooled. 
The excess of carbon disulphide was poured off and the viscous reaction 
product was dissolved by warming in water (100 ml). Ring closure of 
the dithiocarbamate intermediate was easily accomplished by adding 
concentrated hydrochloric acid (15 ml) and finally refluxing the solution 
at 1000  for 1 h. On cooling, a crystalline solid separated out which 
was filtered and was recrystallised from benzene to give 2-mercapto-
4-methylimidazoline (131) (28 g, 34%), m. p.96-98°  (1it 22m. M.P. 100
0
). 
2. 35 	2-Mercapto-4, 5, 6, 7-tetrahydrobenzjmidazoj.e (132). A mixture 
of 2- amino cyclohexanone hydrochloride 
123 
 (20 g, 0. 13 mole) and 
potassium isothiocyanate (10. 5 g, 0. 13 mole) in water (100 ml) was 
heated on a steam bath for 7 h. A fine yellow powder began to fall out 
of solution within the first hour of heating. Alter chilling the mixture 
overnight, the precipitate was collected at the pump, washed well with 
water and dried. Recrystallisation from ethyl alcohol gave 2-mercapto-
4, 5, 6, 7-tetrahydrobenzimi.dazo].e (132) (13. 3 g, 6 5%), M. P. 279-2810 
(lit? 5m. p.  28 2-283°). 
2.36 	3-Mercapto-1, 2,4-triazole (133) was prepared by a two step 
synthesis. 
(a) 	1-Formyl-3-thiosemicarbazide. Formic acid (125 ml) contained 
in a round bottom flask was heated on a steam bath for 15 min and then 
thiosemicarbazide (61 g, 2 mole) was added. The mixture was swirled 
until the thiosemicarbazide had dissolved. The heating was continued 
for 30 mm, during which time crystalline 1-formyl-3-thiosemicarbazide 
separated. Boiling water (200 ml) was added and the milky solution 
that resulted was filtered. After standing for 1 h, the filtrate was 
cooled in an ice bath for 2 h and the i-formyl-3-thicemicarbazide 
that separated was collected by filtration and air dried overnight, yield 
56 g (71%), m.p.177-l78°  dec. 
(b) 	3-Mercapto-1, 2,4-triazole. A solution of 1-formyl-3-thio- 
semicarbazide (35. 5 g, 0.3 mole) and sodium hydroxide (12 g, 0. 3 mole) 
in water (60 ml) was heated on a steam bath for 1 h. The solution was 
cooled for 30 min in an ice bath and then treated with concentrated 
hydrochloric acid (30 ml). The reaction mixture was cooled in an ice 
bath for 2 h and the 3-mercapto-1, 2,4-triazole which precipitated was 
collected by filtration. Recrystallisation from water gave white 
crystals (21 g, 7 2%), m. p.  219-210 (lit lllb 
	 o
. 	m. p.  220-222  ). 
2.37 	3-Mercapto-5-methyl-1, 2,4-triazole (134) was also prepared 
by a two step synthesis. 1-Acetyl-3-thiosemicarbazide was prepared 
by the addition of acetyl chloride (39 g, 0. 5 mole) to a stirred suspension 
of thiosemicarbazide (45 g, 0. 5 mole) and dry pyridine (500 ml). The 
temperature was maintained between 
_50 
 and 00  throughout the addition. 
After standing at room temperature overnight most of the pyridine was 
removed by evaporation under reduced pressure. To effect cyclisation 
to 3-mercapto-5-methyl-1, 2, 4-triazole, the residue was dissolved in 
methanol (300 ml) and sodium methoxide (54 g, 1 mole) was added. The 
mixture was heated overnight on the steam bath and then the solvent was 
removed by evaporation under reduced pressure. The residue was 
dissolved in water (100 ml), the solution was decolorised with charcoal 
and concentrated hydrochloric acid (100 ml) was added. The solid 
formed was filtered, washed with water and air dried. Recrystallisa-
tion from water gave shining plates (44.5 g, 78%), m. p. 279-281 0 
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3 	The reaction of steroidal p-ketoaldehydes with 2-amino- 
1, 3, 4-thiadiazole. 
	
3. 1 	The reaction of 173-hydroxy-2-hydroxymethylene-5a- 
androstan-3-one (3) with 2- amino- ].,3,4-thiadiazole (77). 
A solution of 1 713-hydr oxy- 2 -hydr oxyrnethylene - 5a- andr o stan - 
3-one (3) and 2-amino- 1, 3,4-thiadiazole (77) in dry toluene containing a 
catalytic amount of toluene -4- sulphonic acid was refluxed overnight. 
On evaporation of the solvent, the residue was chromatographed over 
silica gel. Elution with methylene chloride-ethanol (95:5) followed by 
recrystallisation of the eluate from ethanol gave light yellow crystals 
(136), m. p.  213-215, in 60% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C22H29N3OS. The i. r. spectrum 
showed absorptions at 3590, 2160, 1565, 1555 (inf), 1545 (inf), 1415, 
1365 and 755 cm 
1 
 and the 'H n. m. r. spectrum exhibited signals at 
5 0. 76, 53.61 and 58.25. 
3. 2 	Discussion 
The i.r. spectrum of the product obtained by the condensation of 
1 73-hydroxy- 2-hydr oxymethylene- 5a.- andro stan-3 -one (3) and 2-amino-
1, 3, 4-thiadiazole (77) shows no carbonyl absorption but exhibits a 
strong absorption at 2160 cm characteristic of a thiocyanate group 
and also absorptions at 1565, 1555 (ml), 1545 (ml), 1415, 1365 and 755 
cm 
1 
 characteristic of a pyrimidine ring. Thus the 1. r. spectrum and 
the molecular formula C 22H29N30S obtained by mass spectroscopy and 
and elemental analysis suggest that the product is 173-hydroxy-2t- 
thiocyanato- 5 a-androst- 2-eno[3, 2-d]pyrimidine (136). The presence 
of a signal at 5 8.25 in the 
1 
 H n. m. r. spectrum confirms the 6'-H of 
the pyrimidine ring and therefore the structure (136). 
The thiocyanate group is known to isomerise to the isothiocyanate 
structure on refluxing in acetonitrile, benzene or toluene. 
125 
 However 
no such isomerisation is observed in the above synthesis of the product 
(136), the 2'-thiocyanate group remaining intact even after prolonged 
heating in refluxing xylene. Absence of isomerisation to isothiocyanate 
is further confirmed in that the product fails to react with a primary 
amine. 
Evidence has accumulated that aminoazoles (e.g. 3-amino-1, 2,4- 
triazole, 3-aminopyrazole etc) react first with the aldehydic rather 
than the ketonic group of a -ketoaldehyde. 
80c 
 Thus the reaction of 2-amino- 
1, 3, 4 -thiadiazole with 1 73 -hydroxy- 2-hydroxymethylene- 5 a-andro stan- 
3-one (3) would be expected to go through the intermediate (135a). Since 
this intermediate (135a) could not be isolated it is therefore possible 
that the intermediate might have an isomeric structure (135b) based 
upon the initial reaction of the amino group of the 1, 3, 4-thiadiazole and 
the 3-carbonyl of the steroidal -ketoa1dehyde (3). However, fission of 
the N-N bond in the rearrangement of either of the possible intermediates 
will yield the same product (136). A similar rearrangement has been 
reported during the reaction of 2-amino-1, 3,4-thiadiazole and the 
simple 1, 3-dicarbonyl compound, acetylacetone, resulting in the 
formation of 2-thiocyanato-4, 6-dimethylpyrimidine (78). 
53 
 The compound 
(78) has also been obtained 
126 
























dimethylpyrimidine with cyanogen bromide and this further supports 
the absence of isomerisation of the thiocyanate group into isothio-
cyanate during the condensation of 2-amino- 1, 3, 4-thiadiazole with a 
3-dicarbonyi compound in refluxing toluene in the presence of a small 
amount of toluene-4-sulphonic acid. 
In a similar manner, 2'-thiocyanato-5a-androst-2-eno[3, 2-d]-
pyrimidine (137), 2'-thiocyanato-5a-cholest-2-eno[3, 2-d]pyrimidine 
and 11-oxo-2'-thiocyanato-5a-spirost-2-eno[3, 2-d]pyrimidine 
were prepared from 2-hydroxymethylene-5a-andros tan- 3-one 
(109), 2-hydroxymethylene-5a-c holes tan- 3-one (110) and 2-hydroxy-
methylene-5 a- spiro stan- 3, li-dione (111) respectively. 
3. 3 The reactions of 17P -hydroxy- 2-hydroxymethylene- 17 a-methyl- 
5a-androstan-3-one (108) with 2-amino-1, 3,4-thiadiazole (77). 
A solution of 17P -hydroxy-  2-hydroxymethylene- 17 a-methyl- 5 a-
androstan- 3-one (108), 2-amino-1, 3, 4- thiadiazole (77) and a small 
amount of toluene -4-sulphonic acid in dry toluene was refluxed over-
night. After evaporation of the solvent, the residue was chromatographed 
over silica gel. Elution with methylene chloride gave a white solid 
which recrystallised from ethanol as white crystals (140), m. p. 125- 
127°, in il% yield. Further elution of the chromatogram with 
methylene chloride-ethanol (95 :5) gave a yellow solid which upon 
recrystallisation from ethanol gave light yellow crystals (141), m. p. 
172-173, in 85% yield. 
Mass spectrometry and elemental analysis of the first product 
(m. p.  125-127 
0 
 ), give its molecular formula as C 23H29 N3S which 
shows that the product does not contain the hydroxyl group at the 17-
position. The loss of hydroxyl group at the 17-position is further 
confirmed by the absence of any absorption around 3600 cm 1  in the 
i. r. spectrum which exhibits absorptions at 2160, 1565, 1540 (inf), 
1440, 1415, 1365, 1350 and 755 cm '. The 1Hn.m.r. spectrum shows 
a signal at 6 8. 30 which is assigned to the hydrogen on the pyrimidine 
ring. The absence of any other signal in the vinyl region eliminates 
the structure (140a) containing a double bond at the 12-position. How-
ever structure (140) is supported by the signal at 6 0. 80 assigned to 
the gem dimethyl group at 17-C and the signal at 6 1.00 assigned to 
19-methyl group. The yield of 17, 17-dimethyl- 2'-thiocyanato- 18-nor-
5a-androst-2, 13-dieno[3, 2-d]pyrimidine (140) is found to be dependent 
upon the amount of toluene -4-sulphonic acid used in the condensation. 
Acid-catalysed dehydration of tertiary alcohols is well known 
Manson et al. 13 obtained 17, 17-dimethyl-18-nor-5a-androst-2, 13-
dieno[2, 3-d]isoxazole (142) in high yield from the reaction of equimolar 
amounts of 1 7-hydroxy- 2-hydroxymethylene- 17 a-m ethyl- S a- andro s tan-
3-one (3) and hydroxylamine hydrochloride in glacial acetic acid. 
The structure of the compound (141), m. p. 172-173°  follows by 
analogy with the structure of 1 73-hydroxy-2' -thioc yanato -5 a- andros t-
2-eno[3, 2-d]pyrimidine (136). 
3.4 	The reaction of 1 71  -hydroxy- 2-hydroxymethyleneandrost-4 - en- 
3-one (4) with 2-amino-1, 3,4-thiadiazole (77). 
A solution of 17P -hydroxy- 2-.hydroxymethyleneandrost-4- en- 3-one 
HOH 
(4) 	ROH 
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(148) 
(4) and 2-amino- 1, 3,4-thiadiazole (77) in dry toluene containing a 
small amount of toluene-4-sulphonic acid was refluxed oven.ight. 
After usual work up of the reaction mixture a yellow solid was 
obtained, which was recrystallised from ethanol to give large yellow 
crystals (143), m. p. 185-187 in 41% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 22H27N3OS. The i. r. spectrum 
exhibited absorptions at 3600 (OH), 2160 (SCN), 1565, and 755 cm '  
whilst 1H n. m. r. spectrum showed signals at 5 0. 80 (s, 18-CH 
3), 
 
1.00 (s, 19-CH3), 3.65 (m, 17-H), 6. 18 (s, 4-H) and 8. 20 (s, 6'-H). 
The product was assigned the structure173-hydroxy-2'-thiocyanato-
androst-2,4-dieno[3, 2-d]pyrimidine (143) by analogy with the formation 
of 1 7 -hydroxy- 2'- thiocyanato -5 a- androst- 2- eno[3, 2- d]pyrimidine 
(136) from 1 7-hydroxy- 2-hydroxymethylene- 5 a- andro s tan- 3 -one (3) 
and 2- amino -i, 3,4-thiadiazole (77). 
In an analogous manner 2'-thiocyanato-5 a-cholest-2, 4-dieno[3, 2-
d]pyrimidine (144) was obtained in 38% yield by the condensation of 2-
hydroxymethylenecholest-4- en- 3-one (112) and 2-amino-1, 3, 4-thia-
diazole (77). 
3.5 	The reaction of 33-hydroxy-16-hydroxym ethylene- 5a-androstan- 
i7-one (7) with 2-amino-1, 3,4-thiadiazole (77). 
Treatment of 33 -hydroxy- 16 -hydroxymethylene-  5 a-andros tan- 17-
one (7) with 2-amino- 1, 3,4-thiadiazole (77) in the manner described 
for the synthesis of 173-hydroxy-2'-thiocyanato-5a-androst_2-eno[3, 2-
d]pyrimidine (136), gave a light yellow solid. Recrystallisation of this 
solid from ethanol gave white crystals of 3-hydroxy-2'-thiocyanato-5a-
androst-16-eno[17, 16-d]pyrirnidine (145), m. p. 192-194 in 75% yield. 
R 
R1=OH, R2=CH3  
R1=C8H17, RH 
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(150a) R0C2H5  
(150b) R = NH-NH2 
qu 
Mass spectrometry and elemental analysis were in agreement with the 
molecular formula C22H29N30S of compound (145). The i. r. spectrum 
had absorptions at 3600 (OH), 2160 (SCN), 1580, 790 and 790 cm 	whilst 
'H n. m. r. spectrum exhibited signals at 6 0. 85 (s, 18-CH 
3 
 ), 0. 97 (s, 
19-CH3), 402 (m, 3-H), 8.35 (s, 6'-H). 
Acetylation of the product (145) gave a monoacetate (146) identified 
by its i. r. spectrum as the 33-acetate. Oxidation of product (145) by 
Jones reagent furnished the 3-oxo derivative (147). 
In an analogous manner, the condensation of 2-amino- 1, 3, 4-thiadia-
zole (77) with 16-hydroxymethylene-3-methoxyoestra-1,3, 5(10)-trien-
17-one (9) afforded 3_methoxy_2t_thiocyanato_oestra_1,3,5(10), 16-
tetraeno[17, 16-d]pyrimidine (148). 
3. 6 	The reaction of 170-hvdroxv-2-methoxvcarbonvl(hvdroxv)methvlene- 
17a-methyl-5a-androstan-3-one (113) with 2-amino-1,3,4-
thiadiazole (77). 
A solution of 1 73-hydroxy- 2- methoxyc arbonyl(hydr oxy)methylene - 
17a.-methyl-5a-androstan-3-one (113) and 2-amino- 1, 3, 4-thiadiazole (77) 
in dry toluene containing a small amount of toluene-4-sulphonic acid was 
refluxed overnight. After evaporation of the solvent, the residue was 
chromatographed over silica gel. Elution with methylene chloride-
ethanol (95:5) followed by recrystallisation of the eluate from ethanol 
gave a light yellow solid (149), m. p. 244-2460, in 65% yield. 
Mass spectrometry and elemental analysis showed that the product 
had a molecular formula of C26H32N602 S2. The i. r. spectrum exhibited 
absorptions at 3600, 3330, 2160, 1690, 1500 and 735 cm '  whilst the 
'H n. m. r. spectrum showed two singlets at 68. 90 and 5 12.00 apart 
from the usual signals for 17-, 18- and 19-methyl groups. 
3. 7 Discussion 
The presence of six nitrogen atoms and two sulphur atoms in the 
molecular formula C 26H32N6 02S2 of the product indicated that two moles 
of 2- amino- 1, 3, 4-thiadiazole have reacted with one mole of the starting 
steroid (113). Ruggieri et al. 1  have shown that the reaction of hydrazine 
hydrate with 1 73 -hydroxy- 2- ethoxycarbonyl(hydroxy)methylene- 17 a-
methyl- 5 a-androstan- 3-one gives 17-hydroxy- 17 a-methyl- 5 a-androstan-
[3, 2-c]-5'-carbethoxy pyrazole (150a) which when further allowed to 
react with hydrazine hydrate yields the corresponding hydrazide (150b). 
By analogy with these reactions, the product obtained by the condensation 
of 2-amino-i, 3, 4- thiadiazole and 1 73 -hydroxy- 2-methoxycarbonyl-
(hydroxy)methylene- 17 a- methyl- 5 a-androstan- 3-one (113) is assigned 
structure (149) which is confirmed by i. r. and 1H n. m. r. spectroscopy. 
The i. r. spectrum shows NH, SCN and CO groups by absorption bands 
at 3330, 2160 and 1690 cm 
1 
 respectively, whilst the 'H n. m. r. spectrum 
shows signals at 5 8. 90 (5''-H) and 6.12-00 (NH), the latter signal dis-
appears when the solution is shaken with deuterated water. All attempts 
to condense a single mole of 2-amino-i, 3, 4-thiadiazole with 3-keto 
oxalyl steroid (113) produced the same product (149). 
Similarly the condensation of 2-methoxycarbonyl(hydroxy)methylene-
5 a-cholestan- 3-one (114) with 2-amino-i, 3, 4-thiadiazole (77) afforded 
6'-(1, 3, 4-thiadiazol- 2-ylcarbonyl)- 2t-thiocyanato-5 a-cholest- 2- eno-
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3. 8 The attempted reaction of 173-acetoxy-2 a-acetyl- 5 a-androstan-
3-one (61) with 2-amino-i, 3,4-thiadiazole (77). 
A solution of 1 7f3-acetoxy- 2a-acetyl- 5 a-androstan-3- one (61) and 
2-amino-1, 3,4-thiadiazole (77) and a small amount of toluene-4-sulphonic 
acid in dry toluene was refluxed overnight. On evaporation of the 
solvent, the residue was taken up in chloroform which was washed with 
water, saturated sodium chloride solution and dried over anhydrous 
magnesium sulphate. On evaporation of the solvent, the residue was 
found to be 17-acetoxy-2a-acetyl-5a-androstan- 3-one (61), by its i. r. 
1 
and H n. m. r. spectra. 
3. 9 Discussion 
By analogy with the formation of 17-hydroxy-2'-thiocyanato-5a-
androst-2-eno[3, 2-d]pyrimidine (136) from the condensation of l7-
hydroxy-2-hydroxym ethylene- Scz-androstan-3-one (3) and 2-amino-1, 3,4-. 
thiadiazole, the reaction of 1 7 - ac etoxy- Za- ac etyl- 5 a-andros tan- 3-one 
(61) with 2-amino-1, 3,4-thiadiazole would be expected to give 173-
acetoxy- 2'- thiocyanato -6 '-methyl- 5 a- androst- 2- eno[3, 2- d]pyrimidine 
(152). However, no such product was isolated from the above conden-
sation reaction. 
The i. r. spectrum of the 17f3-hydroxy derivative of the compound 
(61) while having the characteristic broad f3-diketone band at 1540-1640 
cm '  does not absorb in the 'normal" carbonyl region from 1700 to 1750 
cm'. 
105 
 In contrast to this, acetylacetone'27 has an absorption of 
medium intensity in the region of 1700 cm '  which from its position is 
attributable to the keto form. The i. r. spectrum of 17-hydroxy-2- 
hydroxymethylene- 5 a-androstan-- 3-one (3) exhibits an absorption of 
medium intensity at 1700 cm '. Furthermore the u. v. peak (290 nm)105  
arising from the cyclic hydrogen bonded enolic diketone in the 2-acetyl 
steroid occurs at a longer wavelength than that reported for 2-hydroxy-
methylene-3-keto steroids (ca. 282 nm)7 or for simple -diketones (ca. 
128 
270 nm). 127, 
	
It would therefore appear that the cyclic hydrogen 
bonded enolic form (61a) is more stable than in 17-hydroxy-2-hydroxy-
methylene-5a-androstan-3-one (3). This may be due to greater con-
formational lability in the latter compound, resulting in a greater 
tendency to open to the diketo form. Since acetyl acetone 53 and 17-
hydroxy- 2-hydroxymethylene- 5 a-androstan- 3-one (3) have been shown 
to react readily with 2-amino- 1, 3,4-thiadiazole in dry toluene to give 
2-thiocyanato pyrimidines (78 and 136), the inability of 173-acetoxy-
2a-acetyl- 5 cz-androstan-3-one (61) to condense readily with 2-amino-
1, 3,4-thiadiazole may be due in part to the fact that the cyclic hydrogen 
bonded enolic -diketone is more stable in the 2-acetyl steroid than in 
the 2-hydroxymethylene steroid or the aliphatic 3-diketone. 
Another related reason for the slowness of the reaction is the 
probable steric hindrance caused by the methyl group of the 2-acetyl 
fragment. In anil formation, the carbon of the acetyl carbon will 
become tetrahedral in the transition state (153). In this transition state 
steric hindrance arises because of the close proximity of the methyl pro-
tons and-the thiadiazole ring. 
3. 10 Experimental 
General procedure for the condensation reaction 
A solution of steroidal -ketoaldehyde (0. 001 mole), 2-amino-
1, 3, 4-thiadiazole (77) (0. 0015 mole) and toluene-4-sulphonic acid (20 
mg) in dry toluene (50 ml) was refluxed and stirred overnight. The 
excess of solvent was removed under vacuo, the residue was chromato-
graphed over silica gel (50 g, 80-200 mesh) using either methylene 
chloride or methylene chloride-ethanol (95:5) mixture and the product 
thus obtained was recrystallised from a suitable solvent. 
3. 10. i 1 713-Hydroxy-  ZLthiocyanato_ 5 a-androst- 2-enol3, 2-dipyrimidine 
Starting 3 -ketoaldehyde: 17P - Hydroxy- 2-hydroxymethylene- 5 a-androstan-
3-one (3). 
Silica gel chromatography (eluant methylene chloride-ethanol, 
95:5) followed by recrystallisation from benzene gave white crystals of 
1 713-hydroxy- 2'-thiocyanato- 5 a-androst- 2- eno[3, 2-dlpyrimidine (136) 
(60%), m. p.  213-215; i. r. y 	3590 (OH), 2160 (SCN), 1565, 1415, max 
1365 and 755 cm ; 'H n. m. r. (100 MHz), 60.75 (s, 6H, 18-CH3 and 
19-CH3), 3.62 (m, 1H, 17-H) and 8. 26 (s, 1H, 6T-H) (Found: C, 69-02; 
H9 7.61; N, 11.11; M+,  383.202537. C 22H29N30S requires C, 
68. 89; H, 7.63; N, 10. 96; M, 383. 2031123). 
3. 10. ii 2- Thiocyanato-5 a-androst- 2- eno[ 3, 2-d1pyrimidine (137) 
Starting 13 -ketoaldehyde: 2- Hydroxym ethylene- 5 a-androstan- 3-one (109). 
Silica gel chromatography (eluant methylene chloride) followed 
by recrystallisation from benzene gave light yellow needles of 2'-thio-
cyanato-5ct-androst-2-eno[3,2-d]pyrimidine (137) (85%),  m. p. 210-212; 
i. r. , 	max 2160 (SCN), 1565, 1410, 1365, 1345 and 755 cm; 
'H n. m. r. (100 MHz), 60. 72 (s, 3H, 18-CH3 ), 0. 74 (s, 3H, 19-CH 
3 )
and 8. 28 (s, lH, 6-H) (Found: C, 71. 72; H, 8. 01; N, 11. 67; M+, 
367.205933 	C 22H29 N3S requires C, 71.89; H, 7.96; N, 11.44%; 
M, 367.207136). 
3. 10. iii 2'- Thioc yanato- 5cL-c hole st- 2 - eno[3,  2-d]pyrimidine (138). 
Starting 3-ketoaldehyde: 2-Hydroxymethylene-5ct-c hole stan-3-one (110). 
Silica gel chromatography (eluant methylene chloride) followed 
by recrystallisation from ethanol gave yellow crystals of 2'-thiocyanato-
5ct-cholest-2-eno[3,2-d]pyrimidine (138) (70%), m. p. 159-160; i. r. 
Y 	2160 (SCN), 1465, 1440, 1415, 1365, and 750 cm '; ' max 	 H n. m. r. 
(100 MHz), 6 0. 68, 0. 74, 0. 82 and 0. 88 (methyl groups) and 8. 28 (s, 
1H, 6'-H). 	(Found: C, 75.32; H, 9.44; N, 8.57; M+,  479. 331357. 
C30H45N3S requires C, 75. 10; H, 9. 46; N, 8. 76%; M, 479. 333404). 
3. 10. iv 1 1-Oxo-2'-thiocyanato-Sa- spirost-2-eno[3, 2-d]pyrimidine (139). 
Starting 3-ketoaldehyde 2-Hydroxymethylene - 5a- spir ostan-3, 11 -dione (111) 
Silica gel chromatography (eluant methylene chloride-ethanol, 
95:5) followed by recrystallisation from ethanol gave white crystals of 
11-oxo-2 '-thiocyanato-5a_spirost_ 2 _enol3,2_dlpyrimidine (139) (68%), 
m. p.  241-243
0
; i. r., y 	2160 (SCN), 1695 (CO), 1565, 1450, 1415, 
1365 and 755 cm ; 1H n.m. r. (100 MHz), 6 0. 76 (s, 3H, 18-CH 3 ), 
0. 96 (s, 3H, 19-CH3), and 8.30 (s, lH, 6'-H). 	(Found: C, 68. 75; 
H, 7.95; N, 8. 10; M+,  521. 271406. C30H39N3S03 requires C, 
69.06; H, 7.54; N, 8.08%; M, 521.271198). 
3. 10. v 17, 17-Dirnethyl-2'-thiocyanato- 18 -nor androst-2, 13-dieno[3, 2-
d1pyrimidine (140) and 17-hydroxy- 1 7a-methyl-2 -thiocyanato-5a-
androst-2-eno[3, 2-d]pyrirnidine (141). 
Starting 3-ketoaldehyde: 173-Hydroxy-2-hydroxymethy1ene- l7ct-
niethyl-5a.-androstan-3-one (108). 
Silica gel chromatography (eluant methylene chloride) followed 
by recrystallisation from ethanol gave white crystals of 17, 17-dimethyl-
2'-thiocyanato- 18 -nor androst-2, 13-dieno[3, 2-d]pyimidine (140) (11%) 
m. P. 125-127; i. r. , y max 2160 (SCN), 1565, 1415, 1365, and 755 
c ' 1  m ; 	H n. m. r. (60 MHz), 6 0. 80 (s, 6H, 17-gem dimethyl), 1. 00 
(s, 3H, 19-CH3) and 8.30 (s, 1H, 6T_H)  (Found: C, 72. 75; H, 7. 85; 
N, 10. 5; M+,  379. 208494. 	C 23H29N3S requires C, 72. 78; H, 7. 71; 
N, 10.71%; M, 379. 208209). 
Further elution of the chromatogram with methylene chloride-
ethanol (95:5) followed by recrystallisation from ethanol gave light yellow 
crystals of 173-hydroxy- 1 7a.-methyl-2 '-thiocyanato[3, 2-d]pyrimidine (141) 
(85%), in. p.  172-1730; i. r. , y 	3600 (OH), 2160 (SCN), 1565, 1440, 
1410, 1365 and 755 cm '; 'H n.m. r. (60 MHz), 6 0.75 (s, 3H, 18-CH3), 
0. 90 (s, 3H, 19-CH3), 1. 20 (s, 3H, 17-CH3) and 8. 20 (s, JH, 6'-H) 
(Found: C, 69. 50; H, 7. 85; N, 10. 95; M+,  397. 218722 	C 23H31N30S 
requires C, 69. 48; H, 7.86; N, 10. 57%;  M, 397-218773 ). 
3. 10. vi 1 7-Hydroxy-2'-thiocyanatoandrost-Z, 4-dieno[3, 2-d]pyrimidine 
(1) 
Starting 3-ketoaldehyde: 17-Hydroxy-2-hydroxymethyleneandrost-4-en- 
3-one (4). 
Silica gel chromatography (eluant methylene chloride) followed 
by recrystallisation from ethanol gave yellow crystals of 17-hydroxy-2t-
thiocyanatoandrost-2, 4-dieno[3, 2-d]pyrimidine (143) (41%), m. p.  185-187; 
i. r. , 1 max 3600 (OH), 2160 (SCN), 1620, 1575, 1535, 1430, 1415, 1350 
and 750 cm- 1; 1H n.m. r. (60 MHz), 6 0.80 (s, 3H, 18-CH3 ), 1. 00 (s, 
3H, 19-CH3), 3. 65 (m, 1H, 17-H), 6.18 (s, 1H, 4-H) and 8. 20 (s, lH, 
6'-H) (Found: C, 68. 75; H, 7.25; N, 10. 80; M+,  381. 186086. 
C 22H27N30S requires C, 68. 25; H, 7. 13; N, 11. 02%; M, 381. 1874-74). 
3. 10. vii 2'-Thiocyanato-5a-cholest-2, 4-dieno[3, 2-d]pyrimidine (144). 
Starting 3- ketoaldehyde: 2-Hydroxymethylene -chole st-4-ene -3-one (112). 
Silica gel chromatography (eluant methylene chloride) followed by 
recrystallisation from ethanol gave yellow crystals of 2'-thiocyanato-5a-
cholest-2,4-dieno[3,2-d]pyrimidine (144) (38%), m. p. 184-1860; i. r. 
1 
max 
 2160 (SCN), 1620, 1565, 1535, 1430, 1415, 1350 and 770 cm '; 
'H n. m. r. (100 MHz), 6 0. 70, 0. 82, 0. 88, and 0. 92 (methyl groups), 
6. 16 (s, 1H, 4-H) and 8. 20 (s, 1H, 6'-H) (Found: C, 75. 25; H, 8. 90; 
N, 8. 50; M+,  477. 316335. C30H43N3S requires C, 75. 42; H, 9. 08; 
N, 8. 80%; M, 477. 317754). 
3. 10. viii 3p-Hydroxy-2'-thiocyanato-5a-androst-16-eno[17, 16-d]-
pyrimidine (145). 
Starting -ketoaldehyde: 3-Hydroxy- 16-hydroxymethylene-5ct-androstan-
17-one (7). 
Silica gel chromatography (eluant methylene chloride-ethanol, 
95:5) followed by recrystallisation from ethanol gave 33-hydroxy-2'- 
thiocyanato-5ct-anadrost- 16-eno[17, 16-d]pyrimidine (145) (75%), m. p. 
192-194°; i. r. , 1 max 3600 (OH), 2160 (SCN), 1580, 1535, 1445, 1410, 
1370 and 790 cm '; 'H n.m. r. (100 MHz), 6 0.85 (s, 3H, 18-CH3 ), 
0. 97 (s, 3H, 19-CH3), 4. 02 (s, 1H, 3-H), and 8.35 (s, H, 61 -H) 
(Found: C, 69. 10; H, 7.75; N, 10.95; M+,  383.203Z89, C 22H29N30S 
requires C, 68. 89; H, 7.63; N, 10. 96%; M, 383. 203123 ). 
3.10. ix 	3-Methoxy-2'-thiocyanato-oestra-1,3, 5(10), 16-tetraeno- 
[17, 16-d]pyrimidine (148). 
Starting p-ketoaldehyde: 16-Hydroxymethylene-3-methoxyoestra-1, 3,5-
(10)trien-17-one (9). 
Silica gel chromatography (eluant methylene chloride-ethanol, 
95:5) followed by recrystallisation from ethanol gave 3-methoxy.-2'-
thiocyanato-oestra-1,3,5(10), 16-tetraeno[17, 16-d]pyrimidine (148) (72%), 
in. p.  177-179°; 1. r. 	y max 2160 (SCN), 1605, 1575, 1535, 1500, 1460, 
1410 and 780 cm- 1; 'H n.m. r. (60 MHz), 6 1.00 (s, 3H, 18-CH 3 ), 
3. 75 (s, 3H, 3-OCH3), 6. 60-7. 25 (m, 3H, 1-H, 2-H and 4-H), 8. 35 (s, 
1H, 6-H) (Found: C, 69. 65; H, 6. 25; N, 10. 65; M, 377. 154 98 1. 
C 22H23N30S requires C, 69-99; H, 6. 15; N, 11. 13%; M, 377. 156176). 
3. 10.x 	173_Hydroxy-17a.-methy1-6'-(1,3,4-thiadiazol-2-y1carbamoyl)- 
2'-thiocyanato-5a-androst-2-eno[3, 2-d]pyrimidine (149). 
Starting material: 1 7f3-Hydroxy- 2- methoxyc arbonyl(hydr oxy)methylene - 
l7ct-methyl-5ct-androstan-3-one (113). 
Silica gel chromatography (eluant methylene chloride-ethanol, 
95:5) followed by recrystallisation from ethanol gave 1713-hvdroxv--17a-
methyl-6'-(l, 3,4-thiadiazol-2-ylcarbamoyl)-2'-thiocyanato-5a-androst-2- 
eno[3, 2-d]pyrimidine (149) (65%),  m. p.  244-2460; i. r. 1 max 	/ 3505 (OH), 
3330 (NH), 2160 (SCN), 1690 (CO), 1510, and 745 cm '; 'H n. m. r. 
(100 MHz), 6 0. 77 (s, 3H, 18-CH3), 0. 87 (s, 3H, 19.-OH3), 1. 20 (s, 3H, 
17-CH3 ), 8.90 (s, lH, 5"-H), and 12. 0 (bs, 1H, NH) (Found: C, 59.70; 
H, 4.20; N, 16.20; M+,  524.204927.. C26H32N602 S2 requires C, 
59.51; H, 4.41; N, 16.09%; M, 524.202805), 
3. 10.xi 6-(l,3,4-Thiadiazol-2-ylcarbamoyl)-2'-thiocyanato-5a-c hole st-
2-eno[3, 2.-d]pyrimidine (151). 
Starting material: 2- Methoxycarbonyl(hydr oxy)methylene- 5a-chole st-
an-3-one (114). 
Silic al gel chromatography (eluant methylene chloride -ethanol, 
95:5) followed by recrystallisation from ethanol gave 6'-(1, 3,  4-thiadiazol-
2-y1carbamoyl)-2' -thiocyanato-5a-chole st-2-.eno[3, 2-d]pyrimidine (151) 
( 71%), m.  p.  311-3140; i. r. 	' max 3330 (NH), 2160 (SON), 1690 (CO), 
1500, and 735; 	'H n.m. r. (100 MHz), 6 0. 72, 0. 82, 0.90 and 0.96 
(methyl groups), 6. 16 (s, 1H, 6-H) and 8. 22 (s, 1H, 61 -H) (Found: 
C, 64.95; H, 7.5; N, 13.5; M+,  606.317398. C33H46N60S2 requires 
C, 65.31; H, 7.58; N, 13.85%; M, 606.317434). 
3. 10. xii 33_Acetoxy_2T_thiocyanato_5a_androst_16_eno[17, 16-d}- 
pyrimidine (1) 
A solution of 313-hydroxy-2'-thiocyanato-5a-androst-16-eno[17, 16-
d]pyrimidine (145) (383 mg 1 x 16 3mol) and a few drops of acetic 
anhydride in pyridine (20 ml) was refluxed for 2 h. The solvent was 
evaporated in vacuo and the residue taken up in chloroform. The chloro-
form solution was washed with water, 5% hydrochloric acid, saturated 
sodium chloride solution and dried over anhydrous magnesium sulphate. 
Alter removal of the solvent, the residue was recrystallised from ethanol 
to give 3-acetoxy-2'-thiocyanato-5a-androst- 16-eno[1 7, 16-d]pyrimidine 
(146) (225 mg, 53%), m. p.  175-177; i. r. 	' max 2160 (SCN), 1720 (CO), 
1580, 1540, 1450, 1410 and 900 cm '; 1H n. m. r. (100 MHz), 6 0. 90 (s, 
3H, 18-CH3), 1. 00 (s, 3H, 19-CH3), 2. 00 (s, 3H, 3-OCOCH3), 4. 66 
(m, 1H, 3-H) and 8.50 (s, 1H, 6'-H) (Found: C, 67.40; H, 7.00; N, 
9.90; M+,425.  214789. 	C 24H31N302S requires C, 67. 73; H, 7.29; 
N, 9.87%; M, 425.213686). 
3. 10. xiii 3- Oxo-2' -thioc yanato- 5o.-andr ost- 16-eno[1 7, 16- d]pyrimidine 
(147). 
3-Hydroxy-2'-thiocyanato-5a-androst- 16-eno[17, 16-d]pyrimi din e 
(145) (190 mg, 5 x lO 4mole) in acetone (60 ml) was oxidised with 8N 
chromic acid (2 ml). The reaction was allowed to proceed for 4 mm 
and the excess reagent was decomposed with methanol (10 ml). Water 
(30 ml) was added, the organic solvents removed under reduced pressure 
and the steroid was filtered, washed with water and dried. Recrystallisa-
tion of the crude product from ethanol gave white crystals of 3-oxo-2'-
thiocyanato-5a-androst-16-enq[17,16-d]pyrimidine (147) (80%), m. p. 
226-228°; i. r. , y 
max 
 2160 (SCN), 1700 (CO), 1575, 1535, 1440, 1410 
and 790 cm; 1H n. m. r. (100 MHz), 6 1. 00 (s, 3H, 18-CH3 ), 1. 10 (s, 
3H, 19-CH3), and 8.40 (s, lH, 6-H) (Found: C, 68.95; H, 7.25; 
N, 10. 75; M+, 381.187281- C22H27N30S requires C, 69. 26; H, 
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4 	The reaction of steroidal 3-ketoaidehydes with 4-amino- 
1, 2, 4- triazole. 
4. 1 The reaction of 1 713-hydroxy-  2-hydroxymethylene- 17 a-methyl-
5a-androstan- 3-one (108) with 4-amino-1, 2, 4-triazole (83). 
A solution of 1 7f3-hydroxy- 2-hydroxymethylene- 17 a-methyl- 5 a-
androstan-3-one (108) and 4-amino-1, 2, 4-triazole (83) in dry toluene 
containing a catalytic amount of toluene-4-sulphonic acid was refluxed 
overnight. After evaporation of the solvent under vacuo, the residue 
was chromatographed over alumina. Elution with chloroform-ethanol 
(9:1) mixture, followed by r ecrystallisation from chloroform- ethanol 
gave a white solid (154), m. p.  200-202, in 78% yield. 
Elemental analysis indicated that the product had a molecular 
formula of C 25H36N80 (mol. wt. 464) whilst its mass spectrum showed a 
molecular ion peak at m/e 395. The u. v. spectrum showed 7's, 	at 
max 
320 nm (log 6 4. 20) and the i. r. spectrum (in nujol) showed absorptions 
at 3400, 3100, 1630, 1555, 1500, 1460, 1375, 1190 and 1060 cm '. 
The 1H n. m. r. spectrum exhibited absorptions at 6 0. 75 (3H), 0. 85 (3H), 
1. 20 (3H), 7. 37 (1H), 8. 25 (2H), 8. 52 (1H), 8.62 (lH) and 10.5 (1H). 
Similarly the reaction of 2-hydroxymethylene- 5 a- choles tan- 3-one 
(110) with 4.-amino-1, 2,4-triazole afforded a product (156) in 80% yield 
which had properties similar to that of (154). 
1)4 
4. 2 Discussion 
The presence of eight nitrog ens in the molecular formula 
C 25H36N80 indicates that the product (154) arises from the condensa-
tion of two moles of 4-amino- 1, 2,4-triazole (83) with each mole of 1713-
hydroxy- 2-hydroxymethylene- 17 a- methyl- 5 a-andros tan- 3-one (108). 
Condensation of the amino group of the triazole with each of the carbonyl 
groups in the steroid (108) leads to a bisanil 1713-hydroxy-17 a-methyl-
2(4N-methyleneamino- 1, 2, 4-triazolyl)- 3-(4N-amino- 1, 2, 4-triazolyl)- 
5a-androst-2-ene (154). 	The i. r. spectrum (in nujol) of the steroid 
(154) exhibits absrptiots at 3400 cm 
1 
 and 3100 cm . The absorption 
at 3400 cm '  is assigned to the hydroxyl group at position 17. The 
absorption at 3100 cm '  could not be definitely assigned, though it 
appears to be a characteristic of the 1, 2,4-triazole ring system rather 
than a N-H vibration; 6-methyl-s-triazolo[4, 3-b]pyridazine (157) and 
8-methyl-s-triazolo[4, 3-b]pyridazine (158) which contain no NH groups 
also exhibit a similar absorption at 3130 cm '  (section 9, page 168). 
The N-H bond in the hydrogen bonded steroid (154). might have been 
broadened and lowered to around 3000 cm '  where it would be hidden by 
the C-H bands. The structure (154) is supported by the 'H n. m. r. 
spectrum which exhibits signals at 67. 37 (s, -NCH-), 68. 25 (s, 
triazole 2H's), 68.52 and 68.62 (each s, triazole 2H's) and 610.50 
(s, NH). The signal at 610. 50 disappears on addition of deuterated 
water which indicates that the product (154) has one labile hydrogen. 
The 
1
H n. m. r. spectrum also shows that the bisanil exists preferentially 
in the form (154) rather than in the form (154a) or (154b). The structure 
(154a) does not have any hydrogen attached to nitrogen and therefore the 
bisanil would not be expected to give a signal at 5 10. 5 and the proton 
Ia 
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Ha would be expected to give a doublet around 6 7. 37 because of 
coupling with the proton at position 2. The structure (154b) would be 
expected to show two doublets around 6 7.82 and 611.90 arising from 
51 
the coupling of the two protons Ha and Hb as Burgess has shown that 
17P -hydroxy-  17 a- methyl- 2(2T_pyridylaminomethylene)_5  a-androstan-
3-one (159) exhibits two doublets at 6 7.82 and 611.88 each with a 
coupling constant, J = 11.5Hz, corresponding to protons Ha and Hb 
respectively. 
The mass spectrum does not show a peak corresponding to the 
molecular ion of the steroid (154) but indicates a molecular ion at m/e 
395 due to the formation of the nitrile (155) which arises by the loss of 
a 1, 2, 4-triazole fragment from the bisanil (154). 
The system of conjugated double bonds extending to the two triazole 
rings is the longest chromophore in the molecule and can be expected 
to give the highest ?s max at 320 nm in the u. v. spectrum. 
All attempts to cyclise the product (154) by heating it either in 
dimethyl formamide or in xylene for 12 h failed and the starting corn-
pound (154) was recovered in good yield. 
4. 3 The reaction of 1 73 -hydroxy- 2-hydroxym ethyl eneandro st-4 - 
en-3-one (4) with 4-amino-1, 2,4-triazole (83). 
A solution of 1 7t  -hydroxy- 2-hydroxymethyleneandrost-4- en- 3-one (4) and 
4- amino -i, 2,4-triazole (8 3) in dry toluene containing a catalytic amount 
of toluene-4-sulphonic acid was refluxed overnight. The solvent was 
evaporated and the residue was chromatographed over alumina. 












large yellow crystals (160), m. p. 243-245°, in 37% yield. 
Mass spectrometry and elemental analysis showed that the 
product had a molecular formula of C 22H28N40. The u. v. spectrum 
showed 7s max at 243, 250 and 288 nm (log £ 4.40, 4.42 and 3.95). 
4.4 Discussion 
The i. r. spectrum of the product obtained by the condensation of 
4-amino-1, 2, 4- triazole with 1 71  -hydroxy- 2-hydroxymethyleneandros t-
4-en- 3-one (4) exhibits absorptions at 3130 (w), 1630, 1615, 1485, 1440 
and 1375 cm which resemble the absorptions in the i. r. spectra of 6-
methyl- and 8-methyl-s-triazolo[4, 3-b]pyridazines (157) and (158). 
Thus the condensation product appears from its i. r. spectrum and 
molecular formula 0 22H28N4 0 to be a derivative of s-triazolo[4, 3-b]-
pyridazine (67). In the condensation of 4-amino-i, 2,4-triazole (83) 
with P-dicarboayl compounds, ambiguity in the identity of the products 
arises from the two possible reaction sites. Therefore two possible 
structures (160) and (161) were postulated for the product obtained by 
the condensation of 4-amino-1, 2,4-triazole with the 3-ketoaldehyde 4). 
However, 'H n. m. r. and 
13 
 C n. m. r. spectroscopy show that the con-
densation product has structure (160). 
The 'H n. m. r. spectrum of the condensation product (160) shows 
signals at 6 0.85 (s, 18-CH3), 1. 05 (s, 19-CH3), 3. 70 (t, 17-H). 
6• 
27 (s, 4H), 7.70 (s, 8!_H),  and 8.90 (s, 31 -H), the assignment of the 
chemical shifts to 3'-H and 8'-H being based upon the earlier studies of 
s-triazolo[4, 3-b]pyridazines. 129 Of particular interest in 'H n. m. r. 
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- 	Fig. 1: 	n. m. r. spectrum of 17P-hydroxyandrost-4-eno[3, 2-f]-s-triazolo- 
[4, 3-b]pyridazine (160). 
spectrum is the fact that the 8'-H singlet is broadened due to a small 
long range coupling with the 1-C methylene protons. This long range 
coupling was confirmed by double resonance experiments, irradiation 
at the frequency of the methylene protons sharpened the broad signal 
of the 8'-H. Similar long range coupling has been reported in 5-triazolo- 
[4, 3-b]pyridazines 
129 
 where it was observed that the methyl group 
protons at either positions 8 or 7 of s-triazolo[4, 3-b]pyridazine (67) 
are coupled with the 7-H or 8-H respectively (J = 1. 2Hz). Coupling 
between methyl protons at position 7 and the 6-H has not been observed, 129 
therefore the alternative structure (161) for the condensation product is 
discounted since it would be expected to show a sharp singlet for the 
6t_H due to the absence of long range coupling. 
The structure (160) is also supported by the fact that the chemical 
shifts, 6 8. 90 and 6 7. 70 of 3'-H and 8'-H respectively in the 'H n. m. r. 
spectrum of the condensation product (160) are identical with that of 3-H and 
10-H in 6,7,8, 9-tetrahydro-s-triazolo[4, 3-b]cinn dli ne (164)130  where 
the fusion of the heterocyclic system with the cyclohexane ring is 
similar to that in the steroid structure (160). The signal for the 10-H 
in the 'H n. m. r. spectrum of the compound (164) was also found to be 
split into a triplet by a small long range coupling with the 9-C methylene 
protons (J = 1Hz). 
The assignment for structure (160) is further supported by the 
13C n. m. r. spectrum (Fig. 1). The 13C-chemical shifts of the aromatic 
ring carbons of the triazolopyridazine (160) are given in the Table 1 along 
with those of the two model compounds s-triazolo[4, 3-b]pyridazine (67) 
Table 1 
13C-Chemical shifts of steroidal s-triazolo[4, 3-b]pidazines (p. p. m. ) 
Compound 	3 1 -C 	61 -C 	7-C 	81 -C 	8'a-C Other carbons 
(67) 	139. 04 146. 57 121. 20 124. 61 	143. 31 
(160) 	137.95 150.91 	130.43 	119.58 	143.89 4-C, 117.44; 
5-C, 161.24 
(163) 152. 50 144. 55 	123. 04 	125. 92 	144. 05 
(2-C) 
(170) 137. 52 170.58" 	138.31 	118.68 	144. 05 	C=O, 170.34'  
(172) 137. 38 170.44"' 	138.43 	118. 76 	144.25 	5-C, 140.14 
6-C, 121.49 
C=O, 170. 14 
These values could be interchanged. 
Jo 
and s-triazolo[l, 5-b]pyridazine (163). 131 The assignments quoted for 
the chemical shifts of the five carbons of the steroid (160) follow directly 
by analogy with the values allocated to the comparable ring system (67). 
The chemical shift of 81 -C (119. 58 p. p.m.) in the condensation product 
(160) is found to be in agreement with the chemical shift of 8-C (124.61 
P. p_ m.) in the triazolopyridazine (67) thus confirming a linear fusion of 
the steroid to the heterocyclic system. If the condensation product 
had had the angular structure (161) the chemical shift of 6'-C would 
have been expected to appear in the region of 146. 57 p. p. m. , which is 
the value assigned to 6-C in the compound (67). 
Isomerisation of fused triazoles by acid, base or heat has been 
reported. 
132 
 However, no such transformation was encountered 
during the reaction of 4-amino-1, 2,4-triazole with 173-hydroxy-2-
hydroxymethyleneandrost-4- en- 3-one (4) in refluxing toluene (24 h) 
and indeed the condensation product (160) was recovered unchanged 
after being heated with either formic acid for 12 h or pyridine for 3 h. 
The spectroscopic evidence quoted above which shows that the condensa-
tion product has structure (160) also excludes the isomeric structure 
(162). Reimlinger and Pieren133  as well as Paudler and Helmic 6  
have shown that, in a series of triazolopyrimidines, the triazole proton 
with N-4 of the triazole ring at a ring junction (as in 160) is deshielded 
in comparison with the triazole proton in the isomeric series with the 
triazole N-1 at the ring junction (as in 162). If the condensation product 
had had structure (162), the triazole proton would have had a chemical 
shift comparable to that of the corresponding proton at 2-C (6 8. 38) in 
s-triazolo[l, 5-b]pyridazine (163). 	The low field triazole proton 
(165) 
H 
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in the condensation product is in fact observed at 6 8. 90. This 
corresponds closely to the chemical shift of the proton at 3-C (6 9. 15) in 
s-triazolo [4,3-b]pyridazine (67), 
129
indicating that the structure (160) 
is correctly written with N-4 of the triazole ring occupying the bridgehead 
position. 
Conclusive support for the structure (160) rather than the isomeric 
structure (162) again comes from 13C n. m. r. spectroscopy. One 
major difference between the carbon atom 2 of s-triazolo[1, 5-b]pyridazine 
(163) and the carbon atom 3 of s-triazolo[4, 3-b]pyridazine (67) is that 
2-C of pyridazine (163) is bonded to two ring nitrogens whereas 3-C of 
pyridazine (67) is bonded to a ring nitrogen and a bridgehead nitrogen. 
For nitrogen heterocyclic systems, the carbons bonded to nitrogen atoms 
are known to be appreciably deshielded relative to benzene while 3-
carbons are shielded. 
135 
 Nitrogen atoms at bridgehead positions, 
however have little deshielding effect on the adjacent carbon atoms due 
to the significant delocalisation of the lone pair of electrons. 136 Thus 
the chemical shift of 2-C in pyridazine (163) occurs further downfield 
(152. 5 p. p. m.') as compared to the chemical shift of 3-C in pyridazine 
(67) which occurs at 139. 04 p. p. m. In the 13C n. m. r. spectrum of 
the steroidal triazolopyridazine, the chemical shift of 3'-C is found 
to be 137. 95 p. p. m. , consistent with the structure (160). 
It has been accepted that the initial step of the base- and acid-
catalysed Dimroth-type rearrangements involve an equilibrium-controlled 
covalent hydration process with the initial addition of OEPat position 7 
of the azaindolizine nucleus (166).8 Oe This step is followed by a tautomeric 
ring opening of the 6-membered ring to a carbonyl intermediate analogous 
to (167). This species then cyclises to the rearranged azaindolizine 
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(173) 
(168). 	Thus it is evident that the rearrangement of azaindolizine (166) 
to (168) involves the fission of bond 7-8 and this is unlikely to occur if 
position 7 is occupied by a nitrogen atom. 	This justifies the stabilities 
of s-triazolo[4, 3_b]pyridazines80  towards acids and bases. 
Regardless of the nature of the aminoazole, most of the studies 
show that the exocyclic amino group of the aminoazole reacts 
preferentially with an aldehydic rather than a ketonic group. 
80c 
 Obviously 
this is at variance with the formation of linearly fused product (160) 
from the reaction of 4-amino-1, 2,4-triazole with 2-hydroxym ethylene -3-
oxo steroid (4). The mechanism of this condensation reaction leading 
to the formation of linearly fused product is discussed in section 10. 
4. 5 The reaction of 33-hydroxy-16-hydroxymethy1ene-5a-androstan-
17-one (7) and 4-amino-1, 2,4-triazole (83). 
A solution of 3-hydroxy-l6-hydroxymethylene-5a-androstan- 17- 
one (7) and 4-amino-1, 2,4-triazole (83) in dry toluene containing a 
catalytic amount of toluene-4-sulphonic acid was refluxed overnight. 
The solvent was evaporated in vacuo and the residue was chromatographed 
over alumina. Elution with chloroform followed by recrystallisation 
of the eluate from acetone gave white needles (169), m. p. 287-289
0 
(dec), 
in 78% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 22H30N40. The u. v. spectrum 
showed \ max 215 and 291 rn-n (log 6  427 and 396), whilst the i. r. 
spectrum showed absorptions at 3590, 1515, 1415 and 1375 cm . The 
n. m. r. spectrum exhibited signals at 67.80 and 5 8.95 in addition 
59 
to the signals corresponding to the 18- and 19-methyl protons and 
the proton at 3-C. 
4.6 Discussion 
The 1. r. and u. v. spectra of the condensation product do not 
correlate well with the 1. r. and u. v. spectra of 17-hydroxyandrost-
4-eno[3, 2-f]-s-triazolo[4, 3-b]pyridazine (160) to be of any use in 
determining the structure of the condensation product. This is 
probably because of the presence of 	double bond which is conjugated 
with the aromatic system in the compound (160). However, the signals 
at 6 8. 95 and 6 7.80 in the 'H n. m. r. spectrum of the condensation 
product correlate very well with the signals for 3'-H (68.90) and 81_H 
(57.80) in the 1H n. m. r. spectrum of 17-hydroxyandrost-4-eno[3, 2- 
f]-s-triazolo[4, 3-b]pyridazine (160). 	The signal at 6 7. 80 is also 
found to be broadened by coupling with 15-C methylene protons. 
Therefore on the basis of 1H n. m. r. spectrum, the condensation 
product is formulated as 3-hydroxy-5a-androstano[17,  16-f]-s-
triazolo[4, 3-b]pyridazine (169). The structure is supported by '3C 
n. m. r. spectroscopy. The condensation product (169), was not 
sufficiently soluble in deuterated chloroform to permit its 
13 
 C 3  n. m. r. 
spectrum to be obtained. However, in the '3C n. m. r. spectrum of 
its acetyl derivative (170), the chemical shift of 8'-C (118.68 p. p.m.  ) 
is found to be in agreement with the chemical shift of 8'-C (119.58 p. p.m.) 
in the compound (160), thus confirming the linear fusion of the hetero-
cyclic system to the steroid. 
Under analogous conditions, the reaction of 4-amino-1, 2,4- 
triazole with 3--hydroxy- 16 - hydroxymethyleneandro st-  5-en- i7-one 
and 16-hydroxymethylene-3-methoxyoestra-1, 3, 5(10)-trien-17-one 
gave 3-hydroxyandrost- 5- eno[i 7, 16-f]- s-triazolo[4, 3-b]pyridazine 
(171) and 3-methoxyoestra-1, 3, 5(10)-trieno[17, 16-f]-s-triazolo[4, 3-
b]pyridazine (173) respectively. Acetylation of the sterols (169) and 
(171) gave the corresponding acetyl derivatives (170) and (172). 
The reaction mechanism of these condensation reactions leading 
to the formation of linearly fused products will be discussed in section 
10. 
It is interesting to note that the type of the product(s) formed 
is very much dependent upon the -dicarbonyl compound employed in 
the reaction. For example the reaction of 4-amino- 1, 2, 4-triazole 
with (i) 2-hydroxym ethyl enecyciohexanone gives a mixture of two 
products, 6, 7, 8, 9-tetrahydro-s-triazoio[4, 3-b]cinnoline (164) and 
7, 8, 9, 10-tetrahydro-s-triazoio[3, 4-a]phthalazine (165) (section 9), 
(ii) 2-hydroxymethyiene-3-oxo steroids (108) and (110) without a 
double bond gives the bisaniis (154) and (156) respectively, (iii) 2- 
hydroxym ethylene -3-oxo steroid (4) with 	double bond and 16- 
hydroxymethylene-.17-oxo steroids (7), (8) and (9) gives the linearly 
fused products (160), (169), (171) and (173) respectively. 
0! 
4. 7 Experimental 
General procedure for the condensation reaction. 
A solution of the steroidal 3-ketoaldehyde (1 x 10 3mole), 4- 
amino-i, 2,4-triazole (1.5 x 10 	mole) and toluene -4-sulphonic acid 
(20 mg) in dry toluene (30 ml) was refluxed overnight. The reaction 
mixture was evaporated to dryness, the residue chromatographed over 
alumina (50 g) using either chloroform or 10% ethanol in chloroform 
as the eluant and the product was recrystallised from a suitable solvent. 
For the synthesis of the compounds (154) and (156) an excess of 
4-amino-i, 2,4-triazole (2.3 x 10 3mole) was used. 
4. 7 i 	1 7t3-Hydroxy-  17 a-methyl- 2-(4N-aminomethylene- 1, 2, 4- 
triazolyl)- 3-(4N-amino- 1, 2, 4-triazolyl)- 5 a-androst- 2-ene 
(154). 
Starting 0 -ketoaldehyde: 17P -Hydroxy- 2-hydroxymethylene-
17a-methyl-5a-androstan-3-one (108). 
General: Alumina chromatography (eluant 10% methanol in chloro-
form) followed by recrystallisation from methanol-benzene gave 173-
hydroxy- 17 a- methyl- 2(4N-aminom ethylene - 1, 2, 4 -triazolyl)- 3-(4N-
amino-i, 2, 4-triazolyl)-5 a-androst-- 2- ene (154) (78%), m. p.  200-202°, 
m. s., m/e 395 (M+ -69); u. v. 	max 208 and 320 nm (log 6 3. 95 and 
4. 20); i. r. (nujol), y 
max 
 3400 (OH), 3100 (NH), 1630, 1555, 
1500, 1460, 1375, 1190 and 1060 cm 
l; '
H n. m. r. (60 MHz), 3 0.75 
(s, 3H, 18-CH3), 0.85 (s, 3H, 19-CH3), 1. 20 (s, 3H, 17-CH3), 7. 37 
(s, lH, -N=CH-), 8. 25 (s, triazole 2 H's), 8.52 and 8. 62 (each s, 
triazole 2 H's) and 10. 5 (s, NH, exchanges with D20) (Found: C, 
64.28; H, 7.56; N, 23.95. C 25H36 N80 requires C, 64.65; H, 
7.76; N, 24.13%). 
4.7 ii The attempted cyclisation of 173-hydroxy-17a-methyl-2(4N- 
methyleneamino- 1, 2, 4-triazolyl)- 3-(4N-amino- 1, 2,4-. 
triazoiyl)-5 a-androst- 2-ene (154). 
A suspension of 1 7-hydroxy- 17 a-methyl- 2(4N-methylene-
amino- 1, 2, 4-triazolyl)- 3-(4N-amino- 1, 2, 4-triazoiyl)-5 a-androst- 2-
ene (154) (0.425 g, 1 x 10 3mole) and toluene-4-sulphonic acid (20 mg) 
in xylene (30 ml) was refluxed for 12 h. The excess of xyiene was 
removed under vacuo and the residue was purified by chromatography 
over alumina using 10% ethanol in chloroform as the eluant. Re-
crystallisation of the eluate from chloroform-ethanol gave a white 
solid (275 mg, 65%) which was found to be the starting compound (154) 
by its 'H n. m. r. spectrum. 
The above reaction was repeated using dimethyl formamide 
as the solvent. Again the starting compound (154) was recovered in 
58% yield. 
4. 7 iii 2-(4N-Aminomethylene- 1, 2, 4-triazolyl)- 3-(4N-amino- 1, 2, 4-
triazolyl)-5a-cholest-2-ene (156). 
Starting f3 -ketoaldehyde: 2-Hydroxymethylene- 5 a-cholestan- 3-one 
(110). 
General: Alumina chromatography (eluant 10% methanol in chloro-
form) followed by r ecrystallisation from ethanol- chloroform gave 
white crystals of 2-(4N- aminomethylene- 1, 2, 4- triazolyl)- 3- (4N- 
bi 
amino -1, 2,4-triazoiyi)-5a-cholest-2-ene (156) (80%), m. p.243-245°  
(dec.); m. s., m/e 477 (M+ -69); u. v., 	max 207 and 321 (log 
4.01 and 4.2l); i.r. (nujol), y max 3110 (NH), 1630, 1570, 1460, 
1380 and 1060 cm . 
	
(Found: C, 69.63; H, 9.18; N, 20.14. 
C 32H50 N8 requires C, 70. 28; H, 9. 22; N, 20. 50%). 
4. 7 iv 1 713-Hydroxyandrost-4-  eno[3, 2-fl- s-triazolo[4, 3-bipyridazine 
l6oj. 
Starting 13  -ketoaldehyde: 1713- Hydroxy- 2-hydroxymethyleneandrost-4-
en-3-one (4). 
General: Alumina Chromatography (eluant chloroform) followed by 
recrystailisation from ethanol afforded yellow crystals of 1713-hydroxy-
androst-4-eno[3, 2-fl -s-triazolo[4 , 3-bipyridazine (160) (37%), m. p. 
243-245°; U. v., 	max 243, 250 and 288 nm (log F, 4.40, 4.42 and 
3.95); i. r., y max 3590 (OH), 1630, 1615, 1485, 1440 and 1375 cm '; 
'H n. m. r. (100 MHz), 8 0.85 (s, 3H, 18-CH3), 1.05 (s, 3H, 19-CH 3), 
3.70 (t, 1H, 17-H), 6. 27 (s, lH, 4-H), 7. 70 (s, 1H, 8'-H), and 8. 90 
(s, 1H, 3'-H) (Found: C, 72. 25; H, 7.82; N, 14. 95; M+, 364. 2257. 
C 22H28N40 requires C, 72.48; H, 7.68; N, 15. 37%;  M, 364. 22600)- 
4. 7 v 	313-Hydroxy-  5 a-androstano{17, 16-fl-s-triazolo[4,  3-bpyridazine 
Starting f3-ketoaldehyde: 313- Hydroxy- 16 -hydroxymethylene- 5 a-
androstan-l7-one (7). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from acetone gave white needles of 313-hydroxy-5a- 
androstano[17, 16-f]-s-triazolo[4, 3-b]pyridazine (169) (78%), m. p. 
287-289°  (dec.); u.v., 	max 215 and 291 nm (log6 4.27 and 3.56); 
1. r., Y 
max 
 3590 (OH), 1515, 1415 and 1375 cm 
1; '
H n.m. r. (100 
MHz), 5 0. 90 (s, 3H, 18-CH3), 1. 10 (s, 3H, 19-CH3), 3.60 (m, 1H, 
3-H), 7.80 (s, 1H, 81 -H) and 8.95 (s, lH, 3'-H) (Found: C, 71. 85; 
H 8.30; N, 15.19; M+,  366. 241198. C 22H30 N4 0 requires C, 70. 08; 
H, 8.25; N, 15.30%; M, 366.241949). 
4.7 vi 33-Hydroxyandrost-5-eno17, 16-f}-s-triazolo[4, 3-b]pyridazine 
(171). 
Starting f3 -ketoaldehyde: 3 - Hydroxy- 16 -hydroxymethyleneandro st- 5-en-i?-
one (8). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from ethanol gave white needles of 313-hydroxyandrost-
5-eno{17, 16-f}-s-triazolo{4, 3-b}pyridazine (171) (83%), m. p. 245-247°; 
U. v., 	max 215 and 291 nm (log 6 4. 28 and 3.50); i. r., y 
max 
 3590 
(OH), 1510, 1450, 1430 and 1375 cm- 1; 1H n.m. r. (100 MHz), 5 1.07 
(s ) 3H, 18-CH3), 1. 10 (s, 3H, 19-CH3), 3.55 (m, 1H, 3H), 5.40 (t, 
1H, 6-H), 7.80 (s, 1H, 8t-H) and 8.90 (s, 1H, 3t-H) (Found: C, 72. 25; 
H, 7.70; N, 14.99; M+, 364. 224701. C 22H28N40 requires C, 72.48; 
H, 7.75; N, 15.38%; M, 364. 226300). 
4.7 vii 3-Methoxyoestra-1, 3, 5(10)-trienof 17, 16-fl-s-triazolo(4,  3-
b1pyridazine (173). 
Starting ! -ketoaldehyde: 16- Hydroxymethylene- 3-methoxyo estra- 1, 3, 
5(10)-trien-17-one (9). 
General: Alumina chromatography (eluant chloroform) followed by 
LOW 
recrystallisation from ethanol gave white needles of3-methoxyoestra-
1,3,5(l0)-trieno[17, l6-f]-s-triazolo[4,3-b]pyridazine (173) (85%). 
p. 232-2340; 	1. r. , 1605, 1500, 1450 and 1375 cm '; 	'H max 
m. r. (100 MHz), 6 1. 15 (s, 	3H, 18-CH3 ), 3. 80 (s, 3H, 3-OCH3 ), 
6. 57 - 7.30 (3H, 	1-H, 2-H, 4-H), 7. 80 (s, 1H, 8!_H) 	and 8. 90 (s, 
1H, 31 -H) 	(Found: 	C, 73. 58; 	H, 6. 65; 	N, 15. 21; 	M+,  360. 193466. 
C22H24N40 requires C, 	73. 29; 	H, 	6. 76; N, 	15. 55%; 	M, 360. 195001). 
4. 7 viii 3p-Acetoxy-5a.-androstano[1 7, 16-f]- s-triazolo[4, 3-b]pyri-
dazine (170). 
A solution of 3-hydroxy-5a.-androstano[17, 16-f]-2-triazolo-
[4,3-b]pyridazine (169) (0. 200 g, 5. 14 x 10 4mole) in dry pyridine 
(20 ml) containing a few drops of acetic anhydride was refluxed for 2 h. 
The solution was evaporated to dryness in vacuo. The residue was 
taken up in chloroform, washed with 5% hydrochloric acid solution, 
water and finally with saturated sodium chloride solution. The chloro-
form solution was dried over anhydrous magnesium sulphate, evaporated 
to dryness in vacuo and the residue was recrystallised from ethanol to 
give 33-acetoxy-5a._androstano[l7,  16-f]- s-triazolo[4, 3 -b]pyridazine 
(170)(0.136 g, 61%), m.p.311-313° (dec.); u.v.,7\ 
max 
 214 and 293 
nm (log 6  4.28 and 2.50); i. r. y max 1715 (CO), 1515, 1445 and 1350-
1365 cm '; 1H n.m. r. (100 MHz), 6 0. 92 (s, 3H, 18-CH3), 1. 10 (s, 
3H, 19-CH3 ), 2.02 (s, 3H, 3-OCOCH3), 4. 70 (m, 1H, 3-H), 7. 80 (s, 
1H, 8'-H) and 9. 00 (s, 1H, 3-H) (Found: C, 70. 46; H, 7. 87; N, 
13. 50; M+,  408. 251875. C24H32N40 requires C, 70. 54; H, 7. 83; 
N, 13. 71%;  M, 408. 252512). 
4. 7 ix 3f-Acetoxvandrost- 5-eno[17, 16-fl -s-triazolo[4, 3-bipyrida-
zine (172). 
Treatment of 3-hydroxyandrost-5-eno[17, 16-f]-s-triazolo-
[4, 3-b]pyridazine (170) (0. 200 g, 5.4 x 10 4mole) in the above described 
manner, followed by recrystallisation from methanol gave white needles 
of 3f3-acetoxyandrost-5-eno{17, 16 -fl -s-triazolol4, 3-b1pyridazine (172) 
(67%), m. p.  293-295; i. r. , y max 
 1720 (Go), 1510, 1450, 1430 and 
1375 cm- 1; 'H n. m. r. (100 MHz), 81.15 (s, 6H, 18-CH3 and 19-CH 
3), 
 
2.07 (s, 3H, 3-OCOCH3), 4.65 (m, 1H, 	3-H), 5. 50 (t, 	1H, 	6-H), 7.85 
(s, 	1H, 8'-H) and 9.00 (s, 1H, 3'-H) (Found: C, 	70.02; 	H, 	7.30; N, 
13. 35; M+, 346 (M-60). C 24 H30 N4 0 requires C, 70-93; H, 7. 38; 
















5 	The reaction of steroidal 3-ketoaldehydes with 3-amino- 
pyrazole and its derivatives 
5. 1 	The reaction of 173-hydroxy-2-hydroxymethylene-17a-methyl- 
5a-aridrostan-3-one (108) and 3-aminopyrazole (174). 
A solution of 1 7-hydroxy- 2 -hydroxymethylene- 1 7a.-methyl- 5a-
andr o stan -3-one (108) and 3- amin opyr az ole (174) in absolute alcohol 
was refluxed overnight. The excess of solvent was removed under 
vacuo and the residue was chromatographed over alumina. Elution with 
ethyl acetate-ether (7:3) gave, in order of elution two products (175), 
m. p. 222_224°(34%) and (176), m. p.  186-188° (27%), both recrystallised 
from ethanol. 
Mass spectrometry and elemental analysis indicated that both 
the products (175) and (176) had the same molecular formula C24H33N30. 
The u. v. spectrum of the product (175) showed ? 
max 
 at 232 and 
317 nm (log c 4. 60 and 3. 40) whilst the i. r. spectrum showed absorptions 
at 3590, 1620, 1530, 1445, 925 and 770 cm '. The 'H n. m. r. spectrum 
exhibited, in addition to the signals for 17-, 18- and 19-methyl protons, 
a singlet at 5 8. 15 and doublets at 6 6. 60 and 6 8. 0, each with spin 
coupling constant, J = 2 Hz. 
The u. v. spectrum of the product (176) showed ? 
max 
 at 209, 235, 
238 and 287 nm (log 6  4. 41, 4. 66, 4. 66 and 3. 27) whilst its i. r. spectrum 
exhibited absorptions at 3590, 1625, 1530, 1500, 1440, 1405, 925 and 
765 cm '. The 'H n. m. r. spectrum showed, in addition to the signals 
EOW 
for three methyl groups, a singlet at 5 8. 32 and doublets at 5 6. 46 
and 5 7. 95 each with spin coupling constant, J = 2 Hz. 
5. 2 	Discussion 
In the condensation of 3-aminopyrazole (174), as in the condensation 
of 4-amino- 1, 2, 4-triazole (83) (section 4), with unsymmetrical 3-dicar-
bonyl compounds, ambiguity in the identity of the products results from 
the two possible reaction sites. The i. r. spectra of the two condensation 
products obtained by the reaction of 3-aminopyrazole (174) and 17-
hydroxy-2-hydroxymethylene-17a-methyl-5ct-androstan-3-one (108) show 
no carbonyl absorption. Therefore on the basis of the 1. r. spectra and 
the molecular formula C24H33N30, the two condensation products were 
expected to be 1 73-hydroxy- l7ct-methyl-5a-androst-2-eno[2, 3- g]-
pyrazolo[1, 5-a]pyrimidine (175) and 1 7-hydroxy- 1 7a-methyl-5a-androstano-
[3, 2-f]pyrazolo[1, 5-a]pyrimidine (176). Definite assignment of these 
structures can be made by comparison of the 1. r. , u. v. , 'H n. m. r. and 
13 C n. m. r. spectra of the two products (175) and (176) with those of 
5-methylpyrazolo[1, 5-a]pyrimidine (177) and 7-methylpyrazolo[1, 5-a]-
pyrimidine (178), whose preparation and structure are reported in 
section 9 (page 167). 
The 1. r. spectrum of 5-methylpyrazolo[1, 5-a]pyrimidine (177) is 
found to correlate well with that of isomer (176) whilst the i. r. spectrum of 
7-methylpyrazolo[1, 5-a]pyrimidine (178) correlates well with that of 
isomer (175). 	Of particular interest, in the i. r. spectra of these 
compounds is the region 1500-1630 cm '. The compounds (176) and 
5-methylpyrazolo[1, 5-a]pyrimidine (177) differ from the compounds (175) 
Table 2 
Characteristic 1. r. absorption frequencies (cm) 
Compound 	 y max (cm) 	Compound 	y 
max 
 (cm) 
(175) 	 162O7 	 (176) 	 1625} 
l530J 	 1525 
1500 
(178) 	 1610 s 	 (177) 	
16251 
1540 	 1535 
1505 J 
(189) 	 1625 
1535 
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Fig. 2: u. v. Spectra of 17-hydroxy-17a-methy1-5a-androst-2-eno-
[2, 3-g]pyrazolo[1, 5-a]pyrimidine (175) and 7-methylpyrazolo-
[1, 5-a]pyrimidine (178). 
200 	225 	250 	275 	300 	325 	350 
wavelength (nm) 
Fig. 3: u. v. Spectra of 1 7-hydroxy- 1 7a-methyl-5a-androstano-
[3, 2-f]pyrazolo[1, 5-.a]pyrimidine (176) and 5-methyl-
pyrazolo[1, 5_a]pyrimidine (177). 
07 
and 7-methylpyrazolo[1, 5 -a]pyrimidine (178) in showing an extra 
-1 
absorption in the region 1500-1505 cm 	(Table 2). Thus it is inferred 
from the i. r. spectra that the two products with m. p. 222-224°  and 186-
188°  are 173_hydroxy_17a_methyl_5a_androst_2_eno[2,3_g]pyrazolo[1,5_ 
a]pyrimidine (175) and l7-hydroxy- 1 7a-methyl-5a.-androstano[3, 2_f]-
pyrazolo[1, 5-a]pyrimidine (1 76) respectively. 
The two products (175) and (176) are also distinguished from their 
u. v. spectra. The u. v. spectra of the pyrazolopyrimidine (175) and 
7-methylpyrazolo[1,5-a]pyrimidine (178) are found to show similar 
absorptions (Fig. 2), in contrast to the u. v. spectra of the steroid (176) 
and 5 -methylpyrazolo[ 1, 5- a]pyrimidine (177) which also show similar 
absorptions (Fig. 3). The compounds (176) and (177) differ from the 
compounds (175) and (178) in exhibiting an extra ? max in the region 
228-238 nm. 
Assignment of these structures is further supported by 1H n. m. r. 
spectroscopy. The 1H n. m. r. spectrum of 17-hydroxy-17a-methyl-5a-
androst-2-eno[2,3-g]pyrazolo{1,5-a]pyrimidine (175) shows signals at 
6 0.82 (s, 18-CH3), 0. 90 (s, 19-CH3 ), 1. 25 (s, 17-CH3), 6. 60 (d, 
J = 2Hz, 3'-H), 8. 00 (d, 2'-H) and 8. 15 (s, 5'-) whilst the 'H n. m. r. 
spect rum of 1 7-hydroxy- 1 7-methy1- 5ct-andr ostano[3, 2 -f]pyrazolo-
[1,5-a]pyrimidine (176) shows signals at 6 0.85 (s, 18-CH 3), 0. 92 (s, 
19-CH3), 1.25 (s, 17-CH3), 6. 50 (d, J = 2Hz, 3'-H), 8. 0 (d, 2'-H) 
and 8.37 (s, 7'-H). A number of authors have attempted to show that 
for related nitrogen heterocycles an empirical correlation exists between 
the chemical shifts and the electron densities. However, it has been 
pointed out that the observed chemical shifts are not a very reliable 
Table 3 
'3C-Chemical shifts of steroidal pyrazolo[1, 5-a]pyrimidines (p. p.m. ) 
Compound 2'-C 3 1 -C 3'a-C 5-C 6 1 -C 7'-C Other Carbons 
(175) 143. 68 96.68 147. 70 150. 85 115. 62 142. 96 
(176) 144.48 94. 73 147. 61 158. 98 117.38 133.10 
(177) 145. 01 95. 68 148.30 158. 90 108. 74 134.43 
(178) 144.39 96.97 148.91 148.91 107.42 146.13 
(184) 146. 53 82. 67 148.89 154. 28 119. 10 145. 17 CN, 112. 99 
(185) 147. 19 80. 85 148. 73 163. 94 120. 66 134. 14 CN, 113. 18 
(189) 149. 11 82. 12 149.20 154. 62 119. 71 145.24 CN, 114.43 
CH2CN, 111.63 
(191) 143. 98 96. 08 148.83 149. 00 110.48 149. 00 4-C, 110.73; 
5-C, 162.33 
(203) 144.71 96. 04 149.38 147. 06 120. 06 157. 01 C=O, 170.54 
measure of it-electron density. Nevertheless, available spectral 
evidence from related azoloazines with bridgehead nitrogen, 77, 129, 137-139  
postulate higher 6 value for the proton at position 7' in the steroid (176) 
compared with the 6 value for the proton at position 5' in the steroid 
(175). 	The chemical shift of 7'-H (6 8.37) in the steroid (176) is 
obviously higher than the chemical shift of 5'-H (6 8. 15) in the steroid 
(175) and this further supports the structural assignment of the two 
compounds (175) and (176). 
The most striking difference in the 'H n. m. r. spectra of the 
compounds (175) and (176) is the fact that the signal of 7'-H of the 
compound (176) is broadened due to a small long range coupling with the 
protons at 1-C whereas 5'-H of the compound (175) gives a sharp signal 
because of the absence of any long range coupling. This long range 
coupling between 1-C protons and the 7'-H in the compound (176) possibly 
arises because of the higher bond order of the 6'-7' bond 
8 Od
and was 
confirmed by double resonance experiments. Irradiation at the frequency 
of 1-C protons sharpened the signal of 7'-H. Similar long range coupling 
has been reported 
77 
 in azolo[a]pyrimidines (179) where it was observed 
that the methyl group protons at either positions 6 or 7 are coupled 
with the 7-H or 6-H respectively (J = 1Hz). Coupling between the 
methyl protons at position 5 and the 6-H has not been observed. 77 
The assignments for structures (175) and (176) are also confirmed 
by 13C n. m. r. evidence. The 13C-chemical shifts of the aromatic ring 
carbons of the pyrazolopyrimidines (175) and (176) are given in the 
Table 3. The assignments quoted for the chemical shifts of the five 
carbons of the steroids (175) and (176) follow directly by analogy with 
R3  
R3  
1 	2 	 3 
(180) RH, RC8H17, RH 
(184) 	CN, RZOH, R3=CH 
1 	2 	 3 
(186) R=CN,R=C8H172 R 
2 
3 
(181) 	R1=H, RC8H17 , R=H 
N-NH 	 (185) 
1 	2 	 3 





the values allocated to the model compounds (177) and (178) (section 9). 
The chemical shift of 5'-C (150. 85 p. p.m. ) in the condensation product 
(175) is found to be in good agreement with the chemical shift of 5-C 
(148. 58 p. p. m. ) in 7-methylpyrazolo[1, 5-a]pyrimidine (178), confirming 
an angular fusion of the steroid to the heterocyclic system, whilst the 
chemical shift of 7'-C (133.10 p.p.m. ) in the condensation product (176) 
is found to be in good agreement with the chemical shift of 7-C (134. 43 
p. p. m. ) in 5-methylpyrazolo[1, 5-a]pyrimidine (177) confirming a linear 
fusion of the steroid to the heterocyclic system. 
Under analogous reaction conditions, the condensation of 3-amino-
pyrazole (174) with 2-hydroxymethylene- 5a-chole stan-3 -one (110) gave 
5a-cholest-2-eno[2, 3-g]pyrazolo[1, 5-a]pyrimidine (180) and 5a.-cholestano-
[3, 2-f]pyrazolo[1, 5-a]pyrimidine (181) whilst the condensation of 3-
aminopyrazole (174) with 2-hydroxymethylene- 5a- Spiro stan-3, 11 -dione 
(ill) gave 11-oxo-5a-spirost-2-eno[2, 3- g] pyrazolo[1, 5-a]pyrimidine 
(182) and 1 1-oxo-5a- spirostano[3, 2-f]pyrazolo[1, 5-a]pyrimidine (183). 
Similarly the reaction of 3-amino-4-cyanopyrazole (126) with 
17-hydroxy-2-hydroxymethylene- 17a-methyl-5a.-androstan-3-one (108) 
gave 17p-hydroxy-17a-methyl-5a-androst-2-eno[2,3-g]-3'-cyanopyrazolo-
[l,5-a]pyrimidine (184) and 17p-hydroxy-17a.-methyl-5a-androstano-
[3, 2-f]-3 '-cyanopyrazolo[l, 5_a]pyrimidine (185), and with 2-hydroxy-
methylene-5a-chole stan-3-one (110) gave 5a-cholest-2-eno[2, 3- g]-3 i...  
cyanopyrazolo[1, 5-a]pyrimidine  (186) and 5a-c hole stano[3, 2-f]-3 - 
cyanopyrazolo[l, 5-a]pyrimidine (187). 
It is observed that the angularly fused product becomes the 
major product as 3-aminopyrazole (174) is replaced by 3-amino-4-cyano- 
H0H NCH2CN'NH2  
ON 
(92) 
(108) R1:OH,R2zCH3  




2  R OH, R=CH3 
R1=C8H 2 17, RzH 
pyrazole (126). In one particular example, the reaction of 3-amino-4-
cyanopyrazole (126) with 2-hydroxymethylene-5a- spirostan-3, 11-dione 
(111), only the angularly fused product, 11-oxo-5a-spirost-2-eno[2,3-g]-
3 '-cyanopyrazolo[l, 5_a]pyrimidine (188) was isolated. 
5. 3 	The reaction of 17f3-hydroxy-2-hydroxymethylene-17ct-methyl- 
5ct-androstan-3-one (108) with 3-amino-4-cyano-5-cyanomethyl-
pyrazole (92). 
A solution of 173_hydroxy-2_hydroxymethylene-5a-androstan-3-
one (108) and 3-amino-4-cyano-5-cyanomethylpyrazole (92) in absolute 
alcohol was refluxed overnight. The reaction mixture was allowed to 
cool to room temperature. The white crystals formed were filtered, 
washed with ethanol and dried to give a pure product (189), m. p.  265-2670 , 
in 71% yield. Mass spectrometry indicated that the product had a mole- 
cular formula of C27H33N50. The u. v. spectrum showed \ 	at max 
207, 232 and 313 nm (loge 4. 07, 4.65 and 3.76) and the i.r. spectrum 
had absorptions at 3600, 2220, 1625, 1535, 1490, 1440, 1405, 1380, 960, 
930 and 760 cm- '. The 1H n. m. r. spectrum showed, apart from the 
signals for the methyl groups, a singlet at 6 4. 05 corresponding to two 
protons and another singlet at 6 8.40 corresponding to one proton. 
5.4 	Discussion 
U. v. , i. r. 'H n. m. r. and 
13 
 C n. m. r. spectroscopy show that 
the condensation product of the reaction between 173_hydroxy-2-hydroxy-
methylene-17ct-methyl-5ct-androstan-3-one (108) and 3-amino-4-cyano- 
(3 
5-cyanomethylpyrazole (92) is 17-hydroxy-17a-methyl-5a-androst-2-
eno[2,3_g]_3T_cyano_2_cyanomethylpyrazolo[1,5_a]pyrimidine (189). 
The u. v. spectrum of the product (189) shows only one 
max 
 at 232 nm 
in the region 228-238 nm whilst the 1. r. spectrum (Table 2) exhibits no 
absorption in the region 1500-1505 cm '  but shows two absorptions at 
1625 and 1535 cm 
1 
 comparable to the absorptions at 1620 and 1530 cm '  
in the L r. spectrum of the angularly fused compound (175). The 'H 
n. m. r. spectrum shows two singlets at 6 4. 05 and 6 8. 40 which are 
assigned to 2'-CH2CN and 5'-H, although a downfield shift of 0. 25 p. p. m. 
is noticed for the latter resonance relative to the chemical shift of the 
corresponding resonance in 17-hydroxy-17a-methyl-5a.-androst-2-eno-
[2,3-g]pyrazolo[l,5-a]pyrimidine (175). The singlet at 6 8.40 due to 
5-H is found to be sharp and this is in agreement with the assignment of 
angular structure (189). The structure (189) is further confirmed by 
the 
13 
 C n. m. r. spectrum in which the chemical shift of 5'-C (154. 62 
p. p.m. ) (Table 3) is found to agree with the chemical shift of 5'-C (150. 85 
p. p. m. ) in 173-hydroxy- 17a-methyl-5ct-androst-2-eno[2, 3 -g]pyrazolo-
[1, 5-a]pyrimidine (175). 
Similarly the reaction of 3- amino-4-cyano-5 -c yanomethylpyrazole 
(92) with 2-hydroxymethylene-5a-cholestan-3-one (110) gave 5a-chole st-2-
eno[2, 3-g]-3 _cyano_2T_cyanomethylpyrazolo[1, 5_a]pyrimidine (190). 
It is evident that the substituents on the pyrazole nucleus markedly 
influence the course of the condensation of 3-aminopyrazoles with 2-
hydroxymethylene-3-oxo steroids. Thus the condensation of 3-aminopyraz-
ole (174) with 2—hydroxymethylene-3-oxo steroids gives a mixture of a 
linearly and an angularly fused product and the percentage yield of angularly 
fused product is increased when 3-aminopyrazole (174) is replaced by 
OH 









R1 :CN,RZCH2CN, RH 
1 	2 	3 
R.RH, R = COCH3  
1 	 2 	3 
RCN,RH,R=COCH3 
3-amino-4-cyanopyrazole (126). However, the reaction of 3-amino-4-
cyano- 5-c yanoniethylpyrazole (92) with 2 -hydroxyrnethylene -3 -oxo 
steroids leads exclusively to the formation of angularly fused products. 
5. 5 	The reaction of 173-hydroxy-2-hydroxymethyleneandrost-4- 
en -3-one (4) with 3- an-iinopyr azole (174). 
A solution of 1 7f3-hydroxy- 2-hydroxyrnethyleneandrost-4-en-3 - 
one (4) and 3-aminopyrazole (174) in absolute alcohol was refluxed over-
night. The excess of solvent was removed under vacuo and the residue 
was chromatographed over alumina. Elution with ethyl acetate followed 
by recrystallisation of the eluate from acetone gave yellow crystals 
(191), m. p.  230-2320 , in 72% yield. Mass spectrometry indicated that 
the product had a molecular formula of C23H29N30. The u. v. spectrum 
showed A 
max 
 at 209, 235 (sh), 242, 265 (sh) and 370 mn (log P, 3. 89, 
48, 4. 57 and 3. 98) and the i. r. spectrum had absorptions at 3595, 
1630, 1590, 1520, 1460, 1060, 1045, 895, 860 and 770 cm. The 'H 
n. m. r. spectrum showed a singlet at 5 8. 25 and two doublets at 5 6. 70 
and 5 8. 05 each with spin coupling constant, J = 2Hz. 
6 	Discussion 
The i. r., 	- 1H n. m. r. and 
13 
 C n. m. r. spectra of the condensation 
product of the reaction between 1 7-hydroxy.-2-hydroxymethyleneandrost-
4-en-3-one (4) and 3-aminopyrazole (174) resemble closely the i. r. , 'H 
n. m. r. and 
13 
 C n. m. r. spectra obtained for 17-hydroxy-17a-methyl-5a-
androst-2-eno[2,3-g]pyrazolo[l,5-ajpyrimidine (175), thus the product 
is formulated as 17-hydroxyandrost-2, 4.-dieno[2, 3-g]pyrazolo[l, 5-a]-
pyrimidine (191). The i. r. spectrum of the steroid (191) shows no 
absorption in the region 1500-1505 cm (Table 2), but shows two 
absorptions at 1630 and 1520 cm '  comparable to the absorptions at 1620 
and 1530 cm in the i. r. spectra of the angularly fused product (175). 
The i. r. spectrum also contains an additional absorption at 1590 cm 
which arises because of ns double bond present in the steroid (191). 
In the 'H n. m. r. spectrum, the two doublets at 6 6. 70 and 6 8. 05 are 
assigned to 3'-H and 2'-H respectively whilst the sharp singlet at 
6 8. 25 is assigned to 5t-H. In the 
13 
 C n. m. r. spectrum, the chemical 
shift of 51 -C (149. 00 p. p. m. ) is found to be comparable with the chemical 
shift of 51 -C (150.85 p.p.m.)in 17-hydroxy-17a.-methyl-5a-androst-2-
eno[2, 3-g]pyrazolo[1, 5-a]pyrimidine (175) (Table 3). 
Under analogous conditions, the reaction of 17-hydroxy-2-
hydroxymethyleneandrost-4-en-3 -one (4) with 3 -amino-4-c yanopyrazole 
(126) and 3 - amino- 4-c yano-5-c yanomethylpyrazole (92) gave 1 73-hydroxy-
androst-2, 4-dieno[2, 3-g]-3'-cyanopyrazolo[l, 5-a]pyrimidine (192) and 
173-hydroxyandrost-2, 4-dieno[2, 3- g]-3'-cyano-Z '-cyanomethylpyrazolo-
[1, 5-a]pyrimidine (193) respectively. The 173-acetoxy derivatives (194) 
and (195) were obtained by acetylation of the steroids (191) and (192) 
respectively using acetic anhydride in pyridine. 
5. 7 	The reaction of 313-hydroxy-16-hydroxymethylene-5a-androstan- 
17-one (7) with 3-aminopyrazole (174). 
A solution of 3 -hydroxy- 1 6-hydroxymethylene- So.- androstan-1 7- 
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The excess of solvent was removed under vacuo and the residue was 
chromatographed over alumina. Elution with ethyl acetate followed by 
recrystallisation of the eluate from acetone gave white needles (197), 
m. p. 240-2420 , in 91% yield. Mass spectrometry and elemental analysis 
indicated that the product had a molecular formula of C 23H31N30. The 
u. v. spectrum showed 7 max at 236, and 327 nm (log 6 4. 51 and 3. 38) 
and the i. r. spectrum showed absorptions at 3590, 1600, 1545, 1510, 
1455, 1345, 1030, 900 and 775 cm '. 1Hn.m.r. spectrum showed, 
apart from the signals for 18-CH 
32 
 19-CH3 and 3-H, doublets at 6 6. 70 
and 6 8. 15 each with spin coupling constant, J = 2Hz and a singlet at 
6 8.45. 
5. 8 	Discussion 
The i. r. spectrum of the condensation product obtained by the 
reaction of 33-hydroxy-16_hydroxymethylene-5a-androstan-l7-one (7) 
and 3-aminopyrazole (174) exhibits absorptions at 1600, 1545 and 1510 cm-
in the region 1500-1630 cm 1, these compare well with the absorptions 
in the spectrum of 173-hydroxy-17a.-methyl-5a-androstano[3,2-f]-
pyrazolo[1, 5-a]pyrimidine (176) and thus it was predicted that the 
condensation product had structure (196). However, the condensation 
product is identified by its u. v. , 1H n. m. r. and 
13 
 C n. m. r. spectra as 
3-hydroxy-5a.-androst-16-eno[16, 17-g]pyrazolo[1,5-a]pyrimidine (197). 
The u. v. spectrum of the condensation product (197) and that of 1713-
hydr oxy- 1 7a- methyl- 5ct-androst-2-eno[2, 3- g]pyr azolo[ 1, 5- a]pyrimidine 
(175) both exhibit only one 
max 
 at 232 nm in the region 228-238 nm as 
compared to 
twomax's 
 at 235 nm and 238 nm in the u. v. spectrum of 
the linearly fused pyrazolopyrimidine (176). In the 1H n. m. r. spectrum 
(1 
of the product (197), the 5'-H gives a sharp singlet at 5 8.45. 	In 
the alternative structure (196), the signal at 6.45 would be expected 
to be broadened due to long range coupling between the 7'-H and the 
protons at position 15. 
77 
 The structure (197) is further confirmed by 
13 	 13 
C n. m. r. evidence. In the C n. m. r. spectrum of the acetyl 
derivative (203), the chemical shift of 5'-C (145. 17 p. p.m.) (Table 3) 
agrees well with the chemical shift of 5-C (148. 58 p. p. m. ) in pyrazolo-
pyrimidine (178) and the chemical shift of 5'-C (150-85 p. p.m.) in the 
angularly fused product (175). Therefore it is concluded from u. 
1 	 13 
H n. m. r. and C n. m. r. evidence that the product obtained by the 
condensation of 3-aminopyrazole (174) and 313-hydroxy-  16 -hydroxy-
methylene-5 a-androstan- l7-one (7) is 33-hydroxy- 5 a-androst- 16- eno- 
[16, 17-g]pyrazolo[l, 5-a]pyrimidine (197). 	This behaviour is parallel 
to the one observed in the reaction of 3-aminopyrazole (174) with 17-
hydroxy- 2-hydroxymethyleneandrost-4- en- 3-one (4). 
Under analogous reaction conditions, the condensation of 3-amino-
pyrazole (174) with 3 -hydroxy- 16 -hydroxymethyleneandro s t- 5-en- l7-one 
and 16-hydroxymethylene- 3-methoxyoestra- 1, 3, 5(1 0)-trien-1 7-one 
gave 33-hydroxyandrost_5-16-dieno[16, 17-g]pyrazolo[1, 5-a]pyrimidine 
(198) and 3-methoxyoestra-1, 3, 5(10), 16-tetraeno[16, 17-g]pyrazolo[1, 5-a]-
pyrimidine (199) respectively. The compounds, 3-hydroxy- 5 a-androst-
l6-eno[16, 17-g]-3'-cyanopyrazolo[l, 5-a]pyrimidine (200), 3-hydroxy-
androst-5, 16-dieno[16,  17-g]-3-cyanopyrazolo[l, 5-a]pyrimidine (201) 
and 3-methoxyoestra-1, 3, 5(10), 16-tetraeno[16, 17_ g]_3t_ c yanopyrazolo _ 
[1, 5-a]pyrimidine (202) were also obtained by the reaction of 3-amino-
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(8) and (9) respectively. 
The sterols (197), (198), (200) and (201) were acetylated using 
acetic anhydride in pyridine to give the corresponding 33-acetyl 
derivatives (203)-(206). 
The reaction mechanism of these condensations is discussed in detail 
in section 10, where it is shown that the formation of the linearly fused 
products, resulting from the reaction of 3-aminopyrazole (174) and its 
4- cyano derivative (1 26) with 2-hydroxymethylene- 3-oxo steroids without 
a 	double bond, is a two step reaction. Evidence for this two step 
reaction sequence comes from the condensation of 2(2'-pyr idyl- amino -
methylene)- 5 a-cholestan- 3-one (207) with 3-aminopyrazole (174), which 
is discussed below. 
5.9 	The reaction of 2- hydroxymethylene- 5 a- c holes tan- 3- one (110) 
with 2-aminop\rridine. 
A solution of 2-hydroxym ethylene -5a-choles tan- 3-one (110) and 
2-aminopyridine was allowed to stand at room temperature overnight. 
The product was recovered by evaporation of the solvent and extraction 
of the residue with chloroform. The crude product was chromatographed 
over alumina and recrystallisation of the eluate from acetone gave yellow 
crystals (207), m. p.  135-138°, in 60% yield. 
Mass spectrometry and elementary analysis indicated that the 
product had a molecular formula of C 33H50N20. The i. r. spectrum 
had absorptions at 1640, 1590, 1545, 1475, 1440, 1415, 1360 and 770 cm:1  
The 
I 
 H n. m. r. spectrum showed signals at 66. 60-6.95 , 6 7. 50 and 
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Fig. 5: 13 C n. m. r. (spin coupled) spectrum of 17-acetoxy-2(2'-pyridylaminomethylene)_5a_androstan-3_one (56) 
'9 
ring and doublets at 67.82 and 6 10.92 each with spin coupling 
constant, 3 = 11. 5Hz. 
5. 10 Discussion 
Burgess 
51 
 has recently investigated the reaction of 2-aminopyridine 
with the steroidal -ketoaldehydes and has shown with the help of i. r. and 
n. m. r. spectroscopy that the product obtained by the reaction of 2-
aminopyridine and 1 7f3 - hydroxy- 2-hydroxymethylene- 5 a- andro stan- 3-one 
(3), has the enaminone structure (56) and not (208). 
Further support for structure (56) by 13C n.m.r. spectroscopy is 
given here. In the 
13
C n. m. r. spin-coupled spectra, the carbons 
attached with hydrogen atoms are readily distinguished, by their large 
C-H couplings, from the tetras ubs tituted carbons which appear as singlets. 
In the 
13
C n. m. r. spectrum (Fig. 4) of the compound (56), the downfield 
signals at 170. 99 p. p.m. and 200. 78 p. p.m. are assigned to the carbon 
of the acetyl group at position 17 and 3-C respectively. It is noticed 
that the signal at 200. 78 p. p. m. corresponding to 3-C remains a singlet 
in the spin-coupled spectrum (Fig. 5) and this is consistent with the 
assignment of enaminone structure (56). If the condensation product 
had had structure (208) the carbon of the aldehyde group at position 2 
would be expected to appear as a doublet in the region of 200 p. p. m. 
Thus by analogy with the structure of 173-hydroxy-2(2'-pyridyl-
aminomethylene)-5a-androstan-3-one (56), the - product obtained by the 
condensation of 2-aminopyridine and 2-hydroxymethylene- 5 a-cholestan- 
3-one (110) is assigned structure (207). 	The doublets at 6 7. 82 and 









respectively. The coupling constant (J = 11.5Hz) between the two 
doublets is consistent with those reported for 17-acetoxy-2(2'-pyridy1-
aminomethylene)-5a-androstan-3-one (56)51  and 2-(2acetylviny1amino)- 
140 
pyridine (209) 	and indicates that the two protons are trans to one 
another. 
5. 11 The reaction of 2(2!_pyr  idyl-  aminomethylene)_5a_choles  tan-  3_ 
one (207) with 3-aminopyrazole (174). 
A solution of 2(21 -pyridyl-aminomethylene)- 5 a-cholestan- 3-one 
(207) and 3-aminopyrazole (174) in dry toluene containing a catalytic 
amount of toluene-4-sulphonic acid was reflu.xed for 7 h. The solvent 
was removed in vacuo and the residue was chromatographed over 
alumina. Elution with ethyl acetate followed by recrystallisation of the 
eluate from ethanol gave white crystals (60%), m. p.  138-1400 , identical 
(m. p.,  1. r. and 'H n. m. r.) with that of 5a-cholestano[3, 2-f]pyrazolo-
[1, 5-a]pyrimidine (181). 
The formation of 5a-cholestano[3, 2-f]pyrazolo[l, 5-a]pyrimidine 
(181) from 2(2'-pyridyl-aminom ethylene) - 5 a-cholestan- 3-one (207) and 
3-aminopyrazole (174) shows that the condensation of 2-hydroxym ethylene -
3-oxo steroids with 3-aminopyrazole is a two step reaction. It also 
indicates that 3-aminopyrazole reacts first with the 2-formyl group of 
the steroid and not with the 3-carbonyl group as it might appear from 
the structure of the final condensation product (see section 10). 
5. 1 . 	Exp.m ental - 
General irocedure for the condensation reaction 
A solution of the steroidal -ketoaldehyde (1.5 x 10 3mole) and 
3-aminopyrazole (174) or its derivative (92 or 126) (2 x lO 3mole) in 
absolute alcohol (30 ml) was refluxed overnight. The reaction mixture 
was evaporated to dryness under vacuo, the residue was chromatographed 
over alumina (50 g) and the crude products thus obtained were recrystal-
used from suitable solvents. 
5. 12. i 1713-Hydroxy- 17 a-methyl- 5a-androst- 2- enof 2, 3-g]pyrazolo- 
[1, 5-a]pyrimidine (175) and 1 7-hydroxy- 17 a-methyl-5 a-
androstano[3, 2-f]pyrazolo[1, 5-alpyrimidine (176). 
Source: 1 7 -Hydroxy- 2-hydroxymethylene- 17 a- methyl- 5 a-androstan-
3-one (108) and 3-aminopyrazole (174). 
General: Alumina chromatography (eluant ethyl acetate-ether, 7:3). 
j-Hydroxy- 17 a-methyl- 5 a-androst- 2- eno{2, 3-glpyrazolo[1, 5-al -
pyrimidine (175) was recrystallised from ethanol as long white needles 
( 34%), m. p.  222-224°; u. v., 	max 232 and 317 nm (log E 4. 60 and 
3.40); i. r., i 
max 
 3590, 1620, 1530, 1445 and 770 cm '; 'H n. m. r. 
(100 MHz), 5 0.84 (s, 3H, 18-CH3), 0.90 (s, 3H, 19-CH), 1. 24 (s, 
3H, 17-CH3), 6.62 (d, J2Hz, lH, 3'-H), 8.03 (d, J2Hz, lH, 2t-H) 
and 8. 20 (s, lH, 5'-H) (Found: C, 75.69; H, 8.70; N, 10.88; M+, 
379.261508. C 24H33N30 requires C, 75.93; H, 8.77; N, 11.08%; 
M, 379. 262349). 
1 73-Hydroxy- 17 a-methyl- 5 a-androstanol3, 2-flpyrazolo{1, 5-alpyrimidine 
(176) was recrystallised from ethanol as light brown crystals (27%), m. p. 
186-188°; u.v., 
max 
 209, 235, 238 and 287 nm (loge 4. 41, 4. 66, 
4.66 and 3. 21); i. r. , y 
max 
 3590 (OH) 1625, 1530, 1500, 1440, 1405 
and 765 cm 
1; '
H n.m. r. (100 MHz), 5 0.80 (s, 3H, 18-CH3), 0.87 
(s, 3H, 19-CH3), 1.22 (s 3H 17-CH3), 6.46 (d, J=2Hz, 1H, 3'-H), 
7.95 (d, J=2Hz 1H, 2'-H) and 8.32 (s, 1H, 7'-H) (Found: C, 75. 73; 
H, 8.87; N, 10. 97; M+ 379. 261132. C 24 H33N30 requires C, 75-39; 
H, 8.77; N, 11.08%; M, 379.262349). 
5. 12. ii 5a-Cholest-2-eno[2, 3-gpyrazolo[1, 5-alpyrimidine (180) and 
5a-cholestano[3, 2-flpyrazolo[l, 5-apyrimidine (181). 
Source: 2-Hydroxymethylene- 5 a-cholestan- 3-one (110) and 3-amino-
pyrazole (174). 
General: Alumina chromatography (eluant ether). 
5 a-Cholest- 2- enol2,  3-gipyrazololl,  5-alpyrimidine (180) was recrystallised 
from ethanol as white crystals (35%),  m. p.  165-1670 (dec. ); u. v. , max 
283 and 317 nm (log 6  4. 59 and 3. 19); i. r. , 	max 1620, 1530, 1450, 
1440, 795 and 770 cm 
1; '
H n.m. r. (100 MHz), 5 0. 70, 0.80, 0.84, 
0. 90 (methyl groups), 6.62 (d, J=2Hz, lH, 3'-H), 8.02 (d, J=2Hz, 1H, 
2'-H) and 8. 20 (s, 1H, 5'-H) (Found: C, 80. 76; H, 10. 08; N, 9.04; 
M+, 461. 376241. C 31H47N3 requires C, 80.63; H, 10. 27; N, 9.11%; 
M, 461. 376980). 
5 a-Cholestano[3, 2-f]pyrazolo[l, 5-alpyrimidine (181) was recrystallised 
from ethanol as long yellow needles (18%),  m. p.  138-140°; U. V. , max 
206, 229, 233 and 280 nm (log 6  4. 33, 4. 76, 4.74 and 3.56); i. r. 
max 1620, 1530, 1500, 1465, 1450, 1405 and 765 cm 1; 'H n. m. r. 
(100 MHz), 50. 70, 0. 80, 0. 84, 0. 90 (methyl groups), 6.47 (d, 3=2Hz, 
1H, 3'-H), 7.98 (d, J2Hz, 1H, 2-H) and 8.32 (s, 1H, 7'-H) (Found: 
C, 80.41; H, 10.35; N, 8.83; M+,  461.376241. 	C 31H47N3 requires 
C, 80.63; H, 10.27; N, 9.11%; M, 461.376980). 
5. 12. iii 11 -Oxo-5 a-spirost- 2- eno[ 2, 3-gpyrazolo[1, 5-alpyrimidine 
(182) and 1 l-oxo-5 a-spirostano[3, 2-fipyrazololl,  5-apyrimidine 
Source: 2-Hydroxymethylene-5a-spirostan-3, 11-dione (111) and 3-
amino pyrazole (174). 
General: Alumina chromatography (eluant ethyl acetate-ether, 1:3). 
11 -Oxo-5 a- spirost- 2- enof 2, 3_glpyrazolo[1, 5-a]pyrimidine  (182) was 
recrystallised from acetone as white crystals (40%),  m.p. 243-2450 ; 
U. V. , 	max 207, 227 and 314 rim (log E 4. 33, 4.62 and 3.96); i. r. 
Y max 1700 (CO), 1620, 1530, 1450, 1380, 1350 and 770 cm- 1; 'Hn.m.r. 
(100 MHz), 5 0.78 (s, 3H, 18-CH3), 1. 04 (s, 3H, 19-CH3), 6.63 (d, J 
2Hz, 1H, 31 -H), 8.05 (d, J=2Hz, 1H, 2'-H) and 8. 20 (s, 1H, 5t-H) 
(Found: C, 73. 68; H, 8. 27; N, 7.95; M+,  503. 312372. C 31H41N30 
requires C, 73. 91; H, 8. 21; N, 8. 35%;  M, 503. 314775). 
11-Oxo-5a-spirostanol3, 2_f]pyrazololl, 5-alpyrimidine (183D was re-
crystallised from ethanol as yellow crystals (27%), m. p.  270-272°; u. v., 
max 208, 231, 280 and 316 nm (log a 4. 22, 4. 70, 3.57 and 3. 53); 
i. r., y max 1695 (CO), 1620, 1500, 1445, 1405, 1380 and 765 cm 1; 
n. m. r. (100 MHz), 50. 78 (s, 3H, 18-CH3), 1.02 (s, 3H, 19-CH 3), 
 
6.45 (d, 3=2Hz, 1H, 3'-H), 7.96 (d, J2Hz, 1H, 2'-H) and 8.35 (s, 1H, 
7'-H) (Found: C, 73. 73; H, 8. 22; N, 8. 20; M+,  503 312836. 
C 31H41N303 requires C, 73. 91; H, 8. 21; N, 8.35; M, 503. 314775). 
5. 12. iv 17t3-Hydroxy- 17 a-methyl-5a-androst-2-eno[2, 3_g]_3T_cyano_ 
pyrazolc 1, 5-alpyrimidine  (184) and 1 7-hydroxy- 17 a-methyl- 
5a-androstano[3, 2_fl_ 3'_cyanopyrazolo[l, 5-alpyrimidine (185). 
Source: 17P -Hydroxy- 2-hydroxymethylene- 17 a- methyl- 5 a-andro stan-
3-one (108) and 3 -amino -4-cyanopyrazole (126). 
General: Alumina chromatography (eluant ethyl acetate-ether, 3:2). 
1713-Hydroxy- 17 a-methyl-5 a-androst- 2- eno[2, 3- g]-  3'-cyanopyrazolo-
{1, 5-alpyrimidine  (18 was recrystallised from ethanol as white crystals 
(24. 7%), m. p.  246-248°; u. v., 7 max 206, 226 and 315 rim (log F 3.91, 
4.55 and 3.66); i. r. , 1 
max 
 3600 (OH), 2220 (CN), 1620, 1535, 1465, 
1440, 1365 and 755 cm '; 'H n. m. r. (100 MHz), 6 0.84 (s, 3H, 18-CH 3), 
 
0.90 (s, 3H, 19-CH3), 1.24 (s, 3H, 17-CH3), 8.28 (s, 1H, 2'-H) and 
8.42(s, 1H, 5'-H) (Found: C, 73.93; H, 7.86; N, 13.49; M+, 
404. 256375. C 25H32N40 requires C, 74.21; H, 7.98; N, 13.86%; 
M, 404. 256774). 
17f3-Hydroxy-17a-methyl-5a-androstano[3, 2-fl-3'-cyanopyrazololl, 5-al-
pyrimidine (185) was recrystallised from acetone as white crystals 
(18. 5%),  m. p.212-215°; u. v., max 207, 235, 240 and 315 rim (log 6 
4. 05, 4.66, 4.66 and 3.33); i. r., 1 
max 
 3590 (OH), 2220 (CN), 1630, 1510, 
1460, 1440, 1405 and 755 cm 
1; '
H n.m. r. (100 MHz), 5 0.82 (s, 3H, 
18-CH3), 0. 90 (s, 3H, 19-CH3), 1. 22 (s, 3H, 17-CH3), 8. 22 (s, 1H, 
2t-H), and 8.42 (s, 1H, 7'-H) (Foun1 M+,  404. 257598. C 25H32N40 
requires M, 404. 256774). 
5. 12. v 5a-Cholest-2-eno[2, 3-g]-3 1_cyanopyrazolo[1, 5-a]pyrimidine 
(186) and 5a_c hole stano[3, 2_f]_3 1_cyanopyrazolo[1,  5-a]-
pyrimidine (187). 
Source: 2-Hydroxymethylene-5a.-cholestan-3-one (110) and 3-amino-
4-cyanopyrazole (126). 
General: Alumina chromatography (eluant ethyl acetate-ether, 1:1). 
5a.-Cholest-2-eno[2, 3-g]-3  '-cyanopyrazolo{l  5-a]pyrimidine  (186) was 
recrystallised from acetone as light yellow crystals (51%),  m. p.  207-2090 ; 
U. V. , 	232, 279 and 314 nm (log 	4. 58, 3. 73 and 3. 77); jr. ,'y' 
max 	 max 
2220 (CN), 1625, 1535, 1465, 1440, 1375 and 775 cm- 1; 'H n. m. r. 
(100 MHz), 5 0. 70, 0. 80, 0. 82, 0. 88, 0. 95 (methyl groups), 8. 27 (s, 
1H, 2'-H), 8.42 (s, 1H, 5'-H) (Found: C, 78. 95; H, 9.53; N, 11.54; 
M+, 486. 373134. C32H46N4 requires C, 78. 95; H, 9.53; N, 11. 52%; 
M, 486. 372229). 
5a-C hole stano{3, 2_fJ_3  '-cyanopyrazolo[l, 5-a]pyrimidine (187) was 
recrystallised from acetone as light yellow crystals (17%, m. p.  214-217°; 
m/e 486; i. r. , y 
max 
2220 (CN), 1630, 1550, 1505, 1460, 1405 and 
750 cm '; 'H n. m. r. (60 MHz), 5 0. 70, 0. 80 and 0. 90 (methyl groups), 
8.25 (s, 1H, 2-H) and 8.45 (s, 1H, 71_H). 
5. 12. vi 11-Oxo-5a-spirost-2-eno[2, 3_g]-3'-cyanopyrazolo[1, 5-a]-
pyrimidine (188). 
Source: 2-Hydroxymethylene-5a-spirostan-3, 11-dione (ill) and 
3-amino-4-cyanopyrazole (126). 
General: Alumina chromatography (eluant ethyl acetate) gave 11-oxo-5a-
spirost-2-eno[2, 3-g]-3 '-cyanopyrazolo{l, 5-a}pyrimidine (188) which was 
recrystallised methanol as yellow crystals (45%),  m. p. 288- 2900;  u. v. 
max 207, 227 and 314 nm (loge 4.33, 4.62 and 3. 96); i. r. , 1 
max 
 2220 
(ON), 1700 (CO), 1540, 1450, 1385, 1370 and 755 cm 
l; '
H n. m. r. 
(100 MHz), 6 0.76 (s, 3H, 18-CH3), 1.02 (s, 3H, 19-CH3), 8.26 (s, 1H, 
2—H) and 8.42 (s, 1H, 5'-H) (Found: 0, 72.45; H, 7.63; N, 10. 36; 
M+, 528.310046. 0 32H40N403 requires C, 72.69; H, 7.63; N, 10.60%; 
528. 310024). 
5. 12. vii 1713-Hydroxy-17 a-methyl-5a-androst-2-eno[2, 3-gl-3'-cyano-
2' -cyanomethylpyrazolo[l, 5-a]pyrimidine (189). 
Source: 	17P -Hydroxy- 2-hydroxymethylene- 17 a-methyl- 5 a-andros tan- 
3-one (108) and 3-amino-4-cyano-5-cyanomethylpyrazole (92). 
General: After cooling the reaction mixture to room temperature, 1 7J 
hvdroxv- 17 a-methyl-S a-androst- 2- enof 2, 3-21- 3 '-cyano- 2'-cyanomethyl-
pyrazolo{l, 5-alpyrimidine (189) was obtained directly as white crystals 
(71%) m. p. 265-267°; u.v., -A max207, 232 and 313 nm (log 6  4. 07, 
4.65 and 3.76); i. r. , 1 
max 
 3600 (OH), 2220 (ON), 1625, 1535, 1490, 
1440, 1405, 1380 and 760 cm 
l; 1
H n. m. r. (60 MHz), 6 0.85 (s, 3H, 
18-CH3), 0.90 (s, 3H, 19-CH3), 1. 25 (s, 3H, 17-CH3), 4.05 (s, 2H, 
2'-CH2CN) and 840 (s, 1H, 5'-H) (Found: C, 72.95; H, 7.55; N, 
15.69; M+,  443. 269215. G 27H33N50 requires C, 73.09; H, 7.50; 
15-79%; M, 443. 268497). 
5. 12. viii 5 a-Oholest- 2- eno[2,  3-g]- 3' -cyano- 2'- cyanomethylpyrazolo - 
[-a1pyrimidine (190). 
Source: 2-Hydroxymethylene-5a-choles tan- 3-one (110) and 3-amino- 
4-cyano-5-cyanomethylpyrazole (92). 
General: Alumina chromatography (eluant chloroform) gave 5a- 
cholest- 2- enol2, 3-1- 3 '-cyano- 2'cyanomethylpyrazolo[l, 5-apyrirnidine 
(190) which was recrystallised from ethanol to give a white solid ( 28%), 
m.p.260-262°; u.v., 7 max 208, 231 and 311 nm (log 4.05, 4.48 
and 3.69); i. r. , 	max 2220 (CN), 1620, 1540, 1490, 1460, 1440, 1400, 
1380 and 755 cm 1; 1H n.m. r. (100 MHz), 5 0. 70, 0.80, 0.84 and 
0.90 (methyl groups), 4.06 (s, 2H, 2'-CH2CN), and 8.44 (s, 1H, 5'-H) 
(Found: C, 76.39; H, 8.91; N, 12.87; M+,  525. 382049. C 34 H47N5  
requires C, 77.66; H, 9.02; N, 13.33%; Mt 525. 383128). 
5. 12. ix 1 7f3-Hydroxyandrost- 2, 4-dieno[2, 3-gjpyrazolo[1, 5-alpyrimidine 
(191 ) 
Source: 1 73-Hydroxy- 2-hydroxymethyleneandrost-4- ene- 3-one (4) and 
3-aminopyrazole (174). 
General: Alumina chromatography (eluant ethyl acetate) gave 173-
hydroxyandrost- 2, 4-dieno[2, 3-glpyrazolo[1, 5-alpyrimidine  (191) which 
was recrystallised from acetone as yellow crystals (72%),  m. p.  230-
232°; U. V. , max 209, 235 (sh), 242 and 370 nm (log E 3. 89, 4.48, 
4.59 and 3.98); i. r., y max 3595 (OH), 1630, 1590, 1520, 1460 and 770 
cm 
l; '
H n.m. r. (100 MHz), 5 0.80 (s, 3H, 18-CH3), 1.00 (s, 3H, 
19-CH3), 3.66 (m, 1H, 17-H), 6.56 (d, J2Hz, 1H, 3'-H), 7.00 (s, 
1H, 4-H), 8.05 (d, J=2Hz, 1H, 2'-H) and 8.18 (s, 1H, 5'-H) (Found: 
C, 75.82; H, 8.16; N, 11.44; M+,  363. 231059. C 23H29N30 
requires C, 75.98; H, 8.04; N, 11.56%; M, 363. 231050). 
5. 12.x 1713-Hydroxyandrost-2, 4-dieno[2, 3-g]-3 '-cyanopyrazolo-
[l,5-a}pyrimidine (192). 
Source: 1 7- Hydroxy- 2-hydroxymethyleneandrost-4-en-3 -one (4) 
and 3- amino- 4-cyanopyrazole (126). 
General: Alumina chromatography (eluant chloroform) gave 1 7f3-hydr oxy-
androst-2,4-dieno[2,3-g]-3'-cyanopyrazole (192) which was recrystallised 
from ethanol to give yellow crystals (53 07o), m. p. 258_2600; u. v. , A max 
209, 239, 251, 313 and 364 (log 64. 18, 4. 50, 4. 25, 3. 59 and 3. 94); 
i. r. , 	max 3600 (OH), 2220 (CN), 1630, 1595, 1530, 1480, 1375 and 
760 cm '; 'H n.m. r. (100 MHz), 6 0.82 (s, 3H, 18-CH3), 1. 04 (s, 
3H, 19-CH3), 3. 68 (t, 1H, 17-H), 6. 98 (s, lH, 4-H), 8. 26 (s, 1H, 
Z!_H) and 8. 40 (s, lH, 5'-H) (Found:
1 
4' M+,  388. 225263. C24H28N40 
requires M, 388. 226300). 
5. 12. xi 17-Hydroxyandrost-2, 4-dieno[2, 3-gJ-3  '-cyano-Z'-cyano- 
methylpyrazolo[1, 5-a]pyrimidine (193). 
Source: 17p-Hydroxy-2-hydroxymethyleneandrost-4-en-3-one (4) 
and 3- amino- 4-c yano-5-cyanornethylpyrazole (92). 
General: Alumina chromatography (eluant chloroform) gave 17-hydroxy- 
androst-2, 4-dieno[2, 3-g -3 '-cyano-2 '-cyanomethylpyrazolo[1,5-al - 
pyrimidine (193) which was recrystallised from acetone as yellow crystals 
(23 %), m.  p.  268-2700; i. r. ,Y 	3590 (OH), 2220 (CN), 1630, 1595, 
max 
1530, 1490, 1380 and 925 cm '; 'H n.m. r. (60 MHz), 5 0.85 (s, 3H, 
18-CH3 ), 1. 05 (s, 3H, 19-CH3 ), 3. 70 (m, 1H, 17-H), 4. 10 (s, 2H, 
2'-CH2CN), 7. 02 (s, 1H, 4-H) and 8. 50 (s, 1H, 51 -H) (Found: C, 72-89; 
H, 6. 81; N, 16. 25; M, 427. 235968. C26H29N50 requires C, 73. 02; 
H, 6.84; N, 16. 39%; Me 427.237198). 
5. 12. xii 313 -Hydroxy-5a-androst-16- enoI16 , 17-gipyrazolo[1 , 5-a]-
pyrimidine (197). 
Source: 313  -Hydroxy- 16-hydroxymethylene-5 a-androstan- l7-one (7) 
and 3-aminopyrazole (174). 
General: Alumina chromatography (eluant ethyl acetate) gave 
hydroxy-5a-androst-16-eno[16, 17-g]pyrazolo[l, 5-alpyrimidine  (197) which 
was recrystallised from acetone as white fine crystals (91%), m. p. 
240-241°; u.v., 	
max 
 236 and 327 nm (log p 4.51 and 3.38); i. r., 
Y max 3590 (OH), 1600, 1545, 1510, 1455, 1345 and 775 cm- '; 'H n.m.r. 
(60 MHz) 5 0. 90 (s, 3H, 18-CH3), 1. 18 (s, 3H, 19-CH3), 3.65 (m, 1H, 
3-H), 6. 70 (d, J2Hz, 1H, 3'-H), 8. 15 (d, J2Hz, 1H, 2!_H)  and 8.45 
(s, 1H, 5'-H) (Found: C, 75.34; H, 8.63; N, 11.84; M+,  365 245445. 
C 23H31N30 requires C, 75-57; H, 8.55; N, 11.50%; M, 365.246700)- 65.246700).
5. 12. xiii 313-Hydroxyandrost-  5, 16-dieno[16, 1 7-g]pyrazolo[1, 5-al 
prrimidine (198). 
Source: 	313-Hydroxy-16-hydroxymethyleneandrost-5- en- 17-one (8) 
and 3-aminopyrazole (174). 
General: Alumina chromatography (eluant chloroform) gave 313-hydroxy-
androst-5, 16-dieno[16,  17-gipyrazolofi, 5-apyrimidine (198) which was 
recrystallised from alcohol as white long needles (84%), m. p.  248-2490; 
u.v. , max 206, 234 and 330 nm (log 6  3.99 4.58 and 3.53); i. r. 
max 3595 (OH), 1600, 1545, 1510, 1455, 1370 and 755 cm '; 1H n. m. r. 
(60 MHz), 5 1. 12 (s, 3H, 18-CH3), 1. 25 (s, 3H, 19-CH3), 3.55 (m, 1H, 3-H), 
5.45 (t, lH, 6-H), 6.70 (d, J2Hz, 1H, 3'-H), 8.15 (d, J=2Hz, 1H, 
2'-H) and 8.40 (s lH, 5'-H) (Found: C, 75.82; H, 8.10; N, 11.95; 
M+, 363. 229650. C 23H29N30 requires C, 75.98; H, 8.04; N, 
11.57%; M, 363.231050). 
12. xiv 3-Methoxyoestra-1, 3, 5(10), 16-tetraeno{16, 17-gipyrazolo-
[1, 5-a]pyrimidine (199). 
Source: 	16-Hydroxymethy1ene-3-methoxyoestra-1, 3, 5(10)-trien-17- 
one (9) and 3-aminopyrazole (174). 
General: 3-Methoxyoestra-1, 3, 5(10), 16-tetraeno{16, 17-gpyrazo10-
[1, 5-apyrimidine (199) crystallised directly as white needles upon 
cooling the reaction mixture (98%), m. p.  203-2050 (dec); i. r. , y max 
1600, 1545, 1510, 1495, 1455, 1345, 775 and 755 cm- 1; 1H n. m. r. 
(100 MHz), 6 1. 20 (s, 3H, 18-CH3), 3.74 (s, 3H, 3-OCH3), 6.62- 
78 (m, 3H, 3'-H, 2-H and 4-H), 7. 20 (d, 1H, 1-H), 8. 06 (d, 
3=2Hz, lH, 2'-H) and 8. 33 (s, 1H, 5'-H) (Found: C, 76. 64; H, 7. 13; 
N, 11.98; M+, 359. 198064. C 23H25N30 requires C, 76. 84; H, 7.01; 
N, 11.69%; M, 359.199752). 
5.12.xv 313-Hydroxy-5a-androst-16-eno[16, 17_g1-3-cyanopyrazolo1l, 5-
a]pyrimidine (200). 
Source: 	3p-Hydroxy-16-hydroxymethylene-5a-androstan-17-one (7) 
and 3- amino -4-cyanopyrazole (126). 
General: Alumina chromatography (eluant chloroform) gave 3f3-hydroxy-
5a-androst-16-eno[16, 17_g].3t_cyanopyrazo1o[1,  5-a]pyrimidine (200) 
which was recrystallised from ethanol as white crystals (40%), m. p. 
71 
316-318°  (dec); u. v., 
max 
 207, 234 and 323 nm (log e  3. 94, 4.41 
and 3. 74); 1. r. , 	max 3590 (OH), 2220 (CN), 1610, 1555, 1520 
and 770 cm '; 'H n.m. r. (60 MHz), 5 0. 92 (s, 3H, 18-CH3 ), 1. 18 
(s, 3H, 19-CH3), 4.70 (m, 1H, 3-H), 8.30 (s, 1H, 2'-H) and 8.55 (s, 
1H, 5-H) (Found: C, 73. 70; H, 7. 91; N, 14. 15; M+,  390. 242024. 
C 24H30N40 requires C, 73. 80; H, 7. 75; N, 14. 35%; M, 390. 241949). 
5. 12. xvi 313-Hydroxyandrost-5,  16-dieno[16 , 17-gI-3 '-cyanopyrazolo-
[1,5-a]pyrimidine (201). 
Source: 33-Hydroxy-16-hydroxymethyleneandrost-5-en-17-one (8) 
and 3- amino- 4-cyanopyrazole (126). 
General: Alumina chromatography (eluant chloroform) gave 3 j3-hydr oxy-
androst-5, 16-dieno[16 , 17-g]-3  '-cyanopyrazolo[l, 5-ajpyrimidine (ZOl) 
which was recrystallised from ethanol as light yellow crystals (38%), 
m. p.308-311°  (dec); u. v. 	max 207, 233 and 322 nm (log E.  4. 12, 
4.54 and 3.82); i. r. , 	max 3590 (OH), 2220 (CN), 1610, 1540, 1520, 
1370 and 770 cm '; 1H n. m. r. ( 	MHz), 5 0. 92 (s, 3H, 18-CH3 ), 
1. 20 (s, 3H, 19-CH3), 3.70 (m, 1H, 3-H), 8.42 (s, 1H, 2'-H) and 
8. 65 (s, 1H, 5'-H) (Found: C, 74. 03; H, 7. 24; N, 14. 38; M+, 
388. 223760. C24H28N40 requires C, 74.18; H, 7.27; N, 14.43%; 
M, 388. 226300). 
5. 12. xvii 3-Methoxyoestra-1, 3,5(10), 16-tetraenoll6, 17-g]-3-cyano-
pyrazolo[1, 5_a]pyrimidine (202). 
Source: 	16-Hydroxymethylene-3-methoxyoestra-1,3, 5(10)-trien- 
17-one (9) and 3-amino-4-cyanopyrazole (126). 
General: Alumina chromatography (eluant chloroform) gave 3-methoxy-
oe str o- 1, 3, 5(10), 1 6-tetraeno{1 6, 17- gJ-3 '-c yanopyrazolo[l, 5- a]pyrimidine 
(202) which was recrystallised from ethanol-chloroform as white crystals 
(53%), m.  p.  255-257°; 1. r. , Ymax 2220 (ON), 1610, 1520, 1500 and 
955 cm '; 'H n. m. r. (100 MHz), 6 1.22 (s, 3H, 18-CH3), 3. 76 (s, 
3H, 3-OCH3), 6. 70-6.88 (m, 2H, 2-H, and 4-H), 7.30 (d, 1H, 1-H), 
8. 32 (s, 1H, 2'-H) and 8.58 (s, 1H, 5'-H) (Found: C, 74. 73; H, 6.31; 
N, 14. 66; M, 384. 195502. C24H24N40 requires C, 74. 96; H, 6. 30; 
N, 14.58%; M, 384. 195001). 
5. 12. xviii 17-Acetoxyandrost-2, 4-dieno[2, 3-g]pyrazolo[1, 5-a] 
pyrimidine (194). 
A solution of 17f3-hydroxyandrost-2,4-dieno[2,3-g]pyrazolo-
[1,5-a]pyrimidine (192) (400 mg, 1. llxlO 3mole) in pyridine(25 ml)con-
taming a few drops of acetic anhydride was refluxed for 2 h. The 
solvent was evaporated in vacuo and the residue taken up in chloroform. 
The chloroform solution was washed with water, 5% hydrochloric acid, 
saturated sodium bicarbonate solution and water again before being dried 
over anhydrous magnesium sulphate and was evaporated to dryness. The 
residue was chromatographed over alumina. Elution with chloroform 
gave 1 7f3-ac etoxyandrost- 2, 4-dieno[2, 3- g]pyrazolo{l, 5 -ajpyrimidine 
(194) which was recrystallised from acetone as yellow crystals (290 mg, 
65%), m. p.  185-1870; u. v. , 	max 206, 242 and 374 nm (log E  4. 08, 
4.54 and 3. 77); i. r. , y 
max 
 1715 (0=0), 1625, 1585, 1520, 1455, 1420, 
1370, 1355, 1245, 1035, 895, 860 and 770 cm '; 1H n0 m. r. (100 MHz), 
6 0.84 (s, 3H, 18-CH3 ), 1. 00 (s, 3H, 19-CH3), 2. 04 (s, 3H, l7-0000H3), 
4.62 (t, 1H, 17-H), 6. 58 (d, J=2Hz, 1H, 3'-H), 7. 00 (s, 1H, 4-H), 8. 00 
73 
(d, J=ZHz, 1H, 2'-H) and 8. 20 (s, 1H, 51_H)  (Found: C, 74. 22; H, 
7. 71; H, 10. 55; M+,  405. 239142. C25H31N302 requires C, 74. 03; 
H, 7.71; N, 10.37%; M, 405.241614). 
Similarly treatment of the compounds (192), (197), (198), (200) 
and (201) with acetic anhydride in pyridine gave the corresponding acetyl 
derivatives (195), (203)_(206). 
5. 12. xix 1713-Acetoxyandrost-2, 4-dieno[2, 3-g]-3 '-cyanopyrazolo-
[1, 5-a]pyrimidine  (195) was recrystallised from ethanol as yellow 
crystals (54%), m. p.  235-2370; i. r. 	' max 2220 (CN), 1720 (C=O), 
1628, 1595, 1520, 1575, 1370 and 760 cm '; 'H n. m. r. (100 MHz), 
6 0. 86 (s, 3H, 18-CH3 ), 1. 04 (s, 3H, 19-Cl-I3 ), 2. 04 (s, 3H, 17-OCOCH3 ), 
62 (m, 1H, 17-H), 6. 96 (s, 1H, 4-H), 8. 26 (s, lH, 2t_H)  and 8. 40 
(s, 1H, SI_H)  (Found: C, 72.29; H, 6.93; N, 12.81; M+,  430. 237711. 
C 26H30N402 requires C, 72. 52; H, 7. 03; N, 13. 02%; M, 430. 236863). 
12.xx 33-Acetoxy-5a_androst-16-eno[16, 17-g]pyrazolo[1, 5-aJ 
pyrimidine (203) was recrystallised from ethanol to give white needles 
(61%), m. p.264-265°; u. v. , 	max 235 and 330 nm (logE 4.58 and 
3. 56); i. r., y 
max 
 1720 (CO), 1600, 1545, 1510, 1460 and 775 cm '; 
'H n. m. r. (100 MHz), 6 0.90 (s, 3M, 18-CH3 ), 1. 16 (s, 3H, 19-Cl-i3 ), 
2. 00 (s, 3M, 3-OCOCH3), 4. 68 (m, 1H, 3_H), 6. 63 (d, 3=2Hz, 1H, 3-H), 
8. 04 (d, 3=2Hz, 1H, 2_H) and 8.33 (s, 1H, 5'-H) (Found: C, 73-82; 
H, 8. 14; N, 10. 35; M+,  407. 254023. C25H33N302 requires C, 73.66; 
H, 8. 17; N, 10. 32%; M, 407. 257263). 
5. 12. xxi 3f3-Acetoxyandrost-5, 16-dieno[16, 17-g]pyrazolo{l, 5-al-
2yrimidine (204) was recrystallised from ethanol as long white needles 
(85%), m. p. 229_2310; u. v. 	max 206, 234, 284 and 331 nm (log 
84, 4.57, 3. 16 and 3.33); 1. r. , 1 max 1720 (CO), 1600, 1545, 1510, 
1460, 1445 and 775 cm- '; 1Hn.m.r. (100 MHz), 6 1.12 (s, 3H, 
18-CH3 ), 1.20 (s, 3H, 19-CH3), 2.02 (s, 3H, 3-OCOCH3), 4.60 (m, 
lH, 3-H), 5.42 (t, 1H, 6-H), 6. 64 (d, J=2Hz, 1H, 3'-H), 8. 06 (d, 
J=2Hz, 1H, 2'-H) and 8.34(s, 1H, 5t-H) (Found: C, 74.16; H, 7.61; 
N, 10. 65; M, 405. 239518. C25H31N302 requires C, 74. 03; 
H, 7. 71; N, 10. 37%;  M , 405. 241614). 
5. 12.xxii 313-Acetoxv-5a.-androst-16-enoIl6. 17-1-3'-cvanoiwrazolo- 
1, 5-ajpyrimidine (205) was recrystallised from ethanol as white crystals 
(58%), m. p. 335-337; u. v. , -A max  207, 234 and 323 nm (log E.  4. 11, 
50 and 3.81); 1. r. , 1 
max 
 2220 (CN), 1720 (CO), 1610, 1550, 1520, 
1365 and 755 cm '; 1Hn.m.r. (100 MHz), 6 0.92 (s, 3H, 18-CH3 ), 
1. 18 (s, 3H, 19-CH3), 2.02 (s, 3H, 3-OCOCH3), 4. 70 (m, 1H, 3-H), 
8.32 (s, 1H, 2'_H) and 8. 56 (s, 1H, 5'-H) (Found: C, 72. 36; H, 7.45; 
N, 12.92; M+,  432. 253011. C26H32N402 requires C, 72. 18; H, 7.46; 
N, 12.96%; M, 432. 252512). 
12. xxiii 313-Acetoxyandrost-5, 16-dieno[16, 17-gi-3 '-cyanopyrazolo-
1, 5-ajpyrimidine (206) was recrystallised from ethanol as white crystals 
(59%), m. p.  298-300°  (dec); u. v. 	'max 208, 239 and 324 nm (log 
4. 07, 4.49 and 3. 75); i. r. , 1 max 2220 (CN), 1720 (Ca), 1610, 1550, 
1520, 1380 and 950 cm '; 'H n. m. r. (100 MHz), 8 1. 12 (s, 3H, 18-CH 3), 
1. 22 (s, 3H, 19-CH3 ), 2.02 (s, 3M, 3-OCOCH3), 4. 58 (m, 1H, 3-H), 
5.45 (t, 1H, 6-H), 8.32 (s, 1H, 3'-H) and 8.58 (s, 1H, 51 -H) (Found: 
C, 72. 39; H, 6. 99; N, 13. 13; m/e, 370. C26H30N402 requires 
C, 72.52; H, 7.03; N, 13.02%; MtCH3COOH, 370). 
5. 12. xxiv 2(2 '-Pyr idyl- aminomethylene)-5a-c hole stan-3-one (207). 
A solution of 2-hydroxymethylene-5a-androstan-3-one (110) (500 
Mg., 1. 21 x 10 3mole) and 2-aminopyridine (120 mg, 1. 26 x l0 3mole) 
in pyridine (5 ml) was allowed to stand at room temperature overnight. 
The solvent was removed in vacuo and the residue taken up in chloroform. 
The chloroform solution was washed with 5% hydrochloric acid and water. 
It was dried over anhydrous magnesium sulphate and the solvent was 
evaporated to dryness. Chromatography (eluant chloroform) of the 
residue followed by recrystallisation from acetone gave yellow crystals 
of 2(21 _pyr idyl- aminomethylene)-5a-cholestan-3-one (207) (355 mg, 60%); 
m. p. 135-1380; 	max 1640, 1590, 1545, 1475, 1440, 1415, 1360 
and 770 cm 1; 'H n. m. r. (60 MHz), 6 0. 65, 0. 78, 0. 82 and 0. 92 
(methyl groups), 6. 60-6. 95 (m, ZH, pyridine ring 3-H and 5-H), 7. 50 (dd, 
lH, pyridine ring, 4-H), 7. 82 (d, J=1 l. 5Hz, -NH-CH=C-), 8. 25 (d, 1H, 
pyridine ring 6-H) and 10. 90 (d, J=11. 5Hz, 1H, N-H) (Found: C, 80. 44; 
H, 10. 14; N, 5. 52; M+ 490. 393935. C33H50N20 requires C, 80. 75; 
H, 10. 19; N, 5. 71%;  M, 490. 392294). 
5. 12. xxv The reaction of 2(2'_pyr idyl- aminomethylene)-ScL-c hole stan-
3-one (207) with 3-aminopyrazole (174). 
A solution of 2(2t_pyridyl_aminomethylene)5Q._c hole stafl_3-one 
(207) (400 mg, 8. 15 x 10 4mole) and 3-aminopyrazole (174) (90 mg, 
PEO 
1. 08 x 10 3mole) in dry toluene containing a catalytic amount of 
toluene-4- suiphonic acid was refluxed for 7 h. The solvent was 
removed in vacuo and the residue was chromatographed over alumina 
(50 g). Elution with ethyl acetate followed by recrystallisation of the 
eluate from ethanol gave white crystals of5ct-cholestano[3, 2.-f]pyrazolo-
[1, 5-a]pyrimidine  (181) (185 mg, 60%), m. p. 138-140°  (identified by its 
M. P. , 1. r. and 'H n. m. r. spectra). 










6 	The reaction of steroidal 13-ketoaldehydes with 3-amino-1, 2,4- 
triazole and its derivatives. 
6. 1 	The reaction of 173-hydroxy-2-hydroxymethylene-17a-methyl- 
5a-androstan-3-one (108) with 3-amino-1,2,4-triazole (95). 
A solution of 1 7-hydroxy- 2-hydr oxymethylene- 1 7ct-methyl- 5a-
androstan-3-one (108) and 3-amino-1,2,4-triazole (95) in absolute alcohol 
was refluxed overnight. The excess of solvent was removed under vacuo 
and the residue was chromatographed over alumina. Elution with 
benzene-chloroform (3:1) gave two products (210), m.p. 118-1200 , in 
45% yield and (211), m. p. 248-250°, in 25% yield. 
Mass spectrometry and elemental analysis indicated that both 
the products had the same molecular formula C23H32N40. 
The u. v. spectrum of the product, m. p. 118-120°, showed ? max 
at 220 and 283 nm (log 6 4.34 and 3. 58) whilst the i. r. spectrum showed 




 H n. m. r. 
spectrum exhibited two singlets at 6 8. 34 and 6 8. 48, apart from the 
signals for the 17-, 18- and 19-methyl protons. 
The u. v. spectrum of the product, m. p.  248-250°, showed ?\ max 
at 218 and 283 nm (log . 4. 26 and 3. 65) and the i. r. spectrum exhibited 
absorptions at 3600, 1620, 1545, 1520, 1445 and 775 cm '. The 'H n. m. r. 
spectrum showed singlets at 6 8. 40 and 68. 50 apart again from the signals 
for the 17, 18- and 19-methyl protons. 
6. 2 	Discussion 
The reaction of 3-amino-i, 2, 4-triazole (95) with the 3-ketoaldehyde 
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(108) can theoretically lead to four different s-triazolopyrimidine 
derivatives (210) - (213), depending upon the reaction site in the triazole 
part and upon the initial condensation step with the cyclic 3-ketoaldehyde 
(108). However, in practice, only two products are formed whose 
structures follow from the evidence below. 
The alkyl-s-triazolo[4,3-a]pyrimidines (e. g. 99, R 1 2 =R =H; ?\ max 
290 nm) are distinguished from the s-triazolo[1, 5-a]pyrimidines (e. g. 98, 
R R 1=2=H; 	max 270 nm) by the absorption at longer wavelength of the 
former. 
142 
 The two steroidal condensation products have almost identical 
u. v. spectra and thus these two products have structures either (210) and 
(211) or (212) and (213). 
The condensation of 3-amino- 5-benzy1thio- s-triazole with acetyl-
143 
in refluxing acetic acid was reported by Okabe et al.  to have 
given 3-benzylthio-5, 7-dimethyl- s-triazolo[4, 3-a]pyrimidine (215). 
However, it was later established, 
132 
 with the aid of 
13 
 C n. m. r. spectro-
scopy and a modification of the original synthetic work that only 2-benzyl-
thio-s-triazolo[l, 5-a]pyrimidine (214) can be obtained by this method of 
condensation and this is found to be in agreement with the literature 
reported by Maury80 that s-triazolo[4,3-a]pyrimidines (99) have never 
been obtained by the reaction of -ketoacetals, 3-ketoaldehydes or 
diketones with 3-amino- 1, 2, 4-triazoles. Thus it seems very unlikely 
that the two steroidal condensation products have structures (212) and (213). 
It has been demonstrated 
132 
 in numerous examples that s-triazolo-
[4, 3-a]pyrimidines (99) rearrange very readily to s-triazolo[1, 5-a]-
pyrimidines (98) under basic, acidic or ieutral conditions. The two 
steroidal condensation products, however, remain unchanged when 
heated in boiling pyridine or toluene for 12 h. The effect of acid on 
these products could not be investigated since the hydroxyl group at the 17 
position is eliminated by a Wagner-Meerwein rearrangement. However, 
the two similar condensation products obtained by the reaction of 3-amino-
1, 2,4-triazole (95) with 2-hydroxymethylene-5a-cholestan-3- one (110) 
do not undergo any change when heated in boiling formic acid for 12 h. 
Therefore, it appears that the two products obtained by the condensation 
of 3-amino-1,2,4-triazole (95) with the 3-ketoaldehyde (108) are s-
triazolo[1, 5-a]pyrirnidine derivatives (210) and (211) and not s-triazolo-
[4, 3- a]pyr imidine derivatives (212) and (213). 
In the 'H n. m. r. spectra (d6-DMSO), the resonance of the triazole 
proton in the isomer, m. p.  118-120°, occurs at 6 8. 50 whilst in the 
isomer, M. P. 248-250°, it occurs at 6 8. 55. Reimlinger and Pieron133  
as well as Paudler and Helmic, 
76 
 as stated earlier (section 4, page 56) 
have shown in a series of s-triazolopyrimidines that the triazole proton 
in s-triazolo[4,3-a]pyrimidines (99) is deshielded and occurs at a lower 
field (>69)  in comparison with the triazole proton in the isomeric s-
triazolo[1, 5-a]pyrimidines (98) which occurs at a higher field (<69). 
Since the chemical shift of the triazole proton in both the isomers, m. p. 
0 	 0 
118-120 and m. p.248-25O , is found to be less than 69, the structures 
(212) and (213) are rejected. This is further confirmed by the following 
13 
C n. m. r. evidence. 
The 13C chemical shifts of 2'-C in s-triazolo[1,5-a]pyrimidines 
(210) and (211) where the 21 -C atom is bonded to two ring nitrogens, are 
expected 135' 
136a 
 to occur considerably further downfield compared to 
Table 5 
13C-Chemical shifts of steroidal s-triazolo{1, 5-a]pyrimidines (p. p.m. ) 
Compound 2 1 -C 3'a-C 51C 6 1 -C 7'-C Other carbons 
(210) 155. 83 154.23 165.38 120.19 133. 77 
(211) 155. 94 154.23 155.35 118.59 144.99 
(216) 156. 08 155. 13 165. 69 111. 25 134. 98 
(217) 155. 56 155. 96 154. 03 110. 06 148. 15 
 168.35 154.87 164.35 119.71 132.71 
 168. 34 154. 86 154. 86 117. 77 144. 07 
(232) 164.48* 154.86 166.O8 119.21 133.09 
(236) 155. 29 155. 01 153. 32 112. 90 140.52 4-C, 110.30; 
5-C, 165. 00 
 168.34 155.67 152.28 112.48 139.59 4-C, 110.36; 
5-C, 165.32 
 164.59 152.46 152.64 112.36 139.85 4-C, 110.49; 
5-C, 165. 71 
(244) 	156.29 155.80 151.75 123.52 159.22 
(1-C, (2-C, (3-C, (4-C, (5-C, 	(10-C, 
126. 07) 111.66) 157. 75) 113. 94) 137. 44) 131. 61) 
These values could be interchanged. 
the chemical shifts of 1-C in s-triazolo[4, 3-a]pyrimidines (212) and 
(213) where the l'-C is bonded to a ring nitrogen and a bridgehead 
nitrogen. Since s -triazolopyrimidine and s-triazolopyridazine are 
both 10 iT electron systems, it is reasonable to compare the chemical 
shifts of 2'-C in s-triazolo[1,5-a]pyrimidines (210) and (211) with that 
of 2-C in s-triazolo[ 1, 5-b]pyridazine (163) and the chemical shifts of 
l'-C in s-triazolo[4,3-a]pyrimidines (212) and (213) with that of 3-C in 
s-triazolo[4, 3-b]pyridazine (67). The chemical shifts of the unsub-
stituted triazole carbon in the steroidal condensation products are found 
to be 155.83 p. p.m. and 155. 94 p.  p.m. (Table 5) which are in good 
agreement with the chemical shift of 2-C (152. 04 p. p. m. ) in s-triazolo- 
131 
[1,5-b]pyridazine (163). 	If the two condensation products had had 
structures (212) and (213), the chemical shifts of the unsubstituted triazole 
carbon would have been in the region of 139. 04 p. p. m. which is the 
chemical shift of 3-C in s-triazolo[4,3-b]pyridazine (67). 131  
Under analogous reaction conditions, the condensation of 3-amino-
5-methylthio-1, 2, 4-triazole (224) with 173-hydroxy-2-hydroxymethylene-17a.-
methyl-5a-androstan-3-one (108) gave two products (225) and (226) in which 
the chemical shifts of 2'-C (168. 35 p. p. m. and 168. 35 p. p.m. ) are 
again found to resemble closely the chemical shift of 2-C (164. 1 p.  p.m.  ) 
in 2-benzylthio-5, 7-dimethyl-s-triazolo[1, 5-a]pyrimidine (214). 132 if 
the two condensation products had had structures like (212) and (213) then 
the chemical shifts of 1-C in both the isomers would have been in agree-
ment with the chemical shift of 1 '-C (144. 2 p. p.m.) in 5, 7-dimethyl-s-
triazolo[4, 3-a]pyrimidine (215). 132  
In conclusion, the reaction of 2-hydroxymethylene-3-oxo steroid 
Table 4 
Characteristic i. r. absorption frequencies (cm-1  
Compound y (cm1 ) Compound y 	(cm) max max 
(210) 1620 (211) 1620 1 s  
1510 1545 	S 






1410 s 1520 
(233) 1625 (236) 1630 I s 
1515 1550 S 
1415 s 1510 




(108) with 3-amino-1, 2,4-triazole (95) leads to the isomeric s-triazolo- 
[1, 5-a]pyrimidine derivatives (210) and (211) which are further distinguished 
as follows. 
(1) 	The i. r. spectra of the two steroid isomers (210) and (211) which 
show some important differences when compared with each other also 
show some important similarities with the i. r. spectra of 5-methyl-s-
triazolo[1, 5-a]pyrimidine (216) and 7-methyl- s-triazolo[1, 5-a]pyrimidine 
(217) (Table 4). 	The compound (211) and 7-methyl-s-triazolo[l, 5-a]- 
pyrimidine (217) differ from the compound (210) and 5-methyl-s-triazolo-
[1, 5-a]pyrimidine (216) in showing an extra absorption band at 1545 cm '  
in the region 1500-1520 cm '. Secondly, the compound (210) and 5-
methyl-s-triazolo[1, 5-a]pyrimidine  (216) are distinguished by a strong 
absorption at 1405 or 1410 cm '  which is absent in the i. r. spectra of 
the compound (211) and 7-methyl-s -triazolo[1, 5-a]pyrimidine (217). 
(g) 	In the 'H n. m. r. spectra, the chemical shifts of the 7'-H 
6 8.50 ) and the 51-H ( 6 8.48 ) 	in the triazolopyrimidines (210) and 
(211) respectively, are found to be almost identical. However, the 
most important difference is that the signal for 7'-H in the triazolo-
pyrimidine (210) is broadened by a small long range coupling with the 
methylene protons at position 1 whilst the signal for St_H  in the triazolo-
pyrimidine (211) is found to be sharp. Thus, the assigrment of structures 
(210) and (211) is consistent with the observation made by Makisumi 
et al. 
77 
 that the methyl protons at position 6 of s-triazolo[1, 5-a]-
pyrimidine (69) are coupled with the 7-H whilst no such coupling takes 
place between the methyl protons at position 6 and the 5-H. 
R3  
(218) 	R1 HR2 R3 	 (219) 
(220) 	R1 =H, RC8H17,R3 H 	(221) 
(225) R1 =SCH3,R2=OH,R3=CH3 (226) 
(227) 	R1 =SCH 3, R= R
3
= H 	 (228) 
(229) R1 =SCH37 RC8H17,RH (230) 





R =SCH3  
102 
(h) 	Assignment of structures (210) and (211) is further supported by 
13 	 13 
C n. m. r. evidence. The C-chemical shifts of the aromatic ring 
carbons of the triazolopyrimidines (210) and (211) are given in Table 5, 
along with those of the two model compounds (216) and (217). The 
assignments for the chemical shifts of the five carbons of the steroids 
(210) and (211) follow directly by analogy with the values allocated to 
triazolopyrimidines (216) and (217) (section 9). 	The chemical shift of 
7'-C (133. 77 p. p.m.) in the triazolopyrimidine (210) is found to agree 
well with the chemical shift of 7-C (134. 98 p.  p.m. ) in 5-methyl-s-
triazolo[l, 5-a]pyrimidine (216) thus confirming a linear fusion of the 
steroid to the heterocyclic system. The chemical shift of 5'-C 
(155.35 p.p.m.) in the compound (211) is found to be in agreement with 
the chemical shift of 5-C (154.03 p. p.m.) in 7-methyl-s-triazolo[1, 5-a]-
pyrimidine (217) thus confirming an angular fusion of the steroid to the 
heterocyclic system. 
Under analogous reaction conditions the condensation of 3-amino-
1, 2,4-triazole (95) with 2- hydroxymethylene- 5 a-andro s tan- 3 -one (109), 
2-hydroxymethylene- 5 a-cholestan- 3-one (110) and 2-hydroxymethylene-
5a-spirostan-3, 11-dione (ill) gave 5a-androstano[3, 2-f]-s-triazolo-
[1, 5-a]pyrimidine (218) and 5a-androst-2-eno[2, 3-g]-s-triazolo[l, 5-a]-
pyrimidine (219); 5a-cholestano[3, 2-f]-s-triazolo[l, 5-a]pyrimidine (220) 
and 5a-cholest-2-eno[2, 3-g]-s-triazolo[l, 5-a]pyrim'idine (221); and 11-
oxo-5a-spirostano[3, 2-f]-s-triazolo[1, 5-a]pyrimidine (222) and 11-oxo-5a-
spirost- 2-eno{2, 3-g]-s-triazolo[l, 5-a]pyrimidine (223) respectively. 
Similarly the condensation of 3-amino -5 -methylthio- 1, 2, 4- triazole 
(224) with the 13-ketoaldehydes (108)-(111) gave the 2'-methylthio derivatives 
HOH 
NN 
OH 3-kN)'~- N H 2 
H 
(127) 
(108) R1 OH,RCH3 










(225) and (226); (227) and (228); (229) and (230); and (231) and (232) 
respectively. 
6. 3 The reaction of 1 71  -hydroxy- 2-hydroxymethylene- 17 a-methyl-
.Sa-androstan-3-one (108) with 3-amino-5-methyl-1, 2,4-triazole (127). 
A solution of 1 7i  -hydroxy- 2-hydroxymethylene- 1 7 a-methyl- 5 a-
androstan- 3-one (108) and 3-amino-5-methyl-1, 2, 4-triazole (127) in 
absolute ethanol was refluxed overnight. The excess of solvent was 
removed under vacuo and the residue was chromatographed over alumina. 
Elution with chloroform followed by recrystallisation of the eluate from 
ethyl acetate gave white crystals (233), m. p.  232-234, in 68% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 24H34 N40. The u. v. spectrum 
showed 
max 
 at 219 and 289 nm (log E, 4. 51 and 3. 77). The i. r. 
spectrum exhibiting absorptions at 3600, 1625, 1515, 1465, 1440, 1410, 
1380 and 775 cm compares well with the i. r. spectrum of 1713-hydroxy-
17a-methyl- 5a-androstano[3, 2-f]-s-triazolo[1, 5-a]pyrimidine (210). 
The 'H n. m. r. spectrum showed a singlet at 6 8. 32 (1H) which is 
broadened by coupling with the protons at. position 1 and another singlet 
at 6 2. 56 (3H),apart from the signals for the 17-, 18- and 19-methyl 
protons. All this evidence indicates that the steroid is 1713-hydroxy-
17 a-methyl- 5 a-androstano[3, 2-f]- Z'-methyl- s-triazolo[1, 5-a]pyrimidine 
(233), and this structure is further confirmed by the 
13 
 C - chemical shift 
of 7'-C (133. 09 p. p.m.) which compares well with the chemical shift 
of 7'-C (133. 77 p. p.m.) in the compound (210) (Table 5). 
Similarly the reaction of 3-amino-5-methyl-1, 2,4-triazole (127) 









	 (127) R=CH3  





RSCH3 , R=COCH3 
i U'± 
5 a-spirostan-3, 11-dione (111) gave 5a-cholestano[3, 2_f]_21_ methyl_ s _ 
triazolo[l, 5-a]pyrimidine (234) and 11 -oxo- 5a-spirostano[3, 2-f]- 2'-
methyl- s-triazolo[l, 5-a]pyrimidine (235) respectively. 
6.4 	The reaction of 1 73 -hydroxy- 2-hydroxymethyleneandrost-4 - en- 
3-one (4) with 3-amino-1, 2, 4-triazole (95). 
A solution of 1 73 -hydroxy- 2-hydroxymethyleneandrost-4- en- 3-
one (4) and 3-amino-1, 2, 4-triazole (95) in absolute alcohol was refluxed 
overnight, evaporated to dryness under vacuo and the residue was 
chromatographed over alumina. Elution with ethyl acetate followed 
by recrystallisation from ethanol gave yellow crystals (236), m. p.  252- 
254°, in 57% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 22H28N4 0. The u. v. spectrum of 
the product showed 7, max at 226 and 343 nm (log E 4. 34 and 4. 21) whilst 
the i. r. spectrum had absorptions at 3600, 1630, 1590, 1550, 1510 and 
780 cm . The 
1 
 H n. m. r. spectrum exhibited two sharp singlets at 
6 8.40 and 6 8. 52 corresponding to the proton on the triazole ring and 
the pyrimidine ring respectively. The i. r. spectrum, in which an 
absorption at 1550 cm and the absence of any absorption at 1400 cm 
are noteworthy (Table 4) and the 
1 
 H n. m. r. spectrum which shows the 
pyrimidine ring proton as a sharp singlet at 6 8. 52, both correlate well 
with the i. r. and 'H n. m. r. spectra of the compound (211) and indicate 
that the structure of the steroid is 17p-hydroxyandrost-2,4-dieto[2, 3_g]_s-
triazolo[l, 5-a]pyrimidine (236). This is confirmed by the '3C-chemical 
shift observed for the 5'-C (155. 32 p. p. m. ) which again agrees with the 
chemical shift of 5'-C (155. 35 P. p.m.) in the compound (211) (Table 5). 
Similarly the condensation of 1 71 -hydroxy- 2-hydroxymethylene-
androst-4-en-3-one (4) with 3-amino- 5-methylthio- 1, 2,4-triazole (224) 
and 3-amino-5-methyl-1, 2,4-triazole (1 27) gave 17 13-hydroxyandrost-
2,4-dieno[2, 3-g]-2 '-methylthio-s- triazolo[1,  5-a]pyrimidine (237) and 
1713-hydroxyandrost- 2, 4-dieno[2, 3-g]-2'-methyl-s-triazolo(l, 5-a]-
pyrimidine (238) respectively. 
It is interesting to note that the A4 double bond in the steroid and 
the substituents on the triazole nucleus markedly influence the course of 
the condensation of 3-amino-1, 2, 4-triazoles with unsymmetrical 3-
dicarbonyl compounds. Thus, whilst the condensation of 3-amino-1, 2,4-
triazole (95) and 3-amino - 5-methylthio - 1, 2,4-triazole (224) with 2-
hydroxymethylene-3-oxo steroids without a A4  double bond gives a 
mixture of linearly fused and angularly fused products, condensation with 
a 2-hydroxym ethylene- 3-oxo steroid with a A4 double bond gives only 
angularly fused products. Further, the condensation of 3-amino-5-methyl-
1, 2,4-triazole (127) with 2-hydroxym ethylene- 3-oxo steroids without a 
A4 double bond gives only linearly fused products whereas condensation 
with 2-hydroxymethylene-3-oxo steroids with a 	double bond gives only 
angularly fused products demonstrating that the A4 double bond in the 
steroid nucleus overcomes the opposing effect of the methyl substituent 
of the triazole (127) on the course of the condensation reaction. 
6. 5 The reaction of -hydroxy- 16 -hydroxymethyleneandrost- 5-en-
l7-one (8) with 3-amino-1, 2,4-triazole (95). 





1 	 2 
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(8) and 3-amino- 1,2, 4-triazole (95) in absolute alcohol was refluxed 
overnight. The reaction mixture was diluted with water, the white 
precipitate was filtered, washed, dried and recrystallised from ethanol 
to give a white solid (240), m. p.  176-180 °  in 55% yield. Mass 
spectrometry indicated that the product had a molecular formula of 
C 22H28N40. The product was not soluble in bromoform and deuterated 
chloroform, thus the i. r. and 'H n. m. r. spectra could not be measured. 
Acetylation of the product gave the 33-acetate (241). The i. r. 
spectrum of the acetyl derivative showed absorptions at 1720 (C0), 1605, 
1550, 1500, 1450, 1370 and 780 cm '. The u. v. spectrum showed 7 max 
at 216 and 290 nm (log G 4. 36 and 3. 74) whilst the 'H n. m. r. spectrum 
exhibited two sharp singlets at 6 8. 42 and 6 8. 64 corresponding to the 
proton on the triazole ring and the proton on the pyrimidine ring respectively. 
The i. r. , u. v. and 1H n. m. r. spectra of this acetyl derivative resemble 
closely the i. r. , u. v. and 'H n. m. r. spectra of 17-hydroxy-17.t-methy1-
5a_androst_2_eno[2,3-g]-s-triazolo[1,5-a]pyrimidine (211) and thus the 
product of the condensation of 3-amino-1, 2,4-triazole (95) with 33-hydroxy-
16-hydroxymethyleneandrost-5-en-17-one (8) is formulated as 31 -
hydroxyandrost-5, 16-dieno[16, 17_g]-s-triazolo[i,5-a]pyrimidine (24). 
Similarly the condensation of 3-amino-1, 2, 4-triazole (95) with 3p-
hydroxy- 1 6-hydr oxymethylene- 5a.- androst- 17- one (7) and 16-hydroxymethylene 
3-methoxyoestra-1,3, 5(iO)-trien-17-one (9) gave 3-hydroxy-5a-androst-
16-eno[16, 17- gI-  s-triazolo[1, 5-a]pyrimidine (242) and 3-methoxyoestra- 
1,3,5(10), 16-tetraeno[16, 17- g] - s -triazolo[ 1, 5 - a]pyrimidine (244). 	The 
product (242) was also acetylated to give the acetyl derivative (243). 
The condensation of 3-amino-5-methyl- 1,2, 4-triazole (127) with 
3-hydroxy-16-hydroxymethy1ene-5a.-androstan-i7-one (7) also leads to 
HO 
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(248) 
the formation of an angularly fused product, 33-hydroxy-5a-androst-
l6-eno[1€l7-g]-2'-methyl-s-triazolo[l,5-a]pyrimidine (245) though in 
poor yield. It was noticed that the reaction of 16-hydroxymethylene-17- 
oxo steroids, like the reaction of 2-hydroxymethylene- L\4-3-oxo 
steroid with aminotriazoles (95), (127) and (224), gives only angularly 
fused products whereas the reaction of 2—hydroxymethylene -3 -oxo- steroids 
without a L double bond leads to linearly fused products or a mixture 
of linearly and angularly fused products, depending upon the amino-
triazole employed in the reaction. 
6. 6 	The reaction of 33-hydroxy-16-hydroxymethylene-5a-androstan 
17-one (47) with 3 -amino- 5 -methylthio- 1, 2,4-triazole (224). 
In absolute alcohol. 
A solution 33-hydroxy-16-hydroxymethylene_5a_androstan17_ 
one (7) and 3-amino-5-methylthio-1,2,4-triazole (224) in absolute alcohol 
was refluxed overnight. The solution was evaporated to dryness under 
vacuo and the residue was chromatographed over alumina. Elution with 
chloroform gave a solid which recrystallised from alcohol as white 
needles (246), m. p.  244-246°, in 45% yield. Further elution of the 
column with 10% ethanol in chloroform gave a light yellow solid which was 
recrystallised from acetone to give white crystals (247), m. p.  181- 1850 
in 22% yield. 
In toluene. 
Only one product (246) was obtained in 77% yield when the above 
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Fig. 6: u. V. Spectra of 3p_hydroxy_5a-androst-16-eno[16, 17-g]_2T_ 
methylthio- s-triazolo[1, 5-a]pyrimidine (246) and 3 3-hydroxy-
16[3 '-(5-methylthio)- s_triazolyl_aminomethylene]androstafl-
17-one (247). 
6. 7 	Discussion 
Mass spectrometry and elemental analysis of the first product, 
m. p.  244-246°, showed that it had a molecular formula of C23H32 N4OS. 
The u. v. spectrum showed ?\ max at 211, 241, 286 and 307 nm (log E 
4. 25, 4. 46, 3. 85 and 3. 87) whilst the i. r. spectrum exhibited absorp-
tions at 3600 (OH), 1600, 1555, 1490, 1440, 1420, 1350 and 780 cm- 1. 
These absorptions in the u. v. and i. r. spectra of the product correlate 
well with that of 1 7p-hydroxy- 1 7a-methyl-5a-androst-2-eno[2, 3_g]_2'_ 
methylthio- s-triazolo[l, 5-a]pyrimidine (226) (see page 115) thereby 
indicating that this steroid has the structure, 33-hydroxy-5a.-androst-
16-eno[16, 17_g]_21 _methylthio_s_triazolo[l,5_a]pyrimidine (246). This 
structure is confirmed by the 'H n. m. r. spectrum which shows the 
2'-SCH3 and the 5'-H, both as sharp singlets at 6 2. 64 and 6 8. 67 
respectively. 
The u. v. spectrum of the second product, m. p. 181- 1850, 
exhibiting 	max at 208 and 320 nm (log C. 4. 04 and 4. 26) (Fig. 6) 
does not show any similarity with either of the analogous linearly or 
angularly fused products, and this must mean that the steroid is not a 
derivative of the s-triazolo[1,5-a]pyrimidine system (69). The ? max 
at 320 nm shows that the steroid contains a highly conjugated chromophore. 
Furthermore, when this steroid is heated in dry toluene containing a small 
amount of toluene -4- sulphonic acid for 3 h, 3-hydroxy-5a-androst-16-
eno[16, 17-g]-2'-methylthio-s-triazolo[l, 5-a]pyrimidine (246) was obtained 
in 85% yield. It is, therefore, evident that the steroid must be an inter-
mediate between the starting 3-ketoaldehyde (7) and the final cyclized 
product (246) and the most obvious structure to choose is the enaminone 
(247). 
I U' 
The 'H n. m. r. spectrum of the enaminone exhibited two doublets 
at 6 7. 60 and 6 9. 70 (J=l2Hz) and a broad singlet at 6 13. 18 which are 
assigned to the vinyl proton, the amino proton and the proton on the 
triazole ring respectively. The coupling between the first two protons 
was confirmed by double irradiation experiments. Sawyer and Wibberley14°  
found that the 'H n. m. r. spectrum of 2(2-acetylvinylamino)pyridine (209) 
where the enaminone system is similar to that in the steroid (247) showed 
two doublets at 6 7. 93 and 6 11. 69, each with spin coupling constant, 
J12Hz. These signals were assigned to the vinyl proton and to the 
amino proton respectively. Similarly the 'H n. m. r. spectrum of the 
enaminone (248) has also been reported 
73 
 to exhibit two doublets at 
6 7. 56 and 6 11. 90 (J=12Hz). The observed chemical shift of the vinyl 
proton in the steroidal enaminone and the coupling constant are in good 
agreement with the proposed structure (247). The magnitude of the 
coupling constant (12Hz) between the amino proton and the vinyl proton 
on the adjacent carbon is consistent with these two protons being trans 
to one another, 
144 
 as shown in structure (247). The coupling constant, 
if the two protons had been cis would have been observed at the much 
lower value of 0-2Hz. 144 
It is observed that the chemical shift of the amino proton in the 
steroidal enaminone (247) occurs at a higher field compared with the 
chemical shifts of the corresponding protons in the enaminones (209) 
and (248). This is attributed to the amino proton in the steroid (247) 
having a lower electron density in its vicinity because of the presence of 
only weak hydrogen bonding to the 17-ketone. The enaminones (209)140 








hydrogen bonding. The most likely reason for the absence of significant 
hydrogen bonding in the steroidal enaminone (247) appears to be that the 
adjacent five membered D-ring of the steroid imposes a conformation on 
the enaminone such that the carbonyl oxygen and the amino proton are 
not close enough to permit hydrogen bonding between them. Similarly, 
Burgess 51 observed an upfield chemical shift (6 10. 70) of the amino 
hydrogen in the 'H n. m. r. spectrum of 3-acetoxy-16(2'-pyridyl-
aminomethylene)andro st- 5-en- 17-one (58) relative to the corresponding 
chemical shift (6 11. 88) in 173-acetoxy-2(2 '-pyridyl-aminomethylene)-5a-
androstan-3-one (56). 
Under analogous reaction conditions, the condensation of 3-amino-
5-methylthio -1, 2, 4-triazole (224) with the 3-ketoaldehydes (8) and (9) 
gave 3 3-hydroxy- 1 6[3 I -(5' -methylthio)- s -triazolyl- aminomethylene]androst-
5-en-17-one (249) and 313-hydroxyandrost-5, 16-dieno[16, 17-g]-2'-
methylthio-s-triazolo[1,5-a]pyrimidine (250); and 3-methoxy-16[3'-
(5'-rnethylthio)-s-triazolyl-aminomethylene]oestra-1,3,5(10) trien-17-one 
(251) and 3-methoxyoestra-1,3,5(10),16.-tetraeno[16,17-g]-2'-methylthio-
s-triazolo[1, 5-a]pyrimidine (252) respectively. The enaminone s (249) 
and (251) were also converted to the triazolopyrimidInes (250) and (252) 
respectively upon heating in dry toluene in the presence of toluene-4-
sulphonic acid. The sterols (246) and (250) were acetylated to give the 
corresponding 313-acetates  (253) and (254). 
None of the enaminones (247), (249) and (251) showed peaks 
corresponding to their molecular ions in the mass spectrometry but 
exhibited peaks at m/e (M+_18)  corresponding to the triazolopyrimidines 









Likewise the condensation of 3-aminopyrazoles (section 5), 
the condensation of 3- amino- 1, 2, 4-triazoles with 2-hydroxymethylene 
3-oxo steroids without a L double bond resulting in the formation of 
linearly fused products is also a two step process. Evidence for this 
two step reaction sequence comes from the reaction of 2(2_pyridyl-
aminomethylene)-5a-chole stan-3-one (207) with 3-amino-1, 2,4- triazole 
(95) which is reported below. 
6. 8 	The reaction of 2(2t_pyr idyl- aminomethylene)_5a_cholestan3_ 
one (207) with 3-amino-1, 2, 4-triazole (95). 
A solution of 2(2'_pyr idyl -aminomethylene)-5a-c hole stan-3-one 
(207) and 3-amino-1, 2, 4-triazole (95) in dry toluene containing a catalytic 
amount of toluene -4- sulphonic acid was refluxed for 5 h. The excess 
of solvent was removed under vacuo and the residue was chromatographed 
over alumina. Elution with ethyl acetate followed by recrystallisation of 
the eluate from ethyl acetate gave white shining plates (68%), m. p. 170-
173°, identical (m. p. , i. r. and 
I 
 H n. m. r. spectra) with that of 5a-
cholestano[3, 2-f]-s-triazolo[1,5-a]pyrimidine (220). 
The mechanism of these condensation reactions is discussed 
in detail in section 10. 
6.9 Experimental 
General procedure for the condensation reaction 
A slution of the steroidal -ketoaldehyde (1.5 x 10 3mole) and 
3-amino-1, 2,4-triazole (95) or its derivative (127 or 224) (2 x lO 3mole) 
in absolute alcohol was refluxed overnight. The reaction mixture was 
evaporated to dryness under vacuo, the residue was chromatographed 
over alumina (50 g) and the products thus obtained were recrystallised 
from suitable solvents. 
6.9. i 1713-Hydroxy-17a-methyl-5a-androstano{3, 2-fl -s -triazololl, 5-al-
rimidine (210) and 1 73 -hvdroxy- 17 a-methyl- 5 a-androst- 2- eno-
[2, 3-gl-s-triazolo[1, 5-alp')rrimidine  (211). 
Source: 17P -Hydroxy- 2-hydroxymethylene- 17 a-methyl- 5 a-androstan-
3-one (108) and 3-amino-1, 2,4-triazole (95). 
General: Alumina chromatography (eluant benzene- chloroform, 3:1). 
1 7f3-Hydroxy- 17 a-methyl-S a-androstano[3, 2-fl- s-triazolo[i,  5-al-
pyrimidine (210) was recrystallised from chloroform-ether as white 
needles (45%), m. p.  118-120; u. v. , 	max 220 and 283 nm (log 6 4. 34 
and 3.58); i. r., y 
max 
 3600, 1620, 1510, 1440, 1405, 1370 and 775 cm '; 
'H n. m. r. (100 MHz), 6 0.82 (s, 3H, 18-CH3), 0.88 (s, 3H, 19-CH 3), 
1. 22 (s, 3H, 17-CH3), 8. 34 (s, 1H, 2'-H) and 8. 50 (s, 1H, 7'-H) 
(Found: C, 72.64; H, 8.58; N, 14.86; M+,  380. 255601. C 23H32N40 
requires C, 72.58; H, 8.48; N, 14.73%; M, 380.257598). 
1 713-Hydroxy-l7  a-methyl- 5a-androst- 2-eno[2, 3-gl-s-triazolo[1, 5-al- 
pyrimidine (211) was recrystallised from ether as white crystals (25%), 
m. p. 248-250°; u. r. , A max  218 and 283 nm (log E 4. 26 and 3. 65); 
i. r. , 	1 	3600, 1620, 1545, 1520, 1445, 1370, 1355 and 775 cm '; 
max 
n. m. r. (100 MHz), 6 0. 82 (s, 3H, 18-CH3), 0. 90 (s, 3H, 19-CH 3), 
1.24 (s, 3H, 17-CH3), 8.40 (s, 1H, 2t_H)  and 8.50 (s, 1H, 51 -H) 
(Found: C, 72. 70; H, 8. 54; N, 14. 50; M+,  380. 255976. C23H32N40 
requires C, 72. 58; H, 8.48; N, 14. 73%; M, 380. 257598). 
6. 9. ii 	5a-Androstano[3, 2_f]- s-triazolo[1, 5-a]pyrimidine (218) and 
5a-androst-2-eno[2, 3-g]-s-triazolo[1, 5-a]pyrimidine (219). 
Source: 2-Hydroxymethylene-5ci.-androstan-3-one (109) and 3-amino-
1,2,4-triazole (95). 
General: Alumina chi:omatography  (eluant ethyl acetate). 5a-Androstano-
[3, 2-f]- s-triazolo[1, 5-a]pyrimidine (218) was recrystallised from ethanol 
to give a single large crystal (46%), m. p. 174-1760; u. v. , A max 220 and 
285 nm (log E  4.28 and 3.65); i. r. , 	max 1630, 1510, 1440, 1405 and 775 
cm '; 'H n. m. r. (100 MHz), 6 0. 76 (s, 3H, 18-CH3) 0. 84 (s, 3H, 19-CH 3'
8.35 (s, 1H, 2'-H) and 8.50 (s, 1H, V-H) (Found: C, 75.23; H, 8. 72; 
N, 15. 85; M+,  350. 246730. C 22H30N4 requires C, 75. 38; H, 8. 63; N, 
16. 00%;  M, 350. 247035). 
5a-Androst-2-eno[2, 3- g]-  s-triazolo[1, 5-a]pyrirnidine (219) was 
recrystallised from ethanol to give white crystals (2 1%),  m. p.  272-273°; 
u.v., A max 218 and 282nm (log e4.37 and 3.77); i.r., T max 1620, 
15451  1520, 1450 and 780 cm- 1; 'H n. m. r. (60 MHz) 6 0. 72 (s, 3H, 
18-CH3), 0.82 (s, 3H, 19-CH3), 8.44 (s, 1H, 2'-H) and 8.54 (s, 1H, 
5'-H) (Found: C, 75. 19; H, 8. 63; N, 15. 80; M+,  350. 245612. 
C22H30N4 requires C, 75. 38; H, 8. 63; N, 16. 00%;  M, 350. 247035). 
6. 9. iii 5a-Cholestano[3, 2-fl-s-triazolo[l, 5-alpyrimidine (220) and 
5a-cholest-2-eno[2, 3-g-s-triazolo[l, 5-alpyrimidine  (221). 
Source: 2-Hydroxymethylene- 5 a-cholestan- 3-one (110) and 3-amino-
1, 2,4-triazole (95), 
General: Alumina chromatography (eluant ethyl acetate) 
	
5 a-Cholestano- 
[3, 2-f]-s-triazolo[l, 5-alpyrimidine  (220) was recrystallised from ethanol 
to give white crystals (48%),  m. p. 170-173; u.v., 	max 221 and 284 
nm (log 64.35 and 3.75); i. r. , 1 
max 
 1630, 1510, 1465, 1440, 1405 and 
775 cm 
l; '
H n. m. r. (60 MHz), 6 0. 70, 0. 80, 0.85 and 0.90 (methyl 
groups), 8.45 (s, 1H, 2-H) and 8.55 (s, 1H, 7'-H) (Found: C, 78. 10; 
H, 10. 00; N, 11.97; M+, 462. 372602. C30H46 N4 requires C, 77. 86; 
H, 10.03; N, 12.12%; M, 462. 372229). 	5a-Cholest-2-eno[2, 3-gl-s- 
triazolo[l, 5-ajpyrimidine (221) was recrystallised from ethanol to give 
white crystals (23%), m. p. 176-1780; u.v., 	max 217 and 282 n 
(log 6 4.23 and 3.58); i. r. , 1 max 1620, 1545, 1515, 1440, 1380, 1355 
and 775 cm 
1; '
H n.m. r. (100 MHz), 60.70, 0.80, 0.82 and 0.90 
(methyl groups), 8.40(s, 1H, 2'-H) and 8.52 (s, 1H, 5'-H) (Found: 
C, 77.93; H, 9.97; N, 12.12; Mt 462. 371326. C30H46 N4 requires 
77.86; H, 10.03; N, 12.12%; M, 462. 372229). 
6.9. iv 11-Oxo-5-spirostanof3, 2-fl -s-triazolo[1, 5-alpyrimidine (222) 
and 11-oxo-5a-spirost-2-eno{2, 3-g-s-triazo1o[1, 5-alpyrimidine 
(223). 
Source: 2-Hydroxymethylene- 5 a- spirostan- 3, 11- dione (111) and 3-amino-
1, 2,4-triazole (95). 
General: Alumina chromatography (eluant ethyl acetate). 11-Oxo--5a- 
spirostano[3, 2-fl-s-triazolo[l, 5-alpyrimidine  (222) was recrystallised 
from ethanol, to give white needles (37%), m.p.217-2l9°; u.v., max 
221 and 285 nm (log E, 4. 36 and 3.65); i. r. , y max 1690 (C=O), 1625, 
1510, 1450, 1405, 775 cm '; 'H n.m. r. (100 MHz), 6 0.74 (s, 3H, 
18-CH3), 1.00 (s, 3H, 19-CH3), 8.34 (s, 1H, 2'- H) and 8.48 (s, 1H, 
7'-H) (Found: C, 70.98; H, 7.87; N, 10.82; M+,  504. 308274. 
C 30H40N403  requires C, 71.38; 	H, 	7.99; N, 	11.11%; 	M, 504. 310024). 
11 -Oxo- 5a-spirost- 2-enol2,  3-gl-s-triazolo[1,  5-alpyrimidine (223) was 
recrystallised from ethanol to give white crystals (18%), m. p.  176-1790; 
u.v., 	max 217 and 282nm (loge 	
max 
4.41 and 3.73); i.r., y 	1695 
(C=0), 1625, 1545, 1520, 1365 and 775 cm 
l; '
H n. m. r. (60 MHz), 
60.75 (s, 3H, 18-CH3), 1.03 (s, 3H, 19-CH3), 8.50 (s, 1H, 2'-H) and 
8.60 (s, 1H, 51 -H) (Found: C, 71. 17; H, 8. 15; N, 10. 79; M, + 
504. 307597. C30H40 N403 requires C, 71. 38; H, 7. 99; N, 11. 11%; 
M, 504. 310024). 
6.9. v 1713-Hydroxy-17a-methyl-5a-androstano[3, 2-fl- 2 '-methylthio- s-
triazolo[1, 5-alpyrimidine  (225) and 17P -hydroxy-  17 a-methyl- 5 a-
androst- 2-eno[2, 3-gi- 2'-methylthio- s-triazolo[1, 5-a]pyrimidine 
(226). 
Source: 17P - Hydroxy-  2-hydroxymethylene- 17 a-methyl- 5 a-andros tan- 3-
one (108) and 3-amino-5-methylthio-1,2,4-triazole (224). 
General: Alumina chromatography (eluant ethyl acetate-methylene chloride, 
9:1). 
1 713-Hydroxy-  17 a-methyl- 5 a-androstano[3, 2-f}- 2-methylthio- s-triazolo-
[1, 5-a]pyrimidine  (225) was recrystallised from ethanol to give fine white 
crystals (52%),  m. p. 207-2080; u. v. , 	212, 217, 237 and 315 nm max 
(log 6 4.40, 4.40, 4.43 and 4.03); i. r. , 3600 (OH), 1620, 1510, 1440, 
1415, 1370, 1345 and 770 cm '; 1H n. m. r. (100 MHz), 6 0.80 (s, 3H, 
18-CH3), 0.88 (s, 3H, 19-CH3), 1. 22 (s, 3H, 17-CH3), 2.66 (s, 3H, 
2'-SCH3) and 8. 30 (s, 1H, 7'-H) (Found: C, 67. 31; H, 8. 10; N, 12. 79; 
M+, 426.246147. C 24 H34N40S requires C, 67.57; H, 8.04; N, 13.14%; 
M, 426.245320). 
1 7-Hydroxy- 17 a-methyl-5 a-androst- 2- eno[ 2, 3-g]- 2'-methylthio-s-
triazolo[1, 5-a]pyrimidine (226) was crystallised from acetone to give 
white needles (27%), m. p.  230-2320; u. v., max 
 209, 239, 283 and 308 
nm (log E, 4. 26; 4. 50, 3.89 and 3.91); i. r., y max 3600 (OH), 1615, 
1545, 1515, 1440, 1400, 1360 and 770 cm ; 1H n. m. r. (100 MHz), 
6 0.80 (s, 3H, 18-CH3), 0.90 (s, 3H, 19-CH3), 1. 24 (s, 3H, 17-CH 3), 
2. 70 (s, 3H, 2v_  SCH3) and 8. 38 (s, 1H, 5t-H) (Found: C, 68. 12; H, 
8.22; N, 13. 13; M+,  426. 245734. C 24H34N40S requires C, 67. 57; 
H, 8.04; N, 13. 14%; M, 426. 245320). 
6.9. vi 5 a- An d r o s ta no [ 3, 2-fl-2'-methylthio-s-triazolo[1, 5-a]pyrimidine 
(227) and 5 a-androst-2-eno[2, 3-gi- 2'-methyl-s-triazolo[l,  5-al-
pyrimidine (228). 
Source: 2-Hydroxymethylene- 5 a-androstan- 3-one (109) and 3-amino- 5-
methylthio-1, 2,4-triazole (224). 
General: Alumina chromatography (eluant ether-ethyl acetate, 1:1). 
5a-Androstano[3, 2-fl -2'-methylthio-s-triazolo{l , 5-a]pyrimidine (227) 
was recrystallised from acetone to give white shining crystals (55%), 
m. p. 182-183°; u.v., 	max 213, 228, 237 and 316 nm (log 64.38,4.38, 
4.40 and 3.97);. i. r., 1 max 1620, 1510, 1435, 1415, 1345 and 770 cm '; 
'H n. m. r. (100 MHz), 5 0. 72 (s, 3H, 18-CH3), 0.78 (s, 3H, 19-CH 3), 
2.70 ( s , 3H, 2 -SCH3) and 8.38 (s, 1H, 7'-H) (Found: 0, 69.42; H, 8. 18; 
N, 14. 07; M+, 396. 231886. C 23H32N4S requires 0, 69. 66; H, 8. 14; 
N, 14.14%; M, 396. 234757). 
5 a-Androst- 2-eno[2, 3- gi- 2'-methylthio-s-triazolo[l, 5-alpyrimidine  (228) 
was recrystallised from ethanol as white fluffy crystals (32%), m. p.  216- 
217°; u.v., 	max 210, 239, 281 and 307 nm (log 6 4. 22, 4. 40, 3.81 
and 3.81); i. r., 1 max 1620, 1510, 1435, 1415, 1345 and 770 cm 1; 
'H n.m. r. (100 MHz), 5 0.74 (s, 3H, 18-CH3), 0.78 (s, 3H, 19-CH 3), 
2.66 (s, 3H, 2-SCH3) and 8. 32 (s, 1H, 5-H) (Found: 0, 69.62; H, 8.35; 
N, 14.03; M+,  396.232662. 0 23H32N4S requires 0, 69.66; H, 8.14; 
N, 14.14%; M, 396. 234757). 
6. 9. vii 5a-Cholestano[3, 2-f]- 2'-methylthio-s-triazolo[l, 5-alpyrimidine 
(229) and 5a-cholest-2-eno[2, 3-g]-2'-methylthio-s-triazolo[l, 5-al-
pyrimidine (230). 
Source: 2-Hydroxymethylene- 5 a-cholestan- 3-one (110) and 3-amino- 5 
methylthio-1, 2,4-triazole (224). 
General: Alumina chromatography (eluant ether-ethyl acetate, 1:1). 
5 a-Cholestano[3, 2-f]-2'-methylthio-s-trjazolo[l, 5-alprrimidine (229 
was recrysta 111 sed fioii ethyl acetate as white shining plates (42%), m. p. 
192-1930; u.v., 	max 213, 228, 237 and 316 nm (log 6 4. 28, 4. 31, 
4. 34 and 3.90); i. r., 1 max 1620, 1510, 1465, 1440, 1415, 1350 and 
770 cm 1; 'H n.m. r. (100 MHz), 	6 0. 68, 0. 78, 0.82 and 0.88 (methyl 
groups), 2.66 (s, 3H, 2'-SCH3) and 8.30 (s, 1H, 7t-H) (Found.- C, 72. 91; 
H, 9.56; N, 10.86; M+,  508. 356695. 	C 31H48N4S requires C, 73. 18; 
H, 9. 52; N, 11. 02%; M, 508. 359951). 
5a_C hole st-2-eno[2, 3-g]-2'-methylthio- s-triazolo[1, 5_alpyrimidine 
(230) was recrystallised from ethanol to give white crystals (30%), m. p. 
189-191°; U. v., 	211, 239, 282 and 308 nm (log 6 4. 18, 4. 49, max 
3. 79 and 3.87); 1. r. , y max 1615, 1545, 1510, 1400, 1360 and 770 cm; 
'H n. m. r. (100 MHz), 5 0. 68, 0. 76, 0. 82 and 0. 90 (methyl groups), 
2. 70 (s, 3H, 2'-SCH3 ) and 8.38 (s, IH, 5-H) (Found: C, 72.94; H, 
9. 58; N, 10. 78; M+,  508. 359951. 	C31H48N4S requires C, 73. 18; 
H, 9.52; N, 11. 02%; M, 508. 359951). 
6. 9. viii 1 1-Oxo-5cL-spirostano[3, 2_f]_2'-methylthio- s-triazolo[1, 5-a]-
pyrimidine (231) and 1 1-oxo-5a-spirost-2-eno[2, 3-g]-2'-methyl-
thio-s-triazolo[1,5-a]pyrimidine (232). 
Source: 2-Hydroxymethylene-5a-spirostan-3, 11-dione (iii) and 3-
amino- 5 -methylthio- 1, 2, 4-triazole (224). 
General: Alumina chromatography (eluant ether-ethyl acetate, 2:3). 
11 -Oxo-5o.-spirostano[3, 2_f]_2 -methylthio-s-triazolo[1, 5-a]pyrimidine 
() was recrystallised from ethanol to give white crystals (15%), m. p. 
228-230°; U. V. , 	max 213, 228, 238 and 316 nm (log 6 4. 33, 4. 37, 
4.40 and 3. 97); i. r. , y 
max 
 1690 (C0), 1620, 1510, 1450, 1415, 1345 
and 770 cm '; 1H n.m. r. (100 MHz), 5 0. 76 (s, 3H, 18-CH3), 0. 98 (s, 
3H, 19-CH3), 2. 66 (s, 3H, 2'-SCH3) and 8.34 (s, 1H, 7'-H) (Found: 
C, 67.39; H, 7.72; N, 10.20; M, 550.300342. C31H42N403S 
requires C, 67. 60; H, 7. 69; N, 10. 18%;  M, 550. 297746). 
11-Oxo-5a.- spirost-2-eno{2, 3- g]_2 -methylthio- s-triazolo[1, 5-a]- 
117 
pyrimidine (232) was recrystallised from ethanol to give white crystals 
(18%), m. p.  265-2670; u. v., 	max 210, 239, 282 and 307 nm (log £ 
4. 20, 4.48, 3.77 and 3.82); i. r. , y 
max 
 1695 (C =0), 1615, 1545, 1510, 
1450, 1400, 1355 and 770 cm '; 1H n. m. r. (100 MHz), 6 0.76 (s, 3H, 
18-CH3), 1.00 (s, 3H, 19-CH 3),  2.70 (s, 3H, 2'-SCH3) and 8. 38 (s, 
1H, 5'-H) (Found: C, 67. 05; H, 7.82; N, 9.90; M+,  550. 298728. 
C 31H42N403S requires C, 67. 60; H, 7.69; N, 10. 18%;  M, 550. 297746). 
6. 9. ix 173-Hydroxy- 17 a-methyl-5 a-androstano[3, 2-f]-2'-methyl-s-  -fl-2'-meth l
triazolo[l, l [1 5-alpyrimidine  (233). 
Source: 17P - Hydroxy-  2-hydroxymethylene- 17 a-methyl- 5 a-andros tan-
3-one (108) and 3-amino-5-methyl-1, 2,4-triazole (127). 
General: Alumina chromatography (eluant chloroform) gave 1713-hydroxy-
17a-methyl-5a-androstano[3, 2-fl-2'-methyl-s-triazolo{l,  5-apyrimidine 
(233) which was recrystallised from ethyl acetate as long white needles 
(68%), m. p.  232-234; u. v., 	max 219 and 289 nm (log 6 4.51 and 
3. 77); i. r. , y 
max 
 3600 (OH), 1625, 1515, 1470, 1440, 1415, 1385 and 
775 cm ; 'H n. m. r. (100 MHz),60. 80 (s, 3H, 18-CH3), 0.88 (s, 3H, 19- 
1. 24 (s, 3H, 17-CH3), 2.56 (s, 3H, 2'-CH3) and 8. 34 (s, lH, 7'-H) 
(Found: C, 72.89; H, 8.85; N, 13.85%;M+,  394.272785. C 24 H34N4 0 
requires C, 73.05; H, 8.69; N, 14.21%; M, 394. 273247). 
6.9.x 5a-Cholestano{3, 2-fl -2'-methyl-s- triazolo[l, 5-a]pyrimidine (234). 
Source: 2-Hydroxymethylene- 5 a-cholestan- 3-one (110) and 3-amino-5-
methyl-1, 2,4-triazole (127). 
General: Alumina chromatography (eluant ether-ethyl acetate, 1:1) gave 
I Z.0 
5a-cholestano{3, 2_fl_21 _methyl_s_triazolo[1, 5-ajpyrimidine (234) which 
was easily recrystallised from acetone to give fine white needles (35%), 
m. p.  185-187°; u.v., A max 
 217 and 286 nm (log 6 4.59 and 3.84); i. r.
1625, 1510, 1465, 1410, 1380, 1360 and 770 cm '; 'H n. m. r. 
max 
(100 MHz), 50. 70, 0. 78, 0.84 and 0.90 (methyl groups), 2.56 (s, 3H, 
2'-CH 
3) 
 and 8.34 (s, 1H, 7'-H) (Found: C, 78. 36; H, 10.43; N, 11.77; 
M+, 476. 387943. C 31H48N4 requires C, 78. 10; H, 10. 15; N, 11.75%; 
M, 476. 387878). 
6.9.xi 11-Oxo-5a-spirostano[3, 2f]2t_methy1s_triazolo[1, 5-al-
pyrimidine (235). 
Source: 2-Hydroxymethylene- 5 a-spirostan- 3, 11- dione (111) and 3-
amino- 5-methyl-i, 2, 4-triazole (127). 
General: Alumina chromatography (eluant ethyl acetate) gave 11-oxo-
5a-spirostano{3, 2 f1_ 2t _methyl_s_triazolo[l, 5-alpyrirnidine (235) which 
was recrystailised from acetone as white crystals (60%), m. p.  274-276; 
u. v. , max 217 and 287 nm (log 	 max 4.63 and 3. 85); i. r. , 1 	1695 
(C0), 1625, 1515, 1450, 1410, 1380 and 775 cm- 1; 1H n. m. r. (60 MHz), 
60. 75 (s, 3H, 18-CH3), 1. 20 (s, 3H, 19-CH3), 2.60 (s, 3H, 2'-CH3) 
and 8.40 (s, 1H, 7!_H)  (Found: C, 71.60; H, 8.30; N, 10. 62; Mt 
518. 324335. C 31H42N403 requires C, 71.77; H, 8.17; N, 10.81%; 
M, 518. 325673). 
6. 9. xii 1 73-Hydroxyandrost- 2, 4-dieno{2, 3-g]- s -triazolo[l, 5-a]pyrimidine 
(236). 
Source: 17P -Hydroxy- 2-hydroxymethyleneandro st-4 - en- 3-one (4) and 
3-amino-1, 2,4-triazole (95). 
General: Alumina chromatography (eluant ethyl acetate) gave 17f3-
hydroxyandrost-2, 4-dieno[2, 3-g-s-triazolo[l, 5-alpyrimidine  (236) 
which was recrystallised from ethanol as yellow crystals (57%), m. p. 
252-254°; u. v. , 	max 226 and 343 nm (log E  4. 34 and 4. 21); i. r., 
Y max 3600 (OH), 1630, 1580, 1550, 1510, 1460, 1450 and 780 cm- 
1 H 1H n. m. r. (100 MHz), 5 0.84 (s, 3H, 18-CH3), 1.04 (s, 3H, 19-CH 3), 
3.50 (m, lH, 17-H), 6.94 (s, 1H, 4-H), 8.40 (s, 1H, 2'-H) and 8.52 
(s, lH, 5'-H) (Found: C, 72.03; H, 7.74; N, 15.06; M+,  364. 224701. 
C 22H28N40 requires C, 72.48; H, 7.75; N, 15.38%; M, 
364. 226300). 
6. 9. xiii 1 7-Hydroxyandrost- 2, 4-dieno[2, 3-gi- 2'-methylthio-s-
triazolo[1, 5-a]pyrimidine  (237). 
Source: 1 7f3 -Hydroxy- 2- hydroxymethyleneandro s t-4- en- 3-one (4) 
and 3-amino-5-methylthio-1, 2,4-triazole (224). 
General: Alumina chromatography (eluant ethyl acetate) gave 17f3-
hydroxyandrost- 2, 4-dieno[2, 3-gi- 2'-methylthio-s-triazolo{i, 5-al-
pyrimidine (237) which was recrystallised from ethanol as yellow 
crystals (58%), m. p.  226-228°; u. v. , 	max 215, 249 and 325 nm 
(log 6 4. 23, 4.34 and 4. 16); i. r. , 1 max 3600 (OH), 1630, 1590, 1550, 
1505, 1410, 1350 and 775 cm 
1; '
H n. m. r. (100 MHz), 5 0.80 (s, 3H, 
18-CH3), 1. 00 (s, 3H, 19-CH3), 2. 70 (s, 3H, 2'-SCH3), 3. 70 (m, 1H, 
17-H), 6.80 (s, 1H, 4-H) and 8. 34 (s, 1H, 5'-H) (Found: C, 67. 25; 
H, 7.34; N, 13.42; M+,  410. 212269. C 23H30N4 0S requires C, 67. 28; 
H, 7. 37; 	N, 13. 65%; M, 410. 214021). 
6. 9. xiv 1 713-Hydroxyandrost-2, 4-dieno[2, 3-g]- 2'-methyl-s-triazolo- 
[1, 5-alpyrimidine  (238). 
Source: l?P-Hydroxy-2-hydroxymethyleneandrost-4- en- 3-one (4) 
and 3-amino-5-methyl-1, 2,4-triazole (127). 
General: Alumina chromatography (eluant chloroform) gave 1j3-hydroxy- 
androst- 2, 4- dieno[ 2, 3-gi- 2'-methyl- s-triazolo[ 1, 6-a]pvrimidine (238) 
which was recrystallised from acetone-chloroform as light yellow crystals 
(28%), m. p.  248-2500; u. v. . 	max 207, 227 and 343 im (log E 4. 10, 
4. 28 and 4.01); i. r., ' max 3590 (OH), 1625, 1590, 1550, 1510, 1465, 
1410 and 775 cm ; 1H n. m. r. ( 60 MHz), 5 0.85 (s, 3H, 18-CH 3), 
1.05 (s, 3H, 19-CH3), 2.65 (s, 3H, 2'-CH3), 3.70 (m, lH, 17-H), 
6.90 (s, 1H, 4-H) and 8.50 (s, lH, 5t-H) (Found:141 M+,  378. 240736. 
C 23H30N4 0 requires M, 378. 241949). 
6. 9. xv 1 73-Acetoxyandrost- 2, 4-dieno[2, 3-gi- 2'-methylthio- s-triazolo-
[1, 5-alpyrimidine (239). 
A solution of 1 73-hydroxyandrost- 2, 4-dieno[2, 3-g]- 2'-methylthio- 
s-triazolo[1, 5-a]pyrimidine (237) (250 mg, 6. 1 x 10-4  mole) in pyridine 
(25 ml) containing a few drops of acetic anhydride was refluxed for 2 h. 
The reaction mixture was evaporated to dryness under vacuo and the 
residue taken up in chloroform. The chloroform solution was washed 
with 5% hydrochloric acid, saturated sodium chloride solution and water, 
dried over anhydrous magnesium sulphate. The solution was evaporated 
to dryness and the residue purified by alumina chromatography (eluant 
ethyl acetate) followed by recrystallisation from ethanol to give 1713-
acetoxyandrost- 2, 4-dienol2, 3-gi- 2'-methylthio- s-triazolo[l, 5-al- 
pyrimidine () (123 mg, 45%),  m. p. 248-2500; u. v. , 	216, 
max 
248 and 325 nm (log 6 4. 15, 4. 28 and 4.09); i. r. , y max 1710 (C=O), 
1625, 1585, 1545, 1500, 1410 and 775 cm '; 1H n. m. r. (100 MHz), 
5 0.84 (s, 3H, 18-CH3), 0.98 (s, 3H, 19-CH3), 2.02 (s, 3H, 17- 
OCOCH3), 2.68 (s, 3H, 2'-SCH3), 4.60 (m, 1H, 17-H), 6. 78 (s, 1H, 
4-H) and 8.34 (s, 1H, 5'-H) (Found: C, 66. 04; H, 7. 22; N, 12. 13; 
M+, 452. 221984. C 25H32N402S requires C, 66. 34; H, 7. 13; N, 12. 38%; 
M, 452.224585). 
6.9. xvi 313-Hydroxyandrost- 5, 16-dieno[16, 17-gl-s-triazoio[i, 5-al-
pyrimidine (240). 
Source: 33-Hydroxy-i6-hydroxymethyleneandrost-5- en- 17-one (8) 
and 3-amino-1, 2,4-triazole (95). 
General: The crude material obtained by evaporating the reaction 
mixture (after it has been refluxed for 24 h) to dryness, directly recrystal-
lised from ethanol to give white crystals of 313-hydroxyandrost-5,  16- 
dieno[16,  17-gl-s-triazolo{1, 5-alpyrimidine  (240) (53%), m. p. 176-1800 . 
6. 9. xvii 33-Acetoxyandrost-5, 16-dieno[16, 17-gl-s-triazolo[i,  5-al-
pyrimidine (241). 
Treatment of 3-hydroxyandrost-5, 16-dieno[16,  17-g]-s-triazolo-
[1, 5-a]pyrimidine (240) (300 mg, 8. 24 x 10 4mole) with acetic anhydride 
in pyridine, in a manner described for the preparation of compound (239) 
gave 3f3-acetoxyandrost-5, 16-dieno[16, 17-g]-s - triazoio[i, 5-alpyrimidine 
(241) (185 mg, 55%);  m. p. 281-283°; u. v. 	max 216 and 290 nm (log 6 
4. 36 and 3. 74); i. r. , 1 
max 
 1720 (C=O), 1605, 1555, 1500, 1450, 1370, 
124 
1360 and 780 cm '; 'H n. m. r. (100 MHz), 6 1. 12 (s, 3H, 18-CH 3), 
1. 22 (s, 3H, 19-CH3), 2.02 (s, 3H, 3-OCOCH3), 4.60 (m, 1H, 3-H), 
5.44 (m, 1H, 6-H), 8.44 (s, 1H, 2t-H) and 8.64 (s, 1H, 5'-H) (Found: 
C, 70.93; H, 7.55; N, 13.61; MtCH3COOH,  346. 215113. 
C 24H30N402 requires 70. 89; H, 7.44; N, 13. 791/o; M-60, 
346. 215736). 
6.9. xviii 313-Hydroxy-5a-androst-16-eno[16, 17-g]-s.-triazolo[1, 5-a]-
pyrimidine (242). 
Source: 3-Hydroxy-l6-hydroxymethy1ene-5a-androstan-i7-one (7) 
and 3-amino-1, 2,4-triazole (95). 
General: The reaction mixture (after it has been refluxed for 24 h) on 
standing at room temperature overnight deposited a white solid of-
hydroxy-5 a-androst- 16-eno[16,  17-g]-s-triazolo[1,  5-alpyrimidine  (242) 
(61%), m.p.310-3150; M+366.241902.  C22H30N40 requires 
M, 366. 241949. 
6.9.xix 33-Acetoxy-5a-androst-16-eno[16, 17-g]-s- triazolo[1, 5-a]-
pyrimidine (243). 
3P -Hydroxy-5a-androst-16- eno[16, 17-g]-s-triazoio[1, 5-a]-
pyrimidine (24 2) (275 mg, 7. 5 x 10 4moie) was acetylated using the 
method described for 1 7f3-acetoxyandrost- 2, 4-dieno[2, 3-g]-2,' -methyithio-
s - triazolo[l, 5-a]pyrimidine (239) to give its 3P-acetate. Recrystaliisation 
of the crude product from ethanol gave 3-acetoxy-5a-androst-16-eno-
p16, 17-gJ-s-triazoio[1, 5-a]pyrimidine  (243) (140 mg, 45%);  m. p. 261- 
263°; U. v., 	219 and 278 nm (log 	4.48 and 3.90); i. r., I 
max 	 max 
1715 (0=0), 1605, 1550, 1500, 1450 and 780 cm 
1; '
H n. m. r. (60 MHz), 
60.95 (s, 3H, 18-CH3), 1. 20 (s, 3H, 19-CH3), 2.05 (s, 3H, 3-000CH3), 
4.65 (m, 1H, 3-H), 8.50 (s, 1H, 2'-H) and 8.70 (s, 1H, 5'-H) (Found: 
C, 70.72; H, 8.08; N, 13.68; M+,  408.251988; C 24 H32N402 
requires C, 70.54; H, 7.90; N, 13.72%; M+,  408. 252512). 
6. 9. xx 3-Methoxy--oestra-1, 3, 5(10), 16-tetraeno[16,  17-g-s-triazo10-
[1, 5-a]pyrimidine (244). 
Source: 3-.Methoxy-16-hydroxymethyleneoestra-1, 3, 5(10)-trien-17-
one (9) and 3-amino- 1, 2,4-triazole (95). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation of the crude product from ethanol gave white crystals 
of 3-methoxy-oestra-1, 3, 5(10), 16-tetraeno[16, 17-RI-s-triazolo[1, 5, a 
pyrimidine (244) (63%);  m.p.239-241°; i.r., 1 max 
 1605, 1550, 1495, 
1450, 800 and 785 cm 
1; 1
H n. m. r. (60 MHz), 6 1. 25 (s, 3H, 18-OH 3), 
3.80 (s, 3H, 3-0CH3), 6.65-7. 25 (m, 3H, 1-H, 2-H and 4-H), 	8.45 
(s, 1H, 2'-H) and 8.65 (s, 11-I, 5'-H) (Found: C, 73.17; H, 6.65; N, 
15.49; M+,  360. 195001. C 22H24 N4 0 requires C, 73. 29; H, 6. 72; 
N, 15.55%; M, 360. 194522). 
6. 9. xxi 33-Hydroxyandrost- 5, 16-dieno[16,  17-gi- 2?.methyl_ s _tr iazo1o _ 
{1, 5a]pyrimidine (245). 
Source: 33-Hydroxy-16-hydroxymethyleneandrost-5-en-17 -one (8) and 
3-amino-5-methyl-1, 2, 4-triazole (127). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation of the crude product from ethanol gave white crystals 
of 33-hydroxyandrost-5, 16-dienol16, 17- gi- 2'-methyl-s-triazololl, 5-al- 
pyrimidine (245) (21 %); m. p.  288-290; u. v. , 	max 217 and 283 nm 
(log 6 4. 44 and 3. 75); i. r. , y max 3590 (OH), 1605, 1550, 1500, 1465, 
1415, and 780 cm '; 'H n. m. r. (60 MHz), 6 1. 15 (s, 3H, 18-CH 3 ), 
1. 25 (s, 3H, 19-CH3), 2. 65 (s, 3H, 2'-CH3), 3. 55 (m, 1H, 3-H), 5.45 
(m, 1H, 6-H) and 8. 65 (s, 1H, 5'-H) (Found: C, 72. 95; H, 8. 22; N, 
14. 37; M+,  378. 242192. C23H30N40 requires C, 72. 97; H, 7. 99; 
N, 14.81%; M, 378. 241949). 
6. 9. xxii 33-Hydroxy-5a-androst- 16-eno[16, 17-g]-2-methy1thio- s-
triazolo[1,5-a]pyrimidine (246) and 3-hydroxy-1€[3'-(5'-
methylthio)- s-triazolyl- aminomethylene]- 5a- androstan- 17-
one (247). 
Source: 33-Hydroxy-16-hydroxymethy1ene-5a-a.ndrostan-17-one (7) and 
3 -amino- 5 -methylthio- 1, 2, 4-triazole (224). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation of the eluant from acetone gave white needles of 
hydroxy-5a-androst-16-eno{16, l7_ gJ_2t_ rnethylthio_ s _tr iazolo[l,5_aJ_ 
pyriniidine (246) (45%),  m.p.244-Z460; u.v. 	max 211, 241, 286 and 
307 nm (log 6 4. 25, 4. 46, 3.85 and 3. 87); i. r. , 	max 3600(OH), 1600, 
1555, 1490, 1440, 1420, 1350 and 780 cm '; 1H n. m. r. (100 MHz), 
6 0. 84 (s, 3H, 18-CH3 ), 1. 14 (s, 3H, 19-CH3), 2.64 (s, 3H, 2'-SCH3 ), 
4. 04 (m, 1H, 3-H) and 8. 67 (s, 1H, 5'-H) (Found: C, 66. 96; H, 7. 91; 
N, 13. 50; M+,  412. 229671. C 23H32N40S requires C, 66. 95; H, 7. 82; 
N, 13. 59%;  M, 412. 227106). 
Further elution of the column with 10% ethanol in chloroform 
14( 
followed by recrystallisation from acetone gave white crystals of 
hydroxy- 1 6[ 3  '-(5 -methylthio)- s - triazolyl- aminomethylenel- 5 a- andro stan-
l7-one (247) (22%), m. p. 181-185; u. v., ?\ max 208 and 320 nm (log 
4.04 and 4. 26); 1H n.m. r. (100 MHz), 50.74 (s, 6H, 18-CH3 and 
19-CH3), 2.54 (s, 3H, 5'-SCH3), 4. 14 (m, 1H, 3-H), 7.60 (d, 1H, 
-NH-CHC-), 9.70 (d, 1H, -NH-CH=C-) and 13.18 (bs, 1H, triazole-NH) 
(Found: 
141 
 M +, 412. 229670. C 23H34N402S requires M (-H20), 
412. 229670). 
The compound (246) was obtained as the sole product, in 77% yield, 
when the above condensation was carried out in dry toluene. The compound 
(246) was also obtained in 85% yield when a solution of the -ketoanil (247) 
in dry toluene containing a small amount of toluene-4-sulphonic acid was 
refluxed for 4 h. 
6.9. xxiii 3j3-Hydroxyandrost-5, 16-dieno[16, 17-gl-2'-methylthio-s-
triazolo[1, 5-a]pyrimidine  (250) and 33-hydroxy-16[3'-(5'-
methylthio)- s - triazolyl- aminomethylenelandro s t- 5-ene--
l7-one (249). 
Source: 3f3-Hydroxy-16-hydroxymethyleneandrost-5- en- 17-one (8) and 
3-amino-5-methyl-1, 2,4-triazole (224). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation of the eluate from ethanol gave white needles of 
hydroxyandrost-5, 16-dieno[16, 17-gl_2'-methylthio_s_triazolo[l, 5-al- 
pyrimidine (250) (38%), m. p. 265-266°; u. v. 	max 210, 241, 286 and 
307 nm (log 6 4. 11, 4.43, 3.91 and 3.93); i. r. , 	max 3590 (OH), 1600, 
1555, 1490, 1450, 1415 and 780 cm ; 1H n.m. r. (100 MHz), 5 1.10 
(s, 3H, 18-CH3), 1. 18 (s, 3H, 19-CH3), 2.70 (s, 3H, 2'-SCH3), 
3.50 (m, 1H, 3-H), 5. 36 (m, 1H, 6-H) and 8.48 (s, 1H, 5'-H) (Found: 
C, 67. 36; H, 7.47; N, 13. 68; M+,  410. 212152. C 23H30 N40S 
requires C, 67. 28; H, 7. 37; N, 13. 65%; M, 410. 214022). 
Further elution of the column with 10% ethanol in chloroform gave 
33 -hydroxy- 1 6[3 -(5 '-methylthio)-s - triazolyl- aminomethylenelandrost-  5-
en-l7-one (249) which was recrystallised from acetone as a white solid 
(42%), m. p. 100-1100 u.v., 	max 209 and 320 nm (log P. 4.06 and 4. 34); 
n. m. r. (100 MHz), 5 0.80 (s, 3H, 18-CH3), 0.98 (s, 3H, 19-CH 
3), 
 
2.54 (s, 3H, 5t-SCH3), 3.50 (m, 1H, 3-H), 5. 32 (m, 1H, 6-H), 7. 64 
(d, J=12Hz, 1H, -NH-CH=C-), 9.72 (d, J=12Hz, 1H, -NH-CHC-) and 
13. 32 (bs, 1H, triazole -NH) (Found:14' M+,  410 212559. C 23H32N402S 
requires M (-H20), 410. 214022). 
6.9.xxiv 3-Methoxyoestra-1,3, 5(10), 16 _tetraeno[16, 17-gl_ 2 ' -methylthio_ 
s-triazolo[1, 5-apy,rimidine (252) and 3-methoxy-16{3'-(5'-
methylthio)-s-triazolyl-aminomethyleneloestra-1, 3, 5(10)trien-
17-one (251). 
Source: 3-Methoxy- l6-hydroxymethyleneoestra- 1, 3, 5(10)trien- 17-one 
(9) and 3-amino-5-methylthio-1, 2,4-triazole (224). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation of the eluant from ethanol gave white needles of 3-
methoxyoestra- 1, 3, 5(10), 16-tetraeno[16, 1 7-g]- 2'-methylthio-s-triazolo-
[1, 5-a]pyrimidine (252) (27%), m. p.  184-1860 ; i. r., y max 1605, 1555, 
1490, 1455, 1420, 1350 and 780 cm '; 1H n. m. r. (100 MHz), 	6 1.18 
(s, 3H, 18-CH3), 2.70 (s, 3H, 2'-SCH3), 3.74 (s, 3H, 3-OCH3), 
6. 64-7. 20 (m, 3H, 1-H, 2-H and 4-H) and 8.52 (s, 1H, 5'-H) (Found: 
C, 67. 81; H, 6.47; N, 13. 51; M+,  406. 180323. C 23H26 N40S requires 
C, 67. 95; H, 6.45; N, 13. 79%; M, 406. 182723). 
Further elution of the column with 10% ethanol in chloroform gave 
3-methoxy- 1 6{3'-(5 t-methylthic) - s-triazolyl-aminomethyleneloestra-
1, 3, 5(10)trien-17-one (251) (17 %), which resisted recrystallisation. 
'H n. m. r. (100 MHz), 5 0. 78 (s, 3H, 18-CH3), 2.56 (s, 3H, 5'-SCH 3), 
3.68 (s, 3H, 3-OCH3), 6.60-7. 14 (m, 3H, 1-H, 2-H and 4-H), 7.66 
(d, J12Hz, 1H, -NH-CH=C-), 9.76 (d, J12Hz, 1H, -NH-CH=C-) and 
13.40 (bs, 1H, triazole-NH) (Found: 
141 
 M =, 406. 181231. C23H28N402S 
requires M (-H20), 406. 181723). 
6.9.xxv 313-Acetoxy- 5a-androst-16-eno[16, 17-g-2'-metIylthio-s-
triazolo[1, 5-alpyrimidine (2) 
Treatment of 3-hydroxy-5a-androst-16-eno[16, 17-g]-2'-methyl-
thio-s-triazolo[1, 5-a]pyrimidine (246) (275 mg, 6.67 x 10 4mole) with 
acetic anhydride in pyridine in a manner described for the preparation 
of 1 713-acetoxyandrost-2,  4-dieno[2, 3-g]- 2'-methylthio-s-triazolo[l, 5-a]-
pyrimidine (239) gave its 33-acetate. Recrystallisation of the crude 
product from ethanol gave 33-acetoxy-5a-androst-16-eno[16,  17-g]-2'-
methylthio-s-triazolo[1, 5-a]pyrimidine  (253) (166 mg, 55%); m. p.  191- 
192°; U. V. , 	max 212, 241, 285 and 306 nm (log 6 4. 28, 4. 70, 3.77 
and 3.75); i. r., y 
max 
 1710 (C=O), 1600, 1555, 1490, 1420 and 780 cm 
'H n.m. r. (100 MHz, 5 0.84 (s, 3H, 18-CH3), 1.10 (s, 3H, 19-CH 3), 
2.02 (s, 3H, 3-OCOCH3), 2. 68 (s, 3H, 2'-SCH3), 4.65 (m, 1H, 3-H), 
8.48 (s, 1H, 5LH) (Found: C, 66.23; H, 7.82; N, 12.01; M+, 
Iju 
454. 238562. C25H34N402S requires C, 66. 04; H, 7. 54; N, 12.33%; 
M, 454. 240235). 
6. 9. xxvi 313-Acetoxyandrost-5,  16-dieno[16, 17- g]-2 '-methylthio-s-
triazolo[1, 5-a]pyrimidine (254). 
3-Hydroxyandrost-5, 16-dieno[16, 17_ g]_2r_ methylthio_ s_tr iazolo _ 
[1, 5-a]pyrimidine (250) (250 mg, 6. 1 x 10 4mole) was acetylated using 
the method described for 17-acetoxyandrost-2, 4-dieno[2, 3_g]_2'_ 
methylthio-s-triazolo[1,5-a]pyrimidine (239) to give its 3-acetate. 
Recrystallisation of the crude product from ethanol gave white crystals 
of 33-acetoxyandrost-5, 16-dieno[16, 17- g]-2'-methylthio-s-triazolo- 
[l,5-a]pyrimidine (254) (170 mg, 61%); m. p. 228-2290; u. v. , 	
max 
211, 241, 288 and 307 nm (log E, 4. 11, 4. 47, 3. 82 and 3. 85); i. r. , I max 
1715 (C=O), 1605, 1555, 1490, 1415, 1350 and 780 cm 
1; 1
H n. m. r. 
(100 MHz), 6 1. 12 (s, 3H, 18-CH3 ), 1. 18 (s, 3H, 19-CH3), 2. 02 (s, 
3H, 3-OCOCH3), 2. 70 (s, 3H, 2'-SCH3), 4. 62 (m, 1H, 3-H), 5. 40 (iii, 
1H, 6-H) and 8.50 (s, 1H, 5'-H) (Found: C, 66. 31; H, 7.21; N, 12.26; 
M+, 452. 223262. C25H32N402S requires C, 66. 34; H, 7. 13; N, 12. 38%; 
M, 452. 224585). 
6. 9. xxvii The reaction of 2(2 '-pyridyl-arninomethylene)-5a-ch.ole stan-3 - 
one (207) with 3-amino-1, 2,4-triazole (95). 
A solution of 2(2 '-pyr idyl - aminomethylene)- 5a-chole stan- 3-one 
(207) (400 mg, 8.4 x 10 4mole), 3-amino- 1, 2, 4-triazole (95) (120 mg, 
1.45 x 10 3mole) and toluene-4-sulphonic acid (20 mg) in dry toluene 
(30 ml) was refluxed for 7 h. The excess of solvent was removed under 
vacuo and the residue was chromatographed over alumina. Elution with 
ethyl acetate followed by recrystallisation of the eluate from ethyl acetate 
gave white shining plates (265 mg, 68%); m. p.  170-173°, identical 
(m. p. , i. r. and 
1 
 H n. m. r. spectra) with that of 5a-c hole stano[3, 2-f]-
s-triazolo[1, 5-a]pyrimidine (220). 











(179) 	 (257) 
7 	The reaction of steroidal -ketoaldehydes with 5-aminotetrazole 
7. 1 The reaction of 17-hydroxy-2-hydroxym ethylene- 17 a-methyl-
5a-androstan-3-one (108) with 5-aminotetrazole (100). 
A solution of 1 73 -hydroxy- 2-hydroxymethylene- 17 a- methyl- 5 a-
androstan-3-one (108) and 5 -amino tetrazole (100) in absolute alcohol 
was refluxed overnight. On cooling the reaction mixture to room 
temperature, fine white crystals (255), m. p.  196-1980 , in 84% yield 
were obtained. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 22H31N50. 	The u. v. spectrum 
showed ? max at 216 and Z8Gr rim (log 6 4. 31 and 3. 72). 	The I. r. 
spectrum (in bromoform) exhibited absorptions at 3600, 2140, 1620, 
1545, 1510, 1445, 1380, 1370, 930, and 780 cm '  and the 'H n. m. r. 
showed a singlet at 5 8. 66 apart from the signals for the 17-, 18- and 
19-methyl protons. 
7. 2 Discussion 
The i. r. spectrum of the product obtained by the condensation of 
5- aminotetrazole with 1 73-hydroxy- 2-hydroxymethylene- 17 a-methyl-S a-
androstan-3-one (108) exhibits no carbonyl absorption. Thus the condensa-
tion product appears from its i. r. spectrum and the molecular formula 
C 22H31N50 to be a derivative of the tetrazolo[1, 5-a]pyrimidine  system. 





'3C-Chemical shifts of steroidal tetrazolo[l, 5-a]pyrimidines (p. p.m.) 
Compound 31a-C 	5'-C 	6 1 -C 	7 1 -C 	Other carbons 




159 79 	120.92 	142.76 
158.44 	112.42 	146.84 
167.64 	120.78 	129.54 
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with an unsymmetrical 13-ketoaldehyde can theoretically lead to two 
products. Therefore two possible structures (255) and (256) were 
postulated for the product obtained by the condensation of 5-aminotetrazole 
(100) with the -ketoaldehyde (108). However, 1H n. m. r. and 
13 
 C n. m. r. 
spectroscopy show that the condensation product has structure (255). 
1 
The H n. m. r. spectrum of this condensation product shows signals 
at 	6 0.88 (s, 18-CH3), 0.92 (s, 19-CH3), 1.24 (s, 17-CH 3)and 8.67 
(s, 5'-H). Of particular interest in the 1H n. m. r. spectrum is the fact 
that the signal for the 5'-H is found to be sharp and this is consistent with 
the angular structure (255) assigned to the condensation product. It has 
been previously reported 
77 
 that no long range coupling is observed between 
the methyl group protons at position 6 and the 5-H of azolo[a]pyrimidines 
(179). In contrast the methyl group protons at either position 7 or 6 of 
azolo[a]pyrimidines (1 79) have been found to couple with the 6-H or 7-H 
respectively (J = 0.4-1.0 Hz). 
77 
 Therefore the alternative structure 
(256) is discounted, since the 7'-H would be expected to show a triplet or a 
broad singlet due to a small long range coupling with the methylene 
protons at position 1. 
The assignment of structure (255) is further supported by 13 C 
n. m. r. evidence. The 13C-chemical shifts of the aromatic ring carbons 
of the tetrazolopyrimidine (255) are given in Table 6. The assignments 
quoted for the chemical shifts of the aromatic ring carbons of the steroid 
(255) follow directly by analogy with the values allocated to the comparable 
ring system (257) (section 9). 	The chemical shift of 5'-C (159.79 p. p.m.) 
in the condensation product (255) is found to be in agreement with the 
chemical shift of 5-C (158.44 p. p.m.) in 7-methyltetrazolo[1, 5-a]- 




















5 a-androst- 2- eno[2, 3-g]- s-triazolo[1, 5-a]pyrimidine (211). 	This 
confirms the angular fusion of the steroid to the heterocyclic system. 
If the condensation product had had the linear structure (256), the 
chemical shift of 7'-C would have been expected to appear in the region 
of 133.77 p. p.m., which is the chemical shift of 7'-C in 17-hydroxy- 
17a-methyl-5a-androstano[3, 2-f]-s-triazolo[l, 5-a]pyrimidine (210) 
(section 6, Table 5). 
Under analogous reaction conditions, the condensation of 5- 
aminotetrazole (100) with 1 73-hydroxy- 2-hydroxymethylene- 5 a-andros tan- 3- 
one (3), 2-hydroxymethylene- 5 a- andro s tan- 3-one (109), 2-hydroxymethy- 
lene- 5 a-cholestan- 3-one (110) and 2-hydroxymethyl ene- 5 a- spiro stan- 
3, 11-dione (ill) gave 173-hydroxy-5a-androst-2-eno{2, 3-g}tetrazolo- 
[1, 5-a]pyrimidine (258), 5 a-androst- 2-eno[2, 3-g]tetrazolo[1, 5-a]- 
pyrimidine (259), 5 a-cholest- 2- eno[2, 3-g]tetrazolo[l, 5-a]pyrimidine 
and 11 -oxo-5 a-spirost- 2-eno[2, 3-g]tetrazolo[l, 5-a]pyrimidine 
respectively. 
It is also noticed that the 'H n. m. r. spectrum of the tetrazolo-
pyrimidine (255) in deuterated chloroform also contains a small signal 
at 6 8. 20 in addition to the signal for the 5'-H at 6 8. 66. The small 
signal at 6 8. 20 persists even after further recrystallisation of the 
product from ethanol. This shows that the compound (255) exists in 
equilibrium with its azido form (255a) and this is confirmed by the i. r. 
spectrum of the compound in deuterated chloroform or in bromoform 
which exhibits a distinct azide absorption at 2140 cm '. The i. r. 
spectrum of the compound (255) in nujol does not show any azide 
absorption band in the 2100-2200 cm '  region and the 'H n. m. r. spectrum 
in d6 -DMSO shows no other signal in the aromatic region apart from 
the signal at 6 8. 60 which corresponds to 5'-H in the tetrazolo form 
(255). These observations indicate that the condensation product exists 
solely in the tetrazolo form (255) in d6-DMSO and in the solid state. 
However, in deuterated chloroform the tetrazolo form (255) is found to 
be in equilibrium with a small amount of the azido form (255a). It is 
also observed that the chemical shift of the 5'-H ( 6 8. 60) in the tetrazolo 
form (255) occurs at a lower field when compared with the chemical shift 
(68. 20) of the corresponding proton (6'-H) in the azido form (255a). 
This difference is attributed to the opposing effect 
145 
 of the electron 
withdrawing tetrazole ring (deshielding) and the electron donating azido 
group (shielding). 
Rearrangements of this type have been recently demonstrated in 
several tetrazoloazine series through the simultaneous applications of 
i. r. and 'H n. m. r. spectroscopy. 
82 
 It has been shown that regardless 
of the tetrazoloazine (262), the tetrazolo tautomer (262a) is generally 
favoured in the solid state or in dimethyl suiphoxide solution. 82, 146, 147  
On the other hand the azido form (262b) is stabilised in trifluoroacetic 
acetic acid, presumably through protonation of an anular nitrogen and 
destabilisation of the tetrazoloazine tautomer. ' 148  In other solvents 
both the forms (262a) and (262b) are usually detected. 
Similarly the compounds (258)-(261) exist in equilibrium with their 
corresponding azido forms in deuterated chloroform or bromoform and 
in only their tetrazole forms in d6-DMSO and in the solid state. 
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7. 3 The reaction of 1 73 -hydroxy- 2-hydroxymethyleneandrost-4 - en-
3-one (4) with 5- amino tetrazole (100). 
A solution of 1 73 -hydroxy- 2- hydroxyni - ethyleneandrost-4 - en- 3-
one (4) and 5-aminotetrazole in absolute alcohol was refluxed overnight. 
The reaction mixture was concentrated and allowed to stand at room 
temperature for 24 h. Yellow crystals were obtained which were again 
recrystallised from ethanol to give fine yellow crystals (263), m. p.  143-
145°  in 37% yield. 
Mass spectrometry and elemental analysis indicated that the product 
had a molecular formula of C H N 0. The u. v. spectrum showed 7 
21 27 5 	 max 
at 213, 243 and 311 nm (log 6 4. 15, 4. 11 and 4.06). 	The i. r. spectrum 
showed absorption at 3600, 2140, 1620, 1500-1515, 1430, 1415, 1380 
and 780 cm 1 whilst the 1H n. m. r. spectrum exhibited signals at 6 0.80 
(3H), 1. 06 (3H), 3. 70 (1H), 6. 50 (1H) and 8.60 (1H). 
7.4 Discussion 
The i. r. spectrum of the condensation product obtained by the 
reaction of 1 7 -hydroxy- 2-hydroxymethyleneandrost-4 - en- 3-one (4) and 
5-aminotetrazole does not correlate well with the i r. spectrum of 17t3-
hydroxy- 17 a-methyl- 5 a-androst- 2- eno[2, 3- g]tetrazolo[1, 5-a]pyrimidine 
(255). However, it exhibits an absorption at 2140 cm '  indicating the 
presence of the azido tautomer (263b) in bromoform solution. The 'H 
n. m. r. spectrum of the condensation product (263) in deuteriochloroform 
initially indicates the presence of only one compound which is characterised 
as (263a), since the signal at 6 8.60 corresponding to 7'-H is found to be 
broadened by a small long range coupling with the methylene protons at 
position 1. After 10 minutes however, two additional small signals 
appear at 6 8. 16 and 6 6. 20. Alter 24 h this isomer reaches a con-
centration of about 40% as calculated from the ratio of the integrated 
intensities for the protons from the tetrazolo form to those of the new 
isomer. This new compound is characterised as the azido tautomer 
(263b) by the 1. r. spectrum of the compound (263) in deuterated chloroform 
which shows an azide absorption at 2140 cm . The signals at 6 8. 16 
and 6 6. 20 in the 'H n. m. r. spectrum are assigned to the 6'-H and the 
4-H respectively in the tautomer (263b). After 24 h, the third tautomer 
(263c) is also found to be present (about 10%) in the 'H n. m. r. sample 
tube and signals at 6 8.64 and 66. 98 are assigned to the 7'-H and the 4-H 
respectively. The chemical shift of the 4-H (6 6.98) in the tautomer 
(263c) correlates well with the chemical shift of the 4-H (6 6. 92) in 173-
hydroxyandrost- 2, 4-dieno[2, 3-g]-s-triazolo[l, 5-a]pyrimidine (236) and this 
supports the assignment of structure (263c). The chemical shifts of the. 
6'-H and the 4-H in the tautomer (263b) both occur at a higher field than 
the chemical shifts of the corresponding protons in the tautomers (263a) 
and (263b). This is again attributed to the deshielding and shielding 
effects 
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 of the tetrazole ring and the azido group respectively. 
In d -DMSO, only one isomer is detected and this is characterised 
as (263a) by its 13C n. m. r. spectrum where the chemical shift of the 
7'-C (129.53 p.p.m.) is found to agree well with the value observed for 
the 8-C (126. 12 p.p.m. ) in 6, 7-dihydro-5H-cyclopento[d]tetrazolo[1, 5-a]-
pyrimidine (268a)(Table 6). 
The effects of substituents on the tetrazoloazine equilibrium 
(262a262b) have been investigated. In general, electron-attracting 













substituents stabilise the electron donating azido group, thereby 
favouring (262a) and destabilise the electron withdrawing tetrazole group 
and tautomer (262b). Electron donating substituents have the reverse 
effect. 80f 
7. 5 Acetylation of 1713-hydroxyandrost-4-eno[3, 2-f]tetrazololl, 5-al-
pyrimidine (263a). 
A solution of 1 7-hydroxyandrost-4- eno[3,  2-f]tetrazolo[1, 5-a]-
pyrimidine (263a) in pyridine containing a small amount of acetic anhydride 
was refluxed for 2 h. The solvent was evaporated in vacuo and the 
residue was taken up in chloroform. The chloroform solution was 
washed with water, 5% hydrochloric acid, saturated sodium bicarbonate 
solution and water again before being dried over anhydrous magnesium 
sulphate and evaporated to dryness. The residue was chromatographed 
over alumina. Elution with ethyl acetate gave a product which was 
recrystallised from ethanol to give a yellow solid (264) m. p.  217-2190 , 
in 25% yield. Further elution of the column with chloroform gave another 
product which was recrystallised from ethanol to give a yellow solid 
(265), m. p.  235-237°, in 37% yield. 
Mass spectrometry and elemental analysis of the first product, 
m. p. 217-219°, gave its molecular formula as C 23H29 N502. The u. v. 
spectrum showed ?\ max 213, 243 and 311 nm (log 6 4. 18, 4. 22 and 4. 19) 
and the i. r. spectrum exhibited absorptions at 2140, 1720, 1620, 1515, 
1500, 1430, 1425, 1375 and 780 cm . The H n. m. r. spectrum showed 
a singlet (broadened due to a small long range coupling) at 5 8.60 
corresponding to the proton of the pyrimidine ring. 
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Mass spectrometry and elemental analysis of the second product, 
m.p.235-237
0
, indicated that it had a molecular formula of C 23H29N503. 
The u. v. spectrum showed 7 max at 214, 249 and 287 nm (log 6 4. 13, 
3. 98 and 3. 81). 	The i. r. spectrum exhibited absorptions of 2140, 1720, 
1685, 1625, 1545, 1510, 1415, 1375 and 780 cm 
1 
 whilst the 'H n. m. r. 
spectrum exhibited a sharp singlet at 8 8.65 
7.6 Discussion 
The i. r. and 'H n. m. r. spectra obtained for the first product, 
M. P. 217-2190, resemble closely the i. r. and 'H n. m. r. spectra obtained 
for its precursor 1 73-hydroxyandrost-4- eno{3, 2-f}tetrazolo[1, 5-a]-
pyrimidine (263a) so that the product, m. p. 217-2190 can be formulated 
as 1 713-acetoxyandrost-4-eno[3,  2-f]tetrazolo[1, 5-a]pyrimidine (264a). 
1 
In the H n. m. r. spectrum two small signals at .53. 15 and 66. 15 also 
appear whilst the i. r. spectrum exhibits an absorption of medium intensity 
at 2140 cm ', thus indicating that the compound (264a) exists in equili-
brium with a small amount of the azido tautomer (264). 
The molecular formula C 23H29 N503 of the second product, m. p. 
235-237°, indicate that it differs from that of 173-acetoxyandrost-4-
eno[3, 2-f]tetrazolo[1, 5-a]pyrimidine (264a) in having one extra oxygen 
atom but the product still has a characteristic u. v. spectrum of the 
tetrazolo[1, 5-a]pyrimidine moiety. It therefore appears that this steroid 
4 
has been formed by the reaction of acetic anhydride-pyridine on the 
double bond of its precursor (264a). Epoxide formation can be eliminated 
on the grounds that the reaction conditions were not those normally 
associated with epoxide formation. The i. r. spectrum of the steroid 
i'fU 
shows no absorption around 3600 cm '  thus excluding the enolic 
structures (265c) and (265e) however, it does exhibit absorptions at 
1720 cm '  and 1685 cm '. The absorption at 1720 cm '  is assigned 
to the carbonyl of the 17-acetyl group by analogy with 17f3-acetoxy-
androst-4- eno[3, 2-f]tetrazolo[1, 5-a]pyrimidine (264a) and the absorption 
at 1685 cm '  is attributed to the presence of a new conjugated carbonyl 
group. Thus, it appears that the steroid has either structure (265a) 
or (265c1). 	It has previously been noticed in sections 5 and 6 that the 
number and shape of the absorption bands in the region 1500-1630 cm '  
of heterocyclic steroids characterise the linear or the angular fusion 
of the heterocyclic system to the steroid nucleus. The absorptions at 
1625, 1545 and 1510 cm 
1 
 in the i. r. spectrum of this steroid differ 
significantly from the corresponding absorptions in the i. r. spectra 
of 17-hydroxy- and 173-acetoxyandrost-4-eno[3, 2-f]tetrazolo[1, 5-a]-
pyrimidine (263a) and (264a) but are identical with the absorptions in 
the i. r. spectrum of 17-hydroxy-17a-methyl-5a-androst-2-eno[2, 3-g]- 
tetrazolo[1, 5-a]pyrimidine (255). 	Therefore, the steroid, m. p.  235- 
237°  is formulated as 17-acetoxy-4-oxo-5a-androst-2-eno[2, 3-g]- 
tetrazolo[1, 5-a]pyrimidine (265a). 	This structure is further supported 
by H n. m. r. spectroscopy where the signal for the 5'-H is found to be 
fairly sharp and this is consistent with the assignment of an angular 
structure (265a). If the product had had structure (265d), the signal 
for the 7'-H would have been broadened due to a small long range coupling 
with the methylene protons at position 1. 
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 The i. r. spectrum of the 
steroid (265a) in bromoform shows an azide absorption at 2140 cm 1 
whilst the H n. m. r. spectrum in deuterated chloroform shows a small 
X J. 
signal at 6 8.20 (6'-H in 265b) suggesting that the product exists in 
equilibrium with a small quantity of the azido tautomer (265b). 
The assignment of angular structure (265a) is also found to be in accord 
with the following observation. The reaction of a 4-unsaturated 2- 
hydroxymethylene-3-oxo steroid with an aminoazole affords the same type 
of product (linear or angular) as is obtained by the reaction of a 16- 
hydroxymethylene-17-oxo steroid with the same aminoazole. It will be 
seen shortly that the reaction of 16 -hydr oxymethylene- 17- oxo steroids 
with 5-aminotetrazole leads to linearly fused products. Thus the 
reaction of 17-hydroxy-2-hydroxymethyleneandrost-4-en-3-one (4) 
with aminotetrazole should lead to 17p-hydroxyandrost-4-eno[3, 2_f]- 
tetrazolo[1, 5-a]pyrimidine (263a) and this has been confirmed. The 
product obtained by the reaction of a 2-hydroxymethylene-3-oxo steroid 
(e. g. 108) without a 	double bond with 5-aminotetrazole exists 
predominantly in the form in which the tetrazolopyrimidine system is 
fused angularly to the steroid nucleus (e. g. 255). Therefore, the steroid 
(265) which contains no L double bond is expected to exist predominantly 
in the form (265a) and this is confirmed above by i. r. and 'H n. m. r. 
spectroscopy. The mechanism for the formation of the steroid (265a) 
will be discussed in section 10. 
7. 7 	The reaction of 3 -hydroxy- 1 6-hydroxymethyleneandro st- 5-en- 
17-one (8) with 5-aminotetrazole (100). 
A solution of 33hydroxy_16_hydroxymethyleneandrost-5_en-17-one 
(8) and 5-aminotetrazole (100) in dry toluene was refluxed overnight. The 

















(268c) 	 (268a) 	 (268b) 
chromatographed over alumina. Elution with chloroform followed 
by recrystallisation from ethanol gave white crystals (266), m. p. 198- 
2000, in 54% yield. The same product was obtained in 30% yield 
when the reaction was carried out in absolute alcohol.. 
7.8 Discussion 
Mass spectrometry and elemental analysis indicated that the product 
had a molecular formula of C 21H27N50. The i. r. spectrum exhibited 
absorptions of 2140, 1645, 1540, 1500, 1465, 1455, 1405, 1375 and 790 cm '  
whilst the 'H n. m. r. spectrum showed a singlet at 5 8. 70 apart from 
the signals for the 18- and 19-methyl protons, 3-H and 6-H. 
In 1950, Cook et a1. 
149b 
 reported that the condensation of 2- 
hydroxym ethyl enec yclopentanone (1 24) with 5- aminotetrazole (100) leads 
to the formation of 6, 7-dihydro-5H-cyclopenta[d]tetrazolo[1, 5-a]- 
pyrimidine (268c). The claim to this structure was presumably based 
upon the fact that the amino group of the tetrazole (100) reacts first with 
the aldehydic group and then the direct cyclisation of the intermediate 
keto anil gives the product (268c). The above reaction was repeated 
and it is established here with the aid of 
1 
 H n. m. r. and 
13
C n. m. r. 
spectroscopy that the product has, on the contrary, the linear structure 
(268a). 
In the 'H n. m. r. spectrum of the product (268a), the signal at 
5 8. 72 corresponding to the 8-H is found to be split into a triplet by a 
small long range coupling with the methylene protons at position 7. In 
the '3C n. m. r. spectrum, the chemical shift of 8-C (126. 12 p. p.m.) is 
found to be consistent with the linear structure (268a). If the product 
143 
had had the previously reported structure (268c) then the signal for 
the 5-H in the 'H n. m. r. spectrum would have been a sharp singlet and 
the chemical shift of the 5-C in the 
13 
 n. m. r. spectrum would have 
been in the region of 158.44 p. p.m. which is the chemical shift of the 
5-C of 7-methyltetrazolo[1, 5-a]pyrimidine (257) (Table 6). The i. r. 
and 13C n. m. r. spectroscopy also show that the product (268a) exists in 
equilibrium with the azido form (268b) in bromoform and deuterated 
chloroform solutions. 
By analogy with the formation of 6, 7-dihydro-5H-cyclopenta[d]-
tetrazolo[1, 5-a]pyrimidine (268a) from the reaction of 5-aminotetrazole 
(100) with 2-hydroxymethylenecyclopentanone (124), the product obtained 
by the condensation of 5-aminotetrazole (100) with the 3-ketoaldehyde (8) 
is assigned structure (266). This structure is confirmed by the 'H 
n. m. r. spectrum which shows a broad singlet at 6 8. 70 corresponding 
to the 7'-H. The sterol (266) was acetylated using acetic anhydride in 
pyridine to give the 313-acetate  (267). 
Under analogous reaction conditions, the condensation of 5-amino-
tetrazole (100) with 16-hydroxymethylene-3 -methoxyoe stra- 1,3, 5(1 0)-
trien-17-one (9) gave 3-methoxyoestra-1,3,5(10)trieno[17, 16-f]tetrazolo-
[1,5-a]pyrimidine (269). 
7. 9 Experimental 
General procedure for the condensation reaction. 
A solution of the steroidal -ketoaldehyde (1. 5 x 10 3mole) and 
5-aminotetrazole (100) (CH 3N5. HO,  2 x 10 3mole) in absolute alcohol 
(30 ml) was refluxed overnight. The reaction mixture was cooled to 
room temperature and triturated. The precipitates formed were filtered 
and recrystallised from a suitable solvent. 
7. 9. i 173-Hydroxy-1 7 a-methyl- 5a-androst- 2-eno{2, 3-gltetrazolo[1, 5-al-
pyrimidine (255) was recrystallised from methanol as white crystals (84 %), 
m. P. 196-198°; U. v., 	max 216 and 280 nm (log P,4.31 and 3.72); i. r., 
1 
max 	 3 
3600 (OH), 2140 (-N ), 1620, 1545, 1510, 1445, 1380, 1370, 930 
-1 
and 780 cm ; 1H n. m. r. (100 MHz), 6 0.88 (s, 3H, 18-CH3), 0. 92 
(s, 	3H, 19-CH3), 1. 24 (s, 3H, 17-CH 3)and 8.66 (s, 1H, 5'-H) (Found: 
C, 69. 03; H, 8. 27; N, 18. 20; M+,  381. 251949. C 22H31N50 requires 
C, 69.24; H, 8.19; N, 18. 36%;  M, 381. 252847). 
7. 9. ii 17f3-Hydroxy-5 a-androst- 2- eno{2, 3-gitetrazolo{1, 5-alpyrimidine 
(258) was recrystallised from methanol as white needles (9 2%), m. P. 
199-200°; U. v., 	215 and 279 nm (log 64.29 and 3.73); i. r., I 
max 	 max 
3600 (OH), 2140 (-N3), 1625, 1545, 1510, 1385, 1050 and 780 cm '; 
'H n. m. r. (100 MHz), 6 0.80 (s, 3H, 18-CH3), 0.88 (s, 3H, 19-CH 
3), 
 
3.68 (t, 1H, 17-H) and 8.68 (s, 1H, 5'-H) (Found: C, 68.72; H, 8.01; 
N, 1924; M+,  367. 235799. C 21H29N50 requires C, 68.62; H, 7.96; 
N, 19.06%; M, 367.237198). 
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7. 9. iii 5a-Androst-2-eno[2, 3-g]tetrazolo[1, 5-alpyrimidine (259) was 
recrystallised from ethanol to give yellow fluffy crystals (77%), m. p. 
195-197; 	u. v., 	215, 	248 and 280 nm (log £4. 26, 3. 73 and 
max 
3.63); 	i. r. , Y 2130 (-N 	), 1625, 1545, 	1505, 	1440, 	1420, 1385, 	820 max 	3 
and 780 cm 
l;  
'H n. m. r. (100 MHz), 6 0. 74 (s, 	3H, 	18-CH3), 0.86 
(s, 	3H, 	19-CH 8.66 (s, 	1H, 	5T-H) 	(Found: 	C, 	71. 95; 	H, 3)and  8. 51; 
N, 	20. 10; 	M+,  351. 240969. 	C 21H29 N5  requires C, 	71. 75; 	H, 8. 32; 
N, 19.93%; M, 351.242281). 
7. 9. iv 5a-Cholest-2-eno[2, 3-g]tetrazolo[1,  5-a]pyrimidine (260) was 
recrystallised from methanol as white fluffy crystals (61%), m. p.  173- 
1750 U. v., 	215 and 277 am (log 64.32 and 3.68); i. r., I 
max 	 max 
2140 (-N3), 1625, 1540, 1510, 1460, 1445, 1380 and 780 cm '; 'H 
n. m. r. (100 MHz), 5 0. 72, 0. 86, 0. 90 and 0. 96 (methyl groups), and 
8.66 (s, 1H, 5'-H) (Found: C, 75. 21; H, 9.95; N, 15.15; M+, 
463. 364704. C 29H45N5 requires C, 75. 10; H, 9. 79; N, 15.11%; 
463. 367478). 
7.9. v 11-Oxo-5a-spirost-2-eno[2, 3-gltetrazolo{1, 5-apyrimidine (261) 
was recrystallised from ethanol as a yellow solid (65%), m. p.  200-2020; 
U. V. , 	max 214 and 279 rim (log £ 	
max 
4. 32 and 3. 70); i. r. , 1 	2140 
(-N3), 1700 (Ca), 1630, 1545, 1510, 1450, 1390, 1050, 980, 920, 890 
and 780 cm- 1 ; 'H n.m. r. (100 MHz), 6 0.76 (s, 3H, 18-CH3), 1.24 
(s, 	3H, 19-CH 3)and 8.68 (s, lH, 5'-H) (Found: C, 68. 82; H, 7.79; 
13.73; M+,  505. 303706. C 29H39N503 requires C, 68. 87; H, 7.78; 
N, 13.85%; M, 505. 305273). 
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7. 9. vi 1 73 -Hydroxyandrost-4 - eno[ 3, 2-fitetrazololl, 5-al pyrimidine 
L263a) was recrystallised from ethanol as yellow crystals (37%), m. p. 
143-145°; U. v., 	
max 
 213, 243 and 311 nm (log B 4. 15, 4.11 and 4.06); 
i. r. , 1 
max 	 3 
3600 (OH), 2140 (-N ), 1620, 1500-1515, 1430, 1415, 1380 
and 780 cm ; 1H n. m. r. (100 MHz), 5 0.80 (s, 3H, 18-CH3), 1.06 
(s, 3H, 19-CH3), 3.68 (t, lH, 17-H), 6.48 (s, 1H, 4-H) and 8.60 (s, 
1H, 7'-H) (Found: C, 68.77; H, 7.49; N, 19.09; M+,  361. 188867. 
C 21H23N50 requires C, 68. 99; H, 7.45; N, 19. 17%; M, 361. 190250). 
7. 9 vii The reaction of 17f3-hydroxyandrost-4-eno[3, 2-fltetrazolo[l, 5-al-
pyrimidin (263a) with acetic anhydride in pyridine. 
A solution of 1 73-hydroxyandrost-4- eno[3,  2-f]tetrazolo[l, 5-a]-
pyrimidine (263a) (450 mg, 1. 23 x 10 3mole) in pyridine (25 ml) containing 
a few drops of acetic anhydride was refluxed for two hours. The excess 
of solvent was removed in vacuo and the residue was taken up in chloroform. 
The chloroform solution was washed with 5% hydrochloric acid, water and 
finally with saturated sodium chloride, dried over anhydrous magnesium 
sulphate and the solution was evaporated to dryness under vacuo. The 
residue thus obtained was chromatographed over alumina. Elution with 
methylene chloride followed by recrystallisation of the eluate from 
methanol gave yellow crystals of 1713-acetoxyandrost-4-eno{3, 2-f]-
tetrazolo[1, 5-a]pyrimidine (264a) (125 mg, 25%);  m. p. 217-219°; u. v. 
max 
213, 243 and 311 nm (log 6 	
max 
4. 18, 4. 22 and 4. 19); i. r. , 1 	2140 
(N3), 1720 (C0), 1615, 1515, 1505, 1430, 1420, 1375, 1360 and 780 cm '; 
n. m. r. (60 MHz), 50.85 (s, 3H, 18-CH3), 1.05 (s, 3H, 19-CH 
3), 
 
2.05 (s, 3H, 17-0000H3), 4.60 (s, lH, 17-H), 6.45 (s, lH, 4-H) and 
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8.60 (s, 1H, 7-H) (Found: C, 67.48; H, 7.02; N, 1680; M+, 
407. 230336. C 23H29 N502 requires C, 67 78; H, 7. 14; N, 17, 20%; 
407. 232112). 
Further elution of the column with chloroform followed by 
recrystallisation of the eluate from ethanol gave 1713-acetoxy-4-oxo-5-
androst- 2- eno[2,  3-g]tetrazolo[l,  5-alpyrimidine  (265a) (185 mg, 37%); 
m. p.  235-237°; U. v., 	max 214, 249 and 287 nm (log 6 4. 13, 3.98 and 
3.81), i. r. ' max 2140 (-N3), 1720 (C=O, acetyl group), 1685 (C4 =0) 
1625, 1545, 1510, 1430, 1415, 1370 and 780 cm '; 'H n.m. r. (60 MHz), 
5 0.85 (s, 6H, 18-CH3 and 19-CH3), 2.05 (s, 3H, 17-OCOCH3), 4.65 
(t, 1H, 17-H) and 8. 65 (s, 1H, 5'-H) (Found: C, 65. 28; H, 6.94; N, 
16. 23; M+,  423. 226596. C 23H29N503 requires C, 65. 21; H, 6.91; 
16-54%; M, 423. 227026). 
7. 9. viii 33-Hydroxyandrost- 5- eno[1  7, 16 -fltetrazolo[1, 5-alpyrimidine 
(266). Alumina chromatography (eluant chloroform) of the crude product 
followed by recrystallisation from ethanol gave white crystals of 
hydroxyandrost-5-eno[17, 16-fltetrazolo[1, 5-alpyrimidine (266) (54%); 
m. p.  198-200°; i. r. , 1 max 	 3 
3595 (OH), 2140 (-N ), 1645, 1540, 1500, 
1465, 1455, 1405, 1375 and 790 cm 
1; '
H n.m. r. (60 MHz), 5 1. 12 (s, 
3H, 18-CH3), 1. 15 (s, 3H, 19-CH3), 3.70 (m, 1H, 3-H), 5.40 (t, 1H, 
6-H) and 8.70 (s, 1H, 71 -H) (Found: C, 68.77; H, 7.51; N, 19. 16; 
M+, 365. 220461. C 21H27N50 requires C, 68. 99; H, 7.45; N, 19. 17%; 
M, 365. 221549). 
7. 9. ix 3f3-Acetoxyandrost- 5- eno[17, 16-fltetrazolo{1, 5-a]pyrimidine 
3-Hydroxyandrost-5-eno[17,  16-f]tetrazolo[1, 5-a]pyrimidine 
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(266) (450 mg, 1, 23 x 10
3
7 mole)was acetylated using the method 
described before for 1 7t3-acetoxyandrost-4-eno[3,  2-f]tetrazolo[1, 5-a]-
pyrimidine (264a) to give its 313-acetate.  Recrystallisation of the crude 
product from ethanol gave 313-ac etoxyandrost- 5- eno[1 7, 16-f]tetrazolo-
[1, 5-a}pyrimidine (267) (270 mg, 54%); m. p.  241-2440; i. r. , ' max 
1725 (C=O), 1645, 1500, 1455, 1435, 1410, 1375, 790 cm '; 'H n. m. r. 
(60 MHz), 6 1.12 (s, 6H, 18-CH3 and 19-CH3), 2.03 (s, 3H, 3-0C0CH3), 
4.60 (m, 1H, 3-H), 5.40 (t, 1H, 6-H) and 8.70 (s, 1H, 7'-H) (Found: 
C, 67.43; H, 7.01; N, 16.95; Mt-CH3COOH,  347. 209509. C 23H29N502 
requires C, 67.78; H, 7.14; N, 17. 20%; M,-CH3COOH, 347. 210985). 
7. 9.x 3-Methoxyoestra-1, 3, 5(10)-trieno[17, 16 -fltetrazolo[1 , 5-a]-
pyrimidine (269)was recrystallised from ethanol as white crystals (9 2%), 
M.P. 235-237°; 'H n. m. r. (d6-DMSO) (100 MHz), 6 1. 08 (s, 3H, 
18-CH3), 3. 70 (s, 3H, 3-OCH3), 6. 60-7. 22 (m, 3H, 1-H, 2-H and 4-H), 
9. 26 (s, 1H, 7-H) (Found: 141 M+, 361. 188867. C 21H23N50 requires 
M, 361. 190250). 
7. 9. xi 6, 7-Dihydro-5H-- cyclopenta[dltetrazolo[l, 5-alpyrimidine (268a) 
was recrystallised from ethanol as white crystals (55%), m. p.  152-1540  
(lit l49bm. p. 152-153°); i. r., y 
max 	3 
2140 (-N ), 1655, 1635, 1530, 1500, 
1405, 1345 and 775 cm 
1; '
H n.m. r. (60 MHz), 6 2.35 (m, ZH, 6-H's), 
3. 15 (m, 4H, 5-H's and 7-H's) and 8. 70 (t, 1H, 8-H). 
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8 	The reaction of steroidal 0-ketoaldehydes with 2-amino- 
benz imidazole 
8. 1 The reaction of 1 7)3-hydroxy- 2-hydroxym ethylene -- 17 a-methyl- 5 a-
androstan- 3-one (1 08) with 2-aminobenzimidazole (102). 
A solution of 1 73 -hydroxy- 2-hydroxymethylene- 17 a-methyl- 5 a-
androstan- 3-one (108) and 2-aminobenzimidazole (102) in absolute alcohol 
was refluxed for 7 h. The reaction mixture was evaporated to dryness 
under vacuo and the residue was chromatographed over alumina. Elution 
with chloroform followed by recrystallisation of the eluate from ethanol 
gave yellow crystals (270), m. p.  268-2700 (dec.) in 87% yield. 
Mass spectrometry and elemental analysis indicated that the 
product had a molecular formula of C 28H35N30. The i. r. spectrum 
of this product exhibited signals at 3600, 1635, 1605, 1510, 1450, 1415, 
760 and 730 cm '  and the 'H n. m. r. spectrum showed, apart from the 
signals for the 17-, 18- and 19-methyl protons a multiplet at 6 7. 14-
6 7. 90 corresponding to four protons of the benzene ring and a singlet 
at 6 8. 34 corresponding to one proton. 
8. 2 Discussion 
The i. r. spectrum of the condensation product does not show any 
carbonyl absorption, thus it appears that the product has either structure 
(270) or (271), both consistent with the molecular formula C 28H35N 30. 
However, the 'Hn.m.r. and 
13 
 C n.m.r. evidence favours structure 
(270), namely 1713-hydroxy- 17 a-methyl- 5 a-androstano[3, 2-b]benzimidazo-
[1, 2-a]pyrimidine. 
Table 7 
3C-Chemical shifts of the aromatic ring carbons (p. p.m.) 
Compound 21 -C 	3-C 	4 1 -C 5'a-C 9'a-C 101 a-C 
(104) 	165.72 	107.43 	132.75 	126.75 	144.14 	150.59 
(270) 165.90 115.80 130.65 126. 39 144. 26 150. 28 
(272) 150.94 109.41 136.04 112.66 135.14 148 86 
(5-C) 16-C) (7-C) (1-C) (2-C) (3a-C) 
* 	13 
C-Chemical shifts of 6?_C - 9 1 -C 110. 13, 120. 17, 121.32 and 125.83 
P. P. M. 
** 13 
C-Chemical shifts of 6'-C - 91 -C, 110. 18, 119. 84, 120.69 and 12559 
P. p.m. 
6 	 4 
50 	5 3  







The 'H n. m. r. spectrum of the condensation product (270) 
exhibits a fairly broad singlet at 5 8. 34 which is assigned to the 4'-H. 
The assignment of linear structure (270) is consistent with the observa-
tions made in sections 5 and 6 that in the linearly fused pyrazolo[l, 5-a]-
pyrimidines (e.g. 176) and s-triazolo[1, 5-a]pyrimidines (e. g. 210), the 
1 
signal for the proton of the pyrimidine ring in the H n. m. r. spectrum 
is broadened by a small long range coupling with the protons at position I. 
The alternative structure (271) for the steroidal condensation product 
is discounted, since it would be expected to show a sharp singlet for the 
2'-H due to the absence of any long range coupling. 
The assignment of structure (270) is also supported by 13 C n. m. r. 
evidence. The 13C -chemical shifts of the aromatic ring carbons of 
benzimidazopyrimidine (270) along with those of imidazo[1, 2-a]pyrimidine 
(272)136a and 2-methylpyrimido[l, 2-a]benzimidazole (104) are given in 
Table 7. The assignment of the chemical shifts for six of the ring 
carbons in the compounds (104) and (270) is based upon the comparison of 
the spectra of these two compounds and the '3C-chemical shifts of 
imidazo[l, 2-a]pyrimidine (272). 
136a 
 it is also noted that in nitrogen 
heterocyclic systems, the carbons bonded to nitrogen atoms are 
appreciably deshielded relative to benzene whilst the nitrogen atoms at 
bridgehead positions have little effect on the adjacent carbon atoms due 
to significant delocalisation of the lone pair of e1tron.s 36a The specific 
assignment of the remaining 6'C-9'C carbon resonances although not 
important as far as the distinction of structure (270) from structure 
(271) is concerned, is not possible from the above information alone, 
















other carbon resonances. The chemical shift of 4'-C (130.65 p. p.m.) 
in the condensation product (270) correlates well with the chemical shift 
of 7-C (136. 04 p. p.m.) in imidazo[ 1, 2-3]pyrimidine (272) and with the 
chemical shift of 4-C (132.75 p. p.m.) in 2-methylpyrimido[1, 2-a]-
benzimidazole (104) thus confirming a linear fusion of the steroid to 
the heterocyclic system. If the condensation product had had the angular 
structure (271) the chemical shift of 2'-C would have been expected to be 
in the region of 150. 94 p. p.m., which is the chemical shift of 5'-C in the 
imidazo[1, 2-a]pyrimidine (272). 
Under analogous reaction conditions, the condensation of 2-amino-
benzimidazole (102) with 17I3-hydroxy-2-hydroxymethylene5a_ancirostan_ 
3-one (3), 2-hydroxymethylene- 5a-cholestan- 3-one (110), 2-hydroxy-
methylene-5a-spirostan-3, 11-dione (111) and 17-hydroxy-2-hydroxy-
methyleneandrost-4-en-3-one (4) gave 17-hydroxy-5a-androstano[3, 2-b]-
benzimidazo[ 1, 2-a]pyrimidine (273), 5 a- cholestano[3, 2-b]benzimidazo-
[1, 2-a]pyrimidine (274), 11-oxo-5cz-spirostano[3, 2-b]benzimidazo[l, 2-a]-
pyrimidine (275) and 1 7 -hydroxyandro st-4 - eno[ 3, 2-b]benzimidazo - 
[1, 2-a]pyrimidine (276) respectively. The preparation of the compound 
(274) has been reported by Antaki and Petrow, 
20 
 in 1951, but no spectro-
scopic evidence was given for its structure 
8. 3 The reaction of 2(21 -pyridyl-aminomethylene)- 5 a-cholestan- 3-one 
(207) with 2-aminobenzimidazole (102). 
A solution of 2(2'-pyridyl-aminomethylene)- 5 a-cholestan- 3-one 
(207) and 2-aminobenzimidazole (102) in dry toluene containing a small 
amount of toluene -4-sulphonic acid was refluxed overnight. The reaction 
IbZ  
mixture was evaporated to dryness under vacuo and the residue was 
chromatographed over alumina. Elution with chloroform followed by 
recrystallisation of the eluate from ethanol-chloroform gave yellow 
crystals ( 72%), m. p.  290-2920 , identical (m. p. , i. r. and 'H n. m. r. 
with that of 5a-cholestano[3, 2-b]benzimidazo[1, 2-a]pyrimidine (274). 
8.4 Experimental 
General procedure for the condensation reaction 
A solution of a 2-hydroxymethylene-3-oxo steroid (1 x lO 3mole) 
and 2-aminobenzimidazole (102) (1. 2 x 10 3mole) in absolute alcohol 
(50 ml) was refluxed for 7 h. The reaction mixture was evaporated to 
dryness under vacuo and the residue was chromatographed over alumina. 
Elution with chloroform gave a yellow solid which was recrystallised 
from a suitable solvent. 
8.4. i 17f3-Hydroxy- 17 a-methyl-5a-androstano[3, 2-blbenzimidazo-
{l, 2-alpyrimidine  (270) was recrystallised from chloroform-ethanol as 
fine yellow crystals (87%), m p.  268-2700 (dec. ); i. r. I max 
 3600 (OH), 
1635, 1605, 1510, 1450, 1415, 925, 760 and 730 cm '; 'H n m. r. 
(100 MHz), 5 0. 80 (s, 3M, 18-CH3), 0. 90 (s, 3M, 19-CH3), 1 24 (s, 
3H, 17-CH3), 7.14-7.90 (m, 4H, 6'-H, 7'-H, 81 -Hand 9'-H) and 8.34 
(s, 1H, 4-H) (Found: C, 76-53; H, 8 40; N, 9.52; M+,  429. 277705. 
C 28H35N30 requires C, 78. 27; H, 8. 22; N, 9. 79%; M, 429. 277998). 
8.4. ii 1 7-Hydroxy- 5 a-androstano[3, 2-blbenzimidazo{l,  2-alpyrimidine 
(273) was recrystalli sed from acetone as yellow crystals (75%), m. p. 
284-286° (dec.); i r., 	max 3590 (OH), 1635, 1605, 1510, 1450, 1415, 
1050, 760 and 730 cm 
1; 1
H n.m. r. (60 MHz), 5 0.80 (s, 6H, 18-CH3  
and 19-CH3), 3.70 (in, 1H, 17-H), 7. lb - S. 05 (m, 4H, 6'-H, 7'-H, 
8'-H and 9'-H) and 8.40 (s, 1H, 4'-H) (Found: C, 78-25; H, 8.17; 
N, 10. 1; M+,  415. 262356. 	C 27H33N30 requires C, 78. 02; H, 8.01; 
N, 10.62%; M, 415.262349). 
154 
8.4. iii 5a-Cholestano[3, 2-blbenzimidazofl, 2-alpyrimidine  (274) was 
recrystallised from chloroform-ethanol as yellow crystals (71%), m. p. 
290-292° (lit 
20 
 m. p. 295°); i. r., 1 
max 
 1630, 1605, 1510, 1445, and 
770 cm '  (Found: C, 82-01; H, 9.46; N, 8.12; M+,  511. 392114. 
C 35H49N3 requires C, 82. 13; H, 9.73; N, 10. 17 07o; M, 511. 392629). 
8.4. iv 11-Oxo-5a-androstano[3, 2-b]benzimidazo{l, 2-alpyrimidine  (275) 
was recrystallised from ethanol as yellow crystals (78%),  m. p.310-312°; 
i. r. , 	1 1695 (CO), 1635, 	1610, 	1510, 	1450, 1420, 	1045, 	975, 	915, 
max 
890, 	760 and 730 cm 
1;  'H n. m. r. 	(100 MHz), 5 0. 74 (s, 	3H, 	18-CH 
3), 
 
1.00 (s, 	3H, 19-CH3), 7 	20-8.94 (m, 4H, 	6 1 -H, 71 -H, 	8'-H and 9?H) 
and 8.30 (s, 1H, 	4'-H) (Found: 	C, 	75.84; 	H, 	787; N, 	7.54; 	M+, 
553. 329658. 	C 35H43N303 requires C, 75.90; H, 7.83; N, 7.59%; 
M, 553. 330424). 
8. 4. v 1 713-Hydroxy-androst-4-  eno[3, 2-blbenzimidazo[1, 2-alpyrimidine 
(276) recrystallised from ethanol as yellow crystals (70%), m. p.  198-2000; 
i. r. , 	max 3590 (OH), 1635, 1580, 1505, 1450, 1430, 1215, 1060, 1040, 
870, 765 and 735 cm 
1; '
H n. m. r. (60 MHz), 6 0. 82 (s, 3H, 18-CH 
3), 
 
1.05 (s, 3H, 19-CH3), 3.65 (m, 1H, 17-H), 6.40 (s, 1H, 4-H), 7.10-
8. 96 (m, 4H, 61 -H, 7'-H, 8'-H and 9'-H) and 8.28 (s, 1H, 4'-H) (Found: 
C, 78. 12; H, 7. 60; N, 9. 88; M, 413. 246104. C 27H31 N30 requires 
C, 78.40; H, 7.56; N, 10. 17%;  M, 413. 246700). 
8.4. vi The reaction of 2(2'-pyridyl-aminomethylene)- 5 a-cholestan- 3-
one (207) and 2-aminobenzimidazole (102). 
A solution of 2(2-pyridy1aminom ethylene) -5 a-cholestan-3-one 
155 
(207) (0.490 g, 1 x 1C 3mole) and 2-aminobenzimidazole (102) (0. 158 g, 
1, 2 x lO 3mole) in dry toluene (30 ml) containing p- toluenes ulphonic 
acid (20 mg) was refluxed overnight. The reaction mixture was evaporated 
to dryness under vacuo and the residue chromatographed over alumina. 
Elution with chloroform and recrystallisation of the eluate from ethanol-
chloroform mixture gave yellow crystals (0. 360 g. 72%), m. p. 290-2920 , 
identical (m. p., i. r. and 'H n. m. r.) with that of 5a-cholestano[3, 2-b]-
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9. 	The reaction of various aminoazoles with aliphatic -ketoacetal, 
3-ketoaldehydes and -ketoanils. 
It is apparent from the preceeding sections that the reaction of 
aminoazoles with steroidal 3-ketoaldehydes gives linearly and angularly 
fused products whose structures have been elucidated by correlating 
their spectra (u. v. , 1. r. , 'H n. m. r. and 
13 
 C n. m. r. ) with those of 
some simple model compounds. It is also well known that the reaction 
of an aminoazole (277) with a 13-keto ester affords 5-alkyl-azolo[i, 5-a]-
pyrimidine (278). 80b However the reaction of arninozoles with unsymmet-
rical 3-ketoaldehydes and -diketones is not yet fully exploited. Thus, it 
was felt necessary firstly, to prepare some simple model compounds and 
secondly to investigate the reaction of various aminoazoles with some simple 
unsymmetrical 3-ketoaldehydes and .-ketoanils. 
9. 1 	The reaction of 4.4-dimethoxybut an- 2-one with aminoazoles. 
It has been previously reported 
62d 
 that the reaction between 4, 4-
dirnethoxybutan-2-one (279) and 3-amino-i,2, 4-triazole (95) in refluxing 
xylene furnishes 5-methyl-s-triazolo[i, 5-a]pyrimidine (216) as the sole 
reaction product in high yield. However, repetition of this condensation 
by refluxing a solution of the f3-ketoacetal (279) with the aminotriazole 
(95) in toluene in the presence of a small amount of toluene -4- sulphonic 
acid afforded 5-methyl-s-triazolo[1,5-a]pyrimidine (216), 7-methyl--s-
triazolo[1, 5-a]pyrimidine (217) and the self condensation product 1, 3, 5-
triacetylbenzene (280). The structures of the compounds (216) and (217) 
have already been adequately established by independent synthesis 146b 
and 'H n. m. r. spec tr o sc opy. 
77 
 The formation of 1, 3, 5-triacetylbenzene 
(280) has been previously observed150 during the reaction of tryptamine 
H3 
H2 

























hydrochloride and the -ketoacetal (279). It is evident that the 
compound (280) is formed by the self condensation of three molecules 
of 3-ketobutanol (281, R=H), itself derived from the 13-ketoacetal (279). 
Under similar conditions, 4, 4-dimethoxybutan- 2-one (279) reacts 
with 3- amino -S-methyl-i, 2,4-triazole (127) to give the two condensation 
products 2, 5-dimethyl-s-triazolo[l, 5-a]pyrimidine (282) and 2, 7-
dimethyl-s-triazoio[i, 5-a]pyrimidine (283) accompanied again by 1, 3, 5-
triacetylbenzene (280). During the reaction of 3-aminopyrazole (174) 
with the -ketoacetal (279) only two condensation products, 5-methyl-
pyrazolo[l, 5-a]pyrimidine (177) and 7-methylpyrazolo[l, 5-a]pyrimidine  (178) 
were isolated. The 5-methylazolo[a]pyrimidines (177) 
151b 
 and (28 2) 151a  
have been previously prepared by the condensation of the corresponding 
aminoazole with ethyl acetoacetate, followed by the removal of the residual 
oxygen atom from the intermediate condensation product by treatment 
with phosphorus oxychloride and subsequent hydrogenolysis. The 7- 
151b 	 l5la 
methylazolo[a]pyrimidines (178) 	and (283) 	have also been 
independently prepared from the reaction of the corresponding aminoazole 
with ethyl 2-acetyl-3-ethoxyacrylate followed by decarbethoxylation of the 
corresponding ethyl 7 -methylazolo[a]pyrimidine-6 -carboxylates. Under 
analogous conditions, the condensation of 4-amino-1, 2, 4-triazole (83) 
with the 13-ketoacetal (279) also gave two condensation products, 6-methyl-
s -triazolo[4, 3-b]pyridazine (157) and 8-methyl-s -triazolo[4, 3-b]- 
54 62d 
pyridazine (158), contrary to the earlier reports ' 	which indicate that 
only a single product (157) is formed in this reaction. 
It has been reported 
62d 
 that 5-methyltetrazolo[l, 5-a]pyrimidine 
(257) is the condensation product finally formed in each of the following 
three synthesis. Reaction of 5 -amino tetrazole (100) with ethyl aceto- 
Table 8. 	'3C N. m. r. Chemical Shifts of Azolo[a]pyrimidines (p. pm. ) 
Compound 	2-C 	 3-C 	3a- -C 	5-C 	6-C 	7-C 	5-CH3 
	
7-CH 3  
 145. 01 	95. 68 
 144.39 	96.97 
 156. 08 	- 
 155. 56 	- 
(257) - 	- 
 168. 16 	- 
155. 36 	- 
6 spectrum taken in d DM50. 
148.30 158. 90 108. 74 134.43 24. 77 - 
148. 91 148. 58 107.42 146. 13 - 17.20 
155. 13 165. 69 111. 25 134. 98 25.22 - 
155. 96 154. 03 110. 06 148. 15 - 17. 20 
158. 91 158.44 112.42 146.84 - 16. 63 
155. 75 163. 96 109. 81 145. 64 24.81 16. 93 
and 2-SCH3  
13. 95 
155. 36 164. 75 110. 75 146. 73 24. 98 16. 97 
acetate followed by treatment with phosphorous oxychloride and 
subsequent hydrogenolysis; reaction of 4-methyl- 2- hydraz inopyr imidine with 
nitrous acid and reaction of 5-aminotetrazole (100) with 4, 4-dimethoxybutan-
2-one (279). However, it is observed that the spectroscopic properties 
of the condensation product are consistent with the structure (257) rather 
than structure (284). In the 'H n. m. r. spectrum the singlet at 5 3. 50 
for the 7-methyl group is found to be broadened by a small long range 
coupling with the 6-H and the value of the coupling constant of the two 
doublets at 5 7. 25 (6H) and 'S 8. 90 (5-H) is found to be 4. 00 Hz. 	If the 
product had structure (284), the methyl group would be expected to give 
a sharp singlet and the value of the coupling constant of the two doublets 
would be expected to be about 7. 00 Hz. 
80d 
 In the 13C n. m. r. spectrum, 
the chemical shift of 5-C is found to be 158.44 p.  p.m. [comparable 
with the chemical shift of 5-C (154.03 p. p.m.) in the triazolopyrimidine 
(217), discussed later] consistent with the structure (257). In the 
alternative structure (284), the chemical shift of 7-C would be expected 
to be about 134 p. p. m. making it comparable with the chemical shift of 
7-C in the triazolopyrimidine (216) (Table 8). 
The 'H n. m. r. spectrum of the compound (257) is further complicated 
by the fact that, in addition to the signals for the 7-methyl, the 6-H and 
the 5-H, a singlet at 5 2. 50 and doublets at 5 6.97 and 5 8.50 (J = 4.8 
Hz) also appear indicating that the compound (257) exists in equilibrium 
with the azido form (257a), the ratio of the compound (257) to (257a) 
being 3:1. The presence of the azido form (257a) is also confirmed by 
the appearance of absorption band at 2140 cm '  in the i. r. spectrum. 
Rearrangements of this type have been previously discussed in section 7. 
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Due to the formation of 1, 3, 5-triacetylbenzene (280) as a byproduct 
of these condensation reactions it is inferred that the -ketoacetal (279) 
is initially converted to 3-ketobutanal (281; R=H) by hydrolysis of the 
acetal (279) under the acidic reaction conditions. Support for the inter-
mediacy of the -ketoaldehyde (281; R=H) comes from 1H n. m. r. spectro-
scopy. A solution of the acetal (279) in acetone containing small amounts 
of toluene-4-sulphonic acid and water after being heated on a boiling water 
bath exhibited two doublets at 5 5. 55 and 5 7.85 (J = 5Hz). These 
correspond to the protons of 2-C and 1-C respectively in 3-ketobutanal 
(281; R=H) and a small signal observed at 5 9.75 is ascribable to the 
aldehydic proton of the unenolized form. The chemical shift of the 
hydrogen at 2-C in the 3-ketoaldehyde (281; R=H) is comparable to the 
chemical shift of 3-H ( 55. 50) in ac etylac etone (281; RCH3). The 
possibility that the acetal (279) might have been converted to methoxyvinyl 
ketone (285) rather than the -ketoaldehyde (281; R=H) is not considered 
likely since, the signals for 1-H and 2-H belonging to methoxyvinyl ketone 
(285) appear as doublets at 5 7. 60 and 5 5. 58 with a coupling constant of 
13Hz. 152 
9. 2 The reaction of 2-hydroxymethylenecyclohexanone (123) with 
aminoazoles. 
The condensation of 2-hydroxym ethyl enecyclohexanone (123) with 
various aminoazoles proceeds in a manner analogous to the condensation 
of the aminoazoles with 4, 4-dimethoxybutan- 2-one (279). The only 
exception is the reaction of 3-amino-5-methyl-1, 2,4-triazole (127) with 
the 3-ketoaldehyde (123) which affords the linear product (290) in contrast 
Table 9. 	'3C N. m. r. Chemical Shifts of 5, 6, 7, 8-Tetrahydroazolo[b]guinazolines (p. p. m. 
Compound 	2-C 	3-C 	3a-C 	4a-C 	8a-C 	9-C 	alicyclic carbons 
(286) 155. 38 	- 153. 76 	165. 81 120.51 132. 84 	(21. 65 - 32.89) 
(288) 168. 09 	- 154.32 	164. 84 119.42 131.84 	(21.68 - 32. 75) 
(290) 165. 91 	- 154. 01 	165. 14 119. 73 132. 33 	(21. 94 - 33. 00) 
(291) 146. 69 	80. 27 148. 23 	164.48 121. 09 133. 30 	(21. 57 - 32.75) 
(CN, 	112.88) 
These values could be interchanged. 
Table 11. 	'3C N. m. r. Chemical Shifts of 6, 7-Dihydro-5H-cyclopenta[d]azolo[a]pyrimidines (p. p.m.) 
Compound 	2-C 	3-C 	3a-C 	4a-C 	7a-C 	8-C 	alicyclic carbons 
 155. 12 	- 155.84 175. 08 125.56 129.61 (23. 91 	- 34.17) 
 167. 46 	15 155.47 174. 05 124.35 128. 64 (23.70 - 34.07) 
 146. 36 	81. 14 149. 62 173.41 126. 25 130. 19 (23. 81 - 33.96) 
Table 10. 	13C N. m. r. Chemical Shifts of 6,7,8, 9-Tetrahydro-azolo[ajguinazolines and 7, 8-Dihydro- 
6H-c yclopenta[e]azolo[a]pyrimidine s (p. p. m. 
Compound 	2-C 	3-C 	3a-C 	5-C 	5a-C 	9a-C 	Alicyclic carbons 
(289) 167. 75 	- 154.66 154. 14 118. 42 144. 88 (20. 54 - 23. 96) 
(292) 146. 04 	82.27 149.01 153. 61 119. 82 144. 08 (20.6 - 24. 07) 
(CN, 	112. 74) 
(293) - 	- 158. 43 159. 20 121. 66 143. 64 (20. 21 - 23. 90) 
 155. 69 	- 155.15 150.84 125. 27 151.54 (22.64 - 29. 57) 
8a-C 
 168.69 	- 155.64 149.66 124.50 150.46 (22.63-29.49) 
8a-C 
 09 	82. 18 68 56 125. 80 151. 71 (22. 20 - 29. 51) 
8a-C (CN, 	112.81) 
Table 12. 	13C N. m. r. Chemical Shifts of s-Triazolol4, 3-bpidazine 
derivatives (p. p. m. 
Compound 3-C 6-C 7-C 8-C 8a'-C methyl or 
alicyclic carb 
(157) 138. 41 155. 01 122. 81 124. 14 143. 08 21. 64 
(158) 139. 10 145. 64 118. 86 137.31 145.43 16.46 
(164) 137. 48 155. 85 132.61 121. 04 143. 68 (21. 66-29. 7. 
5a-C 9a-C 10-C lOa-C 
(165) 138. 23 147. 61 128. 68 133. 64 145. 12 (20.50-25.4 
6a-C lOa-C lOb-C 
(300) 138. 03 164. 67 138.41 117.43 143. 99  (24. 12-31. 1 
5a-C 8a-C 9-C 9a-C 
0 
11 
o 	-CHCH-OC H3  
(285) 
160 
to the formation two products (282) and (283) during its reaction with 
the -ketoacetal (279). The compounds (286)149a and(293)149b have been 
prepared before but no spectroscopic evidence has been given for the 
structure of these products. s-Triazolo[4, 3-b]cinnoline (164) has also 
been prepared by the reaction of 3-hydrazino-5, 6, 7, 8-tetrahydrocinnoline 
with formic acid. The 'H n. m. r. spectrum of the compound (164) 
agrees with that recorded in the literature 
130 
 but the melting point is 24°  
lower than previously recorded. 
The linear condensation products (e. g. 291) can be readily 
distinguished from the angular condensation products (e. g. 292) by 'H 
n. m. r. and '3C n. m. r. spectroscopy. For example in the 'H n. m. r. 
spectrum of the linear product 3-cyano-5, 6, 7,-8-tetrahydropyrazolo-
[5, 1-b]quinazoline (291), the signal for the 9-H is broadened by a small 
long range coupling with the 8-H whilst the 5-H in 3-cyano-6, 7, 8, 9-
tetrahydropyrazolo[l, 5-a]quinazoline (292) appears as a sharp singlet 
because of the absence of long range coupling. The long range coupling 
observed in the 9-H signal of the compound (291) was confirmed by double 
irradiation. Similar long range coupling has been observed, 
77 
 as 
previously reported (sections 5 and 6) in azolo[a]pyrimidines (179) where 
it was observed that the methyl protons at 6-C are split into a doublet 
by coupling with the 7-H whilst no such coupling was observed between 
the methyl protons at 6-C and the 5-H. 
77,80d 
 In the 
13
C n. m. r. spectra, 
the chemical shift of 9-C (133. 30 p. p.m.) (Table 9) in the compound 
(291) is found to be comparable with that of 7-C (134.43 p. p.m.) (Table 
8) in the pyrazolopyrimidine (177) whilst the chemical shift of 5-C 
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with the chemical shift of 5-C (148.58, p. p. m. ) (Table 8) in the 
pyrazolopyrimidine (178). These values are also consistent with the 
observation that the carbons bonded to nitrogen atoms are appreciably 
deshielded relative to benzene and occur further downfield compared 
136a 
with the carbons bonded to bridgehead nitrogens. 135, 
	
The structural 
assignment of compound (291) is further supported by the following 
alternative synthesis. 
3-Amino-4-cyanopyrazole (126) on condensation with 2-carbethoxy-
cyclohexanone (125) gave 3-cyano-5,6, 7,8-tetrahydropyrazolo[5, 1-b]-
pyrimidin-9-ol (295; ROH). The possibility of the alternative structure 
3-cyano-6, 7, 8, 9-tetrahydropyrazolo[l, 5-a]pyrimidin-5-ol (296) is ruled 
out since 3-aminopyrazoles are known to react with ethylacetoacetate to 
give 5-methylpyraz olo[1, 5-a]pyrimidine -7- ols and not 7-methylpyrazolo-
[1,5_a]pyrimidine_5_ols.151c Subsequent reaction of the hydroxyl 
group in the intermediate (295; R=OH) with phosphorus oxychloride 
followed by hydrogenolysis furnished a product identical in all respects 
with 3-cyano-5, 6, 7, 8-tetrahydropyrazolo[5, 1-b]quinazoline (291). 
9. 3 	The reaction of aminoazoles with 2-hydroxymethylenecyclopentanone. 
The condensation of various aminoazoles with 2-hydroxymethylene-
cyclopentanone (124) is shown however, to take a different course, in 
that the reaction of 3-amino- 1, 2,4-triazole (95), 3-amino-5-methylthio-
1,2,4-triazole (224) and 3-amino-4-cyanopyrazole (126) with the 13-keto-
aldehyde (124) furnishes only the angularly fused products, 7, 8-dihydro-
6H-cyclopenta[e]-s-triazolo[1,5-a]pyrimidine  (297), 2-methylthio-7,8-
dihydro-6H-cyclopenta[e]-s-triazolo[1,5-a]pyrimidine (298) and 3-cyano-7, 8-
dihydro-6H-cyclopenta[e]pyrazolo[1, 5-a]pyrimidine (299) respectively. 
Scheme 1 
(95) 
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An exception to this behaviour is evidenced by the reaction of 4-amino-
1, 2,4-triazole (83) with the 3-ketoaldehyde (124) where the linear 
product 7, 8- dihydro-6H-cyclopenta[d]- s-triazolo[4, 3-b]pyridazine (300) 
is the only product isolated. The structures of the products were con-
firmed by 'H n. m. r. and 13C n. m. r. spectroscopy. 
It is interesting to note that the type of the products obtained during 
these condensation reactions depends very much on the 3-ketoacetal or the 
3-ketoaldehyde and the aminoazole actually used in the reaction. For 
example, 3-amino-5-methyl-1, 2,4-triazole (127) reacts with the -keto-
acetal (279) to give two isomeric products (282) and (283) whilst only one 
product (290) was obtained from its reaction with 2-hydroxym ethyl ene-
cyclohexanone (123). Secondly, most of the aminoazoles on reaction 
with 13-ketoacetal (279) or t3-ketoaldehyde (123) give two isomeric products 
whereas these aminoazoles lead to the formation of only angular products 
on condensation with 2-hydroxym ethyl enecyclo pen tanone (124), with the 
exception of 4-amino-1, 2,4-triazole (83) which leads to the formation of 
only linear product (300). 
9.4 The reaction of various 3-ketoanils with aminoazoles. 
The reactions of the 3 -ketoanils, 2-(2-ac etylvinylamino)pyridine 
(209), 2-(2'-pyr idyl -aminomethylene)cyclohexanone (301) and 2_(2!_ 
pyridyl-aminomethylene)cyclopentanone (302) with various aminoazoles 
have also been studied (Schemes 1-3). These t3-ketoanils were prepared 
by the reaction of 2-aminopyridine with the respective 13-ketoaldehydes Or 
the -ketoacetal. The structure of the -ketoanil (209) has already been 
adequately established 140 with the help of 'H n. m. r. and mass spectro- 
metry. 	Structures of the -ketoanils (301) and (302) are assigned by 
163 
analogy with the structure of the -ketoanil (209). 
It is observed that the reaction of 3-amino- 1, 2,4-triazole (95) 
with the 13-ketoanil (209) catalysed by toluene-4-sulphonic acid furnishes 
a 20% yield of 5-methyl-s-triazolo[1, 5-a]pyrimidine (216) which indicates 
that the amino group of the triazole (95) condenses with the carbonyl of 
the 13-ketoanil (209) prior to cyclisation and displacement of the 2-amino-
pyridine. However, it is interesting to note that 80% of the product 
isolated from this condensation was 7-methyl-s-triazolo[1, 5-a]pyrimidine 
(217) which presumably arises by a preliminary reroanil reaction of 
the f3-ketoanil (209) to yield 3-ketobutanal (281; RH) prior to condensation 
with the aminotriazole (95). It was further observed that the ratio of the 
compound (216) to (217) is dependent on the catalyst used for the condensa-
tion. When the f3-ketoanil (209) is condensed with the aminotriazole (95) 
in the presence of anhydrous oxalic acid, the preliminary retroanil 
reaction is suppressed and 5-methyl-s-triazolo[1, 5-a]pyrimidine  (216) 
becomes the predominant product (45%). 
The condensation of the 13-ketoanils (301) and (302) with aminoazoles 
proceeds in a manner similar to that of the -ketoanil (209). It is noted 
again that the condensation of the -ketoanil (301) with 3-amino-5-methyl-
thio-1, 2,4-triazole (224) and 3-amino-4-cyanopyrazole (126) and the 
condensation of the -ketoani1 (302) with the aminoazole (126) affords a 
mixture of a linearly fused product (major) and an angularly fused 
product (minor). However when the catalyst toluene -4-sulphonic acid 
was replaced by anhydrous oxalic acid in the condensation of the 3-
ketoanil (301) with 3-amino- 5-methylthio- 1, 2, 4-triazole (224), only 
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9. 5 13 C N. m. r. Spectra 
The assignment of the various carbon resonances in the s-triazolo-
[1, 5-a]pyrimidine system is based upon the comparison of the proton 
coupled and proton decoupled spectra of 2-methylthio-5, 7-dimethyl-s-
triazolo[l, 5-a]pyrimidine (306), 5, 7-dimethyl-s-triazolo[1, 5-a]pyrimidine 
(307), 5-methyl-s-triazolo[l, 5-a]pyrimidine (216) and 7methyl-s-
triazolo[l, 5-a]pyrimidine (217). In the 13C n. m. r. spectrum of the 
compound (306), the 6-C carbon resonance can be easily identified from 
the large carbon-13 proton coupling since this is the only ring carbon 
which has one hydrogen attached to it. By comparing the 
13
C n. m. r. 
spectrum of the triazolopyrimidine (307) with that of traizolopyrimidine 
(306), the chemical shift of 2-C in (307) and the chemical shifts of 2-C 
and SCH3 in (306) can also be determined. Further comparison of the 
spectra of compounds (306) and (307) with those of (216) and (217) enables 
the chemical shifts of all the ring carbons and methyl carbons of the 
compounds (216), (217), (306) and (307) to be assigned. 
The chemical shifts of the various carbons in the tetrazolo[l, 5-a]-
pyrimidine and pyrazolo[l, 5-a] pyrimidine systems follow from the com-
parison with the chemical shifts of above mentioned compounds (216), 
(217) and of related systems 3 The chemical shifts of the various s-
triazolo[4, 3-b]pyridazine derivatives follow from the comparison with 




the 	C n. m. r. chemical shift data is given in Tables 8 to 12. 
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9. 6 Experimental 
9.6. i 2-(2-Acetylvinylamino)pyridine (209). A solution of 4, 4-di- 
-2 
methoxybutan- 2-one (279) (4 g, 3. 03 x 10 mole) and 2-aminopyridine 
(3 g, 3. 2 x 10 2mole) in dry toluene (30 ml) was refluxed for 7 h. The 
reaction mixture was evaporated to dryness under vacuo and the residue 
was chromatographed over alumina (50 g). Elution with ethyl acetate 
followed by recrystallisation of the eluate from acetone gave yellow 
crystals of 2-(2-acetylvinylamino)pyridine (209) (2.8 g, 56 %), m. p.  112- 
114°  (lit, 140 m. p.  114-115°); i. r., 1 max 
 3250 (NH), 1645 (G0), 1600, 
1565 and 1515 cm 
l, 1
H n. m. r. (60MHz), 5 2.15 (s, 3H, GOGH3), 
5.40 (d, J8. 6Hz, 1H, -NH-CHGH-), 6.60-7.00 (m, 2H, 3-H and 5-H), 
7.55 (ddd, 1H, 4-H), 7.95 (dd, 1H, J12Hz and 8.6Hz, -NH-CHCH-) 
25 (d, lH, 6-H) and 11. 70 (d, lH, exchanges with D20, NH). 
The following compounds were also prepared by the same method. 
6. ii 2-(2'- Pyr idyl-  aminomethylene)cyclohexanone (301) was prepared 
from 2-hydroxym ethylene cyclohexanone (123) (3.8 g, 3 x 10 2mole) and 
2-aminopyridine (2.82 g, 3 x 10 2mole). Recrystal]Jsation from 
methanol gave the title compound (301) (56%), m. p.  157-1590 (Found: 
C, 72.71; H, 7.08; N, 14.06; M+,  202. 110485. G12H14N20 requires 
C, 72.69; H, 7.12; N, 14.14%; M, 202. 110607). 
9. 6. iii 2-(2 '-Pyridyl- aminom ethylene) cyclopentanone (302) was prepared 
from 2-hydroxym ethyl enecyclopentanone (124) (3. 36 g 3 x 10 2mole) 
and 2-aminopyridine (2.82 g, 3 x 10 2mole). Recrystallisation from 
methanol gave the title compound (302) (60%), m. p. 163-1650 (Found: 
C, 71.16; H, 6.50; N, 14.98; M+, 188.095346. C11H12N20 requires 
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C, 71-70; H, 6.57; N, 15.21%; M, 188. 094958). 
General procedure for the condensation reactions 
Method-A: A solution of 3-ketoacetal or P-ketoaldehyde (4 x 10 3mole), 
the aminoazole (4 x 10 -3 mole)and toluene-4-sulphonic acid (30 mg) in 
dry toluene (50 ml) was refluxed overnight. Alter cooling, the reaction 
mixture was evaporated to dryness and the residue was chromatographed 
over alumina (40 g). 
Method-B: Method A was modified by employing the corresponding 3-
ketoanil (4 x 10 3mole) instead of the -ketoacetal or -ketoa1dehyde in 
the condensation reaction. 
9. 6. iv 5-M ethyl- s-triazolo[1, 5-alpyrimidine (216), 7-methyl-s-triazolo-
[1, 5-alpyrimidine (217) and 1, 3, 5-triacetylbenzene (280). 
Method-A. Alumina chromatography (eluant ether) gave 1, 3, 5-triacetyl-
benzene (280) which was recrystallised from benzene as white long needles 
(5%), m. p.  158-160 (lit, 150 m. p. 161- 163°). Further elution of the 
column with ether gave a mixture of two compounds which were separated 
by fractional crystallisation from benzene. 5-M ethyl- s - triazololl, 5-al-
pyrirnidine (216) crystallised out first as white long needles (45%), m. p. 
180-182°  (lit, 
62d 
 m. p. 181-182. 5°); i. r., i 	1635, 1615, 1530, 1410, 
max 
800 and 775 cm 1; 'H n. m. r. (60 MHz), 5 2. 75 (s, 3H, 5-CH3), 7.05 
(d, J7Hz, 1H, 6-H), 8.45 (s, 1H, 2-H) and 8.75 (d, J7Hz, 1H, 7-H). 
Concentration of the mother liquor gave long white needles of 7-methyl-
s-triazolo[1, 5-alpyrimidine (217) (15%), m. p.  134-1350 (lit, 
146b 
 M. P. 
136-138°); i. r., Y max 1615, 1545, 1520, 1450, 1430, 1375, 1355 and 
780 cm 1; 'H n. m. r. (60 MHz), 5 2. 90 (s, 3H, 7-CH3), 7. 04 (d, 
J4.5Hz, 1H, 6-H), 8.50 (s, 1H, 2-H) and 8.70 (d, I-4. 5Hz, 1H, 5-H). 
Method-B. 	The two products (216) and (217) were obtained in 17% 
and 62% respectively. 	However, when toluene-4-sulphonic acid 
catalyst was replaced by anhydrous oxalic acid, the two products (216) 
and (217) were obtained in 45% and 16% respectively. 
9.6.v 2, 5-Dimethyl-s-triazolo{1, 5-alpyrimidine  (282), 2, 7-dimethyl 
-s-triazolo[l, 5-apyrimidine (283) and 1, 3, 5-triacetylbenzene (280). 
Method-A. Alumina chromatography (eluant ether) gave 1, 3, 5-triacetyl-
benzene (280) which was recrystallised from benzene as long white 
needles (4. 5%), m. p.  158-160°  (lit 
150 
 m. p. 161-163 
0 
 ). Further elution 
of the column with ether-ethyl acetate (1:1) gave 2, 5-dimethyl-s-triazolo-
[1, 5-alpyrimidine  (282) which recrystallised from n-hexane as white 
crystals (48%),  m. p.82-83°  (lit 5 	m. p.86-88°); 'H n. m. r. (60MHz), 
6 2,60 (s, 3H, 2-CH3), 2.68 (s, 3H, 5-CH3), 6. 85 (d, J7Hz, 1H, 6-H) 
and 8. 58 (d, J7Hz, 1H, 7-H); and 2, 7-dimethyl-s-triazolo[1, 5-al-
pyrimidine (283) which was also recrystallised from n-hexane to give 
white crystals (25%),  m. p. 157-1590 (lIt. lSla  M. P. 161-162°); 'H n.m.r. 
(100 MHz), 	5 2. 62 (s, 3H, 2-CH3), 	6 2.80 (bs, 3H, 7-CH3), 6.90 (d, 
J4. 5, 6-H) and 8.62 (d, J4. 5, 5-H). 
9.6. vi 5-Methylpyrazolo[1, 5-a]pyrimidine  (177) and 7-methylpyrazolo-
[1, 5-alpyrimidine  (178). 
Method-A. Alumina chromatography (eluant ethyl acetate) gave the two 
isomeric compounds, 5-methylpyrazolo[ 1, 5- a]pyrimidine (1 77) which was 
recrystallised from n-hexane as white needles (27%),  m. p.122-124°  
51b m. p. 122-123°  (lit 	 ); i. r, Y 	1625, 1610, 1535, 1510, 1405, 790 
and 770 cm '; 1H n.m. r. (60 MHz) 6 2.60 (s, 3H, 5-CH3) 6.60 (d, 
3=2Hz, 1H, 3-H), 6.65 (d, 37. 5 Hz, 6-H), 8. 15 (d, J2Hz, 1H, 2-H) 
and 8.60 (d, 37. 5Hz, 1H, 7-H); and 7-methylpyrazolo[l, 5-alpyrimidine 
(178) which was recrystallised from n-hexane-benzene to give white 
crystals (16%),  m. p. 59-60 (litSlbm. p. 59-60°); 1. r. 	max 1610, 1540, 
1445, 1430, 1385, 810 and 770 cm '; 'H n.m. r. (60 MHz), 6 2.80 (bs, 
3H, 7-CH3), 6.60 (d, 34.4 Hz, 1H, 6-H), 6.75 (d, 3=2Hz, 1H, 3-H), 
8.20 (d, J=2Hz, 1H, 2-H) and 8.45 (d, 3=4.4Hz, 1H, 5-H). 
Method-B. 7-Methylpyrazolo[1, 5-a]pyrimidine (178) was obtained in 
75% yield as the sole reaction product. 
9.6. vii 6-Methyl-s-triazolo[4, 3-bipyridazine (157) and 8-methyl-s- 
triazolot4, 3-bjpyridazine (158). 
Method-A. Alumina chromatography (eluant ethyl acetate-ether, 1:1) 
gave 6-methyl-s-triazolo[4, 3-bipyridazine (157) which was recrystallised 
d
.  from benzene to give white needles (58%),  m. p. 168-1700 (lit 2 . P. 
168-1690); i. r. , 1 max 3140, 1620, 1540, 1500, 1445, 1425, 1390, 1375, 
1355 and 805 cm 
l; '
H n. m. r. (60 MHz), 6 2.62 (s, 3H, 6-CH3), 7.05 
(d, 3=9. 5Hz, 1H, 7-H), 8.05 (d, 3=9. 5Hz, 1H, 8-H) and 9.05 (s, 1H, 
3-H); and 8-methyl-s -triazolo[4, 3-bipyridazine (l5 which was recrystal- 
used from n-hexane to give white crystals ( 20%), m. p. 124-126
0 
 (1it 29  
m. p.  126-127°); i. r., y max 
 3140, 1610, 1565, 1490, 1430, 1385, 1370, 
135 and 805 cm 
1; '
H n. m. r. (60 MHz), 6 2.75 (d, J=8 Hz, 3H, 8-CH 
3), 
 
6.92 (dd, J=0. 8 and 5 Hz, 1H, 6-H), 8. 25 (d, J5Hz, 1H, 5-H) and 9.08 
(s, 1H, 3-H). 
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Method-B. 6-Methyl-s-triazolo[4, 3-b]pyridazine (157) was obtained in 
25% yield as the only reaction product. 
9.6. viii 7-Methyltetrazolo[l, 5-a]pyrimidine  (257). 
Method-A. Alumina chromatography (eluant methylene chloride-ethyl 
aceyate, 9:1) followed by recrystallisation of the eluate from benzene gave 
7-methyltetrazolo[1, 5-alpyrimidine (257) as white needles (70%), m. p. 
129-1310 (lit 2dm. p. 130-132. 5°); i. r., y 	2140 (-N ), 1625, 1585, max 	3 
1540, 1510, 1440, 1365 and 1350 cm ; 'H n.m. r. (60 MHz), 6 3.50 
(bs, 3H, 7-CH3), 7. 25 (d, 3=4. OHz, 1H, 6-H) and 8.90 (d, lH, 5-H). 
Method-B. 7-Methyltetrazolo{1, 5-a]pyrimidine (257) was obtained as 
the sole reaction product in 63% yield. 
9.6. ix 2-Methylpyrimido[1, 2-a]benzimidazole (104). 
Method-B. Alumina chromatography (eluant ethyl acetate) gave the 2-
methylpyrimido[l, 2-a]benzimidazole  (104) which was recrystallis ed from 
ethanol to give light yellow crystals (64%), m. p.  230-2320 (lit 
85 
 m. p.  229-
232°); 1. r., 1 max 1630, 1610, 1515, 1460, 1440, 780, 765 and 735 cm- 1; 
n. m. r. (60 MHz), 6 2.62 (s, 3H, 2-CH3), 6. 75 (d, J=7Hz, lH, 3-H), 
7. 20-8.05 (m, 4H, 6-9H's) and 8.60 (d, J7Hz, 1H, 4-H). 
9.6. x 5, 6, 7, 8-Tetrahydro-s-triazolo[5, 1, b]guinazoline (286) and 
6, 7, 8, 9-tetrahydro- s-triazolo[l, 5-.a]quinazoline (287). 
Method-A. The two condensation products were separated by shaking the 
mixture with petroleum-ether (60-80°). The insoluble material on re- 
crystallisation from n-hexane-benzene gave 5, 6, 7, 8-tetrahydro-s-triazolo- 
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[5, 1-b]quinazoline (286) (55%);  m. p.  121-123°  (lit 49am. p. 125-126°); 
i. r., y 	1630, 1510, 1430, 1420, 1405, 1350 and 770 cm '; 'H 
max 
n. m. r. (60MHz), 6 1. 97 (m, 2H, 6-H and 7-H), 3. 00 (m, 2H, 5-H and 8-H), 
8.40 (s, 1H, 2-H) and 8. 55 (bs, 1H, 9-H) (Found: C, 62. 10; H, 5.89; 
N, 32. 00; M+, 174. 091873. C 9H10N4 requires C, 62. 04; H, 5. 79; 
N, 32.17%; M, 174.090932). 
The petroleum-ether fraction was evaporated to dryness and the 
residue was recrystallised from n-hexane to give 6, 7, 8, 9-tetrahydro-s-
triazolo{1, 5-a]quinazoline  (287) (37%);  m. p.87-89°; i. r., ' max 1625,
1545, 1510, 1435, 1420, 1405, 1355 and 770 cm 
1; 1
H n.m. r. (60 MHz), 
5 1.95 (m, 2H, 7-Hand 8-H), 2.95 (m, 2H, 6-H and 9-H), 8.35 (s, 1H, 
2-H) and 8.40 (s, 1H, 5-H) (Found: C, 61-95; H, 5.70; N, 32.35; M+, 
174. 092761. 	C 9 H10N4 requires C, 62.04; H, 5.79; N, 32. 17%; M, 
174. 090932). 
9.6. xi 2-Methylthio-5, 6, 7, 8-tetrahydro-s-triazolo[5, 1-biquinazoline 
(288) and 2-methylthio-6, 7, 8, 9-tetrahydro- s-triazolo[1, 5-aiquinazoline 
(289). 
Method-A. Alumina chromatography (eluant ethyl acetate) gave the two 
title products. 
2-Methylthio-5, 6, 7, 8-tetrahydro-s-triazolo[5, 1-b] quinazoline (288) was 
recrystallised from ethanol to give white crystals (63%), m. p.  106-1080; 
i. r., y 	1625, 1510, 1450, 1435, 1425, 1370, 1350 and 770 cm '; 
max 
'H n. m. r. (60 MHz), 6 1.90 (m, ZH, 6-H and 7H), 2.77 (s, 3H, 2-SCH3), 
2.95 (m, 2H, 5-H and 8-H) and 8.35 (bs, 1H, 9-H) (Found: C, 54. 34; 
H, 5.40; N, 25.31; M+,  220. 079812. C10H12N4S requires C, 54.52; 
H, 5.49; N, 25.46%; M, 220.078264). 
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2-Methylthio-6, 7, 8, 9-tetrahydro-s-triazolo[1, 5-alpyrimidine (289) 
was recrystallised from acetone to give large white crystals (26%), m. p. 




H n. m. r. (60 MHz), 5 1.90 (m, ZH, 7-H and 8-H), 2.70 (s, 
3H, 2-SCH 3 ), 3.00 (m, 2H, 6-H and 9-H) and 8.30 (s, 1H, 5-H) (Found: 
C, 54.61; H, 5.51; N, 25.57; M+,  220.077244. C10H12N4S requires 
C, 54.52; H, 5.49; N, 25.46%; M, 220.078264). 
Method-B. The two products (288) and (289) were obtained in 48% and 
16% yields respectively. When toluene -4-sulphonic acid catalyst was 
replaced by anhydrous oxalic acid, only product (288) was obtained in 
60% yield. 
9.6. xii 2-Methyl-5, 6, 7, 8-tetrahydro-s-triazolo[5, 1-b}quinazoline (290). 
Method-A. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from n-hexane gave long white needles of 2-methyl- 
5, 6, 7, 8-tetrahydro-s-triazolo[5, 1-bquinazoline (290) (56%), m. p. 132- 




H n.m. r. (60 MHz), 5 1.90 (m, 2H, 6-Hand 7-H), 2.55 
(s, 3H, 2-CH3), 2.90 (m, 2H, 5-Hand 8-H) and 8.35 (bs, 1H, 9-H) 
(Found: C, 63.38; H, 6.37; N, 29.59; M+,  188. 104757. C10H12N4  
requires C, 63. 79; H, 6.43; N, 29.78%; M, 188. 106191). 
9.6. xiii 3-Cyano-5, 6, 7, 8-tetrahydropyrazolo[5, 1-biguinazoline  (291) 
and 3-cyano-6, 7, 8, 9-tetrahydropyrazolo[1, 5-aguinazoline (292). 
Method-A. Alumina chromatography (eluant ethyl acetate) gave the two 
title products. 
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3-Cyano- 5, 6, 7, 8-tetrahydropyrazolol5, 1 -blguinazoline  (291) was 
recrystallised from methanol to give white crystals (30%),  m. p. ll01ll°; 
i. r., Y 
max 
 2220 (CN), 1630, 1550, 1505, 1460, 1405 and 750 cm '; 
1H n. m. r. (60 MHz), 6 1. 95 (m, 2H, 6-H and 7-H), 3.00 (m, 2H, 5-H 
and 8-H), 8. 27 (s, 1H, 2-H), and 8.42 (bs, 1H, 9-H) (Found: C, 66. 78; 
H, 5. 10; N, 28. 53; M+,  198. 090620. C11H10N4 requires C, 66. 64; 
H, 5.09; N, 28.28%; M, 198.090542). 
3-Cyano-6, 7, 8, 9-tetrahydropyrazolo[1, 5-a]quinazoline  (292) was recrystal- 
used from methanol to give white crystals (15%),  m. p.  116-1180 ; i. r., 
1 	
max 
 2220 (CN), 1620, 1530, 1470, 1370, 1350 and 750 cm 
1; '
H n. m. r. 
(60 MHz), 6 2.03 (m, 2H, 7-H and 8-H), 3.05 (m, 2H, 6-H and 9-H), 
8.35 (s, 1H, 2-H) and 8.50 (s, 1H, 5-H) (Found: C, 66.44; H, 5. 12; 
N, 28.35; M+,  198.091372. C11H10N4 requires C, 66.64; H, 5.09; 
N, 28. 28%; M, 198. 090542). 
Method-B. The two products (291) and (292) were obtained in 50% and 12% 
yields respectively. 
9. 6.xiv 6,7,8, 9-Tetrahydro-s-triazolo[4, 3-blcinnoline (164) and 7, 8, 9, 10-
tetrahydro- s-triazolo[3, 4-aphtha1azine (165). 
Method-A. Alumina chromatography (eluant ethyl acetate-ether, 3:2) 
gave the two title products. 
6, 7, 8, 9- Tetrahydro- s - triazoio{4,3-bjcinnoline (164) was recrystallis ed 
from n-hexane to give white needles (20%),  m. p.95-97°  (1it 30 m. p.  1200); 
i. r., 1 	3140, 1525, 1485, 1425, 1340 and 800 cm '; 'H n. m. r. 
max 
(60 MHz), 6 1. 90 (m, 2H, 7-H and 8-H), 2.95 (m, 2H, 6-H and 9-H), 
7.70 (bs, 1H, 10-H) and 8.90 (s, 1H, 3-H) (Found: C, 61-88; H, 5.79; 
173 
N, 32.47; M+,  174.090423. C 9H10N4 requires C, 62.07; H, 5.72; 
N, 32.17; M, 174. 090542). 
7,8,9, 10- Tetrahydro- s -triazolo[3, 4-alphthalazine (16 5) was recrystallised 
from n-hexane to give white crystals (60%),  m. p.  157-1590 ; i. r. '( max 
3140, 1620, 1545, 1500, 1450, 1430, 1405, 1345 and 775 cm '; 1H n. m. r. 
(60 MHz), 5 1.92 (m, 21-i, 8-H and 9-H), 2.90 (m, 2H, 7-H and 10-H), 8.02 
(s, 1H, 6-H) and 8.97 (s, 1H, 3-H) (Found: C, 61.95; H, 5.80; N, 32.18; 
M+, 174. 090761. C9H10 N4 requires C, 62. 07; H, 5. 72; N, 32. 17%; 
M 174. 090542). 
Method-B. 6.7.8. 9-Tetrahydro-s-triazolo{4, 3-bicinnoline (164) was 
obtained in 15% yield. 
9.6. xv 6, 7, 8. 9-Tetrahydrotetrazolo{1, 5-aJquinazoline  (293). 
Method-A. 6, 7, 8, 9- Tetrahydrotetrazolo[1, 5-aquinazoline (293) 
crystallised directly from the reaction mixture, further recrystallisation 
o 	149b 
from ethanol gave white crystals (73%), m. p.  121-123 (lit. 	M. P. 
122-123°); i. r. , y 
max 	3 
2145 (-N ), 1625, 1545, 1510, 1450, 1435, 1420, 
1365, 1355 and 775 cm '; 'H n.m. r. (60 MHz), 6 2.07 (m, 2H, 7-H and 
8-H), 3. 15 (m, 2H, 6-H and 9-H) and 8.65 (s, 1H, 5-H) (Found: C, 54. 95; 
H, 	5. 10; N, 40. 17; M+,  175. 083652. C 
8 
 H 
9 N 5 
requires C, 54. 82; 
H, 5. 18; N, 39. 99; M, 175. 085742). 
9. 6.xvi 1, 2, 3,4-Tetrahydrobenzimidazo[2, 1-biguinazoline  (294). 
Method-A. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from acetone gave yellow needles of 1, 2, 3, 4-tetrahydro-
benzimidazo[2, 1-bjquinazoline (294) (51%), m. p. 228-230°; i. r., 1 max 1640, 
16 10, 1585, 1515, 1490, 1450, 1435, 1425, 1410, 1360, 760 and 730 
cm '; 'H n. m. r, (60 MHz), 6 1. 86 m (m, 2H, 2-H and 3-H), 2.90 
(m, 2H, 1-H and 4-H), 7.15-7.95 (m, 4H, 7-H, 8-H, 9-Hand 10-H) 
and 8.20 (bs, 1H, 12-H) (Found: 75.42; H, 5.91; N, 18. 79; M+, 
223. 112482. 	C 14H13N3 requires C, 75. 30; H, 5.87; N, 18. 33%; 
M, 223.110942). 
Method-B. 	1, 2, 3,4-Tetrahydrobenzimidazo[2, l -b]quinazoline (294) 
was obtained in 75% yield. 
9. 6. xvii 7, 8- Dihydro-6H-cyclopenta[el- s-triazolo[1, 5-a1pyrimidine 
(297) and 6, 7-dihydro-5H-cyclopenta[d]-s- triazolo[1, 5-a]pyrimidine (303). 
Method-A. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from petroleum -ether (100-120°) gave white needles 
of 7, 8-dihydro-6H-cyclopenta[el-s -triazololl, 5-alpyrimidine (297) (72%), 
m. P. 121-122; i. r. , y max 1625, 1545, 1510, 1455, 1425, 1400, 1350, 
and 770 cm '; 'H n.m. r. (60 MHz), 6 2.45 (m, 1H, 7-H), 3.35 (m, 2H, 
6-H and 8-H), 8.42 (s, 1H, 2-H) and 8.65 (s, lH, 5-H) (Found: C, 60. 28; 
H, 	5. 14; N, 34. 78; M+,  160. 074003. C 
8 H 8 N 4 
 requires C, 59. 97; 
H, 5.04; N, 34.99%; M, 160. 074892). 
Method-B. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from n-hexane gave white crystals of 6, 7-dihydro-5H-
cyclopenta[d]- s -triazolo{l, 5-alpyrimidine  (30 3) (61 %), m.  p.  207-208° 
(lit. 	m. p.  207-208°); 1. r., I max 1660, 1645, 1525, 1435, 1415, 1410 
and 775 cm '; 'H n.m. r. (60 MHz), 6 2.35 (m, 1H, 6-H), 3.15 (m, 2H, 
5-H and 7-H), 8.40 (s, 1-H, 2-H) and 8.65 (bs, lH, 8-H) (Found: C, 
59. 84; H, 5. 01; N, 35. 20; M+,  160. 073182. C 
8  H 8 N 
 4 requires C, 
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59. 97; H, 5. 04; N, 34. 99%; M, 160. 074892). 
9. 6. xviii 2-Methylthio-7, 8-dihydro-6H-cyclopenta{el- s-triazolo[1, 5-a]-
pyrimidine (298) and 2-methylthio-6, 7-dihydro-5H-cyclopenta[d]-s-
triazolo[1, 5-a]pyrimidine (304). 
Method-A. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from methanol gave white crystals of 2-methylthio-7, 8-
dihydro-6H-c yclopenta[eJ- s-triazolo[1, 5-a]pyrimidine (298) (81% ), m. p. 
128-1290; i. r. , Y 
max 
 1610, 1560, 1500, 1415, 1350 and 765 cm '; 'H 
n.m. r. (60 MHz), 6 2.35 (m, lH, 7-H), 2.68 (s, 3H, 2-SCH3), 3.20 
(m, 2H, 6-H and 8-H) and 8.45 (s, 1H, 5-H) (Found: C, 52.24; H, 4.80; 
N, 27. 14; M+,  206. 061356. C 9H10N4S requires C, 52.41; H, 4.89; 
N, 27.81%; M, 206. 062615). 
Method-B. Alumina chromatography (eluant ethyl acetate)followed by 
recrystallisation from methanol gave white lusterous crystals of 
methylthio-6, 7-dihydro-5H-cvclopentald}- s-triazololl. 5-alDvrimidine 
(3 04) (51%),  m. p.  154-157°; i. r. , 1635, 1515, 1435, 1420, 1360, 1350 
and 765 cm '; 'H n.m. r. (60 MHz), 6 2.28 (m, 1H, 6-H), 2.68 (s, 3H, 
2-SCH3), 3. 10 (m, 2H, 5-H and 7-H) and 8.42 (dd, 1H, 8-H) (Found: 
C, 52. 20; H, 4. 90; N, 27. 10; Mt 206. 062296. C 9H10N4S requires 
C, 52.41; H, 4.89; N, 27. 18%; M, 206. 062615). 
9. 6. xix 3-Cyano- 7, 8-dihydro-6H-cyclopenta[e]pyrazolo[1, 5-a]pyrimidine 
(299) and 3-cyano-6, 7-dihydro-5H-cyclopenta[d]pyrazolo[l, 5-a]pyrimidine 
(305). 
Method-A. Alumina chromatography (eluant chloroform) followed by 
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recrystallisation from methanol gave white crystals of 3-cyano-7, 8-
dihydro-6H-cyclopenta{e}pyrazolo[1, 5-apyrimidine (299) (67%), M. P. 
1471490; i. r., 1 
max 
 2220 (CN), 1625, 1550, 1530, 1480, 1425 and 750 cm '; 
'H n.m. r. (60 MHz), 5 2.48 (m, 1H, 7-H), 3.35 	(m, 2H, 6-H and 8-H), 
8.40 (s, 1H, 2-H) and 8.65 (s, 1H, 5-H) (Found: C, 65. 19; H, 4.40; 
N, 30.81; M+,  184. 073050. 	C 10H8N4 requires C, 65.19; H, 4. 38; 
N, 30.43%; M, 184. 074892). 
Method-B. The following two products were obtained. 
3-Cyano-7, 8-dihydro-6H-cyclopenta[elpyrazolo[1 , 5-alpyrimidine (299) 
(17%). 
3-Cyano-6, 7-dihydro- 5H-cyclopenta[dlpyrazolo[1 , 5-alpyrimidine (305) 
(58%), m. p.  148-1500 ; i. r., 1 max 
 2220 (CN), 1645, 1565, 1525, 1460, 
1440, 1420, 1405 and 755 cm '; 'H n.m. r. (60 MHz), 6 2.30 (m, 1H, 
6-H), 3.08 (m, 2H, 5-H and 7-H), 8. 26 (s, 1H, 2-H) and 8. 50 (dd, 1H, 
8-H) (Found: C, 64.99; H, 4 37; N, 30.56; M+,  184. 073703. 
C 10H8N4 requires C, 65.19; H, 4.38; N, 30.43%; M, 184. 074892). 
9. 6. xx 7, 8-Dihydro-6H-cyclopenta[dl - s-triazolol4, 3-bipyridazine (300). 
Method-A. Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from benzene gave white crystals of 7, 8-dihydro-6H-
cyclopenta{dl -s- triazolo{4, 3-bpyridazine (300) (60%),  m. p.  139-1400; 
i. r., 1 	3140, 1545, 1510, 1445, 1420 and 780 cm 
1; '
H n. m. r. 
max 
(60 MHz), 5 2.35 (m, 1H, 7-H), 3.00 (m, 2H, 6-H and 8-H), 7.85 (bs, 
1H, 9-H) and 9.00 (s, 1H, 3-H) (Found: C, 59.86; H, 5.03; N, 35.00; 
M+, 	160. 074115. C 
8 H 8 N 4 
 requires C, 60. 00; H, 5.00; N, 35. 00%; 
M, 160. 074892). 
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9. 6. xxi 3-Cyano-5, 6, 7, 8-tetrahydrop,rrazolo[5, 1-b]quinazolin-9-ol 
(295, R=OH). 
3 -Amino -4-cyanopyrazole (126) (0.75 g. 7.x 10 3mole) and 2-
carbethoxycyclohexanone (125) (1. 2 g, 7 x 10 3mole) were ref1wed 
together in glacial acetic acid (30 ml) for 4 h. During refluxing, the 
product crystallised out as fine yellow needles. After cooling the reaction 
mixture, the crystals were filtered, washed with glacial acetic acid, dried 
to give 3-cyano-5, 6, 7, 8-tetrahydropyrazolo[5, 1-blguinazolin-9-ol  (295, 
ROH) (1.02 g, 75%), m. p.  >3100; 1. r., ' max 2220 (CN), 1680, 1640, 
1585, 1500, 1460, 1375, 750 and 705 cm '; 'H n. m. r. (100 MHz), 
5 1.90 (m, 2H, 6-H and 7-H), 2.50 (i-n, 2H, 5-H and 8-H), 8. 25 (s, 1H, 
2-H) and 13.05 (bs, 1H, NH) (Found: C, 61.95; H, 4.69; N, 25.92; 
M+, 214.087158. C11H10N40 requires C, 61.66; H, 4.71; N, 26.16; 
M, 214, 085456). 
9.6. xxii 9-Chloro-3-cyano-5, 6, 7, 8-tetrahydropyrazolo[5, l-bquinazoline 
(295, R=C1). 
A solution of 3-cyano-5, 6, 7, 8-tetrahydropyrazolo[5, 1-b]quinazolin-9-
ol (295, ROH) (0.64 g, 3 x 10 3mole) in phosphoryl chloride (30 ml) was 
boiled for 3 h and the excess of phosphoryl chloride was removed under 
vacuo. Ice was added to the residue, and the solution was neutralised 
with ammonium hydroxide. The brown precipitate was collected, washed 
with water, dried and 'purified by chromatography over alumina (eluant 
ethyl acetate). Recrystallisation of the eluate from petroleum-ether (60-
800) gave white needles of 9-chloro-3-cyano-5, 6, 7, 8-tetrahydropyrazolo-
[5, l-bjquinazoline (295, RC1) (0. 57 g, 64%), m. p.  139-1400; i. 
178 
Y max 2220 (CN), 1610, 1540, 1475, 1415, 1380 and 730 cm- '; 'Hn.m.r. 
(60 MHz), 6 1.97 (m, 2H, 6-H and 7-H), 3. 05 (m, 2H, 5-H and 8-H) 
and 8. 35 (s, 1H, 2-H) (Found: C,56. 87; H, 4. 13; N, 23. 89; M+, 
232. 051570 and 234. 048200. C 11H9N4C1 requires C, 56. 77; H, 3.87; 
N, 24, 08%; M, 232. 051350 and 234, 048200). 
9. 6.xxiii 3-Cyano-5, 6-7, 8-tetrahydropyrazolo[5, 1-b]quinazoline (291). 
A solution of 9-chloro-3-cyano-5, 6, 7, 8-tetrahydropyrazolo[5, 1-b]-
quinazoline (295, R=C1) (0.464 g, 2 x 10 3mole) in absolute alcohol (30 
ml) was dehalogenated by shaking with hydrogen and 5% palladium on 
carbon catalyst (0. 7 g). Recrystallisation of the crude product from 
methanol gave white crystals (0. 217 g, 55%), m. p. 110-1120 alone or 
mixed with a specimen prepared from 2-hydroxym ethyl enecyclohexanone 
(123), 
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10 	Reaction mechanism of the condensation of steroidal -keto- 
aldehydes with aminoazoles 
10. 1 	Anil formation. 
It has been shown 152 with the help of 1H n. m. r. spectroscopy 
that 2-formyl-3-oxo steroids (308) exist predominantly in the enolic forms 
(b and c). However, the i. r. spectra of 2-formyl-3-oxo steroids (without 
a L double bond) do exhibit an absorption of medium intensity around 
1700 cm '  which can be attributed to the formyl keto form (a). Consequently 
two mechanisms for anil formation are shown in schemes 4 and 5. 
Scheme 4 illustrates the conventional nucleophilic addition reaction 
to the formyl group followed by elimination of water and rearrangement 
to yield the most stable enaminone form (310). 
The mechanism shown in scheme 5 indicates 1,4-addition of the 
nucleophile to the conjugated carbonyl group followed by elimination of 
water to yield the same enaminone (310). Overall the reaction is seen 
as a displacement of the hydroxyl group from the enol by the incoming 
nucleophile. A similar mechanism has been observed 
153 
 during the 
formation of ethyl 2 -cyano-3 -anilinoacryloyl-c arbamate (313) from ethyl 
2-c yano-3 -ethoxy- ac ryloyl-c arbamate (3 12) and aniline in cold ethanol, 
where the anilino group has displaced an ethoxy group. The formation 
of ethyl N(2-pyr idyl) -aminomethylene -cyanoac etate (315) by the reaction 
of ethyl ethoxymethylene cyanoacetate (314) and 2-aminopyridine has also 
been reported. 154 
The reason for the condensation of the aminoazole (277) taking 
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carbon atom of the formyl group is more electropositive. This difference 
in reactivity reflects the relative number of inductive effects of neigh-
bouring carbon atoms. A possible reason which might be considered to 
explain this observed order of reactivity is the extra steric hindrance 
which would be encountered in the formation of an intermediate of type (316) 
as compared with the intermediates (3 09) and (311). However, this is 
not considered to be a very likely explanation since the products (154) and 
(156) arise from the reaction of 4-amino-i, 2, 4-triazole (83) with 2-
hydroxymethylene-3-oxo steroids (108) and (110) respectively, where the 
relevant tetrahedral intermediates at carbon-3 are seen to be even more 
steric ally demanding. Again, the formation of the linearly fused products, 
5a-c hole stano[3, 2-f]pyrazolo[1, 5-a]pyrimidine (181), 5a-c hole stano[3, 2-f]_ 
s-triazolo{1, 5-a]pyriniidine (220) and 5a.-cholestano[3, 2-b]benzimidazo[l, 2_a]-
pyrimidine (274) from the condensation of 2(2'-pyr idyl -aminomethylene)-
5a.-cholestan-3-one (207) and the corresponding aminoazoles shows that 
the aminoazole can indeed react with the 3-carbonyl group. 
The formation of the 13-ketoanil (310) is in accord with the 
observations that (i) 2(2-benzoylethylideneamino)-5- phenyl - s -triazolo[i, 5-
a]pyrimidine (317) was isolated as a by-product during the reaction of 
3, 5-diamino- 1, 2, 4-triazole and P, p_dimethoxypropiophenoneôZd and 
(ii) the reaction of 4- amino- 5 -c arbethoxyimidazole with 4, 4-dimethoxy-
butan-2-one (279) yields the intermediate (248) which has been isolated 
and characterised by i. r. and 'H n. m. r. spectroscopy. 
130 
 Finally the 
condensation of an aminoazole with the aldehydic carbonyl group in steroidal 
3-ketoaldehydes is justified by the isolation of the 13-ketoanils (247), (249) 
and (252) during the reaction of 16-hydroxymethylene-17-oxo steroids with 
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10. 2 	Mechanism of cyclization of the 2(2'-azolyl-aminomethylene)- 
3-oxo system. 
It was noted earlier (sections 4-8) that the condensations of 
aminoazole s with 2 -hydroxymethylene -3- oxo steroids lead to linearly 
and/or angularly fused products. Schemes 6 and 7 show the mechanisms 
by which 2(2-azolyl-aminomethylene)-3-oxo steroids may cyclize to 
afford linearly fused and angularly fused steroids respectively. 
In the me chanism shown in scheme 6 rotation about the C-N bond 
must occur whilst the molecule is in enaminone form (310) so as to bring 
the azole ring nitrogen into the proximity of the carbonyl group. This 
involves the destruction of the hydrogen bonded six membered ring with 
the associated loss of free energy. 	Cyclization then occurs through 
the formation of a bond between the azole ring nitrogen and the carbon-3 
of the steroid followed by loss of a molecule of water to give the aromatic 
system (318). The same mechanism can be used to explain the formation 
of the angularly fused products (319) which are obtained from the reaction 
of 1 6-hydroxymethylene -17- oxo steroids and 3-amino-1, 2, 4-triazole s 
and 3-aminopyrazoles, in these particular syntheses the primary conden-
sation products (247), (249) and (252) are isolated. 
Scheme 7 illustrates the mechanism which allows the formation 
of linearly fused condensation products. A second molecule of the 
aminoazole (277) is shown to attack the residual 3-carbonyl group to 
give the bisanil (320) which then spontaneously cyclises with the displace-
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Support for the intermediate (320) comes from the reaction of 
4-amino-1, 2, 4-triazole (83) with 2-hydroxymethylene-3-oxo steroids 
(108) and (110) where the bisanils (154) and (156) were isolated as the 
sole products in high yields (section 4). Again, the overall mechanism 
shown in scheme 7. is supported by the formation of high yields of linearly 
fused products (181), (220) and (274) from the reactions of various amino-
azoles with the independently prepared enaminone 2(2'_pyr idyl -amino.-
methylene)-5a-chole stan-3-one (207). These syntheses clearly indicate 
that the amine which first functionalises the formyl carbonyl group becomes 
the leaving group in the final stage of cyclisation. 
10.3 	The formation of 4_oxo_173_acetoxy-5-androst-2-eno[2,3-g]- 
tetrazolo[l, 5-a]pyrimidine (265a). 
It was noted in section 7 that acetylation of 173-hydroxyandrost-4-
eno[3, 2-f]tetrazolo[1, 5-a]pyrimidine (263a) using acetic anhydride in 
pyridine gave 4-oxo- 173-acetoxy-5 -androst-.2-eno[2, 3-g]tetrazolo[1,5-a]-
pyrimidine (265a) as the unexpected product along with the normal 1713-
acetyl derivative (264a). A possible mechanism for the formation of the 
compound (265a) is illustrated in scheme 8. The primary acetylation 
product becomes protonated at the 4'-nitrogen and an acetate ion, which 
is produced by the reaction of pyridine with acetic anhydride attacks the 
potential electrophilic centre carbon-5 in the intermediate (322) to give 
the 5.-acetoxy derivative (323). The reaction of pyridine with the 
intermediate (323) results in fission of the tetrazole ring to give the 
intermediate (324) which could exist in equilibrium with the tautomeric 
intermediate (325). Loss of a proton from carbon 4 and a pyridine 
H 
p25% (b) 
75 % (c) 
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CH3  
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molecule followed by recyclisation of the tetrazole ring leads to the 
enol acetate (326) which in acidic conditions undergoes hydrolysis and 
rearrangement to afford the product (265a). 
It is interesting to note that acetylation of 17-hydroxyandrost-
2, 4-dieno[2, 3 -g]pyrazolo[l, 5-a]pyrimidine (191) and 17f3-hydroxyandrost-
2, 4-dieno[2, 3- g]-2 '-methylthio-s-triazolo[l, 5-a]pyrimidine (237) gave 
only the expected 173-acetyl derivatives (194) and (239) respectively. 
These observations indicate that the tetrazolo- azidopyr imidine equilibrium 
is responsible for the formation of the 4-oxo- steroid (265a). 
10.4 A correlation between f3-dicarbonyl structure and condensation 
products. 
It can be seen by comparing sections 4-8 with section 9 that the 
reaction of aminoaz ole s with 2-hydr oxymethylene -3.- oxo steroids and 2-
hydroxyrnethylenecyclohexanone yields the same type (linear and/or 
angular) of products whilst the reaction of aminoazoles with 2-hydroxy-
methylene- 
4_3 
 -oxo steroids and 16-hydroxymethylene- 1 7-oxo steroids 
proceeds in a manner analagous to the condensation of arriinoazoles with 
Z-hydroxymethylenecyclopentanone. This correlation can best be 
explained as follows. 
It has been shown 155 that the direction of enolisation of cyclic f3-
ketoaldehydes is strongly dependent upon structure and the trends may be 
rationalised in terms of the strain in double bonds (Tr strain). The 
application by Bhacca and Williams 152 of the method devised by Gabrish'55  
1 
to the H n. m. r. spectrum of 17-hydroxy-2-hydroxymethylene-17cv- 
methyl-5a-androstan-3 -one (108), determined in deuterated chloroform, 
184 
showed that the steroid (108) is greater than 99% enolised and exists 
as a mixture of 22% hydr oxymethylene -ketone (c) and 78% formyl-enol 
(b). This is consistent with the observation that tautomers with double 
bonds in six membered rings are, in general, favoured in comparison 
with those with semicyclic double bonds. 
156 
 Similarly 2-formylcyclo-
hexanone has been shown 
157 
 to exist to the extent of more than 99%  in 
the enol form, 24% hydroxymethylene-ketone (c) and 76% formyl-enol (b). 
2-Formylcyclopentanone (124) has likewise been shown 
157 
 to be 
only 89% enolised, in the proportion 22% formyl-enol (b) and 78% hydroxy-
methylene-ketone (c). The application by Huynh and Julia '58 of the 
method devised by Gabrish155 to the 'H n. m. r. spectrum of 2-hydroxy-
methylenechole st-4-en-3 -one (112), determined in deuterated chloroform 
solution, showed that the steroid existed in solution as a mixture of 75% 
hydroxymethylene-ketone (c) and 25% formyl-enol (b). The chemical 
shifts for the ?!aldehydic  protons in 2 -hydr oxymethylenec hole st-4- en- 3 - 
one (112) and 17p-hydroxy-2-hydroxyrnethyieneandrost-4-en-3-one (4) 
are identical and thus it is reasonable to assume that the equilibrium 
between the hydr oxymethylene -ketone and formyl-enol tautomers is the 
same in both steroids. The equilibrium between the two tautomeric forms 
in 1 7-hydroxy- 2-hydroxymethyleneandrost-4-en-3- one (4) is thus the 
same as that observed for the simple formyl ketone (124) whereas a con-
verse ratio is observed in the equilibrium between the tautomers of l 71 -
hydroxy-2-hydroxymethylene-l7ct-methyl-5a-androstan-3-one (108). 
This difference is due to the stability conferred on the hydroxymethylene-
ketone tautomer by the A double bond. 
Thus it can be seen that a similarity in the initial composition 
of the mixture of the tautomeric forms (b and c) at equilibrium correlates 
well with the observed similarities in the type of products obtained by 
the condensation of an aminoazole with a 3-dicarbonyl compound. It is 
not however possible to predict the structure (linear or angular) of the 
specific condensation product from the initial composition of the tautomeric 
forms of the 3-dicarbonyl compound since the final outcome of any 
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11 	The reaction of steroidal a.-bromo ketones with 2-mercatto 
imidazoles and 3-mercapto-1, 2, 4-triazoles. 
11. 1 	The reaction of 2a-bromo-5a-cholestan-3-one (118) with 2-mercapto 
imidazole (128). 
A solution of 2a-bromo-5ct-cholestan-3-one (118) and 2-mercapto-
imidazole (128) was refluxed in absolute alcohol for 24 h. The reaction 
mixture was concentrated under vacuo, diluted with water and neutralised 
with 28% ammonium hydroxide solution. The white precipitates formed 
were filtered, washed with water and dried. Alumina chromatography of 
this white solid gave two products, (327), m. p.  205-2070, in 26% yield and 
(328), m. p. 150-151°, in 35% yield. 
Mass spectrometry and elemental analysis of the first product, 
m. p.205-207°  showed that it had a molecular formula of C30H46N2S. 
The i. r. spectrum exhibited absorptions at 1465, 1440 and 1380 cm 
whilst the 
I 
 H n. m. r. spectrum showed a singlet at 6 7. 25 corresponding 
to two protons apart from the signals for the methyl groups. 
Mass spectrometry and elemental analysis of the second product, 
m. p.  150-151°  indicated that it had a molecular formula of C32H52N2OS. 
The i. r. spectrum showed absorptions at 1495, 1460, 1445, 1365, 1065 
and 905 cm whilst the 'H n. m. r. spectrum exhibited a singlet at 6 7. 05 
(2H), a doublet of doublets at 6 4. 02 (1H) and a quartet at 6 3. 35 (2H), 
apart from the signals for the methyl groups. 
11.2 Discussion 
The reaction of 2-mercaptoimidazoles with a-halo ketones as 
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which on dehydration give imidazo{2, 1-b]thiazoles (107). Since the i. r. 
spectrum of the first steroidal condensation product, m. p. 205_2070, shows 
no carbonyl absorption, the product was assigned structure, 5a-cholest-2-
eno[2, 3-b]imidazo[2, l-b]thiazole (327), consistent with the molecular 
formula C30H46N2S. In the 'H n. m. r. spectrum, both the protons 5'-H 
and 6-H were found to have the same chemical shift, 6 7.25. 
The molecular formula, C32H52N20S of the second product, m. p. 
150-151 
0 
 indicates that it differs from the molecular formula of 5a-cholest-
2-eno[2, 3-b]imidazo[2, 1-b]thiazole (327) by C 2H60. It appears that this 
steroid has been formed by the reaction of ethanol with the precursor (329a) 
of the first product (327). The possibility of a hydroxyl group or a carbonyl 
group in the second product is ruled out since, the 1. r. spectrum exhibits 
no absorption above 1495 cm '. The above evidence suggests that the 
steroid is 5ci._cholestano[2,3_b]_3p_ethoxy_2T,31 _dihydroimidazo[2, 1-b]-
thiazole (328). This structure is supported by 'H n. m. r. spectrum which 
exhibits a singlet at 6 7. 05 (5'-H and 61 -H), a doublet of doublets at 6 4. 02 
(2' -H) and a quartet at 6 3. 35 (3'-O-CH2-CH3). The triplet corresponding 
to the methyl protons of ethoxy group overlaps with the signals of the 
angular and side chain methyl groups of the steroid. 
It is known from the general reactions of a-bromo ketones with 2-
mercaptoimidazole that the initial product from the reaction of the steroid 
(118) with this reagent (128) will first be the S-alkylated product which may 
exist either in the acyclic form (329a) or the cyclic form (329b). De-
hydration of the intermediate (329b) leads to the fully aromatic system 
(327). However, if the intermediate (329a) reacts first with ethanol present 
in the reaction mixture, then hemi-ketal (330) results. Ring closure 
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(336) R=H 
(338) R=0H3 
of the ethoxy group precludes its elimination. 
The reaction of 2-mercaptoimidazole (128) with 16a-bromo-3-
methoxyoestra-1,3, 5(10)-trien-17-one (122) affords 16a-(imidazo-2-thiol)- 
3-methoxyoestra-1, 3, 5(10)-trien-17-one (331). 	The structure (331) is 
confirmed by the i. r. spectrum which exhibits absorptions at 1720 cm '  
(C=0) and 3300 cm (NH) and the 'H n. m. r. spectrum which shows signals 
at 5 0. 87 (s, 18-CH3 ), 5 3. 75 (s, 3-OCH3 ), 5 6. 66-7. 20 (m, 1-H, 2-H and 
4-H) and 5 7. 00 (s, 4-H and 5r_H)  and 5 7.70 (bs, NH). Intermediates of 
type (331) as previously remarked in the introduction (page 16) have been 
isolated and characterised and are shown to exist in acyclic and cyclic 
forms. 
Under analogous conditions, the condensation of 2a-br omo- 5a-chol 
-estan-3-one (118) with 2-mercapto-4, 5-diphenylimidazole (129), 2-
mercapto-4, 5-dihydroimidazole (332) and Z-mercaptobenzimidazole (333) 
gave 5a-chole st-2-eno[3, 2-b]-5', 6 '-diphenylimidazo[Z, 1 -b]thiazole (334) 
5a-cholest-2-eno[2,3-b]-51 , 6 -dihydroimidazo[2, l-b]thiazole (335) and 
5ci-chole st-2-eno[2, 3-b]thiazolo[3, 2-a]benzimidazole (336) respectively. 
92 
Mohan and Pajari have assigned structure (337), on the basis 
of 'H n.m.r. spectroscopy, for the product obtained by the reaction of 2-
mercapto- 5-methoxybenzimidazole and c hioroac etone. Since the methoxy 
group (in compound 337) and the methyl group (in compound 338) are both 
electron donating groups, the product obtained by the condensation of 2a-
bromo-5a-cholestan-3-one (118) and 2-mercapto-5-methylbenzimidazole 
(130) is by analogy assigned structure (338). 
Similarly the reaction of 2a-bromo- 173-hydroxy- 1 7a.-methyl-5a-




























mercapto-4, 5-dihydroimidazole (332), 4, 5, 6, 7-tetrahydrobenzimidazole 
(132), 2-mercaptobenzimidazole (333) and 2-mercapto-5-methylbenz-
imidazole (130) gave 173-hydroxy- 17a-methyl-5a-androst-2-eno[2, 3-b]-
5!, 6'-diphenyliniidazo[2, 1-b]thiazole (339), 17ç3-hydroxy- 17a-rnethyl-5a-
androst_2_eno[2,3_b]_51 ,6'-dihydroimidazo[2, 1-b]thiazole (340), 1713-
hydroxy- 17a-methyl-5a-androst-2-eno[2, 3-b]-5, 6, 7, 8-tetrahydrothiazolo-
[3, 2-a]benzimidazole (341), 173-hydroxy- 1 7ct-methyl-Sct-androst-2-eno-
[2, 3-b]thiazolo[3, 2-a]benzimidazole (342) and 1 713-hydroxy- 1 7a-methyl-
5a-androst-2-eno[2, 3-b]-6 '-methylthiazolo[3, 2-a]benzimidazole (343) 
respectively. 
The reaction of 2-mercaptoirnidazoles with 2a-bromo-1713-hydroxy-
androst-4-en-3-one (119) has also been studied. However, the products 
were obtained in relatively poor yield. Thus, the condensation of 2a-
bromo-1713-hydroxyandrost-4-en-3-one (119) with 2-mercaptoimidazole 
(128), 2-mercapto-4, 5-dihydroimidazole (332), 2-mercaptobenzirnidazole 
(333) and 2- merc apto- 5-methylbenzin-iidazole (130) afforded 1 73-hydroxy-
androst-2, 4-dieno[2, 3 -b]imidazo[2, 1 -b]thiazole (344), 1713-hydroxyandrost-2, 
4-dieno[2,3-b]-51 , 6'-dihydroimidazo[2, l-b]thiazole (345), 173-hydroxy-
androst.-2, 4-dieno[2, 3 -b]thiazolo[3, 2-a]benzimidazole (346) and l73-hydroxy-
androst-2, 4-dieno[2, 3-b]-6'-methylthiazolo[3, 2-a]benzimidazole (347) 
respectively. 
11.3 	The reaction of 2a-bromo-1713-hydroxy-17a-methyl-5a-androstan-3- 
one (117) with 2- mercapto-4-methyl-4, 5-dihydr oimidazole (131). 
A solution of 2o.-bromo-1713-hydroxy-17a-methyl-5a-androstan-3-

































-Chemical 	shifts 	of 	56 dihydroimidazo[2,1-b}thiazoles 
3-C 	5-C 	6-C 	7a-C 
(ppm.) 
3-CH 3 	5CH3  
 94-13 132-06 	52.33 	68-22 	168-31 1378 	22-44 
92.79 	130'75 	44.07 	58-84 	168-06 	1225 	- 
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alcohol was refluxed for 24 h. The reaction mixture was concentrated 
under vacuo, diluted with water and neutralised with 28% ammonium 
hydroxide. The white solid which precipitated was filtered and dried 
and recrystallised from ethanol to give white fluffy crystals (348), m. p. 
220-222°  in 42% yield. 
Mass spectrometry and elemental analysis of the product indicated 
that it had a molecular formula of C24H36N2OS. The 1. r. spectrum 
exhibited absorptions at 3570, 1635, 1555, 1435 cm '  whilst the 1H n. m. r. 
spectrum showed multiplets at 5 4. 05 (lH), 5 3. 80 (1H), 5 3. 18 (lI- and a 
doublet at 5 1. 35 (3H), apart from the signals for the 17-, 18- and 19-
methyl groups. 
11.4 	Discussion 
To establish the structure of the steroidal condensation product, 
the reaction of 2-mercapto-4-methyl-4, 5-dihydroimidazole (13 1) with 
chioroacetone, 
159 
 which can theoretically give two products (349) and (350), 
was reinvestigated. 
13 
 C N. m.r. spectroscopy shows that the product 
obtained by the above reaction has structure (350). The 13C-chemical 
shifts of the various carbons in the compounds (350) and (351) are given 
in Table 13. The compound (351) was prepared by the reaction of chioro-
acetone with 2 -mercapto-4, 5 -dihydroiniidazole (332). 
In the 
13 
 C n. m. r. spin-coupled spectrum of the compound (351), 
the carbons 3 and 7a are easily distinguished from the other carbons as 
they remain singlets. Since the bridgehead carbon is expected to have 
the largest relaxation time (lowest intensity peak), the down field signal 
at 168. 06 p. p. m. was assigned to 7a-C. The other down field signal at 
191 
130. 76 P. p. m. was therefore assigned to 3-C. The signal at 92. 79 p.p. m. 
was attributed to 2-C without ambiguity as 2-C appears as a doublet in 
the spin-coupled spectrum in contrast to 5-C and 6-C which appear as 
triplets. Out of the remaining two carbon resonances, the low field signal 
(58. 84 p. p. m. ) was assigned to 6-C whilst the high field signal (44. 07 p. p. m. ) 
was assigned to 5-C by analogy with the observation 
136 
 that in nitrogen 
heterocyclic compounds, the carbons bonded to ring nitrogens are deshielded 
and occur further downfield compared with the carbons bonded to bridgehead 
nitrogen s. 
In the 13C n. m. r. spectrum of the compound (350), the chemical 
shifts of 2-C, 3-C and 7a-C are easily assigned by comparing its spectrum 
with that of the compound (351). It is known 160 that replacement of a proton 
by a methyl group on a sp3 carbon causes the latter to become more 
deshielded by 6-10 p.  p.m. Consequently the shift of 58.84 p. p.m. in 
the compound (351) to 68.22 p. p.m. in its 6-methyl derivative (350) identifies 
this signal as arising from the 6-carbon. However, it is noticed that the 
chemical shift of the 5-C is also shifted down field by 8. 26 p. p. m. If the 
compound, however, had structure (349), this would mean that the carbons 
5-C and 6-C would have chemical shifts of 68.22 p. p.m. and 52.33 p. p. m. 
respectively. This possibility is ruled out since by substituting a hydrogen 
at 5-C in structure (351) by a methyl group, the chemical shift of 5-C could 
not be expected to increase by 24. 15 p. p. m. nor could the chemical shift 
of 6-C decrease by 6. 51 p. p.m. 
Further confirmation of structure (350) is based on an analogy with 
the work of Kcchergin and Shchukin 
90a
on the synthesis of 3-methyl-6-
phenylimidazo[2, 1-b]thiazole (352) in which the phenyl group at position 6 
H3  
Bj 








was established by an unambiguous synthesis. 
By analogy with the structure (350), the product obtained by the 
condensation of 2-mercapto- 4-methyl-4, 5.-dihydr oimidazole (131) and 
2a-bromo-173-hydroxy-17a-methy1_5a_androstan_3_one (117) is assigned 
structure (348). In the 1 H n. m. r. spectrum, the multiplet at  4. 05 was 
assigned to 6'-H, the two multiplets at 6 3. 18 and 3. 80 were assigned to 
two protons at 5T-C and the doublet at 6 1. 35 was attributed to 6'-methyl 
protons. 
11.5 The reaction of 2ct-bromo-173-hydroxy_17a_methy1_5a_androstan 
3-one (117) with 3-mercapto-1,2,4-triazole (133). 
A solution of 2a-bromo- 173-hydroxy- 1 7ct-methyl-5a-androstan-3-
one (117) and 3-mercapto-1, 2, 4-triazole (133) in absolute alcohol was 
refluxed for 24 h. The reaction mixture was concentrated under vacuo, 
diluted with water and neutrallised with 28% ammonium hydroxide. The 
white solid formed was filtered, dried and chromatographed over alumina. 
Elution with chloroform followed by recrystallisation of the eluate from 
ethanol gave white crystals (353), rn. p.  115-118°  in 23% yield. 
Mass spectrometry and elemental analysis showed that the product 
had a molecular formula of C22H31N3OS. The 1. r. spedium exhibited 
absorptions at 3590, 1465, 1440, 1420 and 1355 cm '  whilst the 'H n. m. r. 
spectrum showed a singlet at 6 8. 07 apart from the signals for the 17-, 
18- and 19-methyl protons. 
11. 6 	Discussion 
The reaction of 3-mercapto- 1, 2, 4-triazole (133) with an a-halo 
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ketone can theoretically lead to two products depending upon the mode of 
cyclisation. Therefore two structures (353) and (354) both consistent 
with the molecular formula C22H31N30S were proposed. The i. r. 
spectrum is not of much help in distinguishing the two structures. 
6-.Methylthiazolo[3, 2-b]-s-triazole (357) has been prepared by the 
reaction of 3-mercapto-1,2,4-triazole (133) and chloroacetone161  and by 
the cyclisation 3-(2-propynylthio)-1, 2,4-triazole (356) with sodium ethoxide.162  
However, the structure of the compound (357) was assigned without ambiguity 
by Tamura and co-workers, 
163 
 who prepared this compound in 90% yield by 
dehydroc yclisation with polyphosphor ic acid of 3-amino- 2-for mamido-4-
methylthiazolium mesitylenesulphonate (355) which in turn was readily 
obtained by the reaction of 2-formamidothiazole with O-mesitylenesulphonyl-
hydroxylamine. The analogous isomer, 5-methylthiazolo[2, 3-c]- s-triazole 
(359) has been obtained by the reaction of 2-hydrazino-4-methylthiazole 
with formic acid. 
161 
 Further, the two isomeric compounds (357) and (359) 
are distinguished by 'H n. m. r. spectroscopy. The triazole proton 3-H in 
5-methylthiazolo[2, 3-c]-s-triazole (359) is de shielded and occurs at a lower 
field (6 8. 60)161  in contrast to the triazole proton 2-H in 6-methylthiazolo-
[3, 2-b]-s-triazole (357) which occurs at 6 8. 13. 163 
Thus by analogy with the formation of 6-methylthiazolo[3, 2-b]-s-
triazole (357) by the reaction of chioroacetone with the thiol (133), the 
product obtained by the condensation of 2a-bromo-1713-hydroxy-17a-methyl-
5a.-androstan-3-one (117) and 3-mercapto-1,2,4-trIazole (133) is assigned 
structure (353). This structure is supported by the 1H n. m.r. spectrum 
in which the chemical shift (6 8. 07) of the triazole proton correlates well 
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Similarly the reaction of 2a-bromo-5ct-cholestan--3-one (118) 
with 3-mercapto-1,2,4-triazole (133) and 3-mercapto-5-methyl-1, 2, 4-
triazole (134) gave 5a-cholest-2-eno[2,3-f]thiazolo[3, 2-b]-s-triazole 
and 5a.-chole st-2-eno[2, 3_f]_2'_methylthiazolo[3, 2-b]- s-triazole 
respectively. However, under analogous conditions the reaction of 
16_a_bromo_3-methoxyoestra-1,3,5(10)trien-17-Ofle (122) with 3-mercapto-
1,2, 4-triazole (133) and its 5-methyl derivative (134) gave only 3-methoxy-
oestra- 1, 3, 5(10)trieno[16, 17_f]_173_ethoxy_5',61 _dihydrothiazolo[3,2_b]_ 
s-triazole (362) and 3-methoxyoestra-1, 3, 5(10)trieno[16, 17-f]-173-ethoxy-
2'-methyl-51 , 6_dihydrothiazolo[3, 2-b]-s-triazole (363) respectively. The 
structures of the products were identified by 'H n.m. r. spectroscopy. 
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11.7 	Experimental 
General procedure for the condensation reactions 
A solution of the steroidal a-bromo ketone (1 x 10 mole) and 
mercaptoazole (1.5 x 10 	mole) in absolute alcohol (40 ml) was refluxed for 
24 h. The reaction mixture was concentrated under vacuo, diluted with water 
and neutralised with 28% ammonium hydroxide. The white solid formed was 
filtered, washed with water and dried. The crude product was either directly 
recrystallised from a suitable solvent or chromatographed over alumina (40 g) 
before recrystallisation. 
11.7. i 	5a-Cholest-2-eno{2, 3-blimidazo[2, 1-b1thiazole (327) and 5c- 
cholestano[2, 3-bl-313-ethoxy-2',  3'_dihydro[2.  1-b1thiazole  (328). 
Source: 	2 a-Bromo- 5 a-cholestan- 3-one (118) and 2-mercaptoimidazole 
(1 28) 
General: Alumina chromatography (eluant ethyl acetate) followed by recrystal-
lisation of the eluate from ethanol gave white shining flakes of 5a-cholestano-
[2, 3-b]-3-ethoxy-2', 3'-dihydroimidazo[2, l-b]thiazole (328) (35%), m. p.  150- 
151 	
max 
0, i. r,, 1 	1495, 1465, 1455, 1365 and 1065 cm '; 'H n.m. r. (100 
MHz), 5 0. 62, 0.80 and 0. 90 (methyl groups), 3. 35 (q, ZH, 3'-O-CH2-CH3), 
4.02 (dd, lH, 2'-H) and 7.05 (s, 2H, 5'-H and 6'-H) (Found: C, 74. 77; 
H, 10. 27; N, 5.30; MtS,  480.406916. C 32H52N-OS requires C, 74. 94; 
H, 10. 23; N, 5.46%; M-S, 480.407944). 
Further elution of the column with chloroform followed by recrystallisation 
of the eluate from ethanol gave white crystals of 5a-cholest-2-eno[2, 3-b]- 
imidazo[2, 1-b]thiazole (3 27) ( 26 %), m. p.  205-207°; i. r. 	1 max 1465, 1440 
196 
and 1380 cm '; 'H n.m. r. (60MHz), 50. 70, 0.80, 0.87 and 0.92 
(methyl groups) and 7. 25 (s, 2H, 5'-H and 6'-H) (Found: C, 76. 69; 
H, 10. 00; N, 5.80; M+,  466. 338027 
	
C 30 H46N 2S requires C, 77. 19; 
H, 9.94; N, 6.00%; M, 466. 338155). 
11.7. ii 	16a-(Imidazo-2-thiol)-3-rnethoxyoestra-1, 3, 5(10)-trien-17- 
one (331). 
Source: 	16 a-Bromo-3-methoxyoestra- 1, 3, 5(10)trien- l7-one (122) 
and 2-mercaptoimidazole (128). 
16 a-(Imidazo- 2-thiol)- 3-methoxyoestra- 1, 3, 5(10)-trien-17-one 
(331) was recrystallised from ethanol to give white crystals (47%), m. p. 
150-153; i. r. , 	y 
max 
 3300 (NH), 1720 (C=O), 1605, 1575, 1520, 1500, 
1460, and 1380 cm '; 1H n.m. r. (60 MHz), 	5 0. 87 (s, 3H, 18-CH3), 
3. 75 (s, 3H, 3-OCH3), 6.60-7. 20 (m, 3H, 1-H, 2-H and 4-H), 7. 05 (s, 
2H, 4'-H and 5'-H) and 7.70 (bs, 1H, NH) (Found; 141 m/e 382. 
C 22H26N202S requires M, 382). 
11.7. iii 	5a-Cholest-2-eno[2, 3-bl -5', 6t_diphenylimidazol2, 1-b]- 
thiazole (334). 
Source: 	2a-Bromo-5a-cholestan-3-one (118) and 2-mercapto-4, 5- 
diphenylimidazole (1 29). 
General: Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from acetone gave white crystals of 5a-cholest-2-eno-
[2, 3-bl-5', 6'-diphenylimidazo[2, 1-b1thiazole  (334) (45%), m. p.  237-2390 ; 
i. r., y 
max 
 1600, 1500, 1465, 1440 and 1380 cm 
1; '
H n. m. r. (100 
MHz), 5 o. 64, 0. 79, 0. 82 and 0.88 (methyl groups) and 7.06-7.64 
(aromatic protons) (Found: C, 81.44; H, 8.62; N, 4.45; M+,  618. 399477. 
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C42H54N2S requires C, 81. 50; H, 8.80; N, 4. 56%; M, 618.400752). 
11. 7. iv 	5a-Cholest-2-eno[2, 3-bl-5',6'-dihydroimicjazo[2, 1-b1thiazole 
(335). 
Source: 	2a-Bromo-5 cz-cholestan-3-one (118) and 2-mercapto-4, 5- 
dihydroimidazole (128). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from ethanol gave fine brown crystals of 5a-cholest-
2- enol2, 3-bl-5', 6'-dihydroimidazo[2, l -blthiazole (335) (41%), m. p. 
211-213°; i. r., Y 
max 
 1640, 1560, 1440-1460, 1400 and 1380 cm '; 
'H n. m. r. (100 MHz), 5 0. 66, 0.80 and 0. 87 (methyl groups), 3.63 and 
4.12 (each s, 4H, 5'-H's and 6'-Hs) (Found: C, 76. 65; H, 10. 33; 
N, 5. 78; M+,  468. 3538764). C 30 H48N2S requires C, 76. 84; H, 10. 32; 
N, 5.98%; M, 468. 353804). 
11.7. v 	I 5a-Cholest-2-eno[2, 3-blthiazolo[3, 2-albenzimidazole  (336). 
Source: 	2 a-Bromo- 5 a-cholestan- 3-one (118) and 2-mercaptobenzimi- 
dazole (333). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from chloroform-ether gave a white solid of 5 a-cholest-
2- eno[ 2, 3-blthiazolo[3, 2-albenzimidazole (336) (47%); m. p.  250-252; 
i. r., y 
max 
 1480, 1465 and 1380 cm '; 1H n. m. r. (100 MHz), 5 0. 58, 
0. 68, 0.82 and 0. 90 (methyl groups) and 7. 14-7. 78 (aromatic protons) 
(Found: C, 78. 71; H, 9. 30; N, 5.43; M+, 516. 357110. C34H48N2S 
requires C, 79. 01; H, 9.37; N, 5.42%; M, 516. 353804). 
11. 7. vi 	5 a-Cholest- 2-eno[2, 3-bl-6 -methylthiazolo[3, 2-albenz- 
imidazole (338). 
Source: 	2a-Bromo-5a-cholestan-3-one (118) and 2-mercapto-5- 
methylbenzimidazole (130). 
General: 	Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from ethanol gave white crystals of 5 a-cholest- 2-eno- 
2, 3-bl -6 '-methylthiazolo[3, 2-albenzimidazole (338) (25%), m. p. 227-
229; 1. r., i max 1480, 1460, 1380 and 1270 cm '; 'H n.m. r. (100 
MHz), 60.66, 0.82 and 0.90 (methyl groups), 2.45(d, 3H, 6'-CH 3), 
6.94 and 7.48 (m, 3H, 5'-H, 7'-H and 8'-H) (Found: C, 79.05; H, 
9. 34; N, 5. 19; M+,  530. 370136. 
9.50; N, 5.28%; M, 530. 369453). 
C 35H50N2S requires C, 79.19; H, 
11.7. vii 	17J3-Hydroxy-17 a-methyl-5a-androst-2-eno[2, 3-bl-5', 6'- 
diphenylimidazo{2, 1 -bithiazole (339). 
Source: 	2a-Bromo-173-hydroxy-17a-methyl-5a-androstan-,3_one 
(117) and 2-mercapto-4, 5-diphenylimidazole (129). 
Recrystallisation of the crude product from acetone gave white 
crystals of 17-hydroxy- 17 a-methyl- 5 a-androst- 2- eno[ 2, 3-bl -5', 6'-
diphenylimidazo[2, 1-bithiazole (339) (62%), m. p.  255-257%; i. 
1 
max 
 3570 (OH), 1590, 1495, 1465, 1455, 1435 and 1375 cm-1; 'H 
n.m. r. (60 MHz), 6 0.85 (s, 6H, 18-CH3 and 19-CH3), 1. 20 (s, 3H, 
17-CH3), 7.05-7.45 (m, 10H, aromatic protons) (Found: C, 78. 57; 
H, 7.39; N, 5.15; M+,  536.284862. C 35H40N 20S requires C, 78. 36; 
H, 7.52; N, 5.23%; M, 536. 286121). 
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11. 7. viii 	17!3-Hydroxy-17a-methyl-5a-androst-2-eno[2, 3-bl -5 1 , 6'- 
dihydroimidazo[2, 1 -bithiazole (340). 
Source: 	2a-Bromo-17P-hydroxy-17a-methyl.-5a-andros tan- 3-one (117) and 
2-mercapto-4, 5-dihydroimidazole (332). 
Recrystallisation of the crude product from benzene gave white 
crystals of 1 7-hydroxy- 17 a-methyl- 5 a-androst- 2-eno{2, 3-bl-5 l, 6 '-dihydro- 
imidazo[2, 1-b1thiazole  (340) (38%), m.p. 263-2650; 1. r. , 	 3590 
max 
(OH), 1645, 1565, 1445 and 1400 cm 
1; 	
'H n.m. r. (60 MHz), 	5 0.90 
(s, 	6H, 18-CH3 and 19-Cl-i3), 1. 25 (s, 3H, 17-CH 3)and 3.65-4. 25 (m, 
4H, 5'-H's and 6'-H's) (Found: C, 71. 28; H, 8.82; N, 7.02; M+, 
386. 238205. C23H34 N20S requires C, 71, 50; H, 8.88; N, 7, 26 %; 
M, 386. 239173). 
11.7. ix 	17-Hydroxy-17a-methy1-5a-androst-2-eno[2, 3-bl -5', 671, 8'- 
tetrahydrothiazolol3, 2-albenzimidazole  (341). 
Source: 	2 a-Bromo- 1 713  -hydroxy- 17 a-methyl- 5 a-andro stan- 3-one 
(117) and 2-mercapto-4, 5, 6, 7-tetrahydrobenzimidazole (132). 
Recrystallisation of the crude product from ethanol gave white 
crystals of l713-hydroxy-17a-methyl-5a-androst-2-eno[2, 3-bl-5', 6', q'  8'-
tetrahydrothiazolo[3, 2-a]benzimidazole (341)  (26%),. m. p.  285-2870; i. r., 
max 3570 (OH), 1625, 1460, 1440, 1390, 1375 and 1365 cm '; 'H 
n. m. r. (60 MHz), 5 0. 90 (s, 6H, 18-CH3 and 19-CH 3)and 1. 25 (s, 3H, 
17-CH3) (Found: C, 74. 18; H, 8.71; N, 6.21; M+,  438. 270369. 
C 27H38N20S requires C, 73. 97; H, 8. 74; N, 6. 39%;  M. 438. 270471. 
11. 7. x 	1713-Hydroxy- 17 a-mthyl-5 a-androst- 2- eno{ 2, 3-bithiazolo- 
[3, 2-a]benzimidazole (342). 
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Source: 	2a-Bromo-1713-hydroxy-17a-methyl-.5a-.androstan-3-one (117) 
and 2-mercaptobenzimidazole (333). 
Recrystallisation of the crude product from ethanol gave white 
crystals of 1 713-hydroxy-  17 a-methyl- 5 a-androst- 2- eno[ 2, 3-b1thiazolo-
[3, 2-albenzimidazole  (34 2) (52%), m. p.  224-2260; i. r. , y max 
 3590 
(OH), 1595, 1520, 1480 and 740 cm '; 'H n. m. r. (100 MHz), 6 0.90 
(s, 3H, 18-CH3), 0. 94 (s, 3H, 19-CH3), 1. 24 (s, 3H, 17-CH3) and 
7.42-7.98 (m, 4H, aromatic protons) (Found: C, 74,44; H, 7.80; N, 
6. 23; M+,  434. 2389164. C 27H34N20S requires C, 74. 65; H, 7.895; 
N, 6.45%; M, 434. 239173). 
11. 7. xi 	17P-Hydroxy-17a-m ethyl -5cz-androst-2-eno[2, 3-bl-6'- 
methylthiazolo[3, 2-albenzimidazole  (343). 
Source: 	2 a-Bromo -1 7 -hydroxy- 17 a-methyl-S a-andro stan- 3-one 
(117) and 2-mercapto-5-methylbenzimidazole (130). 
Recrystallisation of the crude product from benzene gave white 
crystals of 173-hydroxy-17a-methyl-5a-androst-2-eno[2, 3-bi- 6Lmethyl_ 
thiazolo[3, 2-albenzimidazole  (343) (49%); m. p.  158-160 
0 
 i. r., Y max 
3570 (OH), 1625, 1480, 1460, 1420, 1375 and 1365 cm 
1; '
H n. m. r. (60 
MHz), 0.90 (s, 6H, 18-CH3 and 19-CH3), 1.25 (s, 3H, 17-CH3), 2.45 
(s, 	3H, 6'-CH 
3) 
 and 6.85-7.50 (m, 3H, aromatic protons) (Found: 
C, 74. 78; H, 7.84; N, 5.96; M+,  448. 254856. C 28H36 N20S requires 
C, 75.00; H, 8.09; N, 6.25%; M, 448. 254823). 
11. 7. xii 	1 73- Hydroxyandro st- 2, 4- dieno[ 2, 3-blimidazo[  2, 1 -b]thiazole 
(344) 
Source: 	2 a-Bromo- 17-hydroxyandrost-4-en-3-one (119) and 2- 
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mercaptoimidazole (128). 
Recrystallisation of the crude product from acetone gave yellow 
crystals of j3-hydroxyandrost-2, 4-dieno[2, 3 -b]imidazo[2, 1 -b]thiazole 
(344) (18%), m. p. 158-1600; 'H n. m. r. (60 MHz), 5 0. 80 (s, 3H, 18-CH 3), 
1. 10 (s, 3H, 19-Cl-I3 ), 3. 63 (t, 1H, 17-H), 5. 97 (s, 1H, 4-H), 7. 20 and 
7.30 (each singlet, 2H, 5'-H and 6'-H) (Found:141 M+,  368. 189773. 
C 22H28N20S requires M, 368.192225). 
11. 7. xiii 	17-Hydroxyandrost-2, 4-dieno[2, 3-b]-5 1,6  '-dihydroimidazo- 
[2, 1-b1thiazole (345). 
Source: 	2a-Bromo-17-hydroxyandrost-4- en- 3-one (119) and 2-mer- 
capto-4, 5-dihydroimidazole (332). 
Recrystallisation of the crude product from ethanol gave a yellow 
solid of 173_hydroxyandrost-2,4-dieno[2,3-b]-51 ,6'-dihydroimidazo[2, 1-b]-
thiazole (345) (15%),  m.  p.  255-2570 (dec. ); 1. r. , 1 max 3560 (OH), 1620, 
1580, 1550, 1440 and 1420 cm; 'H n.m. r. (60 MHz), 5 0.80 (s, 3H, 
18-CH3), 1. 08 (s, 3H, 19-CH3), 3. 70 (m, 3H, 6'-H's and 17-H), 4. 15 
(m, 2H, 5'-H's) and 5.55 (s, 1H, 4-H) (Found: C, 71.58; H, 7. 96; 
N, 7.43; MtS,  338. 234517. C22H30N20S requires C, 71. 31; H, 8. 17; 
N, 7.57%; M-S, 338. 235801). 
11. 7. xiv 	173-Hydroxyandrost-2, 4-dieno[2, 3-b]thiazolo[3,2-a]- 
benzimidazole (346). 
Source: 	2a-Bromo-l7-hydroxyandrost-4-en-3-one (119) and 2-mer- 
captobenzimidazole (333). 
Recrystallisation of the crude product from a large excess of ethanol 
gave a brown solid of 1 7-hydroxyandrost-2, 4-dieno[2, 3-b]thiazolo[3, 2-a]- 
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benzimidazole (346) (27%),  m. p. 275-279; i. r. , Y max 3560 (OH), 1615, 
1470, 1460 and 1450 cm 
1; '
H n. m. r. (60 MHz), 60.85 (s, 3H, 18-CH 3), 
1. 15 (s, 3H, 19-CH3), 3. 73 (t, 1H, 17-H), 6.54 (s, 1H, 4-H), and 7. 20-
7.90 (m, 4H, aromatic protons) (Found: C, 74. 38; H, 7. 18; N, 6.53; 
M+, 418.206584. C 26 H30N20S requires C, 74.60; H, 7.23; N, 6.70%; 
M, 418, 207154). 
11. 7.xv 	1713-Hydroxyandrost-2,4-dieno[2, 3-bl-6'-methylthiazolo[3, 2-al- 
benzimidazole (347), 
Source: 	2a-Bromo-17-hydroxyandrost-4- en- 3-one (119) and 2- 
mercapto-5-methylbenzimidazole (130). 
Recrystallisation of the crude product from acetone gave a white 
solid of 1713-hydroxyandrost- 2, 4-dieno[2, 3-bl-6 '-methylthiazolo[3, 2-a 
benzimidazole (347) (22%), m. p.  245-247°; i. r.., 1 max 3560 (OH), 1610, 
1455 and 1360 cm 
1; '
H n. m. r. (60 MHz), 5 0.80 (s, 3H, 18-CH3), 
1. 10 (s, 3H, 19-CH3), 	2.50 (s, 3H, 6'-CH3), 3.68 (t, 1H, 	17-H), 6.45 
(s, 	1H, 4-H) and 6. 98-7. 75 (m, 3H, aromatic protons) (Found: C, 	74. 73; 
H, 7.40; N, 6.29; M+_S, 400. 247712. C 27H32N20S requires C, 75. 00; 
H, 7.47; N, 6.48%; M-S, 400. 251451). 
11.7.xvi 	173-Hydroxy-17a-methy1-5a-androst-2-eno12, 3-bl-6'-methyl- 
5',6'-dihydroimidazo[2, 1-b1thiazole  (348). 
Source: 	2a-Bromo-17-hydroxy-17a-methyl-5a-androstan-3-one (117) 
and 2-mercapto-4-methyl-4, 5- dihydroimidazole (131). 
Recrystallisation of the crude product from ethanol gave white 
crystals of 1 7f3 -hydroxy- 17 a-methyl- 5 a-androst- 2- enol 2, 3-bl -6  '-methyl-
5',6'-dihydroimidazo[2, 1-b1thiazole (348) (42%),  m.p. 220-2220 (dec.); 
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i. r,, y max 3570 (OH), 1635, 1555, 1435, 1395, 1375 and 1365 cm '; 
n. m. r. (60 MHz), 5 0.85 (s, 6H, 18-CH3 and 19-CH3), 1, 20 (s, 3H, 
17-CH3), 1, 35 (d, J6Hz, 3H, 6'-CH3), 3. 18 and 3, 80 (each m, 2H, 5'-
H's) and 4.05 (m, 1H, 6'-H) (Found: C, 71. 85; H, 9.55; N, 7. 10; 
M+, 400. 252081. C 24H36 N20S requires C, 71. 95; H, 9.57; N, 6.99%; 
M, 400. 252821). 
11. 7.xvii 17-Hydroxy-17a-methyl-5a-androst-2-eno{2, 3-f1thiazolo-
[3, 2-bi-s-triazole (353). 
Source: 	2a-Bromo- 173-hydroxy- 17 a-methyl-5 a-androstan-3-one (117) 
and 3-mercapto- 1, 2, 4-triazole (133). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from ethanol gave white crystals of 17-.hydroxy-17a-
methyl-5 a-androst- 2-eno{2, 3- fithiazolo[3, 2-bi -s-triazole (353) ( 23%), 
m. p.  115-118; i. r. , 1 max 
 3590 (OH), 1465, 1445, 1420, 1355 and 
1240 cm '; 'H n. m. r. (60 MHz), 5 0.90 (s, 3H, 18-CH3), 0.95 (s, 3H, 
19-CH3), 1. 23 (s, 3H, 17-CH 3)and 8. 07 (s, 1H, 2'-H) (Found: C, 68. 23; 
H, 7.95; N, 10. 66; M+,  385. 215538. C 22H31N30S requires C, 68. 53; 
H, 8. 11; N, 10. 99%; M, 385. 218773). 
11. 7. xviii 5 a-Cholest- 2- eno[2, 3-fithiazolo{3, 2-hi- s-triazole (360). 
Source: 	2a-Bromo-5a-androstan-3-one (118) and 3-mercapto-1, 2,4- 
triazole (133). 
General: Alumina chromatography (eluant chloroform) followed by 
recrystallisation from ethanol gave white needles of 5 a-cholest- 2- eno-
[2, 3-f]thiazolo[3, 2-bi-s-triazole (360) (32%), m. p.  188-190°; i. r. 
204 
max 1465, 1440, 1420, 1380 and 1355 cm '; 1H n.m. r. (60 MHz), 
6 0. 69, 0. 83 and 0.89 (methyl groups) and 8. 02 (s, 1H, 2'-H) (Found: 
C, 74. 31; H, 9.63; N, 8.70; M+,  467. 333948. C 29H45N3S requires 
C, 74,46; H, 9.70; N, 8.99%; M, 467. 333404). 
11. 7.xix 	5a-Cholest-2-eno[2, 3-fl-2'-methylthiazolol3, 2-bl-s- 
triazole (361). 
Source: 	2a-Bromo-5 a-cholestan- 3-one (118) and 3-mercapto- 5- 
methyl-i, 2,4-triazole (134). 
General: Alumina chromatography (eluant chloroform followed by -re-
crystallisation from methanol gave a white solid of 5a-cholest-2-eno[2, 3-
f1-2'-methylthiazolo[3, 2-bl-s-triazole (361) (37%), m. p. 117-120°; 
i. r. Y max 1470, 1440 and 1380 cm 
1; 1
H n.m. r. (100 MHz), 6 0,67; 
0,82, 0. 84 and 0.90 (methyl groups) and 2.48 (s, 3H, 2'-CH3) (Found: 
C, 74. 57; H, 9.81; N, 8.40; M+,  481. 348292. C30H47N3S requires 
C, 74.79; H, 9,84; N, 8.73%; M, 481. 349053). 
11. 7.xx. 	3-Methoxyoestra-1, 3, 5(10)-trieno{16, 17-fl-17 j3-ethoxy- 
5', 6'-dihydrothiazolo{3, 2-b-s-triazole (362). 
Source: 	16 a-Bromo-3-methoxyoestra- 1, 3, 5(10)-trien- 17-one (122) 
and 3-mercapto- 1, 2, 4-triazole (134). 
General: Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from methanol gave white crystals of 3-methoxyoestra-
1,3, 5(10)-trieno[16, 17-f-170-ethoxy--5', 6'-dihydrothiazolo[3, 2-bI - s --
triazole (362) (50%),  m. p.  195-197°; i. r., y max 
 1605, 1570, 1495, 
1475, 1450, 1420, 1380 and 1365 cm 
1; '
H n.m. r. (100 MHz), 6 0.52 
(s, 	3H, 18-CH3), 1.40 (t, 3H, l7-O-CH -CH 3), 3.12 (q, 2H, 17-O-CH2- 
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3. 72 (s, 3H, 3-OCH3), 4,50 (t, 1H, 5'-H), 6.60, 6.74 and 7, 20 
(m, 3H, 1-H, 2-H and 4-H) and 7. 90 (s, 1H, 2'-H) (Found: C, 67, 00; 
H, 7.06; N, 10.02; M+,  m/e 411. C23H29N302S requires C, 67. 15; H, 
7.11; N, 10.22%; M, 411). 
11.7.xxi 	3-Methoxyoestra -1, 3,5(10)-trieno[16 , 17-f1-173- ethoxy-2'- 
methyl-5T, 6'-dihydrothiazolo{3, 2-b]-s-triazole (363). 
Source: 	16 a-Bromo-3-methoxyoestra- 1, 3, 5(10)-trien-17-one (122) 
and 3-mercapto-5-methyl- 1, 2, 4-triazole (134). 
General: 	Alumina chromatography (eluant ethyl acetate) followed by 
recrystallisation from methanol gave white crystals of 3-methoxy-
oestra-1,3,5(10)-trienoll6, 17_fl_1713_ethoxy_21 _methyl_51 ,6t_dihydro_ 
thiazolo{3, 2-b]-s-triazole  (363) (49%), m. p.  193-1950; i. r. , 	max 
1605, 1570, 1500, 1430, 1380 and 1370 cm- '; 1Hn.m.r. (60 MHz), 
60.60 (s, 3H, 18-CH3), 1. 23 (t, 3H, 3'-O-CH2-CH3), 2.40 (s, 3H, 
2'-CH3), 3, 30 (q, 2H , 17-O-CH2 -CH 3) 3.75 (s, 3H, 3-OCH3), 4. 50 
(t, 1H, 5'-H) and 6.65-7. 30 (m, 3H, 1-H, 2-H and 4-H) (Found: C, 
67. 55; H, 7. 29; N, 9. 78; M+,  425. 214102. C 24H31N302S requires 
C, 67. 73; H, 7. 35; N, 9. 88%; M, 425. 213687). 
Ut) 
References 
1 	(a) C. D. Kockakian and J. R. Murlin, J. Nutrition, 1935, 10, 437; 
(d) C. D. Kockakian, Vitamins and Hormones, 1946, 4, 255. 
2 	G. F. Woods, Reports on the progress of Applied Chemistry, 
1968, 53, 229. 
3 	E. Eisenberg and G. S. Gordon, J. Pharmac. Exp. Theraa. , 1950, 
': 
4 	L. G. Her ,  schberger E. G. Shipley and R. K. Meyer, Proc. Soc. 
Exp. Biol. Med. , 1953, 83, 175. 
5 	H. L. Krushemper, Anabolic Steroids, Academic Press, New 
York, 1968, Chapter 1. 
6 	A. Boris, R. H. Stevenson, and T. Tramal, Steroids, 1950, 15, 61. 
7 	R. 0. Clinton, A. J. Manson, F. W. Stonner, H. C. Neuman, 
R. G. Christiansen, R. L. Clarke, J. H. Ackermann, D. F. Page, 
J. W. Dean, W. E. Dickinson, and C. Carabateas, J. Amer. Chem. 
Soc. , 1961, 83, 1478. 
8 	(a) G. 0 Potts, A. L. Beyler, and D. F. Burnham, Proc. Soc. 
Exp. Biol. Med., 1960, 103, 383; (b) A. Arnold, A. L. Beyler, 
and G. 0. Potts, Proc. Soc.Exp. Biol. Med. , 	1959, 102, 	184. 
9 	P. de Ruggieri, C. Gandolfi, and D. Chiaramonti, Gazz. Chim. 
Ital. , 1963, 93, 269. 
10 K. Morita, Japanese Patent 1436; 	Chem. Abst. , 1964, 60, 12083e. 
11 A. V. Kamernitskii, T. N. Galakhova, I. S. Levina, and B. S. E1'yanov, 
Izv. Akad. Nauk. U. S. S. R, Ser. Khim. , 1977, 10, 2374. 
12 	A. Arnold, G. 0. Potts, and A. L. Beyler, Acta-Endocrinol. 
1963, 44, 490. 
. 	207 
13 	A. G. Manson, F. W. Stonner, H. C. Neumann, R. G. Christiansen, 
R. L. Clarke, J. H. Ackermann, D. F. Dean, D. K. Phillips, 
G. 0. Potts, A. Arnold, A. L. Beyler, and R. 0. Clinton, 
J. Medicin. Chem._, 1963, 6, 1. 
14 	E. Marchetti and P. Donni, Gass. Chim.Ital. , 1961, 91, 1133. 
15. 	P. de Ruggieri, C. Gandolfi, and D.Chiaramonti, Gazz. Chim. 
Ital. , 1962, 92, 768. 
16 	(a) E. Caspi and D. M. Piatak, Canad. J. Chem. , 1963, 41, 2294; 
(b) E. Caspi and D. M. Piatak, Chem. and Ind. , 1962, 1984. 
17 	J. T. Pinhey, E. Rizzardo, G. C. Smith, Aust. J. Chem. , 1978, 
31, 113. 
18 	E. Merck A. -G, German Patent, 1158964; Chem. Abstr. , 1964, 
60, 9334g. 
19 	L. I. Klimova and N. N. Suvorov, Zh. Obsch. Khim. , 1964, 34, 1357. 
20 	H. Antaki and V. Petrow, J. Chem. Soc. , 1951, 901. 
21 	(a) J. M. Kraemer, K. Brueckner, K. Irmscher and K. H. Bork 
Ber. , 1963, 96, 2803; (b) N. J. Doorenbos and C. P. Dorn, 
J. Pharm. Sci. , 1962, 51, 414; (c) N. J. Doorenbos and C. P. Dorn, 
3.Pharm. Sci. , 1961, 50, 271. 
22 	J. A. Zederic, 0. Halpern, H. Carpio, A. Ruiz, D.C. Liman, 
L. Magano, H. Jimenez, A. Bowers, and H. J. Ringold, Chem. 
and Ind. , 1960, 1625. 
23 	P. G. Hotton and E. Nec oechea, J. Medicin. Pharmaceut.Chem. 
1962, 5, 1352. 
24 	J. A. Zederic, H. Carpio, A. Ruiz, D. C. Limon, F. Kincl and 
H. J. Ringold, J. Medicin. Chem. , 1963, 6, 195. 
Im 
25 	A. Bowers and J. Edwards, U. S. Patent, 3076801; Chem. Abstr. 
1963, 59, 12874e. 
26 	(a) K. Takeda and T. Komeno, Chem. Pharm. Bull. , 1960, 8, 468; 
(b) T. Yoneno, Japanese Patent, 12924; Chem. Abstr. , 1964, 
60, 640b. 
27 	(a) K. Takeda and T.Komeno, Chem. Pharm. Bull., 1962, 10, 1173; 
(b) T. Yoneno, U. S. Patent, 3119816; Chem. Abstr. , 1964, 60, 
10757h. 
28 	S. Katz, J. R. Broich and W. Metcalf, Metal. Clin. Exptl. , 1963, 
12, 68. 
29 	L. L. Smith and D. M. Teller, U. S. Patent, 337108; Chem. Abstr. 
1968, 69, 77625. 
30 	R. Rocchi, A. M. Bellini, G. Fornasini, and C. A. Benassi, 
Farmaco. Ed. Sc. , 1970, 25, 125. 
31 	L. L. Smith, D. M. Teller, and T. H. Foell, J. Medic in. Chem. 
1963, 6, 330. 
32 	P. de Ruggieri, C. Gandolfi, U. Guzzi, D. Chiaramonti, and 
D. Ferrari, Farmaco.Ed.Sci., 1965, 20, 280. 
33 	P. de Ruggieri and C. Gandolfi, Gazz. Chem. Ital. , 1965, 95, 338. 
34 	(a) H. J. Ringold and 0. Manc era, U. S. Patent, 3071577; Chem. 
Abstr. , 1964, 61, 4430g; (b) P. de Ruggieri and C. Gandolfi, 
U.S. Patent, 3114749; Chem. Abstr., 1964, 60, 5599g. 
35 	(a) P. de Ruggieri, C. Gandolfi, and U. Guzzi, Gazz. Chim. Ital. 
1966, 96, 152; (b) P. de Ruggieri, C. Gandolfi, and U. Guzzi, 
Gazz. Chim. Ital. , 1966, 96, 179. 
36 	P. de Ruggieri, C. Gandolfi, and U. Guzzi. Ann. Chimica, 1972, 
62, 71. 
209 
37 	V. Petrow and W. W. Starling, J. Chem. Soc., 1940, 60. 
38 	D. N. Kirk, D. K. Patel, and V. Petrow, J. Chem. Soc., 1956, 
627 and 1184. 
39 J. C. Sheehan, W. F. Erman, J. Amer. Chem. Soc. , 1957, 79, 6050. 
40 I. M. Heilborn, E. R. H. Jones, and F. S. Spring, J. Chem. Soc. 
1937, 801. 
41 P. Catsoulacos, J. Heterocyclic Chem. , 1973, 10, 933. 
42 P. Catsoulacos and N. 	Kyriakidis, J. Heterocyclic Chem. , 	1975, 
12, 757. 
43 	T. J. Bardos, Z. F. Chielewicz, S. P. Raman, Steroids, 1963, 
2, 105. 
44 	F. Yoneda., S. Tukazawa, and S. Nishigaki, Chem. Comm. , 1971, 83. 
45 	F. Yoneda, S. Tukazawa, and S. Nishigaki, Chem. Pharm. Bull., 
1972, 20, 1428. 
46 	G. Bouchan, E. Stark, H. Pech, and E. Breitmaier, Chem. Ztg., 
1973, 97, 509. 
47 	H. Pech, G. Bouchon, and E. Breitmaier, Chem. Ber., 1974, 107, 
1389. 
48 	G. Bouchon, H. Pech and E. Breitmaier, Chimia, 1973, 27, 212.- 
49 	H. Jochen, P. Hans, and B. Eberhard, Chem. Ztg. , 1973, 97, 658. 
50 	P. Catsoulacos and E. Souli, J. Heterocyclic Chem. , 1974, 11, 87. 
51 	G. A. Burgess, Ph. D. Thesis, University of Edinburgh, Scotland 
1976. 
52 	(a) H. Singh and K. K. Bhutani, Indian J. Chem. Sec. B. , 1978, 16, 
95; (b) H. Singh, K. K. Bhutani, R. K. Malhotra, and D. Paul, 
Experientia, 1978, 34, 557; (c) H. Singh and M. K. Biyani, Indian 
J. Chem. Sec. B. , 1977, 15, 570. 
210 
53 	R. F. Lauer and G. Zenchoff, J. Heterocyclic Chem. , 1976, 13, 
291. 
54 	D. Liberman and R. Jacquier, Bull. Soc. Chim. (Fr.), 1962, 355. 
55 	S. Linholter and R. Rosenrn, Acta Chem. Scand. , 1962, 16, 2389. 
56 	E. A. Steck and R. P. Brundage, J. Amer-Chem. Soc. , 1959, 81, 
6290 and references therein. 
57 	(a) H. G. 0. Becker and H. Boettcher, Wiss.Z. Tech. Hochsch. 
Chem.Leuna-Merseburgh, 1966, 8, 122; Chem. Abstr. , 1968, 
69, 27360; (b) H.G. 0. Becker and H. Boettcher, Tetrahedron, 
1968, 24, 2687. 
58 	H. G. 0. Becker, H. Boettcher, R. Ebisch, and G. Schmoz, 
J. Prakt. Chem., 1970, 312, 780. 
59 	H. G. 0. Becker, D. Nagel, and H. J. Timple, J. Prakt. Chem. 
1973, 315, 77. 
60 	A. N. Kost and F. Gents, J. Gen. Chem. USSR, 1958, 28, 2796. 
61 	C. BVilow, Ber. , 1909, 42, 2208. 
62 	(a) C.F.H. Allen, H. R. Beilfuss, D. M. Burness, G. A. Reynolds, 
J. F. Tinker, and J. A. VanAllen, J. Org. Chem. , 1959, 24, 779; 
(b) idem, p.787; (c) idem, p.  793; (d) idern. p.  796. 
63 	(a) S. Checchi, P. Papini, and M. Ridi, Gass. Chim. Ital, 1955, 
85, 1160; (b) S. Chechi, P. Papini, and M. Rjdi, Gass. Chim. 
Ital. , 1955, 85, 1558. 
64 	J. L. Imbach, R. Jacquier, and J. L. Vidal, Bull. Soc. Chim. (Fr. ), 
1970, 1929 and references therein. 
65 	E. C. Taylor and K. S. Hartke, J. Amer. Chem. Soc. , 1959, 81, 2452. 
66 	A. Takamizawa, Y. Hamashima, S. Sakai, and S. Nagakura, Bull. 
Chem. Soc. Jap. , 1968, 41, 2141. 
211 
67 	(a) A. Takamizawa and S. Hayashi, Japanese Patent 2346 and 
2347 (1962); Chem. Abstr. , 1963, 58, 7952c and 10213h respectively. 
68 	(a) H. Reimlinger, M. A. Pieren, and R. Merenyi, Ber. , 1970, 
103, 3252; (b) H. Rein- linger, M. A. Pieren, and R. Merenyi, 
Ber. , 1972, 105, 103. 
69 	W. Reid, and E. U. Kcher, Ann. Chem. , 1961,647, 116. 
70 	C. BU.flow and K. Haas, Ber. , 1909, 42, 4638. 
71 	H. Dorn and A. Zubek, Chem. Ber., 1968, 101, 3265. 
72 	I. Hori, K. Saito, and H. Midorikawa, Bull.Chem. Soc. Jap., 
1970, 43, 849. 
73 	P. Guerret, J. L. Imbach, R. Jacquier, and G. Maury, Bull. Soc. 
Chim.(Fr.), 1971, 1031. 
74 	L. A. Williams, J. Chem. Soc. , 1962, 2222. 
75 	E. Tenor and C. F. Kruger, Chem. Ber. , 1964, 97, 1373. 
76 	W. W. Paudler and L. S. Helmic, J. Heterocyclic Chem. , 1966, 
3, 269. 
77 	Y. Makisumi, H. Watanabe, and K. Tori, Chem. Pharm. Bull., 
1964, 12, 204. 
78 	D. R. Sutherland, G. Tennant, J. Chem. Soc. (C), 1971, 2156. 
79 	L. A. Williams, J. Chem. Soc. , 1960, 1829. 
80 	"The Chemistry of Heterocyclic Compounds, U  A Weissberger 
and E. C. Taylor, Ed. , Special Topics in Heterocyclic Compounds, 
Interscience, New York, 1977, (a) p. 188; (b) p. 196; (c) p.  199; 
(d) p.  204; (e) p.  214; (f) p.  216. 
81 	L. E. Brady and R. M. Herbst, J. Org. Chem. , 1959, 24, 922. 
82 	C. Wentrup, Tetrahedron, 1970, 26, 4969. 
212 
83 	A. W. Spassov, E. V. Glovinsky, and G. C. Russer, Z. Chem. 
1968, 8, 421. 
84 	C. Temple, W.C. Coburn, M.C. Thorpe, and J. A. Montgomery, 
J. Or Chem. , 1965, 30, 2395. 
85 	L. M. Werbel, A. Curry, E. E. Elsiager, C. A. Hess, M. P. Hutt, 
and C. Youngstrom, J. Heterocyclic Chem. , 1969, 	6, 787. 
86 	P. M. Kochergin, 	A.M. Tsyganova, and L. M. Viktorova, Khim. 
Geterosiki. Soedin. , 1967, 93. 
87 	K. T. Potts and R.M. Ruseby, J. Org. Chem., 1966, 31, 3528. 
88 	H. Singh and S. Singh, Indian J. Chem. , 1973, 11, 311. 
89 	P. M. Kochergin and M. N. Shchukina, Zh. Obshch. Khim., 1956, 
26, 458. 
90 	(a) P. M. Kochergin and A. N. Krasovskii, Khim. Geterosiki. Soedin., 
1969, 945; (b) P. M. Kochergin and A. M. Viktorova, Khim. 
Geterosikl. Soedin. , 1965, 313. 
91 	(a) H.Andersay and K. Westphal, Ber., 1937, 70, 2035; 
(b) S. Kamo and T. Noguchi, Japanese Patent, 7137836. 
92 	J. Mohan and H. K. Pujari, Indian J. Chem., 1972, 10, 274. 
93 	A. R. Todd, E. Ber gel, and 	Karimullah, Ber. , 1936, 69, 217. 
94 	R. C. Elderfield and R. N. Prasad, J. Org. Chem. , 1959, 24, 1410. 
95 	G. DeStevens and A. Halamandaris, J. Amer. Chem. Soc., 1957, 
79, 5710. 
96 	M. Fefer and L. C. King, I. Org. Chem. , 1961, 26, 828. 
97 	P. M. Kochergin, Zh. Obsch. Khim. , 1960, 30, 1529; English 
Translation, 1960, 30, 1542. 
98 	H. 3. Ringold, E. Batres, 0. Halpern, and E. Nec oechea, 3. Amer. 
Chem. Soc. , 1959, 81, 427. 
'1j 	
99 	P. de Ruggieri, C. Gandolfi, and U. Guzzi, Gazz. Chim. Ital. 
1965, 95, 455. 
100 	J. L. Beton, T. G. Halsall, E.R. H. Jones, and P. C. Phillips, 
J. Chem. Soc. , 19.57, 753. 
101 	F. L. Weisenborn, D. C. Remy, and T. L. Jacobs, J. Amer. 
Chem. Soc. , 1954, 76, 554. 
102 	P. de Ruggieri, C. Gandolfi, and D. Chiaramonti, Gazz. Chim. 
Ital. , 1963, 93, 269. 
103 	N. A. Nelson and R. Schut, J. Amer. Chem. Soc. , 1958, 80, 6630. 
104 	J. Fajkas, Chem.Listy, 1957, 51, 1885. 
105 	G. I. Fujimoto and R. W. Ledeen, J. Org. Chem. , 1964, 29, 2059. 
106 	R. E. Counsell, P. D. Klimstra, and F. B. Cotton, J. Org. Chem. 
1962, 27, 248. 
107 	E. J. Corey, J. Amer. Chem. Soc. , 1953, 75, 4832. 
108 	K. Yasuda, Chem. Pharm. Bull. (Tokyo), 1964, 12, 1217. 
109 	W. S. Johnson, D. K. Banerjee, W. P. Schneider, C. D. Gutshe, 
W. E. Schelberger, and L. J. Chinn, J. Amer. Chem. Soc. , 1952, 
74, 2832. 
110 	W. S. Johnson and W. F. Johns, J. Amer. Chem. Soc. , 1957, 79, 
2005 
111 	(a) C. Ainsworth, Org. Synthesis, 1959, 39, 27; (b) C. Ainsworth, 
Org. Synthesis, 1960, 40, 99. 
112 	W. S. Johnson and W. E. Shelberg, J. Amer. Chem. Soc. , 1945, 
67, 1745. 
113 	R. Wade, S. M. Birnbaum, M. Winitz, R. J. Koe gel, and 
J. P. Greenstein, 3. Amer.Chem. Soc. , 1957, 79, 648. 
214 
114 	(a) C. F.H. Allen and A. Bell, Org. Synthesis, 1944, 24, 12; 
(b) C. F. H. Allen and A. Bell, Org. Synthesis, 1946, 26, 11. 
115 	R. K. Robins, J. Amer. Chem. Soc. , 1956, 78, 784. 
116 	E. C. Taylor and K. S. Hartke, J. Amer. Chem. Soc. , 1959, 81, 
2452. 
117 	G. T. Morgan and J. Reilly, J. Chem. Soc. , 1916, 155. 
118 	J. S. Minha and R. M. Herbst, J. Org. Chem. , 1950, 15, 1082. 
119 	W. Marckwald, Ber. , 1892, 25, 2354. 
120 	M. V. Bhatt, B. H. Iyer, and P. C. Guha, Curr. Sci. , 1948,17, 
184. 
121 	0. Billeter and A. Steiner, Ber. , 1887, 20, 231. 
122 	T. B. Johnson and C. 0. Eden, J. Amer. Chem. Soc. , 1942, 64, 
2706. 
123 	H. E. Baumgarten and F. A. Bower, J. Amer. Chem. Soc. , 1954, 
76, 4561. 
124 	R. G. Jones and C. Ainsworth, J. Amer. Chem. Soc. , 1955, 77, 
1538. 
125 	U. Tonellato, 0. Rossetto, and A. Favo, J. Org. Chem. , 1969, 
34, 4032. 
126 	J. Kinugawe, M. Ochiai, and H. Yamamoto, Yakugaku Zasshi, 
1963, 83, 1086; Chem. Abstr. , 1964, 60, 8027b. 
127 	R. A. Rasmussen, D. D. Tunnicliff, and R. R. Brattain, J. Amer. 
Chem. Soc. , 1949, 71, 1086. 
128 	B. Eistert, E. Merkel, and W. Reiss, Chem. Ber. , 1954, 87, 
1513. 
129 	M. Jopelj, B. Stanovnik, and M. Tisler, Monatsh. Chem. , 1969, 
100, 671. 
215 
130 	J. Daunis, M. Guerret-Rigail, and R. Jacquier, Bull. Soc. 
Chim. (Fr. ), 1971, 3043. 
131 	R. J. Pugmire, J. C. Smith, D. M. Grant, B. Stanovnik, and 
M. Tisler, 	J. Heterocyclic Chem. , 	1976, 	13, 1057. 
132 	T. Novinson, T. Okabe, R. K. Robins, and P. Dea, S. Heterocyclic 
Chem. , 1975, 12, 1187 and references therein. 
133 	H. Reirnlinger and M. A. Peiren, Chem. Ber. , 1970, 103, 3266. 
134 	S. Polanc, B. Vercek, B. Sek, B. Stanovnik, and M. Tisler, 
J. Org. Chem. , 1974, 39, 2143. 
135 	J. B. Stobers, "Carbon-13 NMR Spectroscopy," Academic Press, 
New York, N. Y. , 1972, p. 239. 
136 	(a) R. J. Pugmire, M. J. Robins, D. M. Grant, and R. K. Robins, 
J. Amer. Chem. Soc., 1971, 93, 1887; (b)T. Novinson, R. K. Robins, 
and D. E. O'Brien, S. Heterocyclic Chem. , 1970, 10, 188. 
137 	(a) J. Kobe, B. Stanovnik, and M. Tisler, Tetrahedron, 1970, 
26, 3357; (b) J. Kobe, B. Stanovnik, and M. Tisler, Tetrahedron, 
1968, 24, 239. 
138 	W. W. Paudler and H. L. Blewitt, Tetrahedron, 1965, 21, 353. 
139 W. W. Paudler and J. E. Kuder, J. Org. Chem. , 1966, 31, 809. 
140 J. R. H. Sawyer and D. G. Wibberly, J.C. S. Perkin I, 1973, 1138. 
141 	Elemental analysis was not found to be satisfactory. 
142 	A. H. Becket, R. G. W. Spickett, and S. H. B. Wright, Tetrahedron, 
1968, 24, 2839. 
143 	T. Okabe, E. Taniguchi, and K. Maekawa, Agr.Biol. Chem., 
1973, 37, 441. 
144 	S. Nishigaki, M. Ichiba, K. Shinornura, and F. Yonda, J. 
Heterocyclic Chem. , 1971, 8, 759. 
216 
145 	C. Temple, Jr C. L. Kussner, and J. A. Montgomery, J. Or g. 
Chem. , 1966, 31, 2210. 
146 	(a) K. Shirakawa, Yakugaki Zasshi, 1960, 80,956; Chem. Abstr. 
1960, 54, 24762f; (b) K. Shirakawa, Yakugaki Zasshi, 1960, 
80, 1542; Chem. Abstr., 1961, 55, 10450e. 
147 	C. Temple, R. L. Mac Kee, and K. A. Montgomery, J. Or g. 
Chem. , 1965, 30, 829. 
148 C. Temple and J. A. Montgomery, J. Org. Chem. , 1965, 	30, 	826. 
149 (a) J.W. Cook and R. P. Gentles and S. H. Tucker, Rec. Tray. 
Chim. , 	1950, 69, 343; 	(b) idem. , 1950, 	69, 1201. 
150 	H. J. 	Teaber, 0. Glosaur, and U. Hochmuth, Ber., 	1964, 	57, 	557. 
151 	(a) Y. Makisumi, Chem. Pharm. Bull. , 1961, 9, 883; 
(b) Y. Makisumi, Chem. Pharm. Bull. , 1962, 10, 612. 
152 	N. S. Bhacca and D. H. Williams, "Applications of NMR 
Spectroscopy in Organic Chemistry," Holden Day Inc. 
San Francisco, 1964, p.95. 
153 	G. Shaw, J.Chem. Soc. , 1945, 1834. 
154 	S. Nishigaki, M. Ichiba, K. Shinomura, and F. Yoneda, 
J. Heterocyclic Chem. , 1971, 8, 759. 
155 	E. W. Garbisch, jun. , J. Amer. Chem. Soc. , 1963, 85, 1696. 
156 	G. S. Hammond in M. S. Newman (ed. ), "Steric Effects in 
Organic Chemistry," John Willey and Sons, New York, 1956, p.  445. 
157 	L. Bardou, J. Elguero, and R. Jacquier, Bull. Soc. Chim. (Fr. ), 
1967, 289. 
158 	C. Huynh and S. Julla, Bull. Soc. Chim. (Fr. ), 1971, 3586. 
159 	V. K. Chadha, H. S. Chaudhary, and H.K. Pujari, Indian J. Chem., 
1970, 8, 885. 
217 
160 	L. F. Johnson and W. C. Jankowski, "Carbon-l3 NMR Spectra," 
a collection of assigned, coded and indexed spectra, Wiley 
Inter science Publications, 1972. 
161 	K. T. Potts and S. Husain, J. Org. Chem. , 1971, 36, 10. 
162 	K. Saburo and N. Terushisa, Japanese Patent 7126500; 
Chem. Abstr. , 1971, 75, 140863g. 
163 	Y. Tamura, H. Hayashi, E. Saeki, J-H, Kim and M. Ikeda, 
J. Heterocyclic Chem. , 1974, 459. 
Steroidal Heterocycles: 2-Thiocyanatoandrosteno-[3,2d]pyrimidines 
and -[17,16-d]pyrimidines 
By Joginder S. Bajwa and Peter J. Sykes, Department of Chemistry, University of Edinburgh, West Mains 




THE CHEMICAL SOCIETY 
PERKIN TRANSACTIONS I 
1979 
1618 	 J.C.S. Perkir 
Steroidal Heterocycles: 2'-Thiocyanatoandrosteno-[3,2-d]pyri mid irl 
and -[1 7,1 6-d]pyrimidines 
By Joginder S. Bajwa and Peter J. Sykes, Department of Chemistry, University of Edinburgh, West M 
Road, Edinburgh EH9 3JJ 
The preparation of steroidal heterocycles containing the 2'-thiocyanatopyrimidine ring fused to the 2,3-positio 
16,1 7-position of the steroid nucleus is described. These are prepared by the reaction of 2-amino-1 .3,4-tI 
diazole with 2-hydroxymethylene-3-oxo-steroids and 1 6-hydroxymethylene-1 7-oxo-steroids. 
IT was of interest to prepare fused steroidal pyrimidines 
since other heterocyclic fused steroids have been shown 
to exhibit modified or accentuated hormonal activities.1  
Various pyrimidine bases in the steroid series have 
already been obtained by reactions involving the con-
densation of 2-hydroxymethylene-3-oxo-steroids with 
guanidine, urea, and thiourea 2  or by the treatment of 
ketones with trisformylaminomethane 3 and cyano-
guanidine.4 2-Cyano-3-oxo-steroids and their enol 
ethers have also been used as starting materials for the 
preparation of pyrimidine bases.2 This paper describes 
another convenient synthesis of some androsteno-
[3,2-d]pyrimidines and androsteno[17, 16-d]pyrimidines 
by the reaction of 2-amino-1,3,4-thiadiazole (1) with 
steroidal ç3-diketones. 
The condensation of 173-hydroxy-2-hydroxy-
methylene-5ce-androstan-3-one (2) with 2-amino-1 ,3,4-
thiadiazole (1) in refluxing toluene in the presence of a 
catalytic amount of toluene-p-sulphonic acid gave 17-
hydroxy-2'-thiocyanato-5x-androst-2-eno[3,2-d]pyrimi-
dine (4) in 60% yield. The i.r. spectrum of this corn- 
1 R. E. Counsel! and P. D. Klimstra, 'Medicinal Chemistry,' 
ed. by A. Burger, Wiley—Interscience, New York, 1970, 3rd edn., 
Part II, p.  923. 
8  P. de Ruggieri, C. Landolfi, and D. Chiaramonti, Gazzetta, 
1962, 92, 768. 
H. Bredereck, R. Gompper, and B. Geiger, Be,., 1960, 98, 
1402. 
pound exhibited a strong band at 2 160 cm' indicativ 
a thiocyanate group and also bands at 1565, 1 555i 
1 545infi, 1415, 1365, and 755 cm-1 characteristic c 
pyrimidine ring. The 111 n.m.r. spectrum showe 
singlet at 3 8.25 confirming the 6'-hydrogen of 
pyrimidine ring. 
It is apparent that the final dehydration of the mi 
condensation product (3) results in a rearrangen 
furnishing the thiocyanato-pyrimidine ring syst 
Indeed a similar rearrangement has been report 
during the reaction between 2-amino-1 ,3,4-thiadia 
and the simple 1 ,3-dicarbonyl compound, acetylacet 
resulting in the formation of 2-thiocyanato-4,6-dirnet 
pyrimidine. 
The intermediate condensation product (3) could 
be isolated and it is, therefore, possible that it might F 
an isomeric structure based upon an initial reac 
between the amino-group of (1) and the 3-carbonyl gr 
of the steroid. However fission of the N—N bond in 
dehydration step of either of the possible intennedi 
will yield the same product. 
The thiocyanate group is known to isomerise to 
isothiocyanate structure on refiuxing in acetonit 
'L. L. Smith, D. M. Teller, and T. H. Foell, J. Med 
Chem., 1963, 6, 330. 
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)enzene, and toluene.6  However, no such isomerisation 3-one (10) gave the expected 2'-thiocyanatopyrimidine 





(7) R1-C8H1 ,RH 
(1O)R. OH, R2.Mè 
dimethyl-2'-thiocyanato-18-norandrost-2, 13-dieno- 
[3,2-d]pyrimidine (12) depending upon the quantity of 
toluene-p-sulphonic acid used in the reaction. 
N —N The reaction was also successfully applied to two 
+ 	NH steroids with a 	4-double bond, namely 17(3-hydroxy-2- 
hydroxymethyleneandrost-4-en-3-one 	and 	2-hydroxy- 
(1) methylenecholest-4-en-3-one, 	but the yields 	of 	the 
products, 171-hydroxy-2'-thiocyanatoandrost-2,4-dieno- 
[3,2-d]pyrimidine 	(13) 	and 	2'-thiocyanatocholest-2,4- 
dieno[3,2-d]pyrimidine (14) were lower, being in the 
range 	35-40%. 	Analogously 	fused 	313-hydroxy-2'- 
thiocyanato-5a-androst-16-eno[17,16-d]pyrimidine 	(15), 
and 3-methoxy-2'-thiocyanato-oestra-1 ,3,5(l0) , 16-tetra- 
s eno[17,16-d]pyriniidine 	(17) 	were prepared 	from 3)3- 
N OH H 
hydroxy-16-hydroxymethylene-5a-androstan-1 7-one and 
16-hydroxy-methylene-3-methoxyoestra-1 ,3,5(1O)-trien- 
(3) 17-one 	respectively. 	Acetylation 	of the 	3-hydroxy- 
steroid (15) gave the corresponding acetyl derivative (16) 
whilst oxidation by Jones reagent furnished the 3-oxo 
derivative (18). 
The 	reaction 	of 	17f3-hydroxy-2-ethoxycarbonyl- 
(hydroxy)methylene-17x-methyl-5a-androstan-3-one 
with (1) under the same conditions furnished the expec- 
NCS' 
ted 	17)3-hydroxy-17a-methyl-6'-( 1 ,3,4-thiadiazol-2- 
H 
ylcarbamoyl)-2'-thiocyanato-5c-androst-2-eno[3,2-d]- 
(1.) R1  OH , R2a H 
pyrimidine (19). 	A further example of this reaction was 
illustrated 	by the 	conversion 	of 2-ethoxycarbonyl- 
(6) R1z R2. H (hydroxy)methylene-5x-cholestan-3-one 	into 	6'-(1,3,4- 
(8) R1 	C 8H17 , R. H thiadiazol-2-ylcarbamoyl)-2'-thiocyanato-5-cholest-2- 
(11) OH , R' Me eno[3,2-d]pyrimidine (20). 
Under the same reaction conditions 2-acetyl-17- 
hydroxy-5m-androstan-3-one failed to yield any con- 
N - SC N 
N 
I) 
(13)R1'0H, R's H 
(14) R1= C8H17 ,R2. H 
MeO 
(17) 
roup remaining intact even after prolonged heating in 
fluxing xylene. Absence of isomerisation to isothio-
yanate was confirmed in that the product failed to react 
ith a primary amine. 
In a similar manner 2'-thiocyanato-5a-androst-2-eno-
,2-d]pyrimidine (6), 2'-thiocyanato-5-cholest-2-eno-
,2-d]pyrimidine (8), and 1 1-oxo-2'-thiocyanato-5-
)irostan-2-eno[3,2-d]pyrlmidine (9) were prepared from 
e corresponding 2-hydroxymethylene-3-oxo-steroids 
), 	(7), and 2-hydroxymethylene-5a-spirostane-3, 11- 
ione respectively. 
Using the reaction conditions necessary for the con-
nsation reaction, a 2-hydroxymethylene-3-oxo-steroid 
aving a tertiary hydroxy-group at C-17, also undergoes 








R1 OH R2.' Me 
R1 C8H17 , R2 H 
densation product, probably because ketones, in this 
case the 2x-acetyl group, generally react with amines 
U. Tonellato, 0. Rossetto, and A. Fava, J. Org. Chem., 1969, 
84, 4032. 
Analysis 
'H N.m.r. (9) Found (%) Calculated (%) 
6'-H 18-CH, 	19-CH3 C 	H N C H N 
8.20 0.75 0.75 69.0 7.6 11.1 68.89 7.63 10.9 
8.30 0.70 	0.75 71.7 	8.0 11.85 71.89 7.96 11.4 
8.10 75.3 	9.45 8.55 75.10 9.46 8.7 
8.30 68.75 	7.95 8.1 69.06 7.54 8.0 
0.80 
8.30 17-gem 	1,00 72.75 7.85 10.5 72.78 7.71 10.7 
dimethyl 
8.30 	0.80 	1.00 88.75 7.25 10.8 68.25 7.13 31.0 
8.20 
	
75.25 8.9 8.5 75.42 9.08 
8.35 	0.85 	0.97 89.1 7.75 10.95 68.89 7.63 10.9 
8.35 	1.00 	 69.65 6.25 10.65 69.99 6.15 11.1 
8.50 	1.00 	1.10 68.95 7.25 10.75 69.26 7.14 11.6 
8.50 	0.90 	1.00 67.4 7.0 9.9 87.73 7.29 9.8 
8.90 	0.77 	0.87 59.7 4,2 18.2 59.51 4,41 16.0 
(5' '-H), (1.20, 
12,0 (NH) 	 17-Me) 
8.90 	 64.95 7.5 13.5 65.31 7.58 13.8 
12.00 (NH) 
1620 
much more slowly than aldehydes (the 2-formyl group) to 
yield Schif's bases.7 
EXPERIMENTAL SECTION 
M.p.s were determined on Gallenkamp apparatus and are 
uncorrected. Jr. spectra were recorded in bromoform on a 
Perkin-Elmer 157 G Spectrometer. 1H N.m.r. spectra 
were recorded in deutenated chloroform using tetramethyl-
silane as an internal standard on a Nuclear Magnetic 
Resonance Ltd EM360 (60 MHz) or a Varian HA 100 (100 
J.C.S. Perkin 
3,11-dione (3.5 g, 66%), m.p. 165-166. Jr. (CHBi 
2 930, 2 870, 1 700 (C0), 1 640, 1 585 (COC=CHOU 
1 450, 1 385, and 1 375 cm'; 1H n.m.r. 8 0.72, 0.82, 0.9 
1.00 (methyl groups), and 8.60 (s, 1 H, 2CH0) (Found: 
73.20; H, 8.91. Caic. for C28H4005 : C, 73.68; H, 8.770/c 
General Procedure for the Condensation Reaction.-
solution of steroidal 3-diketone (0.001 mol), 2-amino-1,3, 
thiadiazole (0.0015 mol), and toluene-p-sulphonic acid ( 
mg) in dry toluene (50 ml) was refluxed and stirred overnigil 
The reaction mixture was cooled and the solvent w. 
High resolution 
Yield 	M. p. 	mass spectrum 	characteristic 
Compd. 	Mol. Formula (%) (CC) Found 	calculated jr. abs (P/cm ) 
(4) 9 C,,HNOS 	60 213-215 383.202 537 383.203 123 2 160 )SCN), 
1 665,755 
M. 	cH.,Ns 	85 210-212 367.205 933 367.207 136 2 160 (SCN), 
1 565, 755 
(7) c,,H4,NS 	70 159-160 479.231 357 479.333404 	2160 (SCN), 
1565,765 





	125-127 379.208 494 379.308 209 	2 160 (SCN), 
1 565, 755 
CH,NSO 	41 	185-187 381.186 086 381.187 474 	2 160 (SCN), 
1 620,1 575, 
750 
C10H 3NS 	38 	184-186 477.316 335 477.317 754 	2 160 )SCN), 
1 620,1 565, 
770 
9 	cHN,So 	75 192-194 383.203 289 383.203 123 2 160 (SCN), 
1 580, 790 
(17)8 	C,HNSO 	72 	177-179 377.154 981 377.156 176 2180 )SCN), 
1 805,1 575, 
780 
(18) 	C,,HN,SO 	80 226-228 381.187 281 381.187 474 2160 (SCN), 
1 700 (CO), 
1675,790 
C..HN1SO. 	53 	175-177 425.214 789 425.213 686 	2 160 )SCN(, 
1 720 (CO), 
1 580, 500 
(19)8 	C,F6,,NS1O 	65 	244-246 524.204927 524.202805 	3330 (NH), 
2160 (SCN(, 
1 890 (CO), 
1 510, 745 
(90)8 	C,,H,N,S,O 	71 	311-314 608,517 398 608.317 434 	3350 (NH), 
2 160 (SCN(, 
1 690 (CO(, 
1 500,735 
(11)8 	C,H,,N,SO 	85 	172-173 397.218 722 397.218 773 	2 160 )SCN), 	8.20 	0.75 	0.90 	69.5 	7.85 10.95 89.48 7.86 10.1 
1 565, 755 (3.20 
17-Me) 
Methylene chloride was used for the elution of these compounds over silica gel. S Methylene chloride-ethanol (95 5) was used for elution of these compounds. 
MHz) spectrometer. Mass spectrometry was carried out on 
AEI MS 902 instrument. 
All the starting materials except 2-hydroxymethylerie-5a-
spirostane-3, 1 1-dione, which has not been reported so far, 
were prepared by the known literature methods. 
2-Hydroxyinethylene-5ce-spirostane-3, 1 l-dione.- Sodium 
hydride (1.5 g) was added to a solution of 5-androstane-
3,1 1-dione (5 g) in benzene (100 ml) and ethyl formate (5 ml) 
and the reaction mixture was set aside under nitrogen for 
one day. Methanol (10 ml) was added to decompose the 
excess of sodium hydride and the solution was diluted with 
water (300 ml). The layers were separated and the basic 
solution was extracted with ether to remove the neutral 
material. The aqueous layer was then acidified with 3M-
hydrochloric acid (40 ml) and the liberated enol extracted 
with ether. The ether layer was washed with water and 
saturated sodium chloride solution, dried (MgSO4), and 
evaporated to dryness. The crude product was recrystal-
lised from ethanol to give 2-hydroxyniethylene-5cz-sirostane- 
removed under reduced pressure to leave a residue whi 
was chromatographed over silica gel (50 g;  80-200 mes 
using either methylene chloride or methylene chloricl 
ethanol (95: 5). A summary of results is given in t 
Table. Compounds (4) and (6) were recrystallised fro 
benzene and acetone respectively whilst all other produc 
were recrystallised from ethanol. 
1 7ft-Hydroxy- 1 7cz-rnethyl-2'-thiocyanato-Sce-androst-2-eno-
[3, 2-d]-pyrinoidine (11) and 17,1 7-Diniethyl-2'-thiocyana 
1 8-norandrost-2 , 1 3-dieno[3, 2-d]pyriniidine (12).-The crui 
product from the condensation reaction was chromat 
graphed over silica gel. Elution with methylene chiori 
gave the rearranged steroid (12) which was recrystallis 
from ethanol whilst further elution with methylene chlorid 
ethanol (95: 5) mixture gave the expected condensati 
product (11) which was recrystallised from ethanol. 
[8/506 Received, 201h March, 197 
R. W. Hayes, Chem. Rev., 1963, 63, 489. 
